Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,rRNA Processing R-HSA-72312,-0.7405037242987507,-2.879487577796506,0.0,0.0,0.0,86/190,8.23%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;SNU13;THUMPD1;RPL35;RPL34;RPL18;RPS19;TRMT112;UTP3;NOP10;PDCD11;CSNK1E;UBA52;WDR18;RPL31;RPL36A;RPS27L;RPL10A;RPS13;DNAJC5;RPLP0;EMG1;C1D
gsea,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.74883150866879,-2.877515580506415,0.0,0.0,0.0,86/180,8.23%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;SNU13;THUMPD1;RPL35;RPL34;RPL18;RPS19;TRMT112;UTP3;NOP10;PDCD11;CSNK1E;UBA52;WDR18;RPL31;RPL36A;RPS27L;RPL10A;RPS13;DNAJC5;RPLP0;EMG1;C1D
gsea,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.757268666762228,-2.852459047621571,0.0,0.0,0.0,83/170,8.23%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;SNU13;RPL35;RPL34;RPL18;RPS19;UTP3;PDCD11;CSNK1E;UBA52;WDR18;RPL31;RPL36A;RPS27L;RPL10A;RPS13;DNAJC5;RPLP0;EMG1;C1D
gsea,SARS-CoV-2-host Interactions R-HSA-9705683,-0.6626490292382213,-2.805491728972098,0.0,0.0,0.0,51/151,7.53%,HSP90AA1;HSP90AB1;YWHAH;RPS29;YWHAB;RPS8;RPS27;RPS27A;RPS24;RPS23;RPSA;RPS2;RPS6;RPS7;RPS25;RPS28;RPS4X;RPS10;RPS16;FAU;YWHAZ;RPS21;RPS15A;RPS15;YWHAG;RPS5;RPS11;RPS3;CNBP;YWHAE;RPS9;RPS20;RPS17;RPS12;RPS14;UBE2N;SNRPD2;YWHAQ;G3BP2;AKT3;TPR;RPS19;UBE2V1;SNRPF;MAP1LC3B;RPS27L;SNRPG;TBK1;GJA1;RPS13;SEC13
gsea,Cellular Response To Starvation R-HSA-9711097,-0.830037488928872,-2.7876600430442426,0.0,0.0,0.0,91/136,8.05%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;ATP6V0C;RPL19;RPL37;RPL27A;RPS23;ATP6V1D;RPL5;RPSA;ATP6V1A;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;ATP6V1G2;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;FNIP2;RPL36AL;ATP6V1E1;RRAGA;ATP6V1F;RPL35;RPL34;ATP6V0E2;RPL18;RPS19;LAMTOR3;UBA52;RPL31;RPL36A;EIF2S2;CEBPB;ATP6V1G1;RPS27L;RPL10A;LAMTOR2;RPS13;SEC13;RPLP0;ATP6V1B2
gsea,Influenza Infection R-HSA-168255,-0.7936802415425082,-2.7825248455715617,0.0,0.0,0.0,83/143,7.70%,HSP90AA1;RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RAN;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;CANX;RPL35;RPL34;PABPN1;TPR;RPL18;RPS19;CLTA;UBA52;RPL31;RPL36A;POLR2G;RPS27L;RPL10A;RPS13;SEC13;RPLP0
gsea,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.6513052045119053,-2.761338159917923,0.0,0.0,0.0,127/287,15.88%,RPL6;SERINC1;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;CKB;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;PSMA7;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;SEM1;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;OAZ1;RPS14;RPL36AL;PSMC2;GLUL;PSMB5;RPL35;RPL34;PSMA4;RPL18;RPS19;PSMC6;PSMC5;UBA52;RPL31;RPL36A;RPS27L;PSMC3;PSMA1;RPL10A;CHGA;NDUFAB1;RPS13;AIMP1;RPLP0;PSMC1;IVD;NAT8L;PSMD2;PSME3;GOT2;PHGDH;PSMB3;PSMB1;ADO;DLAT;ALDH6A1;SEPHS2;PSMA3;PSME2;PSMD6;EEF1E1;SERINC3;ACAD8;PSMA5;QDPR;HIBADH;PSMB4;PSMD12;CARNMT1;SLC38A1;PSMA2;PSMD14;PSME4;PSMC4;PPM1K;GLS2;SRR;CHDH;PSME1;PSMD4
gsea,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.8750015541774108,-2.7558686165177657,0.0,0.0,0.0,80/105,7.70%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;PABPC1;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RBM8A;RPL36AL;RPL35;RPL34;RPL18;RPS19;UBA52;PPP2R1A;RPL31;RPL36A;RPS27L;UPF2;PPP2CA;RPL10A;RPS13;RPLP0
gsea,Translation R-HSA-72766,-0.7049828521536178,-2.754110093099431,0.0,0.0,0.0,134/253,12.09%,EEF1A1;RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;EIF4A2;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;EIF3C;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;EIF3A;RPL12;EIF4A1;RPL27;RPL23A;RPL26;RPL7A;PABPC1;RPS9;RPL36;RPL32;EEF1G;EIF3F;SRP14;RPS20;MRPL52;EIF1AX;RPL39;RPS17;RPS12;RPS14;EIF5B;EIF5;RPL36AL;AURKAIP1;EIF4H;EEF1A2;MRPL36;EEF1B2;RPL35;RPL34;RPL18;EEF2;RPS19;TRMT112;MRPL12;MRPS26;UBA52;MRPL11;MRPS21;RPL31;RPL36A;EIF2S2;SRP19;MRPS2;RPS27L;MRPL57;SSR3;EIF3K;DDOST;SSR1;MRPS14;RPL10A;MRPS5;EIF3I;SRP72;MRPL20;RPS13;AIMP1;CHCHD1;RPLP0;MRPS34;EIF3M;MRPS33;SPCS2;OXA1L;MRPS36;SEC61G;MRPL19;MRPL18;MRPL35;MRPS24;EIF3D;SPCS3;MRPL41;SPCS1;EEF1E1;MRPL9;SSR4;MRPS16;MRPL14
gsea,Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.8124951249489296,-2.7376916736743815,0.0,0.0,0.0,79/126,7.70%,HSP90AA1;RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;TPR;RPL18;RPS19;UBA52;RPL31;RPL36A;POLR2G;RPS27L;RPL10A;RPS13;SEC13;RPLP0
gsea,mRNA Splicing R-HSA-72172,-0.5964187606001431,-2.720532657907155,0.0,0.0,0.0,111/188,24.89%,DDX5;HNRNPA2B1;HSPA8;HNRNPA3;WBP11;HNRNPK;SF3B2;U2SURP;SNRNP27;PCBP1;HNRNPA0;SRRM2;RBM8A;CDC40;SRSF1;SNU13;SNRPD2;HNRNPH1;PABPN1;WBP4;HNRNPA1;SNRNP70;HNRNPU;HNRNPD;SRSF3;HNRNPUL1;SNRPC;CWC15;SNRPF;PCBP2;POLR2G;HNRNPC;SNW1;SF3B4;SART1;SRSF5;RBM22;FUS;CPSF6;LSM8;SNRPG;HNRNPF;PQBP1;CPSF2;ZRSR2;SNRNP200;BUD31;LSM2;RBM42;SF3B1;POLR2C;POLR2L;RBM17;SNRPE;DHX15;HNRNPH2;DDX42;PRPF19;ELAVL1;LSM5;CCAR1;PDCD7;SRSF2;HNRNPM;LSM4;HNRNPL;SNRPB;U2AF1L4;PCF11;POLR2I;TRA2B;MAGOHB;BCAS2;DNAJC8;LSM3;SMNDC1;ZMAT5;SRSF10;SF3A2;CD2BP2;CSTF2T;ALYREF;POLR2F;POLR2E;PUF60;PRPF4;PPIL4;SF3A1;SF3B5;PRPF8;U2AF2;FIP1L1;PHF5A;GTF2F1;SRSF7;SF3B3;SYF2;SRSF11;PRPF38A;CDC5L;SF3B6;TFIP11;NCBP2;ZCRB1;LSM7;PPWD1;CWC25;SRSF6;GTF2F2;CPSF1;DDX46
gsea,Cap-dependent Translation Initiation R-HSA-72737,-0.8863900890562888,-2.7160711520637353,0.0,0.0,0.0,89/106,7.93%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;EIF4A2;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;EIF3C;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;EIF3A;RPL12;EIF4A1;RPL27;RPL23A;RPL26;RPL7A;PABPC1;RPS9;RPL36;RPL32;EIF3F;RPS20;EIF1AX;RPL39;RPS17;RPS12;RPS14;EIF5B;EIF5;RPL36AL;EIF4H;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;EIF2S2;RPS27L;EIF3K;RPL10A;EIF3I;RPS13;RPLP0;EIF3M
gsea,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.6630036892977313,-2.7126051693416646,0.0,0.0,0.0,52/95,18.01%,CALM1;PPP3CA;UBB;PPP3R1;PPIA;RPS27A;ORAI2;PSMA7;PPP3CB;RASGRP1;FKBP1A;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;SH3KBP1;PSMC3;PSMA1;AHCYL1;UBC;PSMC1;PSMD2;PSME3;ITPR1;PSMB3;PSMB1;PIK3R1;PRKCB;PSMA3;PSME2;PSMD6;NCK1;PSMA5;PSMB4;PSMD12;CLSTN1;PSMA2;HRAS;PSMD14;NFKBIA;PSME4;PSMC4;PSME1;PSMD4;STIM1;PSMB7;BCL10;FBXW11
gsea,mRNA Splicing - Major Pathway R-HSA-72163,-0.5995019479680715,-2.7069121067837214,0.0,0.0,0.0,107/180,24.89%,DDX5;HNRNPA2B1;HSPA8;HNRNPA3;WBP11;HNRNPK;SF3B2;U2SURP;SNRNP27;PCBP1;HNRNPA0;SRRM2;RBM8A;CDC40;SRSF1;SNU13;SNRPD2;HNRNPH1;PABPN1;WBP4;HNRNPA1;SNRNP70;HNRNPU;HNRNPD;SRSF3;HNRNPUL1;SNRPC;CWC15;SNRPF;PCBP2;POLR2G;HNRNPC;SNW1;SF3B4;SART1;SRSF5;RBM22;FUS;CPSF6;LSM8;SNRPG;HNRNPF;PQBP1;CPSF2;SNRNP200;BUD31;LSM2;RBM42;SF3B1;POLR2C;POLR2L;RBM17;SNRPE;DHX15;HNRNPH2;DDX42;PRPF19;ELAVL1;LSM5;CCAR1;SRSF2;HNRNPM;LSM4;HNRNPL;SNRPB;U2AF1L4;PCF11;POLR2I;TRA2B;MAGOHB;BCAS2;DNAJC8;LSM3;SMNDC1;SRSF10;SF3A2;CD2BP2;CSTF2T;ALYREF;POLR2F;POLR2E;PUF60;PRPF4;PPIL4;SF3A1;SF3B5;PRPF8;U2AF2;FIP1L1;PHF5A;GTF2F1;SRSF7;SF3B3;SYF2;SRSF11;PRPF38A;CDC5L;SF3B6;TFIP11;NCBP2;LSM7;PPWD1;CWC25;SRSF6;GTF2F2;CPSF1;DDX46
gsea,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.5681842895578584,-2.703254248008698,0.0,0.0,0.0,132/235,25.78%,DDX5;HNRNPA2B1;HSPA8;HNRNPA3;WBP11;HNRNPK;SF3B2;U2SURP;SNRNP27;PCBP1;HNRNPA0;SRRM2;RBM8A;CDC40;SRSF1;SNU13;SNRPD2;HNRNPH1;PABPN1;WBP4;TPR;HNRNPA1;SNRNP70;HNRNPU;HNRNPD;SRSF3;HNRNPUL1;SNRPC;CWC15;SNRPF;PCBP2;POLR2G;HNRNPC;SNW1;SF3B4;SART1;SRSF5;RBM22;FUS;CPSF6;LSM8;SNRPG;HNRNPF;SEC13;PQBP1;CPSF2;ZRSR2;SNRNP200;BUD31;LSM2;RBM42;SF3B1;NUP88;POLR2C;POLR2L;RBM17;SNRPE;FYTTD1;DHX15;HNRNPH2;DDX42;SLBP;PRPF19;ELAVL1;LSM5;CCAR1;CHTOP;PDCD7;SRSF2;NUP50;HNRNPM;LSM4;HNRNPL;THOC7;SNRPB;U2AF1L4;PCF11;POLR2I;TRA2B;THOC2;MAGOHB;BCAS2;DNAJC8;LSM3;SMNDC1;ZMAT5;SRSF10;SF3A2;CD2BP2;SEH1L;CSTF2T;ALYREF;POLR2F;POLR2E;PUF60;PRPF4;PPIL4;SF3A1;SF3B5;PRPF8;U2AF2;FIP1L1;PHF5A;GTF2F1;SARNP;SRSF7;SF3B3;NUP205;SYF2;SRSF11;PRPF38A;CDC5L;SF3B6;TFIP11;NCBP2;THOC1;METTL14;ZCRB1;DDX39B;NUP62;LSM7;PPWD1;CWC25;SRSF6;NXF1;GTF2F2;CPSF1;DDX46;NUP107;LSM6;GLE1;CHERP
gsea,Signaling By ROBO Receptors R-HSA-376176,-0.7170224722203613,-2.7030314387012475,0.0,0.0,0.0,107/189,9.88%,RPL6;UBB;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;PFN2;RPL18A;RPL13A;RPS5;PSMA7;RPL29;RPS11;RPL7;RPS3;PPP3CB;RPL35A;RPL12;NELL2;RPL27;RPL23A;RPL26;RPL7A;SEM1;PABPC1;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RBM8A;ELOB;RPL36AL;PFN1;PSMC2;ROBO3;PSMB5;RPL35;RPL34;PSMA4;RPL18;RPS19;PSMC6;PSMC5;UBA52;RPL31;RPL36A;RPS27L;UPF2;PSMC3;PSMA1;CAP1;RPL10A;CDC42;ENAH;UBC;RPS13;RPLP0;PSMC1;PSMD2;PSME3;ELOC;PSMB3;PRKACB;PSMB1;RBX1;PKN2
gsea,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.8952140143757049,-2.6927753615153986,0.0,0.0,0.0,88/100,7.93%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;EIF4A2;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;EIF3C;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;EIF3A;RPL12;EIF4A1;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;EIF3F;RPS20;EIF1AX;RPL39;RPS17;RPS12;RPS14;EIF5B;EIF5;RPL36AL;EIF4H;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;EIF2S2;RPS27L;EIF3K;RPL10A;EIF3I;RPS13;RPLP0;EIF3M
gsea,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.8949173999852542,-2.6742041591569436,0.0,0.0,0.0,87/99,7.93%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;EIF4A2;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;EIF3C;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;EIF3A;RPL12;EIF4A1;RPL27;RPL23A;RPL26;RPL7A;PABPC1;RPS9;RPL36;RPL32;EIF3F;RPS20;EIF1AX;RPL39;RPS17;RPS12;RPS14;RPL36AL;EIF4H;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;EIF2S2;RPS27L;EIF3K;RPL10A;EIF3I;RPS13;RPLP0;EIF3M
gsea,Axon Guidance R-HSA-422475,-0.5513496726384426,-2.669336186130615,0.0,0.0,0.0,160/457,12.17%,HSP90AA1;HSP90AB1;RPL6;UBB;RPS29;EPHA7;RPL3;PRNP;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;HSPA8;RPS7;RPL22L1;RPL23;ACTG1;RPS25;RPL21;MYL6;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;ARPC2;RPL30;RPS15A;RPL41;RPS15;CDK5R1;PFN2;RPL18A;RPL13A;RPS5;MAPK1;PSMA7;RPL29;RPS11;RPL7;RPS3;PPP3CB;RPL35A;RPL12;ACTR2;AP2M1;NELL2;RPL27;RPL23A;RPL26;RPL7A;SEM1;ARPC5;PABPC1;EPHA5;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;SDCBP;RPS12;RPS14;RHOB;RBM8A;ELOB;RPL36AL;PFN1;PSMC2;ROBO3;PSMB5;RPL35;RPL34;PSMA4;RPL18;RPS19;WASL;PSMC6;SEMA5A;ARPC1A;APH1A;CLTA;ACTR3;DPYSL2;MYL12B;PSMC5;UBA52;ITGA2;MAPK3;RPL31;GSK3B;RPL36A;RPS27L;UPF2;SH3KBP1;TRPC4;PSMC3;ARPC3;PSMA1;SCN3B;SCN1B;AP2S1;CAP1;EFNB3;PSENEN;RPL10A;CDC42;SCN2B;ENAH;UBC;RPS13;ROCK2;RPLP0;PSMC1;PSMD2;RDX;PSME3;ELOC;CSNK2B;PSMB3;PRKACB;PSMB1;SCN3A;RBX1;PKN2;KCNQ3;PIK3R1;FGFR1;ARHGEF12;CACNA1H;PSMA3;PSME2;PSMD6;NCK1;CHL1;MYH10;EFNA3;PSMA5
gsea,Selenoamino Acid Metabolism R-HSA-2408522,-0.8803254828018027,-2.66917653566825,0.0,0.0,0.0,76/95,7.70%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;RPS27L;RPL10A;RPS13;AIMP1;RPLP0
gsea,SARS-CoV Infections R-HSA-9679506,-0.5602597034922948,-2.6518407940080824,0.0,0.0,0.0,107/298,15.16%,ATP1B1;HSP90AA1;DDX5;HSP90AB1;UBB;YWHAH;RPS29;YWHAB;RPS8;RPS27;RPS27A;RPS24;RPS23;RPSA;RPS2;RPS6;RPS7;RPS25;RPS28;RPS4X;RPS10;RPS16;FAU;YWHAZ;RPS21;RPS15A;RPS15;YWHAG;RPS5;RPS11;RPS3;AP2M1;CNBP;FKBP1A;YWHAE;RPS9;RPS20;ATP1A2;RPS17;RPS12;RPS14;CHD3;UBE2N;SNRPD2;YWHAQ;G3BP2;CANX;ATP1B2;AKT3;TPR;RPS19;UBE2V1;RBBP7;ATP1A3;UBA52;SAP18;CHMP2A;GSK3B;SNRPF;MAP1LC3B;PTGES3;RPS27L;SH3KBP1;CHMP4B;DDOST;AP2S1;SUMO1;VCP;SNRPG;TBK1;GJA1;S1PR1;HDAC2;UBC;RPS13;IFNGR2;SEC13;ROCK2;PARP4;CSNK1A1;IRAK1;ZDHHC8;IL1R1;PRMT1;RBX1;CTSL;ISCU;NUP88;G3BP1;DDX20;SNRPE;NCK1;DAD1;SEC24A;PARP8;UBE2I;KEAP1;CHMP7;STT3A;GOLGA7;NUP50;GALNT1;ZDHHC3;SAR1B;CRBN;SNRPB;RPN2
gsea,Nervous System Development R-HSA-9675108,-0.5430067025626815,-2.6514098335587795,0.0,0.0,0.0,162/478,12.17%,HSP90AA1;HSP90AB1;RPL6;UBB;RPS29;EPHA7;RPL3;PRNP;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;HSPA8;RPS7;RPL22L1;RPL23;ACTG1;RPS25;RPL21;MYL6;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;ARPC2;RPL30;RPS15A;RPL41;RPS15;CDK5R1;PFN2;RPL18A;RPL13A;RPS5;MAPK1;PSMA7;RPL29;RPS11;RPL7;RPS3;PPP3CB;RPL35A;RPL12;ACTR2;AP2M1;NELL2;RPL27;RPL23A;RPL26;RPL7A;SEM1;ARPC5;PABPC1;EPHA5;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;SDCBP;RPS12;RPS14;RHOB;RBM8A;ELOB;RPL36AL;PFN1;PSMC2;ROBO3;PSMB5;RPL35;RPL34;PSMA4;RPL18;RPS19;WASL;PSMC6;SEMA5A;ARPC1A;APH1A;CLTA;ACTR3;DPYSL2;MYL12B;PSMC5;UBA52;ITGA2;MAPK3;RPL31;GSK3B;RPL36A;RPS27L;UPF2;SH3KBP1;TRPC4;PSMC3;ARPC3;PSMA1;SCN3B;SCN1B;AP2S1;CAP1;EFNB3;PSENEN;RPL10A;CDC42;SCN2B;ENAH;HDAC2;UBC;RPS13;ROCK2;RPLP0;PSMC1;PSMD2;RDX;PSME3;ELOC;CSNK2B;PSMB3;PRKACB;PSMB1;SCN3A;RBX1;PKN2;KCNQ3;PIK3R1;FGFR1;ARHGEF12;CACNA1H;PSMA3;PSME2;PSMD6;HMGCR;NCK1;CHL1;MYH10;EFNA3;PSMA5
gsea,Cellular Response To Chemical Stress R-HSA-9711123,-0.6009922813268737,-2.6475763750138865,0.0,0.0,0.0,85/155,24.06%,UBB;RPS27A;COX6C;COX8A;COX7C;COX5A;PSMA7;SQSTM1;COX7A2L;COX5B;SEM1;PRDX5;COX6A1;PSMC2;COX7B;COX6B1;CYCS;COX4I1;PSMB5;SKP1;PSMA4;AKT3;SOD1;PSMC6;GSTP1;PSMC5;UBA52;GSK3B;NCOR1;MAP1LC3B;PSMC3;PSMA1;VCP;PRDX1;UBC;SRXN1;PSMC1;COX20;PSMD2;PSME3;STAT3;PHGDH;P4HB;CSNK2B;COX14;PSMB3;PSMB1;RBX1;SURF1;SESN1;GCLM;PSMA3;PSME2;PSMD6;PSMA5;PRDX2;PSMB4;PSMD12;KEAP1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;CHD9;PSMB7;NCF2;AKT1;SCO1;TALDO1;MUL1;TXNRD1;NCOA1;SCO2;COX19;PSMD10;PSMB6;ATF4;HMOX2;PSMD7;CREBBP;ATP7A;PRDX3;TXN2
gsea,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.7813072861968198,-2.6446147447827055,0.0,0.0,0.0,17/32,6.84%,ACTG1;ARPC2;MAPK1;ACTR2;WIPF3;ARPC5;WASF1;ABI1;WASL;ARPC1A;ACTR3;MAPK3;BRK1;NCKAP1;CYFIP2;ARPC3;CDC42
gsea,Selective Autophagy R-HSA-9663891,-0.6919957434607423,-2.642948836374782,0.0,0.0,0.0,25/56,9.93%,HSP90AA1;UBB;RPS27A;HSPA8;DYNLL1;DYNLL2;SQSTM1;TOMM20;VDAC1;PINK1;UBE2N;TOMM7;TOMM6;UBE2V1;UBA52;TOMM22;MAP1LC3B;TOMM5;VCP;UBC;PARK7;ATG12;CSNK2B;MAP1LC3A;MTERF3
gsea,SARS-CoV-2 Infection R-HSA-9694516,-0.5786865853732653,-2.6423366428185147,0.0,0.0,0.0,86/227,15.16%,HSP90AA1;DDX5;HSP90AB1;UBB;YWHAH;RPS29;YWHAB;RPS8;RPS27;RPS27A;RPS24;RPS23;RPSA;RPS2;RPS6;RPS7;RPS25;RPS28;RPS4X;RPS10;RPS16;FAU;YWHAZ;RPS21;RPS15A;RPS15;YWHAG;RPS5;RPS11;RPS3;CNBP;YWHAE;RPS9;RPS20;RPS17;RPS12;RPS14;UBE2N;SNRPD2;YWHAQ;G3BP2;CANX;AKT3;TPR;RPS19;UBE2V1;UBA52;CHMP2A;GSK3B;SNRPF;MAP1LC3B;RPS27L;CHMP4B;DDOST;SUMO1;VCP;SNRPG;TBK1;GJA1;UBC;RPS13;SEC13;PARP4;CSNK1A1;IRAK1;ZDHHC8;PRMT1;CTSL;ISCU;NUP88;G3BP1;DDX20;SNRPE;DAD1;SEC24A;PARP8;UBE2I;CHMP7;STT3A;GOLGA7;NUP50;GALNT1;ZDHHC3;SAR1B;SNRPB;RPN2
gsea,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.6926081891598934,-2.6271554294894672,0.0,0.0,0.0,44/72,18.01%,CALM1;PPP3CA;UBB;PPP3R1;PPIA;RPS27A;PSMA7;PPP3CB;RASGRP1;FKBP1A;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PRKCB;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;HRAS;PSMD14;NFKBIA;PSME4;PSMC4;PSME1;PSMD4;PSMB7;BCL10;FBXW11
gsea,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.7232314938724446,-2.626048910032973,0.0,0.0,0.0,66/94,20.90%,COX6C;COX8A;NDUFA1;UQCRB;COX7C;ATP5PB;COX5A;NDUFS5;COX7A2L;UQCRQ;COX5B;NDUFA3;NDUFA2;COX6A1;UQCR11;NDUFA13;COX7B;COX6B1;CYCS;COX4I1;NDUFB3;NDUFB1;NDUFB8;NDUFB10;UQCRH;UQCRC2;NDUFC1;NDUFS7;NDUFA5;NDUFAF3;NDUFS2;UQCR10;NDUFB11;NDUFB9;NDUFB6;SDHA;NDUFAB1;SDHD;NDUFV1;COX20;NDUFA7;UQCRFS1;UQCRC1;NDUFC2;COX14;NDUFB2;SURF1;NDUFA8;NDUFS6;NDUFS8;NDUFA10;NDUFA9;NDUFAF4;NDUFAF7;NDUFV2;NDUFAF2;NDUFB7;CCNI;NDUFB5;NDUFS1;SCO1;NDUFA11;SCO2;NDUFS4;COX19;NDUFA12
gsea,Interleukin-1 Signaling R-HSA-9020702,-0.6269181944660646,-2.622663313826096,0.0,0.0,0.0,53/97,22.17%,UBB;RPS27A;HMGB1;PSMA7;SQSTM1;SEM1;UBE2N;PSMC2;PSMB5;SKP1;PSMA4;USP14;PSMC6;UBE2V1;PSMC5;UBA52;PELI2;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;IRAK1;IL1RAP;IL1R1;PSMB3;PSMB1;NKIRAS1;RBX1;NFKB2;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;PSME1;PSMD4;PSMB7;FBXW11;TANK;TAB2;PSMD10;PSMB6;MAP2K1;PSMD7;S100B
gsea,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.7558010207913797,-2.6211939506878155,0.0,0.0,0.0,98/152,9.78%,RPL6;UBB;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;PSMA7;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;SEM1;PABPC1;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RBM8A;ELOB;RPL36AL;PSMC2;ROBO3;PSMB5;RPL35;RPL34;PSMA4;RPL18;RPS19;PSMC6;PSMC5;UBA52;RPL31;RPL36A;RPS27L;UPF2;PSMC3;PSMA1;RPL10A;UBC;RPS13;RPLP0;PSMC1;PSMD2;PSME3;ELOC;PSMB3;PSMB1;RBX1
gsea,Translation Initiation Complex Formation R-HSA-72649,-0.8668544171022826,-2.6199610657100716,0.0,0.0,0.0,42/52,7.93%,RPS29;RPS8;RPS27;RPS27A;RPS24;RPS23;RPSA;RPS2;RPS6;RPS7;EIF4A2;RPS25;RPS28;RPS4X;RPS10;RPS16;FAU;RPS21;RPS15A;EIF3C;RPS15;RPS5;RPS11;RPS3;EIF3A;EIF4A1;PABPC1;RPS9;EIF3F;RPS20;EIF1AX;RPS17;RPS12;RPS14;EIF4H;RPS19;EIF2S2;RPS27L;EIF3K;EIF3I;RPS13;EIF3M
gsea,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.8668544171022826,-2.6199610657100716,0.0,0.0,0.0,42/52,7.93%,RPS29;RPS8;RPS27;RPS27A;RPS24;RPS23;RPSA;RPS2;RPS6;RPS7;EIF4A2;RPS25;RPS28;RPS4X;RPS10;RPS16;FAU;RPS21;RPS15A;EIF3C;RPS15;RPS5;RPS11;RPS3;EIF3A;EIF4A1;PABPC1;RPS9;EIF3F;RPS20;EIF1AX;RPS17;RPS12;RPS14;EIF4H;RPS19;EIF2S2;RPS27L;EIF3K;EIF3I;RPS13;EIF3M
gsea,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.8667135416924707,-2.6118921284369443,0.0,0.0,0.0,42/52,7.93%,RPS29;RPS8;RPS27;RPS27A;RPS24;RPS23;RPSA;RPS2;RPS6;RPS7;EIF4A2;RPS25;RPS28;RPS4X;RPS10;RPS16;FAU;RPS21;RPS15A;EIF3C;RPS15;RPS5;RPS11;RPS3;EIF3A;EIF4A1;RPS9;EIF3F;RPS20;EIF1AX;RPS17;RPS12;RPS14;EIF5;EIF4H;RPS19;EIF2S2;RPS27L;EIF3K;EIF3I;RPS13;EIF3M
gsea,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.9023849123298013,-2.6094421081432317,0.0,0.0,0.0,77/87,7.70%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;EIF2S2;CEBPB;RPS27L;RPL10A;RPS13;RPLP0
gsea,G2/M Checkpoints R-HSA-69481,-0.5992667240380131,-2.606589495231619,0.0,0.0,0.0,47/115,15.88%,UBB;YWHAH;YWHAB;RPS27A;YWHAZ;YWHAG;PSMA7;YWHAE;SEM1;UBE2N;PSMC2;YWHAQ;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;ORC4;UBE2V2;RNF168;UBC;PSMC1;PSMD2;PSME3;UIMC1;PSMB3;PSMB1;H2BC4;H2AX;PSMA3;PSME2;PSMD6;PSMA5;MCM6;PSMB4;PSMD12;ATRIP;MCM3;RFC3;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.9075009647156294,-2.602733438388126,0.0,0.0,0.0,76/85,7.70%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;PABPC1;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;RPS27L;RPL10A;RPS13;RPLP0
gsea,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.6709058025890202,-2.600101770128277,0.0,0.0,0.0,38/69,15.88%,UBB;RPS27A;PSMA7;H2AZ1;SEM1;LMO1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;H2AJ;UBA52;PSMC3;PSMA1;CCNH;TCF12;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;H2BC4;H2AX;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;CBFB;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.9009444045399905,-2.5986506538555023,0.0,0.0,0.0,82/90,7.93%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;EIF3C;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;EIF3A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;EIF3F;RPS20;EIF1AX;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;RPS27L;EIF3K;RPL10A;EIF3I;RPS13;RPLP0;EIF3M
gsea,Respiratory Electron Transport R-HSA-611105,-0.7271779054568255,-2.59787551124918,0.0,0.0,0.0,65/89,20.90%,COX6C;COX8A;NDUFA1;UQCRB;COX7C;COX5A;NDUFS5;COX7A2L;UQCRQ;COX5B;NDUFA3;NDUFA2;COX6A1;UQCR11;NDUFA13;COX7B;COX6B1;CYCS;COX4I1;NDUFB3;NDUFB1;NDUFB8;NDUFB10;UQCRH;UQCRC2;NDUFC1;NDUFS7;NDUFA5;NDUFAF3;NDUFS2;UQCR10;NDUFB11;NDUFB9;NDUFB6;SDHA;NDUFAB1;SDHD;NDUFV1;COX20;NDUFA7;UQCRFS1;UQCRC1;NDUFC2;COX14;NDUFB2;SURF1;NDUFA8;NDUFS6;NDUFS8;NDUFA10;NDUFA9;NDUFAF4;NDUFAF7;NDUFV2;NDUFAF2;NDUFB7;CCNI;NDUFB5;NDUFS1;SCO1;NDUFA11;SCO2;NDUFS4;COX19;NDUFA12
gsea,Eukaryotic Translation Termination R-HSA-72764,-0.912058883670303,-2.584434667909632,0.0,0.0,0.0,76/83,7.70%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;RPL18;RPS19;TRMT112;UBA52;RPL31;RPL36A;RPS27L;RPL10A;RPS13;RPLP0
gsea,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.8593388550098899,-2.582145349168012,0.0,0.0,0.0,82/99,8.28%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;SRP14;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;SRP19;RPS27L;SSR3;DDOST;SSR1;RPL10A;SRP72;RPS13;RPLP0;SPCS2
gsea,Cellular Response To Heat Stress R-HSA-3371556,-0.6100153059696879,-2.56995409382973,0.0,0.0,0.0,33/86,14.87%,HSP90AA1;EEF1A1;HSP90AB1;UBB;CAMK2B;HSPA8;HSBP1;MAPK1;YWHAE;BAG4;HSPA9;HSPH1;DNAJB6;TPR;MAPK3;GSK3B;ST13;PTGES3;HIKESHI;CAMK2A;VCP;BAG1;HSPA2;HSPA4;SEC13;BAG5;MRPL18;NUP88;CRYAB;AKT1S1;NUP50;HSPA5;HSPA4L
gsea,Orc1 Removal From Chromatin R-HSA-68949,-0.6742444120095453,-2.5690778911076366,0.0,0.0,0.0,35/60,15.88%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;ORC4;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;MCM6;PSMB4;PSMD12;MCM3;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,Viral mRNA Translation R-HSA-192823,-0.9042614407584793,-2.566717189966535,0.0,0.0,0.0,75/83,7.70%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;RPS27L;RPL10A;RPS13;RPLP0
gsea,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.6572525083130298,-2.566191204009954,0.0,0.0,0.0,81/139,20.90%,COX6C;COX8A;NDUFA1;UQCRB;COX7C;ATP5PB;COX5A;NDUFS5;COX7A2L;UQCRQ;BSG;COX5B;NDUFA3;MDH2;NDUFA2;COX6A1;VDAC1;UQCR11;IDH3B;NDUFA13;COX7B;COX6B1;CYCS;COX4I1;NDUFB3;NDUFB1;NDUFB8;NDUFB10;UQCRH;GLO1;UQCRC2;NDUFC1;LDHB;NDUFS7;NDUFA5;FAHD1;NDUFAF3;NDUFS2;LDHA;UQCR10;NDUFB11;NDUFB9;NDUFB6;SDHA;NDUFAB1;IDH3A;SDHD;NDUFV1;COX20;NDUFA7;HAGH;UQCRFS1;UQCRC1;NDUFC2;COX14;IDH2;NDUFB2;DLAT;SURF1;NDUFA8;NDUFS6;NDUFS8;SUCLG1;NDUFA10;NDUFA9;NDUFAF4;NDUFAF7;NDUFV2;NDUFAF2;NDUFB7;CCNI;NDUFB5;NDUFS1;SCO1;MPC2;NDUFA11;IDH3G;SCO2;NDUFS4;COX19;NDUFA12
gsea,C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.6072119329398898,-2.5654812882584026,0.0,0.0,0.0,50/103,18.01%,CALM1;PPP3CA;UBB;PPP3R1;RPS27A;PSMA7;PPP3CB;SEM1;UBE2N;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;UBE2V1;PSMC5;UBA52;PSMC3;PSMA1;AHCYL1;UBC;PSMC1;PSMD2;PSME3;ITPR1;PSMB3;PRKACB;PSMB1;PKN2;NFKB2;UBA3;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;HRAS;PSMD14;NFKBIA;PSME4;PSMC4;CDC34;PSME1;PSMD4;UBE2D1;PSMB7;BCL10;FBXW11
gsea,Eukaryotic Translation Elongation R-HSA-156842,-0.9229030913290515,-2.564685855463095,0.0,0.0,0.0,80/83,7.70%,EEF1A1;RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;EEF1G;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;EEF1A2;EEF1B2;RPL35;RPL34;RPL18;EEF2;RPS19;UBA52;RPL31;RPL36A;RPS27L;RPL10A;RPS13;RPLP0
gsea,Interleukin-1 Family Signaling R-HSA-446652,-0.582663941115602,-2.5633839315555758,0.0,0.0,0.0,58/117,22.17%,UBB;RPS27A;HMGB1;PSMA7;SQSTM1;IL1RAPL1;SEM1;UBE2N;PSMC2;PSMB5;SKP1;PSMA4;USP14;PSMC6;UBE2V1;PSMC5;UBA52;PELI2;PSMC3;PSMA1;TBK1;UBC;PSMC1;PSMD2;PSME3;STAT3;IRAK1;IL1RAP;IL1R1;PSMB3;PSMB1;NKIRAS1;RBX1;NFKB2;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;PSME1;PSMD4;IL18;PSMB7;FBXW11;TANK;PTPN11;TAB2;PSMD10;PSMB6;MAP2K1;PSMD7;S100B
gsea,Selenocysteine Synthesis R-HSA-2408557,-0.9107747998672755,-2.5633076918145865,0.0,0.0,0.0,75/82,7.70%,RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;RPL18;RPS19;UBA52;RPL31;RPL36A;RPS27L;RPL10A;RPS13;RPLP0
gsea,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.6996210487266787,-2.56105015006169,0.0,0.0,0.0,35/53,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PRKACB;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;NUMB;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,Chaperonin-mediated Protein Folding R-HSA-390466,-0.6175483896385511,-2.557928772532617,0.0,0.0,0.0,35/75,15.78%,TUBA4A;TUBA1A;GNB2;TUBB2A;CCT6A;GNG2;PFDN2;TUBB4A;PFDN6;CCT2;TUBB2B;PFDN5;FBXW2;STAT3;FBXW7;TUBB4B;CSNK2B;TCP1;TUBA1B;GNG10;CCT8;VBP1;AP3M1;FBXO6;DCAF7;GNG3;GNB1;CCT5;GNG13;FBXL3;TUBB3;GNG11;PFDN1;GNG7;NOP56
gsea,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.7006341688348505,-2.555755187173514,0.0,0.0,0.0,35/54,15.88%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;GSK3B;PSMC3;PSMA1;UBC;PSMC1;PSMD2;CSNK1A1;PSME3;PSMB3;PRKACB;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,Peptide Chain Elongation R-HSA-156902,-0.9237490575533708,-2.555745730405118,0.0,0.0,0.0,77/79,7.70%,EEF1A1;RPL6;RPS29;RPL3;RPS8;RPS27;RPL38;RPLP1;RPL37A;RPS27A;RPS24;RPL19;RPL37;RPL27A;RPS23;RPL5;RPSA;RPS2;RPLP2;RPS6;RPL4;RPS7;RPL22L1;RPL23;RPS25;RPL21;RPS28;RPL22;RPS4X;RPL11;RPL14;RPL28;RPS10;RPS16;RPL15;RPL9;FAU;RPS21;RPL8;RPL30;RPS15A;RPL41;RPS15;RPL18A;RPL13A;RPS5;RPL29;RPS11;RPL7;RPS3;RPL35A;RPL12;RPL27;RPL23A;RPL26;RPL7A;RPS9;RPL36;RPL32;RPS20;RPL39;RPS17;RPS12;RPS14;RPL36AL;RPL35;RPL34;RPL18;EEF2;RPS19;UBA52;RPL31;RPL36A;RPS27L;RPL10A;RPS13;RPLP0
gsea,RHO GTPase Effectors R-HSA-195258,-0.5362806675204137,-2.5554717983322917,0.0,0.0,0.0,58/210,12.46%,CALM1;PDZD2;YWHAH;YWHAB;RPS27;ACTG1;DYNLL1;MYL6;DYNLL2;YWHAZ;ARPC2;PFN2;YWHAG;MAPK1;H2AZ1;ACTR2;WIPF3;YWHAE;ARPC5;WASF1;RHOB;PAFAH1B1;DIAPH2;PFN1;ABI1;YWHAQ;CDKN1B;WASL;ARPC1A;ZWINT;ACTR3;MYL12B;H2AJ;PPP2R1A;KTN1;MAPK3;BRK1;NCKAP1;PPP1CB;CYFIP2;ARPC3;PPP2CA;CDC42;KIF5B;SEC13;ROCK2;IQGAP2;PPP2R5D;LIN7B;KDM4C;PKN2;NUDC;H2BC4;H2AX;PRKCB;NCK1;MYH10;BAIAP2
gsea,CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.6363387776758606,-2.5520943148122197,0.0,0.0,0.0,47/88,18.01%,CALM1;PPP3CA;UBB;PPP3R1;RPS27A;PSMA7;PPP3CB;SEM1;UBE2N;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;UBE2V1;PSMC5;UBA52;PSMC3;PSMA1;AHCYL1;UBC;PSMC1;PSMD2;PSME3;ITPR1;PSMB3;PSMB1;NFKB2;UBA3;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;CDC34;PSME1;PSMD4;UBE2D1;PSMB7;BCL10;FBXW11
gsea,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.6843756837114714,-2.5519525130487204,0.0,0.0,0.0,20/51,8.25%,HSP90AA1;HSP90AB1;ACTG1;ARPC2;MAPK1;ACTR2;WIPF3;ARPC5;WASF1;ABI1;WASL;ARPC1A;ACTR3;MAPK3;BRK1;NCKAP1;CYFIP2;ARPC3;CDC42;ELMO2
gsea,PCP/CE Pathway R-HSA-4086400,-0.6370000417400562,-2.5505524906654244,0.0,0.0,0.0,45/78,22.31%,UBB;RPS27A;PSMA7;AP2M1;SEM1;PFN1;PSMC2;PSMB5;PSMA4;PSMC6;CLTA;PSMC5;UBA52;PSMC3;PSMA1;AP2S1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PRKCB;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;CLTC;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;AP2B1;CLTB;PSMB7;FZD8;PSMD10;PSMB6;AP2A2;PSMD7;FZD4
gsea,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.6968656572269739,-2.54975985006739,0.0,0.0,0.0,35/54,15.88%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;GSK3B;PSMC3;PSMA1;UBC;PSMC1;PSMD2;CSNK1A1;PSME3;PSMB3;PRKACB;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,Autophagy R-HSA-9612973,-0.580934926092318,-2.5496702141079175,0.0,0.0,0.0,37/120,10.12%,HSP90AA1;EEF1A1;HSP90AB1;UBB;RPS27A;HSPA8;DYNLL1;DYNLL2;GABARAPL1;SQSTM1;GABARAPL2;TOMM20;VDAC1;PINK1;UBE2N;TOMM7;RRAGA;TOMM6;UBE2V1;LAMTOR3;GABARAP;UBA52;TOMM22;CHMP2A;MAP1LC3B;TOMM5;CHMP4B;VCP;LAMTOR2;UBC;PARK7;VPS28;ATG12;CSNK2B;MAP1LC3A;MTERF3;RRAGD
gsea,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.6508907262770248,-2.5449487705496145,0.0,0.0,0.0,50/79,22.86%,UBB;YWHAB;RPS27A;SET;HSPA8;ANP32A;YWHAZ;PSMA7;SEM1;PABPC1;PSMC2;PSMB5;PSMA4;PSMC6;HNRNPD;PSMC5;UBA52;XRN1;DCP2;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;EXOSC4;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;EXOSC3;PSMA5;ELAVL1;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;AKT1;EXOSC9;PSMD10;PSMB6;EXOSC5;PSMD7;EXOSC2
gsea,Host Interactions Of HIV Factors R-HSA-162909,-0.5971734572244245,-2.5426848268805857,0.0,0.0,0.0,63/114,21.19%,SLC25A4;UBB;PPIA;PSIP1;RPS27A;RAN;PSMA7;AP2M1;SEM1;SLC25A5;BANF1;ELOB;NPM1;PSMC2;PSMB5;SKP1;PSMA4;TPR;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;AP2S1;UBC;SEC13;PSMC1;PSMD2;PSME3;ELOC;PSMB3;PSMB1;RBX1;PKN2;NUP88;PSMA3;PSME2;PSMD6;PSMA5;CDK9;PSMB4;PSMD12;NUP50;RANBP1;PSMA2;PSMD14;PSME4;PSMC4;AP1S2;PSME1;PSMD4;AP2B1;HCK;ATP6V1H;B2M;PSMB7;SEH1L;AP1S1;NUP205;PSMD10;PSMB6;AP2A2;HMGA1
gsea,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.7107295295277791,-2.5422622712622185,0.0,0.0,0.0,33/49,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,Mitotic G2-G2/M Phases R-HSA-453274,-0.5499865312054586,-2.541244335558978,0.0,0.0,0.0,55/161,15.88%,HSP90AA1;HSP90AB1;UBB;TUBA4A;RPS27A;DYNLL1;TUBA1A;YWHAG;PSMA7;CETN2;YWHAE;SEM1;PAFAH1B1;PSMC2;PSMB5;TUBB4A;SKP1;PSMA4;PSMC6;AKAP9;CSNK1E;PSMC5;UBA52;PPP2R1A;MZT1;NME7;PPP1CB;PSMC3;DCTN1;PSMA1;CCNH;PPP2CA;UBC;PSMC1;PSMD2;PSME3;DCTN3;TUBB4B;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;DYNC1H1;CEP290;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,G2/M Transition R-HSA-69275,-0.5518584009024721,-2.5402347027490624,0.0,0.0,0.0,55/160,15.88%,HSP90AA1;HSP90AB1;UBB;TUBA4A;RPS27A;DYNLL1;TUBA1A;YWHAG;PSMA7;CETN2;YWHAE;SEM1;PAFAH1B1;PSMC2;PSMB5;TUBB4A;SKP1;PSMA4;PSMC6;AKAP9;CSNK1E;PSMC5;UBA52;PPP2R1A;MZT1;NME7;PPP1CB;PSMC3;DCTN1;PSMA1;CCNH;PPP2CA;UBC;PSMC1;PSMD2;PSME3;DCTN3;TUBB4B;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;DYNC1H1;CEP290;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.580169977662691,-2.539116091209641,0.0,0.0,0.0,62/123,22.31%,CALM1;PPP3CA;UBB;PPP3R1;RPS27A;GNB2;PSMA7;PPP3CB;AP2M1;SEM1;GNG2;PFN1;PSMC2;PSMB5;PSMA4;PSMC6;CLTA;PSMC5;UBA52;PSMC3;PSMA1;CAMK2A;AP2S1;UBC;TNRC6A;PSMC1;PSMD2;PSME3;ITPR1;PSMB3;PSMB1;GNG10;PRKCB;PSMA3;PSME2;PSMD6;GNG3;GNB1;PSMA5;GNG13;PSMB4;PSMD12;CLTC;GNG11;PSMA2;PSMD14;PSME4;PSMC4;GNG7;PSME1;PSMD4;AP2B1;CLTB;PSMB7;PLCB1;CTNNB1;FZD8;PSMD10;PSMB6;AP2A2;PSMD7;FZD4
gsea,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.6884426891335518,-2.5354812935918614,0.0,0.0,0.0,33/51,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;VCP;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;ERLEC1;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,Macroautophagy R-HSA-1632852,-0.5856095126550689,-2.533015151292581,0.0,0.0,0.0,34/107,10.12%,HSP90AA1;UBB;RPS27A;HSPA8;DYNLL1;DYNLL2;GABARAPL1;SQSTM1;GABARAPL2;TOMM20;VDAC1;PINK1;UBE2N;TOMM7;RRAGA;TOMM6;UBE2V1;LAMTOR3;GABARAP;UBA52;TOMM22;CHMP2A;MAP1LC3B;TOMM5;CHMP4B;VCP;LAMTOR2;UBC;PARK7;ATG12;CSNK2B;MAP1LC3A;MTERF3;RRAGD
gsea,Protein Folding R-HSA-391251,-0.6017718183408315,-2.5314435689654258,0.0,0.0,0.0,37/81,15.78%,TUBA4A;TUBA1A;GNB2;TUBB2A;CCT6A;GNG2;PFDN2;TUBB4A;PFDN6;CCT2;TUBB2B;PFDN5;FBXW2;STAT3;FBXW7;TUBB4B;CSNK2B;TCP1;TUBA1B;GNG10;CCT8;VBP1;AP3M1;FBXO6;DCAF7;GNG3;GNB1;ARL2;CCT5;GNG13;FBXL3;TUBB3;TBCC;GNG11;PFDN1;GNG7;NOP56
gsea,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.6841163478040353,-2.5303729168227673,0.0,0.0,0.0,39/54,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;VCP;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RNF5;PSMA3;PSME2;PSMD6;ERLEC1;PSMA5;PSMB4;PSMD12;DERL1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;RNF185;PSMD10;PSMB6;PSMD7
gsea,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.6397415605645598,-2.523631460280052,0.0,0.0,0.0,44/71,22.16%,UBB;RPS27A;PSMA7;RASGRP1;SEM1;UBE2N;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;UBE2V1;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;CDC34;PSME1;PSMD4;UBE2D1;PSMB7;BCL10;FBXW11;TAB2;PSMD10;PSMB6;PSMD7
gsea,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.588977086296914,-2.5220977406123084,0.0,0.0,0.0,53/115,18.01%,CALM1;PPP3CA;UBB;PPP3R1;RPS27A;JUN;MAPK1;PSMA7;PPP3CB;RASGRP1;SEM1;UBE2N;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;UBE2V1;PSMC5;UBA52;MAPK3;PSMC3;PSMA1;AHCYL1;UBC;PSMC1;PSMD2;PSME3;ITPR1;PSMB3;PSMB1;PKN2;PIK3R1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;HRAS;PSMD14;NFKBIA;PSME4;PSMC4;MAPK9;CDC34;PSME1;PSMD4;UBE2D1;PSMB7;BCL10;FBXW11
gsea,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.6929678110779537,-2.521873755522635,0.0,0.0,0.0,33/50,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;VCP;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;ERLEC1;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.6102108834352468,-2.51876456690692,0.0,0.0,0.0,52/92,21.18%,UBB;RPS27A;PSMA7;SQSTM1;SEM1;PSMC2;PSMB5;SKP1;PSMA4;AKT3;PSMC6;PSMC5;UBA52;GSK3B;MAP1LC3B;PSMC3;PSMA1;VCP;PRDX1;UBC;SRXN1;PSMC1;PSMD2;PSME3;PHGDH;CSNK2B;PSMB3;PSMB1;RBX1;SESN1;GCLM;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;KEAP1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;AKT1;TALDO1;MUL1;TXNRD1;PSMD10;PSMB6;ATF4
gsea,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.6937680385425797,-2.5137906268616788,0.0,0.0,0.0,33/53,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;CDKN1B;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;CDK4;PSMB4;PSMD12;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;PSMB7
gsea,Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.6281935178570904,-2.5074539762376644,0.0,0.0,0.0,43/74,23.12%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;CDKN1B;SKP1;PSMA4;AKT3;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;CCNH;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;CDK4;TFDP2;PSMB4;PSMD12;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;MAX;PSMB7;AKT1;PSMD10;PSMB6;PSMD7;E2F4;RB1
gsea,S Phase R-HSA-69242,-0.5427250535463309,-2.504482522078788,0.0,0.0,0.0,67/145,23.12%,UBB;RPS27A;PSMA7;SEM1;SMC1A;PSMC2;PSMB5;CDKN1B;SKP1;PSMA4;AKT3;RAD21;PSMC6;PSMC5;SMC3;UBA52;GSK3B;GINS2;PSMC3;PSMA1;CCNH;PCNA;ORC4;POLD4;UBC;PDS5B;PSMC1;PSMD2;PSME3;STAG2;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;GINS4;PSMA5;MCM6;CDK4;TFDP2;PSMB4;PSMD12;UBE2S;MCM3;RFC3;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;MAX;WAPL;PSMB7;AKT1;ANAPC16;POLE3;ANAPC11;PSMD10;UBE2E1;PSMB6;FEN1;PSMD7;E2F4;RB1
gsea,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.7138695120876248,-2.504176759774212,0.0,0.0,0.0,32/51,15.88%,HSP90AA1;HSP90AB1;UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.8755319647119122,-2.5022996893520624,0.0,0.0,0.0,38/45,7.93%,RPS29;RPS8;RPS27;RPS27A;RPS24;RPS23;RPSA;RPS2;RPS6;RPS7;RPS25;RPS28;RPS4X;RPS10;RPS16;FAU;RPS21;RPS15A;EIF3C;RPS15;RPS5;RPS11;RPS3;EIF3A;RPS9;EIF3F;RPS20;EIF1AX;RPS17;RPS12;RPS14;RPS19;EIF2S2;RPS27L;EIF3K;EIF3I;RPS13;EIF3M
gsea,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.7083761836695026,-2.498551768190747,0.0,0.0,0.0,33/47,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;GSK3B;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;CDK4;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.6527054581967112,-2.4963829863646345,0.0,0.0,0.0,39/61,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7
gsea,Programmed Cell Death R-HSA-5357801,-0.5634123786054093,-2.4958926496608806,0.0,0.0,0.0,71/166,18.17%,HSP90AA1;UBB;YWHAH;PPP3R1;YWHAB;RPS27A;HMGB1;DYNLL1;DYNLL2;YWHAZ;YWHAG;MAPK1;PSMA7;YWHAE;SEM1;NMT1;NDUFA2;SDCBP;MAGED1;PSMC2;CYCS;YWHAQ;PSMB5;DNM1L;PSMA4;AKT3;APPL1;PSMC6;PSMC5;UBA52;MAPK3;CHMP2A;PSMC3;CHMP4B;PSMA1;BAX;UBC;PSMC1;PSMD2;PSME3;STAT3;GSDME;PSMB3;PSMB1;PPP1R13B;PKN2;CDC37;PSMA3;PSME2;PSMD6;PSMA5;TFDP2;PSMB4;PSMD12;CHMP7;PSMA2;PSMD14;PSME4;PSMC4;DIABLO;PSME1;PSMD4;SEPTIN4;IL18;PSMB7;C1QBP;STUB1;BIRC2;AKT1;GNL3;BAD
gsea,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.7127515387900848,-2.4918020895644437,0.0,0.0,0.0,35/50,17.96%,UBB;RPS27A;YWHAZ;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;FBXW7;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;PSMB7;AKT1
gsea,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.6809590961178191,-2.4903082355547874,0.0,0.0,0.0,39/54,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;NFKB2;UBA3;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;FBXW11;PSMD10;PSMB6;UBE2M;PSMD7
gsea,Cellular Response To Hypoxia R-HSA-1234174,-0.6479397030569277,-2.4885996003646227,0.0,0.0,0.0,37/65,15.92%,UBB;RPS27A;PSMA7;SEM1;ELOB;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;HIGD1A;UBC;PSMC1;PSMD2;PSME3;ELOC;PSMB3;PSMB1;RBX1;MIA3;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;CITED2;PSME1;PSMD4;UBE2D1
gsea,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.623900052526629,-2.4865751377958207,0.0,0.0,0.0,42/77,17.45%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;TLE5;PSMC6;PSMC5;UBA52;PPP2R1A;GSK3B;PSMC3;PSMA1;PPP2CA;UBC;PSMC1;PSMD2;PPP2R5D;CSNK1A1;PSME3;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;TLE1;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PPP2R5E;PSMB7;ZRANB1
gsea,Ub-specific Processing Proteases R-HSA-5689880,-0.540201880271272,-2.4865268395095823,0.0,0.0,0.0,74/149,26.22%,UBB;RPS27A;PSMA7;SEM1;TOMM20;MAT2B;VDAC1;PSMC2;PSMB5;PSMA4;USP22;USP14;PSMC6;PSMC5;USP2;UBA52;PSMC3;VDAC2;PSMA1;OTUB1;UBC;H2AC25;PSMC1;PSMD2;PSME3;CYLD;PSMB3;PSMB1;USP19;H2BC4;PSMA3;PSME2;PSMD6;TAF10;USP20;PSMA5;PSMB4;PTRH2;PTEN;PSMD12;KEAP1;SNX3;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;TADA3;SMAD2;USP33;PSME1;PSMD4;DDB2;TADA2B;SMAD1;PSMB7;STAM2;BIRC2;USP9X;MUL1;TANK;PSMD10;PSMB6;POLG2;PSMD7;USP30;USP15;USP5;SMAD3;SMAD7;SMAD4;IKBKG;USP47;USP3
gsea,Regulation Of Apoptosis R-HSA-169911,-0.7002475912988035,-2.4837999902676393,0.0,0.0,0.0,32/48,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PKN2;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,Downstream TCR Signaling R-HSA-202424,-0.6217618497529618,-2.48317491992588,0.0,0.0,0.0,45/75,22.16%,UBB;RPS27A;PSMA7;SEM1;UBE2N;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;UBE2V1;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PIK3R1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PTEN;PSMD12;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;CDC34;PSME1;PSMD4;UBE2D1;PSMB7;BCL10;FBXW11;TAB2;PSMD10;PSMB6;PSMD7
gsea,M Phase R-HSA-68886,-0.49697575493896134,-2.4830619960284985,0.0,0.0,0.0,103/312,17.92%,HSP90AA1;UBB;TUBA4A;RPS27;RPS27A;SET;RAN;DYNLL1;TUBA1A;TUBB2A;DYNLL2;YWHAG;MAPK1;PSMA7;H2AZ1;CETN2;YWHAE;SEM1;ENSA;BANF1;PAFAH1B1;SMC1A;PSMC2;PSMB5;RAB2A;TUBB4A;PSMA4;TPR;RAD21;PSMC6;AKAP9;ZWINT;CSNK1E;PSMC5;SMC3;H2AJ;UBA52;PPP2R1A;MAPK3;CHMP2A;MZT1;NME7;PSMC3;CHMP4B;DCTN1;PSMA1;SUMO1;TUBB2B;PPP2CA;NEK9;UBC;PDS5B;SEC13;PSMC1;PSMD2;PPP2R5D;RAB1A;NCAPH2;RAB1B;PSME3;STAG2;DCTN3;EMD;TUBB4B;SMC4;HDAC8;CSNK2B;TUBA1B;PSMB3;PSMB1;NUDC;H2BC4;NUP88;H2AX;PRKCB;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;UBE2I;PSMD12;CHMP7;NUP50;TUBB3;UBE2S;DYNC1H1;CEP290;PSMA2;CTDNEP1;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;B9D2;KMT5A;PPP2R5E;WAPL;PSMB7;SEH1L;ACTR1A
gsea,Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.6623171935187906,-2.480031469746233,0.0,0.0,0.0,36/57,22.31%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;FZD8;PSMD10;PSMB6;PSMD7;FZD4
gsea,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.672044741971632,-2.479735521120724,0.0,0.0,0.0,39/55,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;NFKB2;UBA3;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;FBXW11;PSMD10;PSMB6;UBE2M;PSMD7
gsea,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.7078221683991998,-2.4795765079615633,0.0,0.0,0.0,31/45,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.6169174503171722,-2.476850302893622,0.0,0.0,0.0,44/76,24.12%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;CDKN1B;SKP1;PSMA4;AKT3;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;CCNH;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;CDK4;TFDP2;PSMB4;PSMD12;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;MAX;PSMB7;AKT1;PSMD10;PSMB6;PSMD7;E2F4;RB1;FZR1
gsea,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.6546319493988079,-2.47682123520764,0.0,0.0,0.0,36/60,18.01%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PRKCB;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;PSME1;PSMD4;PSMB7;BCL10;FBXW11
gsea,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.7097733620944865,-2.4764657146464697,0.0,0.0,0.0,34/48,17.38%,UBB;RPS27A;PSMA7;SEM1;ELOB;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;ELOC;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,ABC Transporter Disorders R-HSA-5619084,-0.6376884037772063,-2.475252643156142,0.0,0.0,0.0,41/65,22.36%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;VCP;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RNF5;PSMA3;PSME2;PSMD6;ERLEC1;PSMA5;PSMB4;PSMD12;DERL1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;ABCA1;RNF185;PSMD10;PSMB6;PSMD7;ABCB6
gsea,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.6312571316230551,-2.4751873145423886,0.0,0.0,0.0,37/63,17.79%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;GSK3B;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;FBXW7;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;CBFB;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;STUB1
gsea,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.6052213989209595,-2.472415032945944,0.0,0.0,0.0,44/80,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;ORC4;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;MCM6;PSMB4;PSMD12;UBE2S;MCM3;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7
gsea,Complex I Biogenesis R-HSA-6799198,-0.7191778474909765,-2.4721358745640933,0.0,0.0,0.0,37/50,20.90%,NDUFA1;NDUFS5;NDUFA3;NDUFA2;NDUFA13;NDUFB3;NDUFB1;NDUFB8;NDUFB10;NDUFC1;NDUFS7;NDUFA5;NDUFAF3;NDUFS2;NDUFB11;NDUFB9;NDUFB6;NDUFAB1;NDUFV1;NDUFA7;NDUFC2;NDUFB2;NDUFA8;NDUFS6;NDUFS8;NDUFA10;NDUFA9;NDUFAF4;NDUFAF7;NDUFV2;NDUFAF2;NDUFB7;NDUFB5;NDUFS1;NDUFA11;NDUFS4;NDUFA12
gsea,Signaling By NOTCH4 R-HSA-9013694,-0.6176327341657697,-2.471223115740829,0.0,0.0,0.0,41/76,17.96%,UBB;RPS27A;YWHAZ;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;MAMLD1;PSMC6;APH1A;PSMC5;UBA52;SNW1;PSMC3;PSMA1;PSENEN;UBC;PSMC1;PSMD2;PSME3;FBXW7;PSMB3;PSMB1;RBX1;HEY1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;PSMB7;ADAM10;AKT1
gsea,HIV Infection R-HSA-162906,-0.5291346578095075,-2.470137218660951,0.0,0.0,0.0,99/205,23.16%,SLC25A4;UBB;PPIA;PSIP1;RPS27A;RAN;PSMA7;AP2M1;SEM1;NMT1;SLC25A5;BANF1;ELOB;NPM1;PSMC2;PSMB5;SKP1;PSMA4;TPR;PSMC6;PSMC5;TCEA1;UBA52;CHMP2A;POLR2G;PSMC3;CHMP4B;PSMA1;CCNH;AP2S1;GTF2H1;UBC;SEC13;PSMC1;PSMD2;VPS28;PSME3;TAF11;ELOC;PSMB3;PSMB1;RBX1;PKN2;TAF3;GTF2H5;NUP88;POLR2C;POLR2L;XRCC4;PSMA3;PSME2;PSMD6;TAF10;GTF2A1;PSMA5;GTF2B;CDK9;PSMB4;PSMD12;CHMP7;CHMP5;NUP50;RANBP1;PSMA2;PSMD14;PSME4;PSMC4;AP1S2;POLR2I;TAF7;PSME1;PSMD4;AP2B1;VPS37D;HCK;ATP6V1H;B2M;PSMB7;SEH1L;AP1S1;POLR2F;SSRP1;POLR2E;GTF2F1;RNMT;VPS4B;NUP205;TBP;CHMP6;PSMD10;TSG101;PSMB6;AP2A2;HMGA1;FEN1;PSMD7;NCBP2;CCNT1;NUP62
gsea,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.6529655142889134,-2.4692801389964805,0.0,0.0,0.0,35/57,18.23%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;VCP;UBC;PSMC1;PSMD2;PSME3;P4HB;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;ERLEC1;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;DISP2
gsea,G1/S DNA Damage Checkpoints R-HSA-69615,-0.6530623800003318,-2.4683082725223606,0.0,0.0,0.0,36/57,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;CDKN1B;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;PHF20;PSMD10;PSMB6;PSMD7
gsea,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.7108530988656083,-2.466788608969323,0.0,0.0,0.0,32/45,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PKN2;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.6400009899283708,-2.4667082021149827,0.0,0.0,0.0,39/64,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7
gsea,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.6400009899283708,-2.4667082021149827,0.0,0.0,0.0,39/64,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7
gsea,TCR Signaling R-HSA-202403,-0.5838780777000072,-2.464805534359463,0.0,0.0,0.0,45/92,18.01%,UBB;RPS27A;PSMA7;SEM1;UBE2N;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;UBE2V1;PSMC5;UBA52;PTPRJ;PSMC3;PSMA1;ENAH;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PKN2;PIK3R1;PSMA3;PSME2;PSMD6;NCK1;PSMA5;PSMB4;PTEN;PSMD12;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;CDC34;PSME1;PSMD4;UBE2D1;PSMB7;BCL10;FBXW11
gsea,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.6357456861136553,-2.4645200232830358,0.0,0.0,0.0,41/65,24.12%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7;RB1;FZR1
gsea,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.637684204162851,-2.464204835464406,0.0,0.0,0.0,39/65,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7
gsea,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.6373959012881443,-2.461850585652946,0.0,0.0,0.0,39/66,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7
gsea,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.698498159929329,-2.45924281884079,0.0,0.0,0.0,32/46,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.6282327559949936,-2.4590665139518197,0.0,0.0,0.0,41/68,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;NFKB2;UBA3;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;BIRC2;FBXW11;TANK;PSMD10;PSMB6;UBE2M;PSMD7
gsea,Hedgehog On State R-HSA-5632684,-0.6082795216658963,-2.458506627162195,0.0,0.0,0.0,42/75,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;CSNK1A1;PSME3;PSMB3;PSMB1;RBX1;CDC73;PSMA3;PSME2;PSMD6;HHIP;SPOP;PSMA5;PSMB4;PSMD12;NUMB;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;PSMD10;PSMB6;SPOPL;GAS8;PSMD7
gsea,Degradation Of AXIN R-HSA-4641257,-0.6758634045715841,-2.458160875520072,0.0,0.0,0.0,31/50,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,HSF1-dependent Transactivation R-HSA-3371571,-0.7419466967468663,-2.4580056838158697,0.0,0.0,0.0,14/29,12.04%,HSP90AA1;HSP90AB1;UBB;CAMK2B;HSPA8;HSBP1;HSPH1;DNAJB6;PTGES3;CAMK2A;HSPA2;MRPL18;CRYAB;AKT1S1
gsea,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.7076059603808706,-2.4548683872598227,0.0,0.0,0.0,33/49,15.88%,UBB;RPS27A;HSPA8;PSMA7;SEM1;PABPC1;PSMC2;PSMB5;PSMA4;PSMC6;HNRNPD;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.6305632473120345,-2.452615841178441,0.0,0.0,0.0,39/64,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7
gsea,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.6747956696739426,-2.4521912608849368,0.0,0.0,0.0,31/49,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;CBFB;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;PSMB7
gsea,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.6576984931324986,-2.4516425476705948,0.0,0.0,0.0,36/55,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;CDKN1B;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;PHF20;PSMD10;PSMB6;PSMD7
gsea,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.6863074178900386,-2.4513702051465014,0.0,0.0,0.0,32/49,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.6478093901088332,-2.450714207596159,0.0,0.0,0.0,20/50,12.46%,ACTG1;ARPC2;MAPK1;ACTR2;WIPF3;ARPC5;WASF1;ABI1;WASL;ARPC1A;ACTR3;MAPK3;BRK1;NCKAP1;CYFIP2;ARPC3;CDC42;ELMO2;NCK1;BAIAP2
gsea,PTEN Regulation R-HSA-6807070,-0.5600803414434163,-2.450509244454124,0.0,0.0,0.0,58/127,18.33%,UBB;RPS27A;CBX6;JUN;MAPK1;PSMA7;SEM1;CHD3;PSMC2;RRAGA;PSMB5;PSMA4;AKT3;PSMC6;LAMTOR3;RBBP7;PSMC5;UBA52;MAPK3;VAPA;PSMC3;PSMA1;LAMTOR2;HDAC2;UBC;TNRC6A;RING1;PSMC1;PSMD2;PSME3;NEDD4;CSNK2B;PSMB3;PSMB1;RRAGD;CNOT6L;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PTEN;PSMD12;CBX8;PSMA2;HDAC5;PSMD14;PSME4;PSMC4;RHEB;GATAD2B;PSME1;PSMD4;EGR1;PSMB7;STUB1;AKT1;MKRN1
gsea,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.6895027789633315,-2.450245253976588,0.0,0.0,0.0,31/47,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.6426709294361194,-2.448545360716155,0.0,0.0,0.0,38/60,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7
gsea,Mitotic Anaphase R-HSA-68882,-0.5210389717680479,-2.447628336084906,0.0,0.0,0.0,78/194,21.37%,UBB;TUBA4A;RPS27;RPS27A;RAN;DYNLL1;TUBA1A;TUBB2A;DYNLL2;PSMA7;SEM1;BANF1;PAFAH1B1;SMC1A;PSMC2;PSMB5;TUBB4A;PSMA4;RAD21;PSMC6;ZWINT;PSMC5;SMC3;UBA52;PPP2R1A;CHMP2A;PSMC3;CHMP4B;PSMA1;SUMO1;TUBB2B;PPP2CA;UBC;PDS5B;SEC13;PSMC1;PSMD2;PPP2R5D;PSME3;STAG2;EMD;TUBB4B;HDAC8;TUBA1B;PSMB3;PSMB1;NUDC;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;UBE2I;PSMD12;CHMP7;TUBB3;UBE2S;DYNC1H1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;B9D2;PPP2R5E;WAPL;PSMB7;SEH1L;ANAPC16;ANAPC11;NUP205;CHMP6;PSMD10;UBE2E1;PSMB6;RCC2
gsea,Regulation Of RAS By GAPs R-HSA-5658442,-0.6460010711995733,-2.4464307327286163,0.0,0.0,0.0,35/60,17.38%,UBB;RPS27A;RASAL2;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;HRAS;PSMD14;PSME4;PSMC4;PSME1;PSMD4;KBTBD7;PSMB7
gsea,Protein Localization R-HSA-9609507,-0.5530129837386351,-2.4460152242313193,0.0,0.0,0.0,78/143,31.34%,SLC25A4;UBB;PRNP;RPS27A;CHCHD2;VAMP2;COX17;CHCHD10;TOMM20;VDAC1;HSPA9;TOMM7;NDUFB8;TIMM8B;TOMM6;ATAD1;DNAJC19;UBA52;TOMM22;VAPA;TOMM5;UBC;TIMM10;MTX2;ACOX1;HSPD1;SEC61G;EMD;TIMM13;CHCHD4;ZFAND6;PEX12;PMPCA;CCNI;UBE2D1;SEC61B;TIMM50;BCS1L;NUDT19;PEX5;GDAP1;GRPEL1;USP9X;PAM16;IDH3G;ABCD2;PMPCB;MPV17;ACOT8;PAOX;COX19;BAG6;FIS1;SLC25A17;TIMM21;SGTA;LDHD;PXMP4;COA6;PEX13;TIMM44;ECH1;SAMM50;FXN;TIMM23;GET3;SERP1;TIMM10B;GET1;TIMM22;UBE2J2;GRPEL2;ABCD1;CROT;GET4;ACO2;UBL4A;HSCB
gsea,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.5209083130234222,-2.4450537337834124,0.0,0.0,0.0,78/195,21.37%,UBB;TUBA4A;RPS27;RPS27A;RAN;DYNLL1;TUBA1A;TUBB2A;DYNLL2;PSMA7;SEM1;BANF1;PAFAH1B1;SMC1A;PSMC2;PSMB5;TUBB4A;PSMA4;RAD21;PSMC6;ZWINT;PSMC5;SMC3;UBA52;PPP2R1A;CHMP2A;PSMC3;CHMP4B;PSMA1;SUMO1;TUBB2B;PPP2CA;UBC;PDS5B;SEC13;PSMC1;PSMD2;PPP2R5D;PSME3;STAG2;EMD;TUBB4B;HDAC8;TUBA1B;PSMB3;PSMB1;NUDC;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;UBE2I;PSMD12;CHMP7;TUBB3;UBE2S;DYNC1H1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;B9D2;PPP2R5E;WAPL;PSMB7;SEH1L;ANAPC16;ANAPC11;NUP205;CHMP6;PSMD10;UBE2E1;PSMB6;RCC2
gsea,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.6220001367267942,-2.4411607027784155,0.0,0.0,0.0,40/70,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7
gsea,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.6582375273543773,-2.4386446209558263,0.0,0.0,0.0,34/58,15.92%,UBB;RPS27A;PSMA7;SEM1;ELOB;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;ELOC;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1
gsea,Iron Uptake And Transport R-HSA-917937,-0.6732325878698381,-2.4370932018205766,0.0,0.0,0.0,20/48,10.63%,FTH1;UBB;RPS27A;ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V1E1;ATP6AP1;ATP6V1F;SKP1;ATP6V0E2;UBA52;NEDD8;ATP6V1G1;UBC;ATP6V1B2;IREB2;SLC22A17;TFRC
gsea,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.6926298573642409,-2.435845735957907,0.0,0.0,0.0,33/49,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;GSK3B;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;PSMB7
gsea,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.8564940226803222,-2.4357441880530537,0.0,0.0,0.0,33/43,7.41%,RPS29;RPS8;RPS27;RPS27A;RPS24;RPS23;RPSA;RPS2;RPS6;RPS7;RPS25;RPS28;RPS4X;RPS10;RPS16;FAU;RPS21;RPS15A;RPS15;RPS5;RPS11;RPS3;RPS9;RPS20;RPS17;RPS12;RPS14;SNRPD2;RPS19;SNRPF;RPS27L;SNRPG;RPS13
gsea,Stabilization Of P53 R-HSA-69541,-0.6729247752183263,-2.4355343124980187,0.0,0.0,0.0,35/49,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;PHF20;PSMD10;PSMB6;PSMD7
gsea,Hedgehog Off State R-HSA-5610787,-0.5796802064375575,-2.433355553285764,0.0,0.0,0.0,40/90,15.88%,UBB;GNAS;RPS27A;PRKAR1A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;ADCY1;GSK3B;PSMC3;PSMA1;PRKAR1B;UBC;PSMC1;PSMD2;CSNK1A1;PSME3;PSMB3;PRKACB;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;NUMB;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.631465589566876,-2.4225753180490424,0.0,0.0,0.0,38/63,18.33%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;AKT3;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;NEDD4;CSNK2B;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PTEN;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;STUB1;AKT1;MKRN1
gsea,Synthesis Of DNA R-HSA-69239,-0.5542608489890167,-2.41812262335511,0.0,0.0,0.0,51/109,22.16%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;GINS2;PSMC3;PSMA1;PCNA;ORC4;POLD4;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;GINS4;PSMA5;MCM6;PSMB4;PSMD12;UBE2S;MCM3;RFC3;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;POLE3;ANAPC11;PSMD10;UBE2E1;PSMB6;FEN1;PSMD7
gsea,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.6046010075091246,-2.416630021058642,0.0,0.0,0.0,20/53,14.84%,CALM1;YWHAB;CAMK2B;PEBP1;MAPK1;AKAP9;VCL;MAPK3;QKI;KSR1;CAMK2A;CNKSR2;BRAF;RAP1A;TRIM24;KDM7A;ARAF;AGGF1;HRAS;MPRIP
gsea,Apoptosis R-HSA-109581,-0.557816564967994,-2.415430081177984,0.0,0.0,0.0,62/146,18.17%,UBB;YWHAH;PPP3R1;YWHAB;RPS27A;HMGB1;DYNLL1;DYNLL2;YWHAZ;YWHAG;MAPK1;PSMA7;YWHAE;SEM1;NMT1;NDUFA2;MAGED1;PSMC2;CYCS;YWHAQ;PSMB5;DNM1L;PSMA4;AKT3;APPL1;PSMC6;PSMC5;UBA52;MAPK3;PSMC3;PSMA1;BAX;UBC;PSMC1;PSMD2;PSME3;STAT3;GSDME;PSMB3;PSMB1;PPP1R13B;PKN2;PSMA3;PSME2;PSMD6;PSMA5;TFDP2;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;DIABLO;PSME1;PSMD4;SEPTIN4;PSMB7;C1QBP;BIRC2;AKT1;BAD
gsea,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.551621421787796,-2.4144614864430634,0.0,0.0,0.0,48/99,23.75%,CAPZA2;DYNLL1;DYNLL2;ARF5;RAB6B;RAB6A;ARF3;PAFAH1B1;NAPG;TMED7;NSF;TMED2;TMED9;DCTN1;ARF4;KIF5B;RAB18;RAB1A;KIFAP3;RAB1B;ACTR10;DCTN3;DCTN6;CAPZB;COPZ1;COPG1;COPG2;PAFAH1B2;DYNC1H1;GALNT1;KIF21A;COPB2;AGPAT3;ACTR1A;DCTN5;PAFAH1B3;PLA2G6;DCTN4;COPE;KDELR1;UBE2Z;ARFGAP2;KIF15;SEC22B;ARCN1;DCTN2;KIF5C;BICD2
gsea,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.6652118092577325,-2.413209149675612,0.0,0.0,0.0,31/46,22.16%,PSMA7;SEM1;OAZ1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;PSMC3;PSMA1;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;PSMD10;PSMB6;PSMD7
gsea,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.5764802807569522,-2.412386859845992,0.0,0.0,0.0,21/80,9.04%,HSP90AA1;UBB;TUBA4A;RPS27A;DYNLL1;TUBA1A;YWHAG;CETN2;YWHAE;PAFAH1B1;TUBB4A;SKP1;AKAP9;CSNK1E;UBA52;PPP2R1A;PPP1CB;DCTN1;UBC;DCTN3;TUBB4B
gsea,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.4683079449326135,-2.412335902019315,0.0,0.0,0.0,146/365,23.18%,CALM1;HSP90AA1;UBB;YWHAB;RPS27A;CAMK2B;RPS6;PEBP1;PRKAR1A;MAPK1;PSMA7;SQSTM1;FKBP1A;SEM1;EEF1G;BAG4;NPM1;PSMC2;PSMB5;CDKN1B;SKP1;PSMA4;MAMLD1;FOXO3;AKT3;TPR;MIB1;PSMC6;AKAP9;GOLGB1;VCL;APH1A;PSMC5;UBA52;PPP2R1A;MAPK3;QKI;GSK3B;CEBPB;POLR2G;NCOR1;SNW1;ERBIN;PPP1CB;KSR1;PSMC3;DCTN1;PSMA1;CAMK2A;CPSF6;VCP;PSENEN;PPP2CA;HDAC2;KIF5B;UBC;DUSP7;PSMC1;PSMD2;PPP2R5D;CSNK1A1;PSME3;STAT3;CNKSR2;FBXW7;HDAC8;PSMB3;PSMB1;MIB2;RBX1;BRAF;RAP1A;RRBP1;HEY1;PIK3R1;POLR2C;POLR2L;FGFR1;CDC37;TRIM24;PSMA3;PSME2;PSMD6;CUX1;AKT1S1;ERLEC1;PSMA5;KDM7A;PDGFA;ARAF;PSMB4;RICTOR;PTEN;PSMD12;NEURL1B;CLTC;CLSTN1;AGGF1;ERBB3;PSMA2;HDAC5;HRAS;PSMD14;PSME4;MPRIP;PSMC4;FGFR3;SMAD2;POLR2I;PSME1;PSMD4;DUSP8;FGFR2;PPP2R5E;PSMB7;RNASEH2A;ADAM10;AKT1;BAD;POLR2F;FAM131B;FGF13;POLR2E;FGF9;DUSP6;FAM114A2;FIP1L1;GTF2F1;RNMT;PTPN11;CTNNB1;ATIC;FZD8;PSMD10;MAML2;PSMB6;MAP2K1;SHOC2;PSMD7;FZD4;NCBP2;CREB1;TLN1;ZFYVE9;CTBP2;CREBBP
gsea,ABC-family Proteins Mediated Transport R-HSA-382556,-0.5883470286019509,-2.41085350605074,0.0,0.0,0.0,45/84,23.27%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;ABCB10;PSMA4;PSMC6;PSMC5;UBA52;EIF2S2;PSMC3;PSMA1;VCP;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RNF5;ABCC4;PSMA3;PSME2;PSMD6;ERLEC1;PSMA5;PSMB4;PSMD12;DERL1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;ABCD2;RNF185;PSMD10;PSMB6;PSMD7;ABCB6;ABCB7
gsea,Metabolism Of Polyamines R-HSA-351202,-0.643450954033881,-2.410547577408666,0.0,0.0,0.0,33/51,22.16%,PSMA7;SEM1;OAZ1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;PSMC3;PSMA1;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;SLC38A1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;PAOX;PSMD10;PSMB6;PSMD7
gsea,Signaling By Interleukins R-HSA-449147,-0.48873346119680083,-2.408573977007015,0.0,0.0,0.0,102/295,19.95%,HSP90AA1;UBB;PPIA;RPS27A;HNRNPA2B1;HMGB1;HSPA8;VAMP2;YWHAZ;SNAP25;JUN;MAPK1;PSMA7;SQSTM1;IL1RAPL1;SEM1;DUSP3;CEBPD;MEF2A;UBE2N;AURKAIP1;HSPA9;PSMC2;PSMB5;CANX;SKP1;PSMA4;FOXO3;USP14;SOD1;PSMC6;UBE2V1;HSP90B1;PSMC5;UBA52;PPP2R1A;MAPK3;PELI2;PTK2B;PDCD4;PSMC3;PSMA1;PPP2CA;CDC42;TBK1;S1PR1;UBC;DUSP7;HNRNPF;NDN;RPLP0;PSMC1;PSMD2;PPP2R5D;PSME3;STAT3;IRAK1;IL1RAP;IL1R1;P4HB;TCP1;MEF2C;PSMB3;PSMB1;NKIRAS1;RBX1;PKN2;NFKB2;PIK3R1;PSMA3;PSME2;PSMD6;PSMA5;HNRNPDL;PSMB4;PSMD12;CLSTN1;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;MAPK9;PSME1;PSMD4;GSTO1;RALA;IL18;HCK;PSMB7;RNASEH2A;HAVCR2;SOS2;AKT1;FBXW11;TALDO1;FGF13;DUSP6;TANK;PTPN11;VRK3;TYK2
gsea,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.6039086215781554,-2.407463670135214,0.0,0.0,0.0,42/74,24.12%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;PSMD7;RB1;FZR1
gsea,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.594214563499737,-2.406440523302044,0.0,0.0,0.0,44/84,21.13%,UBB;RPS27A;PSMA7;H2AZ1;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;H2AJ;UBA52;PSMC3;PSMA1;ORC4;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;H2BC4;H2AX;PSMA3;PSME2;PSMD6;PSMA5;MCM6;PSMB4;PSMD12;UBE2S;MCM3;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6
gsea,HSF1 Activation R-HSA-3371511,-0.794537431346175,-2.401946783153338,0.0,0.0,0.0,11/23,9.20%,HSP90AA1;EEF1A1;HSP90AB1;UBB;HSBP1;YWHAE;HSPH1;DNAJB6;PTGES3;VCP;MRPL18
gsea,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.5850417486490634,-2.4008622904967836,0.0,0.0,0.0,25/75,12.46%,HSP90AA1;HSP90AB1;ACTG1;ARPC2;MAPK1;ACTR2;WIPF3;ARPC5;WASF1;ABI1;WASL;ARPC1A;ACTR3;MAPK3;BRK1;NCKAP1;CYFIP2;ARPC3;AHCYL1;CDC42;ELMO2;ITPR1;PIK3R1;NCK1;BAIAP2
gsea,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.6213688811180107,-2.3999846409097763,0.0,0.0,0.0,44/73,22.16%,UBB;RPS27A;PSMA7;SQSTM1;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;GSK3B;PSMC3;PSMA1;PRDX1;UBC;SRXN1;PSMC1;PSMD2;PSME3;PHGDH;PSMB3;PSMB1;RBX1;GCLM;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;PSMB7;TALDO1;TXNRD1;PSMD10;PSMB6;ATF4;PSMD7
gsea,Mitophagy R-HSA-5205647,-0.7707394611726385,-2.399162833173314,0.0,0.0,0.0,17/27,9.93%,UBB;RPS27A;SQSTM1;TOMM20;VDAC1;PINK1;TOMM7;TOMM6;UBA52;TOMM22;MAP1LC3B;TOMM5;UBC;ATG12;CSNK2B;MAP1LC3A;MTERF3
gsea,Antigen processing-Cross Presentation R-HSA-1236975,-0.6068642757209,-2.393877435284301,0.0,0.0,0.0,45/77,21.13%,UBB;RPS27A;HMGB1;PSMA7;SEM1;NDUFA2;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;LNPEP;PSMA1;UBC;PDIA3;PSMC1;PSMD2;PSME3;SEC61G;PSMB3;PSMB1;CTSL;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;SEC61B;B2M;PSMB7;NCF2;VAMP3;S100A1;PSMD10;SEC22B;PSMB6
gsea,Transcriptional Regulation By TP53 R-HSA-3700989,-0.48885209899018983,-2.3930807701383197,0.0,0.0,0.0,108/302,20.30%,PDZD2;UBB;YWHAH;YWHAB;RPS27A;COX6C;COX8A;YWHAZ;CDK5R1;JUN;YWHAG;COX7C;COX5A;COX7A2L;COX5B;YWHAE;PRDX5;COX6A1;CHD3;ELOB;NPM1;COX7B;COX6B1;CYCS;RRAGA;COX4I1;YWHAQ;PLK2;CDKN1B;AKT3;BNIP3L;LAMTOR3;RBBP7;PRELID3A;BTG2;TCEA1;USP2;UBA52;PPP2R1A;POLR2G;CCNH;PIP4K2A;PCNA;PPP2CA;BAX;LAMTOR2;GTF2H1;PRDX1;HDAC2;UBC;TNRC6A;DYRK2;COX20;TRIAP1;HIPK2;TAF11;ELOC;CNOT6;PRMT1;CSNK2B;COX14;PPP1R13B;TAF3;SURF1;RRAGD;CNOT6L;GTF2H5;POLR2C;SESN1;POLR2L;BRD7;TAF10;KAT6A;PIP4P1;PRDX2;CDK9;TFDP2;RICTOR;PTEN;ATRIP;RFC3;HIPK1;RHEB;CNOT10;GLS2;POLR2I;GATAD2B;TAF7;DDB2;PIP4K2B;KMT5A;CNOT7;PRELID1;AKT1;SCO1;POLR2F;SSRP1;POLR2E;CNOT11;TXNRD1;PHF20;MAPKAPK5;GTF2F1;DDIT4;CNOT8;SCO2;RABGGTB;TBP
gsea,ESR-mediated Signaling R-HSA-8939211,-0.5141528710151494,-2.389586658961733,0.0,0.0,0.0,66/142,27.09%,CALM1;HSP90AA1;DDX5;HSP90AB1;GNB2;JUN;MAPK1;H2AZ1;GNG2;SMC1A;CDKN1B;FOXO3;AKT3;RAD21;SMC3;H2AJ;MAPK3;POLR2G;PTGES3;JUND;TNRC6A;STAG2;GNAI2;PRMT1;GNG10;H2BC4;YY1;PIK3R1;POLR2C;POLR2L;H2AX;GNG3;GTF2A1;GNB1;GNG13;CDK9;CBFB;GNG11;PPID;HRAS;GNG7;POLR2I;UHMK1;AKT1;POLR2F;POLR2E;FOSB;NCOA1;GTF2F1;CXXC5;TBP;KDM1A;CREB1;CCNT1;CTSD;CREBBP;GTF2F2;GTF2A2;CXCL12;PTK2;FKBP5;TNRC6B;EBAG9;STRN;NRAS;XPO1
gsea,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.5594070295255081,-2.3892898028508083,0.0,0.0,0.0,45/95,17.96%,UBB;RPS27A;MAPK1;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;AKT3;PSMC6;PSMC5;UBA52;MAPK3;GSK3B;PSMC3;PSMA1;BAX;UBC;PSMC1;PSMD2;PSME3;FBXW7;PSMB3;PSMB1;RBX1;HEY1;PSMA3;PSME2;PSMD6;PSMA5;CDK4;PSMB4;PSMD12;CBFB;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;SMAD1;PSMB7;STUB1;AKT1
gsea,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.5298481601629268,-2.3884192642794333,0.0,0.0,0.0,56/125,24.64%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;CDKN1B;SKP1;PSMA4;AKT3;PSMC6;PSMC5;UBA52;PPP2R1A;PSMC3;PSMA1;CCNH;PCNA;PPP2CA;ORC4;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;MCM6;CDK4;TFDP2;PSMB4;PSMD12;CDKN2D;MCM3;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;MAX;PSMB7;AKT1;POLE3;DHFR;PSMD10;PSMB6;PSMD7;CCND3;E2F4;RB1;PPP2R2A;ORC6;TYMS
gsea,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.6704739082541209,-2.388357273286649,0.0,0.0,0.0,24/44,18.17%,YWHAH;PPP3R1;YWHAB;DYNLL1;DYNLL2;YWHAZ;YWHAG;MAPK1;YWHAE;NMT1;CYCS;YWHAQ;AKT3;MAPK3;BAX;STAT3;GSDME;PPP1R13B;TFDP2;DIABLO;SEPTIN4;C1QBP;AKT1;BAD
gsea,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.6726372313363109,-2.386838520241625,0.0,0.0,0.0,30/41,22.16%,PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;PSMC3;PSMA1;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;PSMD10;PSMB6;PSMD7
gsea,DNA Replication R-HSA-69306,-0.5428055018231603,-2.3847087786036476,0.0,0.0,0.0,55/123,22.16%,UBB;RPS27A;PSMA7;H2AZ1;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;H2AJ;UBA52;GINS2;PSMC3;PSMA1;PCNA;ORC4;POLD4;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RBX1;H2BC4;H2AX;PSMA3;PSME2;PSMD6;GINS4;PSMA5;MCM6;PSMB4;PSMD12;UBE2S;MCM3;RFC3;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;POLE3;ANAPC11;PSMD10;UBE2E1;PSMB6;FEN1;PSMD7
gsea,Neutrophil Degranulation R-HSA-6798695,-0.4887408348965966,-2.3836632088715057,0.0,0.0,0.0,98/309,17.55%,FTH1;HSP90AA1;EEF1A1;HSP90AB1;PPIA;ATP6V0C;HMGB1;ATP6V1D;CST3;HSPA8;DYNLL1;RAB3A;SNAP25;PGRMC1;ITM2C;MAPK1;ACTR2;COMMD3;ARPC5;SRP14;NDUFA2;PRDX5;RAB6A;RAB14;SDCBP;PDAP1;PSMC2;CD47;CTSB;ALDOC;PKM;NME2;ARL8A;EEF2;LAMTOR3;VCL;GSTP1;ATP6AP2;ACTR1B;TMEM30A;SIRPA;VAPA;CHAMP1;RAP2B;SVIP;LAMP1;CSTB;PTPRJ;CCT2;PSMC3;ARSA;DDOST;CAP1;VCP;RAB24;APRT;LAMTOR2;RAB18;DNAJC5;PDXK;PSMD2;IQGAP2;GDI2;ACTR10;TUBB4B;NDUFC2;CSNK2B;PSMB1;CCT8;RAP1A;PSMD6;KCNAB2;PSMA5;RCAN1;COTL1;RAB3D;KCMF1;PSMD12;PFKL;GOLGA7;CPPED1;PAFAH1B2;DYNC1H1;CEP290;PSMA2;LAMP2;PSMD14;RAB5B;CTSZ;YPEL5;CD63;ACLY;CPNE3;RAB31;B2M;PSMB7;ADAM10;ATP11B
gsea,G1/S Transition R-HSA-69206,-0.545029721607699,-2.382787588235237,0.0,0.0,0.0,53/112,24.64%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;CDKN1B;SKP1;PSMA4;AKT3;PSMC6;PSMC5;UBA52;PPP2R1A;PSMC3;PSMA1;CCNH;PCNA;PPP2CA;ORC4;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;MCM6;CDK4;TFDP2;PSMB4;PSMD12;MCM3;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;MAX;PSMB7;AKT1;POLE3;DHFR;PSMD10;PSMB6;PSMD7;E2F4;RB1;ORC6;TYMS
gsea,Mitochondrial Protein Import R-HSA-1268020,-0.6238644145567325,-2.375722475211438,0.0,0.0,0.0,35/58,25.42%,SLC25A4;CHCHD2;COX17;CHCHD10;TOMM20;VDAC1;HSPA9;TOMM7;NDUFB8;TIMM8B;TOMM6;DNAJC19;TOMM22;TOMM5;TIMM10;MTX2;HSPD1;TIMM13;CHCHD4;PMPCA;CCNI;TIMM50;BCS1L;GRPEL1;PAM16;IDH3G;PMPCB;COX19;TIMM21;LDHD;COA6;TIMM44;SAMM50;FXN;TIMM23
gsea,MAPK6/MAPK4 Signaling R-HSA-5687128,-0.5960448299691755,-2.3754526098031983,0.0,0.0,0.0,37/75,15.88%,UBB;RPS27A;JUN;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;FOXO3;PSMC6;PSMC5;UBA52;SEPTIN7;PSMC3;PSMA1;CDC42;UBC;TNRC6A;PSMC1;PSMD2;PSME3;PSMB3;PRKACB;PSMB1;PKN2;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,Collagen Chain Trimerization R-HSA-8948216,0.6922026387271784,2.372247123081669,0.0,0.0001383032951747956,0.001,11/28,6.39%,COL19A1;COL23A1;COL25A1;COL5A2;COL11A1;COL4A4;COL28A1;COL13A1;COL12A1;COL4A1;COL15A1
gsea,"Cell Cycle, Mitotic R-HSA-69278",-0.4591968650040904,-2.3715695446541023,0.0,0.0,0.0,167/428,27.60%,HSP90AA1;HSP90AB1;UBB;TUBA4A;RPS27;RPS27A;SET;RAN;DYNLL1;TUBA1A;TUBB2A;DYNLL2;YWHAG;MAPK1;PSMA7;H2AZ1;CETN2;YWHAE;SEM1;ENSA;BANF1;PAFAH1B1;SMC1A;PSMC2;PSMB5;RAB2A;CDKN1B;TUBB4A;SKP1;PSMA4;AKT3;TPR;RAD21;PSMC6;AKAP9;ZWINT;CSNK1E;PSMC5;SMC3;H2AJ;UBA52;PPP2R1A;MAPK3;CHMP2A;MZT1;GSK3B;NME7;PPP1CB;GINS2;PSMC3;CHMP4B;DCTN1;PSMA1;CCNH;PCNA;SUMO1;TUBB2B;PPP2CA;ORC4;NEK9;POLD4;UBC;PDS5B;SEC13;PSMC1;PSMD2;PPP2R5D;RAB1A;NCAPH2;RAB1B;PSME3;STAG2;DCTN3;EMD;TUBB4B;SMC4;HDAC8;CSNK2B;TUBA1B;PSMB3;PSMB1;RBX1;NUDC;H2BC4;NUP88;H2AX;PRKCB;PSMA3;PSME2;PSMD6;GINS4;PSMA5;MCM6;CDK4;TFDP2;PSMB4;UBE2I;PSMD12;CDKN2D;CHMP7;NUP50;TUBB3;UBE2S;MCM3;DYNC1H1;RFC3;CEP290;PSMA2;CTDNEP1;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;B9D2;KMT5A;PPP2R5E;MAX;WAPL;PSMB7;SEH1L;ACTR1A;AKT1;FBXW11;ANAPC16;ARPP19;CDK11B;POLE3;ANAPC11;NUP205;DHFR;CHMP6;PSMD10;UBE2E1;PPP1R12A;PSMB6;RCC2;FEN1;SSNA1;PSMD7;CCND3;E2F4;DCTN2;RB1;NUP62;PPP2R2A;FZR1;CENPP;ORC6;TYMS;PPP2R2D;NUP107;CCNE1;LCMT1;PCM1;PHLDA1;PPP2R5A;PPP2R5B;PPP1CC;XPO1;CDK7;MASTL;HAUS2;VPS4A;ANAPC1;PSMB10
gsea,Leishmania Infection R-HSA-9658195,-0.512467026599447,-2.3691308285877857,0.0,0.0,0.0,46/158,13.05%,CALM1;HSP90AB1;GNAS;ACTG1;GNB2;ARPC2;PRKAR1A;JUN;MAPK1;ACTR2;WIPF3;ARPC5;GNG2;WASF1;GLP2R;ABI1;PLK2;WASL;ARPC1A;ACTR3;ADCY1;MAPK3;BRK1;NCKAP1;CYFIP2;ARPC3;AHCYL1;CDC42;PRKAR1B;CHGA;ELMO2;ITPR1;GNAI2;PRKACB;GNG10;MC4R;NFKB2;GPR27;RAMP2;NCK1;GNG3;GNB1;ADRB1;GNG13;BAIAP2;PTRH2
gsea,Attenuation Phase R-HSA-3371568,-0.791813556200944,-2.368444697881203,0.0,0.0,0.0,10/20,9.20%,HSP90AA1;HSP90AB1;UBB;HSPA8;HSBP1;HSPH1;DNAJB6;PTGES3;HSPA2;MRPL18
gsea,Separation Of Sister Chromatids R-HSA-2467813,-0.5193879733732939,-2.3648483796859425,0.0,0.0,0.0,60/145,21.37%,UBB;RPS27;RPS27A;DYNLL1;DYNLL2;PSMA7;SEM1;PAFAH1B1;SMC1A;PSMC2;PSMB5;PSMA4;RAD21;PSMC6;ZWINT;PSMC5;SMC3;UBA52;PPP2R1A;PSMC3;PSMA1;PPP2CA;UBC;PDS5B;SEC13;PSMC1;PSMD2;PPP2R5D;PSME3;STAG2;HDAC8;PSMB3;PSMB1;NUDC;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;UBE2S;DYNC1H1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;B9D2;PPP2R5E;WAPL;PSMB7;SEH1L;ANAPC16;ANAPC11;PSMD10;UBE2E1;PSMB6;RCC2
gsea,ER-Phagosome Pathway R-HSA-1236974,-0.6257845665227956,-2.358354731425872,0.0,0.0,0.0,43/68,22.16%,UBB;RPS27A;HMGB1;PSMA7;SEM1;NDUFA2;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PDIA3;PSMC1;PSMD2;PSME3;SEC61G;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;SEC61B;B2M;PSMB7;VAMP3;S100A1;PSMD10;SEC22B;PSMB6;PSMD7
gsea,Signaling By WNT R-HSA-195721,-0.48777803906294837,-2.35805909780202,0.0,0.0,0.0,79/231,17.45%,CALM1;PPP3CA;UBB;PPP3R1;RPS27A;GNB2;YWHAZ;PSMA7;H2AZ1;PPP3CB;AP2M1;SEM1;GNG2;PFN1;PSMC2;PSMB5;VPS29;SOX4;SKP1;PSMA4;TLE5;CSNK1G2;PSMC6;CLTA;CSNK1E;PSMC5;H2AJ;UBA52;PPP2R1A;VPS35;GSK3B;PSMC3;PSMA1;CAMK2A;AP2S1;PPP2CA;UBC;TNRC6A;PSMC1;PSMD2;PPP2R5D;CSNK1A1;PSME3;ITPR1;CSNK2B;PSMB3;PSMB1;GNG10;RBX1;CDC73;H2BC4;H2AX;PRKCB;PSMA3;PSME2;PSMD6;GNG3;GNB1;PSMA5;GNG13;TLE1;PSMB4;PSMD12;CLTC;SNX3;GNG11;PSMA2;PSMD14;PSME4;PSMC4;GNG7;PSME1;PSMD4;AP2B1;CTNNBIP1;CLTB;PPP2R5E;PSMB7;ZRANB1
gsea,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.5016065995550806,-2.35517611210753,0.0,0.0,0.0,68/157,24.91%,CAPZA2;DYNLL1;DYNLL2;ARF5;RAB6B;RAB6A;ARF3;PAFAH1B1;BET1L;STX16;NAPG;TMED7;NSF;STX6;TMED2;TMED9;DCTN1;ARF4;KIF5B;RAB18;SCOC;RAB1A;KIFAP3;RAB1B;ACTR10;VAMP4;DCTN3;TMF1;DCTN6;CAPZB;CYTH2;CUX1;COPZ1;CYTH4;COPG1;COPG2;NAA30;M6PR;PAFAH1B2;NAA38;DYNC1H1;GALNT1;VPS53;ARFRP1;KIF21A;VPS52;COPB2;AGPAT3;ACTR1A;VAMP3;DCTN5;PAFAH1B3;PLA2G6;DCTN4;COPE;KDELR1;UBE2Z;ARFGAP2;KIF15;SEC22B;ARCN1;DCTN2;KIF5C;BICD2;RIC1;VPS54;SYS1;YKT6
gsea,Signaling By NOTCH R-HSA-157118,-0.5004118375679807,-2.3502426683488613,0.0,0.0,0.0,57/164,15.88%,UBB;RPS27A;YWHAZ;JUN;PSMA7;H2AZ1;SEM1;RAB6A;PSMC2;PSMB5;SKP1;PSMA4;MAMLD1;MIB1;PSMC6;APH1A;PSMC5;H2AJ;UBA52;TMED2;NCOR1;SNW1;PSMC3;PSMA1;PSENEN;HDAC2;UBC;TNRC6A;PSMC1;PSMD2;PSME3;FBXW7;HDAC8;PSMB3;PSMB1;WWC1;MIB2;RBX1;H2BC4;HEY1;H2AX;PSMA3;PSME2;PSMD6;PSMA5;TLE1;TFDP2;PSMB4;PSMD12;NEURL1B;NUMB;PSMA2;HDAC5;PSMD14;PSMC4;PSME1;PSMD4
gsea,Signaling By Nuclear Receptors R-HSA-9006931,-0.4903660015305039,-2.344589032282386,0.0,0.0,0.0,83/188,27.29%,CALM1;HSP90AA1;DDX5;HSP90AB1;GNB2;APOE;JUN;MAPK1;H2AZ1;GNG2;SMC1A;CDKN1B;FOXO3;AKT3;RAD21;SMC3;H2AJ;MAPK3;POLR2G;NCOR1;PTGES3;JUND;TNRC6A;STAG2;GNAI2;PRMT1;GNG10;DLAT;H2BC4;YY1;PIK3R1;POLR2C;POLR2L;H2AX;GNG3;GTF2A1;RDH14;GNB1;GNG13;RXRB;CDK9;APOD;GPS2;CBFB;GNG11;PPID;HRAS;GNG7;POLR2I;UHMK1;AKT1;ARL4C;POLR2F;POLR2E;FOSB;ABCA1;NCOA1;GTF2F1;CXXC5;TBP;KDM1A;CYP26B1;CREB1;CCNT1;CTSD;CREBBP;LDHD;FASN;PLTP;GTF2F2;GTF2A2;CXCL12;PTK2;FKBP5;ALDH1A1;TNRC6B;EBAG9;STRN;RARA;ABCG1;NRAS;XPO1;PDHA1
gsea,Signaling By FGFR3 R-HSA-5654741,-0.6579680379944992,-2.3398987424289173,0.0,0.0,0.0,16/34,19.60%,UBB;RPS27A;MAPK1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;BRAF;PIK3R1;SPRY2;HRAS;FGFR3;FGF13;FGF9;PTPN11
gsea,Mitochondrial Translation Initiation R-HSA-5368286,-0.5712277963774551,-2.3397823723501023,0.0,0.0,0.0,61/82,33.47%,MRPL52;AURKAIP1;MRPL36;MRPL12;MRPS26;MRPL11;MRPS21;MRPS2;MRPL57;MRPS14;MRPS5;MRPL20;CHCHD1;MRPS34;MRPS33;OXA1L;MRPS36;MRPL19;MRPL18;MRPL35;MRPS24;MRPL41;MRPL9;MRPS16;MRPL14;MRPL54;MRPL30;ERAL1;MRPL17;MRPL43;MRPL23;MRPL44;MRPL38;MRPL53;MRPS9;MRPS31;MRPL48;MTIF2;MRPS10;MRPL40;MRPL50;MRPS17;MRPL49;MRPS7;MTIF3;MRPL47;MRPS15;MRPL34;MRPS18A;MRPL42;MRPL46;MRPL4;MRPL33;MRPL10;MRPL51;MRPL3;MRPL24;MRPS25;GADD45GIP1;MRPS18B;MRPL32
gsea,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.8141625049755452,-2.3380694517733263,0.0,0.0,0.0,16/21,9.93%,UBB;RPS27A;SQSTM1;TOMM20;VDAC1;PINK1;TOMM7;TOMM6;UBA52;TOMM22;MAP1LC3B;TOMM5;UBC;ATG12;MAP1LC3A;MTERF3
gsea,TP53 Regulates Metabolic Genes R-HSA-5628897,-0.5955968955478855,-2.3349296091325495,0.0,0.0,0.0,39/77,20.87%,YWHAH;YWHAB;COX6C;COX8A;YWHAZ;YWHAG;COX7C;COX5A;COX7A2L;COX5B;YWHAE;PRDX5;COX6A1;COX7B;COX6B1;CYCS;RRAGA;COX4I1;YWHAQ;AKT3;LAMTOR3;LAMTOR2;PRDX1;TNRC6A;COX20;COX14;SURF1;RRAGD;SESN1;PRDX2;PTEN;RHEB;GLS2;AKT1;SCO1;TXNRD1;DDIT4;SCO2;COX19
gsea,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.75910086401387,-2.333327403432447,0.0,0.0,0.0,18/25,14.73%,TUBA4A;TUBA1A;TUBB2A;CCT6A;PFDN2;TUBB4A;PFDN6;CCT2;TUBB2B;PFDN5;TUBB4B;TCP1;TUBA1B;CCT8;VBP1;CCT5;TUBB3;PFDN1
gsea,RHO GTPases Activate PKNs R-HSA-5625740,-0.6812638455829448,-2.3268192174313707,0.0,0.0,0.0,17/37,11.89%,YWHAH;YWHAB;MYL6;YWHAZ;YWHAG;H2AZ1;YWHAE;RHOB;YWHAQ;MYL12B;H2AJ;PPP1CB;KDM4C;PKN2;H2BC4;H2AX;MYH10
gsea,Degradation Of DVL R-HSA-4641258,-0.6418210148961273,-2.3255873491389285,0.0,0.0,0.0,32/51,17.38%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;UBA52;PSMC3;PSMA1;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RBX1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7
gsea,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.6629960669296383,-2.321275464907761,0.0,0.0,0.0,21/33,18.39%,CAPZA2;DYNLL1;DYNLL2;RAB6B;RAB6A;PAFAH1B1;DCTN1;RAB18;ACTR10;DCTN3;DCTN6;CAPZB;PAFAH1B2;DYNC1H1;GALNT1;AGPAT3;ACTR1A;DCTN5;PAFAH1B3;PLA2G6;DCTN4
gsea,Mitochondrial Translation R-HSA-5368287,-0.5630295246604432,-2.3174613010289296,0.0,0.0,0.0,63/88,33.47%,MRPL52;AURKAIP1;MRPL36;MRPL12;MRPS26;MRPL11;MRPS21;MRPS2;MRPL57;MRPS14;MRPS5;MRPL20;CHCHD1;MRPS34;MRPS33;OXA1L;MRPS36;MRPL19;MRPL18;MRPL35;MRPS24;MRPL41;MRPL9;MRPS16;MRPL14;MRPL54;MRPL30;ERAL1;MRPL17;MRPL43;MRPL23;MRPL44;MRPL38;MRPL53;MRPS9;MRPS31;MRPL48;MTIF2;MRPS10;TUFM;MRPL40;MRPL50;MRPS17;MRPL49;MRPS7;MTIF3;TSFM;MRPL47;MRPS15;MRPL34;MRPS18A;MRPL42;MRPL46;MRPL4;MRPL33;MRPL10;MRPL51;MRPL3;MRPL24;MRPS25;GADD45GIP1;MRPS18B;MRPL32
gsea,Signaling By Hedgehog R-HSA-5358351,-0.5162110151942741,-2.315262319434462,0.0,0.0,0.0,46/123,15.88%,UBB;GNAS;RPS27A;PRKAR1A;PSMA7;SEM1;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;PSMC5;UBA52;ADCY1;GSK3B;PSMC3;PSMA1;VCP;PRKAR1B;UBC;PSMC1;PSMD2;CSNK1A1;PSME3;P4HB;PSMB3;PRKACB;PSMB1;RBX1;CDC73;PSMA3;PSME2;PSMD6;HHIP;SPOP;ERLEC1;PSMA5;PSMB4;PSMD12;NUMB;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4
gsea,Mitochondrial Translation Termination R-HSA-5419276,-0.5692307287814625,-2.314682033898785,0.0,0.0,0.0,59/82,33.47%,MRPL52;AURKAIP1;MRPL36;MRPL12;MRPS26;MRPL11;MRPS21;MRPS2;MRPL57;MRPS14;MRPS5;MRPL20;CHCHD1;MRPS34;MRPS33;OXA1L;MRPS36;MRPL19;MRPL18;MRPL35;MRPS24;MRPL41;MRPL9;MRPS16;MRPL14;MRPL54;MRPL30;ERAL1;MRPL17;MRPL43;MRPL23;MRPL44;MRPL38;MRPL53;MRPS9;MRPS31;MRPL48;MRPS10;MRPL40;MRPL50;MRPS17;MRPL49;MRPS7;MRPL47;MRPS15;MRPL34;MRPS18A;MRPL42;MRPL46;MRPL4;MRPL33;MRPL10;MRPL51;MRPL3;MRPL24;MRPS25;GADD45GIP1;MRPS18B;MRPL32
gsea,DNA Replication Pre-Initiation R-HSA-69002,-0.5508639785859453,-2.314013062026651,0.0,0.0,0.0,45/98,21.13%,UBB;RPS27A;PSMA7;H2AZ1;SEM1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;H2AJ;UBA52;PSMC3;PSMA1;ORC4;UBC;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;H2BC4;H2AX;PSMA3;PSME2;PSMD6;PSMA5;MCM6;PSMB4;PSMD12;UBE2S;MCM3;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;UBE2D1;PSMB7;ANAPC16;POLE3;ANAPC11;PSMD10;UBE2E1;PSMB6
gsea,Protein Ubiquitination R-HSA-8852135,-0.580640250659182,-2.3088074365836393,0.0,0.0,0.0,34/62,24.81%,UBB;RPS27A;UBE2N;RRAGA;UBA52;RTF1;PCNA;VCP;UBE2V2;UBC;UBA1;CDC73;H2BC4;SELENOS;OTULIN;UBE2S;DERL1;UBE2G1;PEX12;CDC34;UBE2D1;BCL10;PEX5;PAF1;USP9X;UBE2E3;UBE2Z;UBE2E1;CTR9;RNF181;PEX13;WAC;USP5;RAD18
gsea,Deubiquitination R-HSA-5688426,-0.46795030282750405,-2.308654453856562,0.0,0.0,0.0,94/216,26.71%,UBB;RPS27A;PSMA7;SEM1;TOMM20;MAT2B;VDAC1;PSMC2;PSMB5;PSMA4;USP22;USP14;UCHL1;PSMC6;PSMC5;USP2;UBA52;VCPIP1;NEDD8;PSMC3;VDAC2;PSMA1;VCP;OTUB1;UBC;H2AC25;PSMC1;OTUD7B;PSMD2;PSME3;UIMC1;CYLD;PSMB3;PSMB1;USP19;H2BC4;YY1;PSMA3;PSME2;PSMD6;TAF10;USP20;FOXK1;PSMA5;JOSD1;STAM;PSMB4;PTRH2;PTEN;PSMD12;KEAP1;YOD1;SNX3;PSMA2;PSMD14;NFKBIA;PSME4;PSMC4;TADA3;SMAD2;USP33;PSME1;PSMD4;UBE2D1;DDB2;TADA2B;SMAD1;PSMB7;ZRANB1;STAM2;BIRC2;USP9X;MUL1;TANK;JOSD2;RAD23B;ACTR8;PSMD10;PSMB6;POLG2;PSMD7;USP30;USP15;INO80E;USP5;OTUB2;SMAD3;SMAD7;SMAD4;IKBKG;USP47;USP3;SENP8;HCFC1
gsea,Regulated Necrosis R-HSA-5218859,-0.6571645249519951,-2.307407525707477,0.0,0.0,0.0,22/39,23.64%,HSP90AA1;UBB;RPS27A;HMGB1;SDCBP;CYCS;UBA52;CHMP2A;CHMP4B;BAX;UBC;GSDME;CDC37;CHMP7;IL18;STUB1;BIRC2;GNL3;TANK;CHMP6;XIAP;FASN
gsea,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.5508016360965987,-2.305830875517704,0.0,0.0,0.0,37/81,22.98%,UBB;RPS27A;VAMP2;NECAP1;AP2M1;UBQLN2;CLTA;UBA52;NEDD8;SH3KBP1;COPS6;AP2S1;COPS8;UBC;VAMP4;TFRC;SNAP91;COPS7A;GPS1;STAM;EPN1;CLTC;M6PR;SH3GL1;COPS3;AGFG1;AP2B1;CLTB;STAM2;VAMP3;PICALM;TOR1A;REPS2;AP2A2;FZD4;STON1;EPN2
gsea,Aggrephagy R-HSA-9646399,-0.7461620476142757,-2.3057970101257426,0.0,0.0,0.0,11/22,7.81%,HSP90AA1;UBB;RPS27A;DYNLL1;DYNLL2;UBE2N;UBE2V1;UBA52;VCP;UBC;PARK7
gsea,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.603111352656704,-2.3002624737306223,0.0,0.0,0.0,12/47,9.00%,CALM1;YWHAH;YWHAB;VAMP2;YWHAZ;YWHAG;YWHAE;RAB14;YWHAQ;LNPEP;KIFAP3;RALGAPB
gsea,Disorders Of Transmembrane Transporters R-HSA-5619115,-0.5039737590065918,-2.2999742917368424,0.0,0.0,0.0,62/128,26.20%,UBB;RPS27A;PSMA7;BSG;SEM1;SLC4A4;PSMC2;PSMB5;SLC1A3;PSMA4;TPR;PSMC6;PSMC5;SLC35A1;UBA52;PSMC3;PSMA1;VCP;UBC;SEC13;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;RNF5;NUP88;PSMA3;PSME2;PSMD6;SLC12A6;ERLEC1;PSMA5;PSMB4;PSMD12;SLC24A4;NUP50;DERL1;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;SLC2A9;PSMB7;SEH1L;ABCA1;NUP205;RNF185;PSMD10;PSMB6;PSMD7;ABCB6;SLC16A1;NUP62;SLC9A9;MAP4K5;NUP107;SLC22A5;ABCC8;LMBRD1
gsea,Mitochondrial Translation Elongation R-HSA-5389840,-0.5691836312603736,-2.2992114866116173,0.0,0.0,0.0,61/82,33.47%,MRPL52;AURKAIP1;MRPL36;MRPL12;MRPS26;MRPL11;MRPS21;MRPS2;MRPL57;MRPS14;MRPS5;MRPL20;CHCHD1;MRPS34;MRPS33;OXA1L;MRPS36;MRPL19;MRPL18;MRPL35;MRPS24;MRPL41;MRPL9;MRPS16;MRPL14;MRPL54;MRPL30;ERAL1;MRPL17;MRPL43;MRPL23;MRPL44;MRPL38;MRPL53;MRPS9;MRPS31;MRPL48;MRPS10;TUFM;MRPL40;MRPL50;MRPS17;MRPL49;MRPS7;TSFM;MRPL47;MRPS15;MRPL34;MRPS18A;MRPL42;MRPL46;MRPL4;MRPL33;MRPL10;MRPL51;MRPL3;MRPL24;MRPS25;GADD45GIP1;MRPS18B;MRPL32
gsea,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.5559280461364292,-2.295229844321513,0.0,0.0,0.0,24/69,14.87%,UBB;HSPA8;HSBP1;MAPK1;YWHAE;BAG4;HSPA9;HSPH1;DNAJB6;TPR;MAPK3;GSK3B;ST13;HIKESHI;BAG1;HSPA2;HSPA4;SEC13;BAG5;MRPL18;NUP88;NUP50;HSPA5;HSPA4L
gsea,DARPP-32 Events R-HSA-180024,-0.7464249810842191,-2.292487281869959,0.0,9.397588167731678e-06,0.001,11/22,9.50%,CALM1;PPP3CA;PPP3R1;PRKAR1A;PPP3CB;PPP2R1A;PPP2CA;PPP1CA;PRKAR1B;PPP2R5D;PRKACB
gsea,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.7650870827569743,-2.292250421476573,0.0,9.349641289324884e-06,0.001,17/23,14.73%,TUBA4A;TUBA1A;TUBB2A;CCT6A;PFDN2;TUBB4A;PFDN6;CCT2;TUBB2B;PFDN5;TUBB4B;TCP1;CCT8;VBP1;CCT5;TUBB3;PFDN1
gsea,Neddylation R-HSA-8951664,-0.480224911607448,-2.2918855146548904,0.0,9.302181181257246e-06,0.001,84/212,22.93%,UBB;RPS27A;PSMA7;SQSTM1;COMMD3;SEM1;KLHL9;ELOB;PSMC2;PSMB5;SKP1;PSMA4;PSMC6;RBBP7;FBXL16;PSMC5;UBA52;NEDD8;COPS6;PSMC3;PSMA1;RNF7;VCP;COPS8;BTBD1;UBC;PSMC1;PSMD2;FBXW2;PSME3;DCAF6;FBXW7;ELOC;PSMB3;PSMB1;RBX1;UBA3;COMMD8;FBXO6;WSB2;PSMA3;PSME2;PSMD6;DCAF7;PUM2;COPS7A;GPS1;PSMA5;TULP4;COMMD5;FBXL3;PSMB4;PSMD12;KEAP1;PSMA2;PSMD14;PSME4;PSMC4;COPS3;PSME1;PSMD4;UBE2D1;COMMD2;DDB2;KBTBD7;DCUN1D5;FBXL14;FBXO32;COMMD4;PSMB7;FBXL4;FBXW11;MUL1;KLHL2;WSB1;KBTBD8;PSMD10;PSMB6;UBE2M;COMMD7;ASB13;PSMD7;NUB1;CAND1
gsea,Cell Cycle Checkpoints R-HSA-69620,-0.47349329797513073,-2.290181187138857,0.0,9.255200468220593e-06,0.001,72/215,21.37%,UBB;YWHAH;YWHAB;RPS27;RPS27A;DYNLL1;DYNLL2;YWHAZ;YWHAG;PSMA7;YWHAE;SEM1;PAFAH1B1;UBE2N;PSMC2;YWHAQ;PSMB5;CDKN1B;PSMA4;PSMC6;ZWINT;PSMC5;UBA52;PPP2R1A;PSMC3;PSMA1;PPP2CA;ORC4;UBE2V2;RNF168;UBC;SEC13;PSMC1;PSMD2;PPP2R5D;PSME3;UIMC1;PSMB3;PSMB1;NUDC;H2BC4;H2AX;PSMA3;PSME2;PSMD6;PSMA5;MCM6;PSMB4;PSMD12;ATRIP;UBE2S;MCM3;DYNC1H1;RFC3;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;UBE2D1;B9D2;PPP2R5E;PSMB7;SEH1L;ANAPC16;PHF20;ANAPC11;PSMD10;UBE2E1;PSMB6;RCC2
gsea,Signaling By FGFR4 R-HSA-5654743,-0.6603185731421355,-2.290134709049816,0.0,9.208691923154158e-06,0.001,15/32,19.60%,UBB;RPS27A;MAPK1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;BRAF;PIK3R1;SPRY2;HRAS;FGF13;FGF9;PTPN11
gsea,MyD88-independent TLR4 Cascade R-HSA-166166,-0.5366313107322224,-2.289227783112441,0.0,9.162648463538386e-06,0.001,38/91,22.63%,UBB;RPS27A;HMGB1;JUN;MAPK1;NDUFA2;DUSP3;MEF2A;UBE2N;SKP1;USP14;UBE2V1;UBA52;PPP2R1A;MAPK3;PPP2CA;TBK1;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C;NKIRAS1;NFKB2;NFKBIA;MAPK9;IRF3;UBE2D1;BIRC2;FBXW11;DUSP6;TANK;PTPN11;VRK3;TAB2;MAP2K1;S100B;CREB1
gsea,Cytokine Signaling In Immune System R-HSA-1280215,-0.44385342731884997,-2.2889281674692525,0.0,9.117063147799389e-06,0.001,141/438,21.40%,HSP90AA1;PDZD2;UBB;PPIA;RPS27A;HNRNPA2B1;HMGB1;CAMK2B;HSPA8;EIF4A2;VAMP2;YWHAZ;SNAP25;JUN;MAPK1;PSMA7;SQSTM1;EIF4A1;IL1RAPL1;SEM1;BCL11B;DUSP3;CEBPD;MEF2A;ELOB;UBE2N;AURKAIP1;HSPA9;PSMC2;PSMB5;CANX;CDKN1B;SKP1;EIF4G2;TRIM35;PSMA4;FOXO3;AKT3;TPR;USP14;SOD1;PSMC6;UBE2V1;HSP90B1;TRIM2;PSMC5;UBA52;PPP2R1A;MAPK3;PELI2;PTK2B;PDCD4;PTPRJ;PSMC3;PSMA1;RNF7;CAMK2A;SUMO1;PPP2CA;CDC42;TBK1;S1PR1;UBC;DUSP7;HNRNPF;IFNGR2;SEC13;NDN;RPLP0;PSMC1;PSMD2;PPP2R5D;PSME3;STAT3;IRAK1;NEDD4;IL1RAP;IL1R1;ELOC;P4HB;TCP1;MEF2C;PSMB3;PSMB1;NKIRAS1;RBX1;PKN2;NFKB2;UBA3;NUP88;PIK3R1;PSMA3;PSME2;PSMD6;PSMA5;HNRNPDL;PSMB4;PSMD12;NUP50;CLSTN1;PSMA2;HRAS;PSMD14;NFKBIA;PSME4;PSMC4;MAPK9;PSME1;IRF3;PSMD4;UBE2D1;EGR1;GSTO1;RALA;IL18;HCK;B2M;PSMB7;RNASEH2A;HAVCR2;SOS2;BIRC2;SEH1L;AKT1;GNL3;FBXW11;TALDO1;FGF13;DUSP6;SEPSECS;TANK;PTPN11;VRK3;TYK2;NUP205;TAB2;PSMD10;UBE2E1;PSMB6;UBE2M;MAP2K1
gsea,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.575068568265049,-2.2884647266545044,0.0,9.071929171820184e-06,0.001,21/57,17.96%,CALM1;HSP90AA1;GNB2;MAPK1;GNG2;CDKN1B;FOXO3;AKT3;MAPK3;GNAI2;PRMT1;GNG10;PIK3R1;GNG3;GNB1;GNG13;GNG11;HRAS;GNG7;UHMK1;AKT1
gsea,Activation Of BH3-only Proteins R-HSA-114452,-0.741343999766271,-2.2832987006814873,0.0,9.027239865555061e-06,0.001,10/23,4.07%,YWHAH;PPP3R1;YWHAB;DYNLL1;DYNLL2;YWHAZ;YWHAG;YWHAE;YWHAQ;AKT3
gsea,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.538044419878745,-2.278511107818379,0.0,1.7965977379487034e-05,0.002,36/87,22.63%,UBB;RPS27A;HMGB1;JUN;MAPK1;DUSP3;MEF2A;UBE2N;SKP1;USP14;UBE2V1;UBA52;PPP2R1A;MAPK3;PPP2CA;TBK1;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C;NKIRAS1;NFKB2;NFKBIA;MAPK9;IRF3;UBE2D1;BIRC2;FBXW11;DUSP6;TANK;VRK3;TAB2;MAP2K1;S100B;CREB1
gsea,Signaling By EGFR In Cancer R-HSA-1643713,-0.7369208359347145,-2.2752199548477523,0.00199203187250996,1.7878338465440754e-05,0.002,8/20,14.67%,HSP90AA1;UBB;RPS27A;UBA52;UBC;PIK3R1;CDC37;HRAS
gsea,Signaling By FGFR2 R-HSA-5654738,-0.5733691145625568,-2.2734716082971844,0.0,2.6687325621956465e-05,0.002,29/61,19.60%,UBB;RPS27A;MAPK1;HNRNPH1;HNRNPA1;UBA52;PPP2R1A;MAPK3;POLR2G;PPP2CA;UBC;HNRNPF;BRAF;PIK3R1;POLR2C;POLR2L;SPRY2;HNRNPM;HRAS;TIA1;POLR2I;FGFR2;TIAL1;POLR2F;FGF13;POLR2E;FGF9;GTF2F1;PTPN11
gsea,Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.5480655339653471,-2.273464212725251,0.0,2.6558401343589522e-05,0.002,47/81,28.43%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;MAMLD1;FOXO3;PSMC6;PSMC5;UBA52;SNW1;PSMC3;PSMA1;UBC;PSMC1;PSMD2;BRD2;PSME3;PSMB3;PSMB1;PSMA3;PSME2;PSMD6;PSMA5;PSMB4;PSMD12;CBFB;PSMA2;PSMD14;PSMC4;PSME1;PSMD4;PSMB7;CTNNB1;PSMD10;MAML2;PSMB6;PSMD7;CREBBP;SMAD3;SMAD4;NRAS;PSMB10;JAG1;PSMD11
gsea,Potential Therapeutics For SARS R-HSA-9679191,-0.5454691186206668,-2.2695508421844064,0.0,2.6430716721745344e-05,0.002,32/81,21.14%,ATP1B1;HSP90AA1;HSP90AB1;AP2M1;FKBP1A;ATP1A2;CHD3;ATP1B2;RBBP7;ATP1A3;SAP18;PTGES3;SH3KBP1;AP2S1;TBK1;S1PR1;HDAC2;IFNGR2;ROCK2;IL1R1;RBX1;NCK1;KEAP1;CRBN;GATAD2B;AP2B1;COMT;FXYD1;ARID4A;TYK2;KDM1A;AP2A2
gsea,Clathrin-mediated Endocytosis R-HSA-8856828,-0.5079777888997995,-2.2695334010108543,0.0,2.6304253962311156e-05,0.002,44/117,18.72%,UBB;RPS27A;HSPA8;VAMP2;ARPC2;NECAP1;ACTR2;AP2M1;ARPC5;UBQLN2;WASL;ARPC1A;CLTA;ACTR3;UBA52;NEDD8;SH3KBP1;COPS6;ARPC3;AP2S1;COPS8;UBC;VAMP4;TFRC;SNAP91;COPS7A;GPS1;STAM;EPN1;CLTC;PIK3C2A;M6PR;SH3GL1;RAB5B;COPS3;AGFG1;AP2B1;CLTB;STAM2;VAMP3;PICALM;TRIP10;TOR1A;PIP5K1C
gsea,Oncogenic MAPK Signaling R-HSA-6802957,-0.5463951657259083,-2.2630062176163785,0.0,2.6178995610109674e-05,0.002,26/67,18.78%,CALM1;YWHAB;CAMK2B;PEBP1;MAPK1;AKAP9;VCL;MAPK3;QKI;PPP1CB;KSR1;CAMK2A;DUSP7;CNKSR2;BRAF;RAP1A;TRIM24;KDM7A;ARAF;AGGF1;HRAS;MPRIP;DUSP8;FAM131B;DUSP6;FAM114A2
gsea,Interleukin-12 Signaling R-HSA-9020591,-0.6641111098997504,-2.2614100599476017,0.0,2.605492454086745e-05,0.002,18/32,19.95%,PPIA;HNRNPA2B1;AURKAIP1;HSPA9;SOD1;PDCD4;CDC42;HNRNPF;RPLP0;P4HB;TCP1;PKN2;PSME2;HNRNPDL;GSTO1;RALA;TALDO1;TYK2
gsea,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.6059834136411202,-2.258417335390252,0.0,3.457603193788071e-05,0.003,25/43,24.81%,UBB;RPS27A;UBE2N;RRAGA;UBA52;RTF1;PCNA;VCP;UBE2V2;UBC;CDC73;H2BC4;SELENOS;DERL1;PEX12;UBE2D1;BCL10;PEX5;PAF1;UBE2E1;CTR9;RNF181;PEX13;WAC;RAD18
gsea,PIP3 Activates AKT Signaling R-HSA-1257604,-0.46368540832018873,-2.257815994261355,0.0,3.441370314943995e-05,0.003,85/224,19.60%,UBB;RPS27A;CBX6;JUN;MAPK1;PSMA7;SEM1;CHD3;PSMC2;RRAGA;PSMB5;CDKN1B;PSMA4;FOXO3;AKT3;PSMC6;LAMTOR3;RBBP7;PSMC5;UBA52;PPP2R1A;MAPK3;VAPA;GSK3B;PSMC3;PSMA1;PIP4K2A;PPP2CA;LAMTOR2;HDAC2;UBC;TNRC6A;RING1;PSMC1;PSMD2;PPP2R5D;PSME3;IRAK1;NEDD4;IL1RAP;CSNK2B;PSMB3;PSMB1;RRAGD;CNOT6L;PIK3R1;FGFR1;PSMA3;PSME2;PSMD6;AKT1S1;PSMA5;PDGFA;PSMB4;RICTOR;PTEN;PSMD12;INSR;CLSTN1;ERBB3;CBX8;PSMA2;HDAC5;PSMD14;PSME4;PSMC4;FGFR3;RHEB;GATAD2B;PSME1;PSMD4;FGFR2;EGR1;PIP4K2B;PPP2R5E;PSMB7;STUB1;AKT1;BAD;MKRN1;FGF13;FGF9;PIP5K1C;RNMT;PTPN11
gsea,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.8110146248653988,-2.2572884301061884,0.0,3.4252891452479946e-05,0.003,8/15,4.07%,YWHAH;PPP3R1;YWHAB;YWHAZ;YWHAG;YWHAE;YWHAQ;AKT3
gsea,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.7408894628996859,2.2498362751712007,0.0,0.0002766065903495912,0.003,11/18,8.19%,PRKG1;PDE1A;KCNMA1;PDE9A;PDE10A;GUCY1A2;PDE11A;KCNMB4;PRKG2;PDE2A;PDE5A
gsea,Intracellular Signaling By Second Messengers R-HSA-9006925,-0.4550654498158498,-2.240180551264809,0.0,4.2616969597852955e-05,0.004,95/260,18.72%,CALM1;UBB;RPS27A;CAMK2B;CBX6;PRKAR1A;JUN;MAPK1;PSMA7;SEM1;CHD3;PSMC2;RRAGA;PSMB5;CDKN1B;PSMA4;FOXO3;AKT3;PSMC6;LAMTOR3;RBBP7;PSMC5;UBA52;PPP2R1A;ADCY1;MAPK3;VAPA;GSK3B;PSMC3;PSMA1;CAMK2A;PIP4K2A;AHCYL1;PPP2CA;LAMTOR2;PRKAR1B;HDAC2;UBC;TNRC6A;RING1;PSMC1;PSMD2;PPP2R5D;PSME3;IRAK1;NEDD4;IL1RAP;ITPR1;CSNK2B;PSMB3;PRKACB;PSMB1;RRAGD;CNOT6L;PIK3R1;FGFR1;PSMA3;PSME2;PSMD6;CAMKK1;AKT1S1;PSMA5;PDGFA;PSMB4;RICTOR;PTEN;PSMD12;INSR;CLSTN1;ERBB3;CBX8;PSMA2;HDAC5;PSMD14;PSME4;PSMC4;FGFR3;RHEB;GATAD2B;PSME1;PSMD4;FGFR2;EGR1;PIP4K2B;PPP2R5E;PDE1C;PSMB7;STUB1;AKT1;CAMKK2;BAD;MKRN1;FGF13;FGF9;PIP5K1C
gsea,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.7003084523661148,-2.238361543750667,0.0,4.2419668812677707e-05,0.004,14/24,19.60%,UBB;RPS27A;MAPK1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;BRAF;SPRY2;FGFR3;FGF13;FGF9;PTPN11
gsea,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.5433937972538335,-2.236428359470532,0.0,5.06690237615026e-05,0.005,15/65,9.04%,HSP90AA1;TUBA4A;DYNLL1;TUBA1A;YWHAG;CETN2;YWHAE;PAFAH1B1;TUBB4A;AKAP9;CSNK1E;PPP2R1A;DCTN1;DCTN3;TUBB4B
gsea,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.5290731969245567,-2.2362539504713688,0.0,4.99780825283912e-05,0.005,24/87,10.02%,UBB;RPS27A;HMGB1;JUN;MAPK1;NDUFA2;DUSP3;MEF2A;UBE2N;SKP1;USP14;UBE2V1;UBA52;PPP2R1A;MAPK3;PELI2;PPP2CA;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C;NKIRAS1;NFKB2
gsea,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.5290731969245567,-2.2362539504713688,0.0,4.99780825283912e-05,0.005,24/87,10.02%,UBB;RPS27A;HMGB1;JUN;MAPK1;NDUFA2;DUSP3;MEF2A;UBE2N;SKP1;USP14;UBE2V1;UBA52;PPP2R1A;MAPK3;PELI2;PPP2CA;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C;NKIRAS1;NFKB2
gsea,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.5290731969245567,-2.2362539504713688,0.0,4.99780825283912e-05,0.005,24/87,10.02%,UBB;RPS27A;HMGB1;JUN;MAPK1;NDUFA2;DUSP3;MEF2A;UBE2N;SKP1;USP14;UBE2V1;UBA52;PPP2R1A;MAPK3;PELI2;PPP2CA;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C;NKIRAS1;NFKB2
gsea,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.4863223801177471,-2.2360204048188006,0.0,4.9751937358579474e-05,0.005,63/156,23.18%,UBB;RPS27A;CBX6;PSMA7;H2AZ1;SEM1;LMO1;PSMC2;PSMB5;PSMA4;PSMC6;PSMC5;H2AJ;UBA52;PSMC3;PSMA1;CCNH;TCF12;UBC;TNRC6A;RING1;PSMC1;PSMD2;HIPK2;PSME3;SMARCE1;PRMT1;CSNK2B;PBRM1;PSMB3;PSMB1;H2BC4;CTSL;H2AX;PRKCB;PSMA3;PSME2;PSMD6;PSMA5;ACTL6B;PSMB4;PSMD12;CBFB;CBX8;PSMA2;PSMD14;PSME4;PSMC4;SMARCC2;PSME1;PSMD4;SETD1B;PSMB7;SMARCD2;KMT2C;PTPN11;PSMD10;PSMB6;PRMT6;PSMD7;CCND3;PML;CREBBP
gsea,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.6883111545483408,-2.234232029318454,0.0,4.952782953263992e-05,0.005,16/27,18.30%,PPIA;HNRNPA2B1;AURKAIP1;HSPA9;SOD1;PDCD4;CDC42;HNRNPF;RPLP0;TCP1;PKN2;PSME2;HNRNPDL;GSTO1;RALA;TALDO1
gsea,Signaling By FGFR R-HSA-190236,-0.5420384180545232,-2.2336225077560568,0.0,4.9305731642359026e-05,0.005,32/72,19.60%,UBB;RPS27A;MAPK1;HNRNPH1;HNRNPA1;UBA52;PPP2R1A;MAPK3;POLR2G;PPP2CA;UBC;HNRNPF;BRAF;PIK3R1;POLR2C;POLR2L;FGFR1;SPRY2;FLRT3;HNRNPM;HRAS;TIA1;FGFR3;POLR2I;FGFR2;TIAL1;POLR2F;FGF13;POLR2E;FGF9;GTF2F1;PTPN11
gsea,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.5859633901835183,-2.2323630025672703,0.0,4.908561676895564e-05,0.005,14/54,10.02%,HSP90AA1;HSP90AB1;PDZD2;UBB;RPS27A;HMGB1;UBA52;PCBP2;TBK1;UBC;ATG12;CYLD;NKIRAS1;NFKB2
gsea,Cytoprotection By HMOX1 R-HSA-9707564,-0.6077026263862372,-2.2321122084143923,0.0,4.8867458472204725e-05,0.005,16/49,10.04%,COX6C;COX8A;COX7C;COX5A;COX7A2L;COX5B;COX6A1;COX7B;COX6B1;CYCS;COX4I1;NCOR1;COX20;STAT3;COX14;SURF1
gsea,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.6343350700310709,-2.2296317110679857,0.0,4.865123077984984e-05,0.005,21/38,22.11%,UBB;YWHAB;RPS27A;PEBP1;MAPK1;UBA52;PPP2R1A;MAPK3;KSR1;PPP2CA;UBC;DUSP7;PPP2R5D;BRAF;ARAF;HRAS;DUSP8;PPP2R5E;DUSP6;MAP2K1;DUSP2
gsea,AURKA Activation By TPX2 R-HSA-8854518,-0.5419042265087892,-2.2290378412186507,0.0,4.843690817729543e-05,0.005,15/66,9.04%,HSP90AA1;TUBA4A;DYNLL1;TUBA1A;YWHAG;CETN2;YWHAE;PAFAH1B1;TUBB4A;AKAP9;CSNK1E;PPP2R1A;DCTN1;DCTN3;TUBB4B
gsea,Spry Regulation Of FGF Signaling R-HSA-1295596,-0.782153674998947,-2.2270430179327128,0.0,4.822446559757045e-05,0.005,10/16,12.76%,UBB;RPS27A;MAPK1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;BRAF;SPRY2
gsea,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.6227880245982995,-2.226266627542679,0.0,4.801387841155486e-05,0.005,14/34,14.67%,CALM1;YWHAB;CAMK2B;PEBP1;MAPK1;VCL;MAPK3;KSR1;CAMK2A;CNKSR2;BRAF;RAP1A;ARAF;HRAS
gsea,Centrosome Maturation R-HSA-380287,-0.5318496636879116,-2.2261288556212135,0.0,4.7805122418461145e-05,0.005,17/74,9.04%,HSP90AA1;TUBA4A;DYNLL1;TUBA1A;YWHAG;CETN2;YWHAE;PAFAH1B1;TUBB4A;AKAP9;CSNK1E;PPP2R1A;MZT1;NME7;DCTN1;DCTN3;TUBB4B
gsea,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.5321316520031245,-2.225006987656184,0.0,5.553120280932355e-05,0.006,23/82,10.02%,UBB;RPS27A;HMGB1;JUN;MAPK1;DUSP3;MEF2A;UBE2N;SKP1;USP14;UBE2V1;UBA52;PPP2R1A;MAPK3;PELI2;PPP2CA;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C;NKIRAS1;NFKB2
gsea,UCH Proteinases R-HSA-5689603,-0.5450144775167378,-2.2196851442956493,0.0,6.319067905888543e-05,0.007,49/82,28.60%,UBB;RPS27A;PSMA7;SEM1;PSMC2;PSMB5;PSMA4;UCHL1;PSMC6;PSMC5;UBA52;NEDD8;PSMC3;PSMA1;UBC;H2AC25;PSMC1;PSMD2;PSME3;PSMB3;PSMB1;YY1;PSMA3;PSME2;PSMD6;FOXK1;PSMA5;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;PSMB7;ACTR8;PSMD10;PSMB6;PSMD7;USP15;INO80E;SMAD7;SENP8;HCFC1;PSMB10;ACTL6A;PSMD11;MCRS1
gsea,TNF Signaling R-HSA-75893,-0.6174119849631902,-2.219313989172395,0.0,6.29194744277314e-05,0.007,16/41,20.92%,UBB;RPS27A;RACK1;BAG4;USP2;UBA52;UBC;CLIP3;OTUD7B;NSMAF;CYLD;OTULIN;BIRC2;TANK;TAB2;TAX1BP1
gsea,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.5349757420909719,-2.2191401094558847,0.0,6.265058778487786e-05,0.007,17/74,9.04%,HSP90AA1;TUBA4A;DYNLL1;TUBA1A;YWHAG;CETN2;YWHAE;PAFAH1B1;TUBB4A;AKAP9;CSNK1E;PPP2R1A;MZT1;NME7;DCTN1;DCTN3;TUBB4B
gsea,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.521351551256822,-2.217697492396872,0.0,6.238398953898476e-05,0.007,24/91,10.02%,UBB;RPS27A;HMGB1;JUN;MAPK1;NDUFA2;DUSP3;MEF2A;UBE2N;SKP1;USP14;UBE2V1;UBA52;PPP2R1A;MAPK3;PELI2;PPP2CA;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C;NKIRAS1;NFKB2
gsea,Deadenylation-dependent mRNA Decay R-HSA-429914,-0.5663422547502958,-2.2172861476961523,0.0,6.211965060026025e-05,0.007,31/54,26.57%,EIF4A2;EIF4A1;PABPC1;XRN1;DCP2;EXOSC4;CNOT6;TUT4;LSM2;CNOT6L;DDX6;EXOSC3;LSM5;LSM4;EIF4B;PAIP1;CNOT10;LSM3;CNOT7;CNOT11;CNOT8;EXOSC9;EXOSC5;EXOSC2;HBS1L;LSM7;EXOSC1;LSM6;EXOSC7;PAN3;DIS3
gsea,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.7412882358706422,-2.207223192302026,0.00199203187250996,6.958973516611432e-05,0.008,8/18,14.67%,HSP90AA1;UBB;RPS27A;UBA52;UBC;PIK3R1;CDC37;HRAS
gsea,Chaperone Mediated Autophagy R-HSA-9613829,-0.8233212255952497,-2.205893407355044,0.0,6.929734132087854e-05,0.008,9/16,7.81%,HSP90AA1;EEF1A1;HSP90AB1;UBB;RPS27A;HSPA8;UBA52;UBC;PARK7
gsea,RAF/MAP Kinase Cascade R-HSA-5673001,-0.4495039640986415,-2.2056669295524065,0.0,6.900739428606315e-05,0.008,75/218,18.77%,CALM1;UBB;YWHAB;NEFL;RPS27A;CAMK2B;PEBP1;RASAL2;MAPK1;PSMA7;RASGRP1;SEM1;PSMC2;PSMB5;RAPGEF2;PSMA4;PSMC6;LAMTOR3;VCL;PSMC5;UBA52;PPP2R1A;MAPK3;PPP1CB;KSR1;PSMC3;PSMA1;CAMK2A;PPP2CA;LAMTOR2;UBC;DUSP7;PSMC1;PSMD2;PPP2R5D;PSME3;CNKSR2;PSMB3;RASGRF1;PSMB1;RBX1;BRAF;RAP1A;PIK3R1;FGFR1;PSMA3;PSME2;PSMD6;ARL2;PSMA5;ABHD17A;PDGFA;ARAF;PSMB4;PSMD12;GOLGA7;ERBB3;PSMA2;HRAS;PSMD14;PSME4;PSMC4;FGFR3;PSME1;PSMD4;DUSP8;FGFR2;KBTBD7;PPP2R5E;GPRIN1;PSMB7;LYPLA1;FGF13;FGF9;DUSP6
gsea,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.6547547507347031,-2.2023080981087633,0.001941747572815534,6.871986347653789e-05,0.008,17/28,25.03%,UBB;RPS27A;MAPK1;SKIL;UBA52;MAPK3;NCOR1;SNW1;UBC;SMAD2;UBE2D1;PARP1;USP9X;PPM1A;SMAD3;SMAD7;SMAD4
gsea,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.5232571139905594,-2.2018154096983165,0.0,6.843471881480952e-05,0.008,24/88,10.02%,UBB;RPS27A;HMGB1;JUN;MAPK1;NDUFA2;DUSP3;MEF2A;UBE2N;SKP1;USP14;UBE2V1;UBA52;PPP2R1A;MAPK3;PELI2;PPP2CA;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C;NKIRAS1;NFKB2
gsea,ER To Golgi Anterograde Transport R-HSA-199977,-0.48445477319174285,-2.2011772517530312,0.0,6.815193072053344e-05,0.008,63/119,30.47%,CNIH2;CAPZA2;DYNLL1;DYNLL2;ARF5;ARF3;BET1L;CNIH1;NAPG;GOLGB1;TMED7;NSF;TMED2;TMED9;DCTN1;ARF4;TRAPPC6B;SEC13;RAB1A;RAB1B;ACTR10;DCTN3;TRAPPC6A;DCTN6;TRAPPC2;MIA3;MCFD2;CAPZB;SEC24A;COPZ1;COPG1;COPG2;DYNC1H1;TRAPPC2L;SAR1B;CTSZ;COPB2;ACTR1A;DCTN5;LMAN2;DCTN4;COPE;KDELR1;TBC1D20;SEC23IP;ARFGAP2;SEC22B;LMAN1;ARCN1;DCTN2;SPTBN2;YKT6;TRAPPC4;PPP6C;ANK1;SEC24C;COPA;SEC23A;SEC22C;COPB1;ANKRD28;USO1;TRAPPC1
gsea,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.5672043033254957,-2.200191813756955,0.0,6.787147010028433e-05,0.008,17/52,10.55%,RPS6;PRKAR1A;MAPK1;SQSTM1;EEF1G;NPM1;SKP1;TPR;VCL;MAPK3;CEBPB;DCTN1;KIF5B;STAT3;RBX1;RRBP1;PIK3R1
gsea,Opioid Signaling R-HSA-111885,-0.5286424033048832,-2.1980586570447547,0.0,7.510367593064251e-05,0.008,27/79,12.59%,CALM1;PPP3CA;PPP3R1;CAMK2B;GNB2;PRKAR1A;MAPK1;PPP3CB;GNG2;GNAL;PPP2R1A;ADCY1;CAMK2A;AHCYL1;PPP2CA;PPP1CA;PRKAR1B;PPP2R5D;ITPR1;GNAI2;PRKACB;GNG10;CAMKK1;GNG3;GNB1;GNG13;PPP1R1B
gsea,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.6404924670504775,-2.1978652574671718,0.0,7.479713031459907e-05,0.008,19/35,18.39%,HSP90AA1;HSP90AB1;CAPZA2;HSPA8;DYNLL1;DYNLL2;DNAJA1;DNAJA2;PTGES3;DCTN1;HSPA2;ACTR10;DCTN3;DCTN6;CAPZB;DYNC1H1;ACTR1A;DCTN5;DCTN4
gsea,MAPK1/MAPK3 Signaling R-HSA-5684996,-0.44636544444504517,-2.195991643460522,0.0,7.449307693933647e-05,0.008,84/221,22.16%,CALM1;UBB;YWHAB;NEFL;RPS27A;CAMK2B;PEBP1;RASAL2;MAPK1;PSMA7;RASGRP1;SEM1;PSMC2;PSMB5;RAPGEF2;PSMA4;PSMC6;LAMTOR3;VCL;PSMC5;UBA52;PPP2R1A;MAPK3;PPP1CB;KSR1;PSMC3;PSMA1;CAMK2A;PPP2CA;LAMTOR2;UBC;DUSP7;PSMC1;PSMD2;PPP2R5D;PSME3;CNKSR2;PSMB3;RASGRF1;PSMB1;RBX1;BRAF;RAP1A;PIK3R1;FGFR1;PSMA3;PSME2;PSMD6;ARL2;PSMA5;ABHD17A;PDGFA;ARAF;PSMB4;PSMD12;GOLGA7;ERBB3;PSMA2;HRAS;PSMD14;PSME4;PSMC4;FGFR3;PSME1;PSMD4;DUSP8;FGFR2;KBTBD7;PPP2R5E;GPRIN1;PSMB7;LYPLA1;FGF13;FGF9;DUSP6;RNMT;PTPN11;TYK2;PSMD10;PSMB6;MAP2K1;SHOC2;DUSP2;PSMD7
gsea,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.5078185433137589,-2.192977527831752,0.0,7.419148553472378e-05,0.008,39/92,25.15%,CALM1;TMSB4X;PPIA;TUBA4A;APLP2;PFN1;CLU;SOD1;VCL;TMX3;OLA1;CAP1;FAM3C;NHLRC2;CALU;VTI1B;TGFB2;MANF;HABP4;ABCC4;VEGFB;PRKCB;SCCPDH;TIMP3;PDGFA;SCG3;HSPA5;LAMP2;CD63;MAGED2;ENDOD1;SELENOP;TEX264;WDR1;CD9;TLN1;PLEK;CYRIB;FN1
gsea,mRNA Splicing - Minor Pathway R-HSA-72165,-0.5897137646235245,-2.1916852066349883,0.0,7.389232631885794e-05,0.008,31/49,24.28%,SF3B2;SRSF1;SNRPD2;SNRPF;POLR2G;SF3B4;SNRPG;ZRSR2;SNRNP200;SF3B1;POLR2C;POLR2L;SNRPE;DDX42;PDCD7;SRSF2;SNRPB;POLR2I;ZMAT5;POLR2F;POLR2E;SF3B5;PRPF8;GTF2F1;SRSF7;SF3B3;SF3B6;NCBP2;ZCRB1;SRSF6;GTF2F2
gsea,RAF Activation R-HSA-5673000,-0.6259984274702611,-2.190066332598058,0.0,7.359556998826011e-05,0.008,19/30,27.02%,CALM1;YWHAB;CAMK2B;PPP2R1A;PPP1CB;KSR1;CAMK2A;PPP2CA;PPP2R5D;BRAF;ARAF;HRAS;PPP2R5E;MAP2K1;SHOC2;PPP2R5A;PPP2R5B;NRAS;PPP1CC
gsea,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.5578158660596515,-2.186919223286256,0.0,8.063130647913778e-05,0.008,30/59,28.60%,RPS2;RPS6;RPS7;RPS9;RPS14;SNU13;THUMPD1;TRMT112;UTP3;NOP10;PDCD11;EMG1;MPHOSPH10;RRP7A;NOL11;NOC4L;GAR1;NOP58;KRR1;NOP56;FBL;UTP18;FCF1;DKC1;NOL6;NHP2;DDX47;UTP11;DIMT1;NOP14
gsea,Protein Methylation R-HSA-8876725,-0.7588923717319158,-2.183265524007236,0.0,8.761098132466982e-05,0.009,6/17,6.60%,CALM1;EEF1A1;RPS2;HSPA8;EEF2;VCP
gsea,Signaling By RAF1 Mutants R-HSA-9656223,-0.6145173119077121,-2.1814092738484683,0.0,8.726331870036557e-05,0.009,13/32,14.67%,CALM1;YWHAB;CAMK2B;MAPK1;VCL;MAPK3;KSR1;CAMK2A;CNKSR2;BRAF;RAP1A;ARAF;HRAS
gsea,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.7685943383173109,-2.1786460533157896,0.0,9.416160476363558e-05,0.009,13/19,13.89%,TUBA4A;TUBA1A;TUBB2A;CCT6A;TUBB4A;CCT2;TUBB2B;TUBB4B;TCP1;TUBA1B;CCT8;CCT5;TUBB3
gsea,NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.7794325296293045,-2.1780922956529754,0.0,9.37908897842512e-05,0.009,7/15,7.28%,UBB;RPS27A;SQSTM1;APH1A;UBA52;PSENEN;UBC
gsea,RHOBTB GTPase Cycle R-HSA-9706574,-0.6234141473793386,-2.1769119320707393,0.0,9.342308237333256e-05,0.009,13/35,12.12%,HSP90AA1;HSP90AB1;ACTG1;CCT6A;RBM15;HNRNPC;PHIP;CCT2;TWF1;ROCK2;CDC37;TXNL1;GPS1
gsea,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.6927643681204706,-2.1768764507339755,0.0,9.305814845781173e-05,0.009,13/23,19.60%,UBB;RPS27A;MAPK1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;BRAF;SPRY2;FGF13;FGF9;PTPN11
gsea,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.6857328452062789,-2.1767587057169284,0.0,9.269605449494088e-05,0.009,13/24,23.64%,HSP90AA1;UBB;RPS27A;SDCBP;UBA52;UBC;CDC37;STUB1;BIRC2;GNL3;TANK;XIAP;FASN
gsea,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.6826259884750039,-2.1744553486603997,0.0,0.00011364525226094124,0.01,10/23,11.22%,HSP90AA1;HSP90AB1;ACTG1;CCT6A;HNRNPC;PHIP;CCT2;TWF1;CDC37;TXNL1
gsea,Transferrin Endocytosis And Recycling R-HSA-917977,-0.6925968933287203,-2.174446517140385,0.0,0.00011320646750317699,0.01,11/24,10.63%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V1E1;ATP6AP1;ATP6V1F;ATP6V0E2;ATP6V1G1;ATP6V1B2;TFRC
gsea,Glucagon-type Ligand Receptors R-HSA-420092,-0.7323979003099121,-2.1740705241170457,0.0,0.00011277105801278015,0.01,10/19,15.43%,GNAS;GNB2;GNG2;GLP2R;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,HIV Life Cycle R-HSA-162587,-0.4795601269149061,-2.1730341254813768,0.0,0.00012638135811777085,0.012,82/136,36.62%,UBB;PPIA;PSIP1;RPS27A;RAN;NMT1;BANF1;ELOB;TPR;TCEA1;UBA52;CHMP2A;POLR2G;CHMP4B;CCNH;GTF2H1;UBC;SEC13;VPS28;TAF11;ELOC;TAF3;GTF2H5;NUP88;POLR2C;POLR2L;XRCC4;TAF10;GTF2A1;GTF2B;CDK9;CHMP7;CHMP5;NUP50;RANBP1;POLR2I;TAF7;VPS37D;SEH1L;POLR2F;SSRP1;POLR2E;GTF2F1;RNMT;VPS4B;NUP205;TBP;CHMP6;TSG101;HMGA1;FEN1;NCBP2;CCNT1;NUP62;GTF2H4;GTF2F2;VTA1;GTF2A2;NUP107;VPS37B;XPO1;CDK7;VPS4A;PDCD6IP;POLR2J;TAF1;LIG4;NUP133;POLR2B;KPNA1;XRCC6;CCNT2;POLR2K;NUP85;RANGAP1;NUP54;GTF2H3;MVB12B;TAF9;POLR2D;POM121;GTF2E1
gsea,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.5832674474840028,-2.16766558266608,0.0,0.0001258989865219015,0.012,22/46,25.03%,UBB;RPS27A;MAPK1;SKIL;UBA52;MAPK3;NCOR1;SNW1;UBC;CDK9;TFDP2;SMAD2;UBE2D1;PARP1;RNASEH2A;USP9X;PPM1A;E2F4;CCNT1;SMAD3;SMAD7;SMAD4
gsea,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.6171670755669204,-2.165262158489345,0.0,0.00013238807665948997,0.013,11/37,10.02%,UBB;RPS27A;HMGB1;UBE2N;USP14;UBE2V1;UBA52;UBC;IRAK1;NKIRAS1;NFKB2
gsea,Interleukin-17 Signaling R-HSA-448424,-0.546749851559119,-2.165210114479098,0.0,0.00013188660667214343,0.013,18/60,9.47%,UBB;RPS27A;JUN;MAPK1;DUSP3;MEF2A;UBE2N;SKP1;UBE2V1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C
gsea,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.44689447368194096,-2.162078121827375,0.0,0.00014521933413909894,0.015,74/193,25.36%,CALM1;TMSB4X;PPIA;TUBA4A;GNB2;YWHAZ;MAPK1;RASGRP1;GNG2;DGKH;APLP2;RHOB;PFN1;CLU;SOD1;VCL;MAPK3;TMX3;OLA1;AAMP;CAP1;CDC42;FAM3C;DAGLA;NHLRC2;CALU;VTI1B;TGFB2;ITPR1;GNAI2;GNG10;ABHD12;MANF;P2RY12;HABP4;RAP1A;ABCC4;VEGFB;PIK3R1;PRKCB;GNG3;GNB1;SCCPDH;TIMP3;GNG13;PDGFA;SCG3;HSPA5;GNG11;LAMP2;ADRA2C;GNG7;MGLL;CD63;MAGED2;ENDOD1;AKT1;SELENOP;PTPN11;TEX264;GNA11;WDR1;VAV2;CD9;TLN1;DGKI;GNA15;DGKD;PLEK;BCAR1;DGKE;CYRIB;FN1;PTK2
gsea,Platelet Degranulation R-HSA-114608,-0.5063707509405577,-2.161040255370676,0.0,0.00014467339679271135,0.015,38/88,25.15%,CALM1;TMSB4X;PPIA;TUBA4A;APLP2;PFN1;CLU;SOD1;VCL;TMX3;OLA1;CAP1;FAM3C;NHLRC2;CALU;VTI1B;TGFB2;MANF;HABP4;ABCC4;VEGFB;SCCPDH;TIMP3;PDGFA;SCG3;HSPA5;LAMP2;CD63;MAGED2;ENDOD1;SELENOP;TEX264;WDR1;CD9;TLN1;PLEK;CYRIB;FN1
gsea,MAPK Family Signaling Cascades R-HSA-5683057,-0.43294937083463964,-2.160832227532272,0.0,0.00014413154886464878,0.015,93/252,22.43%,CALM1;UBB;YWHAB;NEFL;RPS27A;CAMK2B;PEBP1;JUN;RASAL2;MAPK1;PSMA7;RASGRP1;SEM1;PSMC2;PSMB5;RAPGEF2;PSMA4;FOXO3;PSMC6;LAMTOR3;VCL;PSMC5;UBA52;PPP2R1A;MAPK3;SEPTIN7;PPP1CB;KSR1;PSMC3;PSMA1;CAMK2A;PPP2CA;CDC42;LAMTOR2;UBC;DUSP7;TNRC6A;PSMC1;PSMD2;PPP2R5D;PSME3;CNKSR2;PSMB3;RASGRF1;PRKACB;PSMB1;RBX1;PKN2;BRAF;RAP1A;PIK3R1;FGFR1;PSMA3;PSME2;PSMD6;ARL2;PSMA5;ABHD17A;PDGFA;ARAF;PSMB4;PSMD12;GOLGA7;ERBB3;PSMA2;HRAS;PSMD14;PSME4;PSMC4;FGFR3;PSME1;PSMD4;DUSP8;FGFR2;KBTBD7;PPP2R5E;GPRIN1;PSMB7;LYPLA1;FGF13;FGF9;DUSP6;MAPKAPK5;RNMT;PTPN11;TYK2;PSMD10;PSMB6;MAP2K1;SHOC2;DUSP2;PSMD7;CCND3
gsea,MAP Kinase Activation R-HSA-450294,-0.5563024204618037,-2.1588495996281107,0.0,0.00014359374457784038,0.015,18/58,9.47%,UBB;RPS27A;JUN;MAPK1;DUSP3;MEF2A;UBE2N;SKP1;UBE2V1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C
gsea,Insulin Receptor Recycling R-HSA-77387,-0.7181373467375829,-2.152797050775781,0.0,0.0001634970729553318,0.016,10/20,8.05%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V1E1;ATP6AP1;ATP6V1F;ATP6V0E2;ATP6V1G1;ATP6V1B2
gsea,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.5118812969671542,-2.149005517225726,0.0,0.00016289152824068242,0.016,22/78,13.02%,CALM1;HSP90AA1;WASF1;ABI1;AKT3;BRK1;NCKAP1;PTK2B;CYFIP2;AHCYL1;CDC42;AXL;ROCK2;ELMO2;ITPR1;PRKACB;PKN2;PIK3R1;PRKCB;NCK1;BAIAP2;RICTOR
gsea,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.5792323174911675,-2.1456770199430863,0.0,0.0001622904524907168,0.016,24/50,18.98%,UBB;RPS27A;HMGN1;TCEA1;UBA52;POLR2G;COPS6;CCNH;GTF2H1;COPS8;UBC;RBX1;GTF2H5;POLR2C;POLR2L;COPS7A;GPS1;PRPF19;XPA;POLR2I;COPS3;POLR2F;POLR2E;ERCC6
gsea,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.46642991457844696,-2.145288960086244,0.0,0.0001616937964153833,0.016,68/149,27.60%,UBB;RPS27A;YWHAZ;PSMA7;H2AZ1;SEM1;PSMC2;PSMB5;SOX4;PSMA4;CSNK1G2;PSMC6;CSNK1E;PSMC5;H2AJ;UBA52;PPP2R1A;GSK3B;PSMC3;PSMA1;PPP2CA;UBC;PSMC1;PSMD2;PPP2R5D;CSNK1A1;PSME3;CSNK2B;PSMB3;PSMB1;RBX1;CDC73;H2BC4;H2AX;PSMA3;PSME2;PSMD6;PSMA5;TLE1;PSMB4;PSMD12;PSMA2;PSMD14;PSME4;PSMC4;PSME1;PSMD4;CTNNBIP1;PPP2R5E;PSMB7;AKT1;CTNNB1;FZD8;PSMD10;PSMB6;PSMD7;FZD4;CREBBP;XIAP;CTBP1;CBY1;PPP2R5A;LGR4;PPP2R5B;FRAT1;XPO1;PYGO1;PSMB10
gsea,Plasma Lipoprotein Clearance R-HSA-8964043,-0.6655030476199763,-2.145243133961078,0.0,0.00016110151144682876,0.016,9/26,7.28%,UBB;RPS27A;APOE;AP2M1;NCEH1;CLTA;UBA52;AP2S1;UBC
gsea,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.6109434132206422,-2.145213042486228,0.0,0.0001605135497262199,0.016,19/32,23.95%,GNB2;CCT6A;GNG2;CCT2;CSNK2B;TCP1;GNG10;CCT8;GNG3;GNB1;CCT5;GNG13;GNG11;GNG7;CCT7;GNA11;PDCL;GNA15;CCT3
gsea,G2/M DNA Damage Checkpoint R-HSA-69473,-0.5447099183779914,-2.1431162374697212,0.0,0.00015992986409085183,0.016,14/53,14.49%,YWHAH;YWHAB;YWHAZ;YWHAG;YWHAE;UBE2N;YWHAQ;UBE2V2;RNF168;UIMC1;H2BC4;H2AX;ATRIP;RFC3
gsea,Defective B3GALTL Causes PpS R-HSA-5083635,0.6210032740292616,2.14274939538758,0.0,0.0009681230662235693,0.013,15/32,12.57%,ADAMTS18;THSD7B;ADAMTS3;THSD7A;ADAMTS17;ADAMTS9;ADAMTSL1;SEMA5B;SBSPON;ADAMTS1;THSD4;ADAMTS16;ADAMTS20;ADAMTS10;B3GLCT
gsea,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.662487351877869,-2.1424853414847678,0.0,0.00015935040806153717,0.016,14/25,19.60%,UBB;RPS27A;MAPK1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;BRAF;FGFR1;SPRY2;FGF13;FGF9;PTPN11
gsea,Late Phase Of HIV Life Cycle R-HSA-162599,-0.4741476160789024,-2.1383999795571467,0.0,0.00016539076648986256,0.016,58/125,27.46%,UBB;PPIA;RPS27A;RAN;NMT1;ELOB;TPR;TCEA1;UBA52;CHMP2A;POLR2G;CHMP4B;CCNH;GTF2H1;UBC;SEC13;VPS28;TAF11;ELOC;TAF3;GTF2H5;NUP88;POLR2C;POLR2L;TAF10;GTF2A1;GTF2B;CDK9;CHMP7;CHMP5;NUP50;RANBP1;POLR2I;TAF7;VPS37D;SEH1L;POLR2F;SSRP1;POLR2E;GTF2F1;RNMT;VPS4B;NUP205;TBP;CHMP6;TSG101;NCBP2;CCNT1;NUP62;GTF2H4;GTF2F2;VTA1;GTF2A2;NUP107;VPS37B;XPO1;CDK7;VPS4A
gsea,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.409692892211058,-2.1369505385984775,0.0,0.0001647958356751508,0.016,136/406,22.63%,CALM1;HSP90AA1;UBB;YWHAB;RPS27A;ATP6V0C;ATP6V1D;ATP6V1A;APOE;CDK5R1;MAPK1;ATP6V1G2;AP2M1;BCL11B;WASF1;DUSP3;GABRG2;MEF2A;STMN1;ATP6V1E1;ABI1;ATP6AP1;HNRNPH1;ATP6V1F;EGR3;ATP6V0E2;AKT3;HNRNPA1;APH1A;CDK5R2;CLTA;UBA52;PPP2R1A;ITGA2;MAPK3;BRK1;NCKAP1;POLR2G;NCOR1;PTK2B;AAMP;ERBIN;ATP6V1G1;CYFIP2;SH3KBP1;PTPRJ;JUND;AP2S1;TCF12;PSENEN;AHCYL1;PPP2CA;BAX;CDC42;HDAC2;UBC;DUSP7;HNRNPF;AXL;ROCK2;ATP6V1B2;PPP2R5D;ELMO2;STAT3;NEDD4;ITPR1;MEF2C;PRKACB;PKN2;BRAF;RAP1A;VEGFB;PIK3R1;POLR2C;POLR2L;FGFR1;CDC37;GABRA1;PRKCB;NCK1;BAIAP2;STAM;EPN1;PDGFA;SPRY2;FLRT3;RICTOR;CLTC;INSR;DNAL4;HNRNPM;ERBB3;SH3GL1;PTN;HRAS;TIA1;FGFR3;EGR4;POLR2I;VGF;FGFR2;EGR1;AP2B1;RALA;ATP6V1H;TIAL1;RNASEH2A;ADAM10;STAM2;NCF2;STUB1;AKT1;POLR2F;FGF13;TIAM1;POLR2E;FGF9;DUSP6;FOSB;GTF2F1;RNMT;PTPN11;VRK3;CTNNB1;FLT1;TAB2;ASCL1;PXDN;AP2A2;MAP2K1;ID4;ATP6V0B;VAV2;S100B;NCBP2;CREB1
gsea,Mitotic Prometaphase R-HSA-68877,-0.45106763199746464,-2.13694353587705,0.0,0.00016420516959746208,0.016,33/159,10.00%,HSP90AA1;TUBA4A;RPS27;DYNLL1;TUBA1A;DYNLL2;YWHAG;CETN2;YWHAE;PAFAH1B1;SMC1A;TUBB4A;RAD21;AKAP9;ZWINT;CSNK1E;SMC3;PPP2R1A;MZT1;NME7;DCTN1;PPP2CA;NEK9;PDS5B;SEC13;PPP2R5D;STAG2;DCTN3;TUBB4B;SMC4;HDAC8;CSNK2B;NUDC
gsea,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.5416411233461997,2.133980700289722,0.0,0.0007952439472550748,0.015,15/48,6.39%,COL19A1;COL23A1;COL25A1;COL5A2;P3H2;COL11A1;ADAMTS3;COL4A4;COL28A1;COL13A1;P4HA1;COL12A1;COL4A1;P3H1;COL15A1
gsea,Nucleotide Excision Repair R-HSA-5696398,-0.4915912609310198,-2.133930390693147,0.0,0.00017016347146571288,0.017,40/105,20.30%,UBB;RPS27A;CETN2;UBE2N;SUMO2;HMGN1;TCEA1;UBA52;POLR2G;COPS6;CCNH;PCNA;SUMO1;UBE2V2;GTF2H1;POLD4;COPS8;UBC;RBX1;YY1;GTF2H5;POLR2C;POLR2L;COPS7A;GPS1;PRPF19;UBE2I;RFC3;PARP2;XPA;POLR2I;COPS3;PARP1;DDB2;POLR2F;POLR2E;ERCC6;POLE3;RAD23B;ACTR8
gsea,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.42290903238829947,-2.131507963129766,0.0,0.00016955790751031888,0.017,113/319,22.88%,UBB;RPS27A;HMGB1;UBE3A;PSMA7;SEM1;KLHL9;NDUFA2;PJA1;ELOB;UBE2N;PSMC2;PSMB5;CANX;SKP1;PSMA4;PJA2;PSMC6;UBE2V1;FBXL16;PSMC5;UBA52;RNF220;PSMC3;UBE2J1;LNPEP;PSMA1;RNF7;UBE2V2;TRIM32;BTBD1;UBC;HECTD2;SEC13;PDIA3;PSMC1;PSMD2;FBXW2;PSME3;UBE2Q1;NEDD4;FBXW7;SEC61G;ELOC;UBA1;PSMB3;PSMB1;RNF19A;MIB2;RBX1;UBA3;CTSL;FBXO6;PSMA3;PSME2;PSMD6;CBLB;SEC24A;PSMA5;FBXL3;PSMB4;PSMD12;KEAP1;RNF6;HSPA5;UBE2S;RNF138;UBE2G1;HECTD1;PSMA2;PSMD14;PSME4;PSMC4;SAR1B;BLMH;CDC34;PSME1;PSMD4;UBE2D1;SEC61B;KBTBD7;FBXL14;FBXO32;B2M;PSMB7;FBXL4;NCF2;STUB1;VAMP3;FBXW11;DZIP3;MKRN1;KLHL2;UBE2E3;S100A1;TPP2;UBE2Z;WSB1;KBTBD8;ANAPC11;PSMD10;UBE2E1;SEC22B;ANAPC13;PSMB6;UBE2M;MEX3C;ASB13;RNF115;PSMD7;RNF4;RCHY1;RNF130
gsea,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.7071035948434385,-2.131306996153224,0.0,0.00016895663833475037,0.017,11/21,13.89%,TUBA4A;TUBA1A;TUBB2A;TUBB4A;CHMP2A;CHMP4B;TUBB2B;TUBB4B;TUBA1B;CHMP7;TUBB3
gsea,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.6360015122792371,-2.128641323172842,0.0,0.00017483498835020242,0.017,21/29,27.46%,UBB;RPS27A;UBA52;CHMP2A;CHMP4B;UBC;VPS28;STAM;CHMP7;CHMP5;VPS37D;STAM2;VPS36;VPS4B;CHMP6;TSG101;SNF8;VTA1;VPS25;VPS37B;VPS4A
gsea,Transport To Golgi And Subsequent Modification R-HSA-948021,-0.4547034637995405,-2.1261575281957947,0.0,0.0001871245108750797,0.018,72/144,30.47%,CNIH2;CAPZA2;DYNLL1;DYNLL2;ARF5;ARF3;B4GALT6;BET1L;CNIH1;NAPG;GOLGB1;TMED7;NSF;TMED2;TMED9;DCTN1;ARF4;CHGA;TRAPPC6B;SEC13;RAB1A;RAB1B;ACTR10;DCTN3;TRAPPC6A;DCTN6;TRAPPC2;MIA3;MCFD2;CAPZB;SEC24A;COPZ1;COPG1;COPG2;ST8SIA3;DYNC1H1;TRAPPC2L;SAR1B;CTSZ;B4GALT2;MANEA;FUT8;COPB2;ACTR1A;DCTN5;LMAN2;DCTN4;COPE;KDELR1;TBC1D20;SEC23IP;ARFGAP2;SEC22B;LMAN1;ARCN1;B4GALT4;DCTN2;FUCA1;SPTBN2;YKT6;TRAPPC4;PPP6C;ANK1;SEC24C;COPA;MAN2A2;SEC23A;SEC22C;COPB1;ANKRD28;USO1;TRAPPC1
gsea,mTORC1-mediated Signaling R-HSA-166208,-0.6547972142986744,-2.124815450254686,0.0,0.00018646793364393907,0.018,11/23,15.38%,YWHAB;RPS6;FKBP1A;RRAGA;LAMTOR3;RPS6KB1;LAMTOR2;RRAGD;AKT1S1;EIF4B;RHEB
gsea,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.6856339357694498,-2.1229825951267123,0.0,0.0002050382872959639,0.018,12/22,23.64%,HSP90AA1;UBB;RPS27A;SDCBP;UBA52;UBC;CDC37;STUB1;BIRC2;TANK;XIAP;FASN
gsea,Gluconeogenesis R-HSA-70263,-0.6808359310505984,-2.1214450919665717,0.0,0.00020432386817646577,0.018,11/24,14.88%,MDH2;ENO2;MDH1;ALDOC;TPI1;PGK1;GOT2;SLC25A11;PGAM2;G6PC3;PCK2
gsea,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.70108429234288,-2.118662836990037,0.0,0.00022906621158845964,0.018,11/17,17.40%,RPS6;MAPK1;NPM1;SKP1;MAPK3;CEBPB;KIF5B;STAT3;RBX1;CLTC;RNASEH2A
gsea,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.608799331803851,2.1168994032733925,0.0,0.0008021591120138147,0.021,15/33,12.57%,ADAMTS18;THSD7B;ADAMTS3;THSD7A;ADAMTS17;ADAMTS9;ADAMTSL1;SEMA5B;SBSPON;ADAMTS1;THSD4;ADAMTS16;ADAMTS20;ADAMTS10;B3GLCT
gsea,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.42788893730864164,-2.115194629922628,0.0,0.00022827359493936462,0.018,97/272,22.88%,UBB;RPS27A;UBE3A;PSMA7;SEM1;KLHL9;PJA1;ELOB;UBE2N;PSMC2;PSMB5;SKP1;PSMA4;PJA2;PSMC6;UBE2V1;FBXL16;PSMC5;UBA52;RNF220;PSMC3;UBE2J1;LNPEP;PSMA1;RNF7;UBE2V2;TRIM32;BTBD1;UBC;HECTD2;PSMC1;PSMD2;FBXW2;PSME3;UBE2Q1;NEDD4;FBXW7;ELOC;UBA1;PSMB3;PSMB1;RNF19A;MIB2;RBX1;UBA3;FBXO6;PSMA3;PSME2;PSMD6;CBLB;PSMA5;FBXL3;PSMB4;PSMD12;KEAP1;RNF6;UBE2S;RNF138;UBE2G1;HECTD1;PSMA2;PSMD14;PSME4;PSMC4;BLMH;CDC34;PSME1;PSMD4;UBE2D1;KBTBD7;FBXL14;FBXO32;PSMB7;FBXL4;STUB1;FBXW11;DZIP3;MKRN1;KLHL2;UBE2E3;TPP2;UBE2Z;WSB1;KBTBD8;ANAPC11;PSMD10;UBE2E1;ANAPC13;PSMB6;UBE2M;MEX3C;ASB13;RNF115;PSMD7;RNF4;RCHY1;RNF130
gsea,Meiotic Synapsis R-HSA-1221632,-0.5960724155318373,-2.112193163785133,0.0,0.00023380551251787608,0.018,12/35,13.00%,H2AZ1;SMC1A;RAD21;SMC3;H2AJ;TERF1;HSPA2;STAG2;H2BC4;H2AX;SUN1;UBE2I
gsea,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.6422469388347785,-2.111693426729839,0.0,0.00023300205714839884,0.018,6/24,8.23%,FTH1;HSP90AA1;APOE;HSPH1;HSP90B1;C1D
gsea,Signaling By NTRK1 (TRKA) R-HSA-187037,-0.47799580215079596,-2.110158620509934,0.0,0.00023847989151675253,0.018,41/101,23.15%,YWHAB;CDK5R1;MAPK1;AP2M1;BCL11B;DUSP3;MEF2A;EGR3;CDK5R2;CLTA;PPP2R1A;MAPK3;JUND;AP2S1;TCF12;PPP2CA;DUSP7;PPP2R5D;STAT3;MEF2C;BRAF;RAP1A;PIK3R1;CLTC;DNAL4;HRAS;EGR4;VGF;EGR1;AP2B1;RALA;RNASEH2A;DUSP6;FOSB;VRK3;ASCL1;AP2A2;MAP2K1;ID4;CREB1;ID2
gsea,EPH-Ephrin Signaling R-HSA-2682334,-0.5021173806574264,-2.108514987245974,0.0,0.0002689378047318434,0.019,40/81,25.72%,EPHA7;ACTG1;MYL6;ARPC2;ACTR2;AP2M1;ARPC5;EPHA5;SDCBP;WASL;ARPC1A;APH1A;CLTA;ACTR3;MYL12B;ARPC3;AP2S1;EFNB3;PSENEN;CDC42;ROCK2;PKN2;MYH10;EFNA3;CLTC;HRAS;AP2B1;CLTB;GPRIN1;ADAM10;TIAM1;EPHA4;AP2A2;VAV2;SDC2;MYL12A;GIT1;MYL9;PTK2;MYH14
gsea,Signaling By FGFR1 R-HSA-5654736,-0.5730124294187363,-2.1079612003799766,0.0,0.00027425614448686324,0.019,17/41,19.60%,UBB;RPS27A;MAPK1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;BRAF;PIK3R1;FGFR1;SPRY2;FLRT3;HRAS;FGF13;FGF9;PTPN11
gsea,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.6424835749065467,-2.1043532571392713,0.0,0.0002919623578212231,0.022,11/28,15.92%,PDZD2;UBB;RPS27A;UBA52;PCBP2;TBK1;UBC;ATG12;CYLD;IRF3;UBE2D1
gsea,RNA Polymerase II Transcription Termination R-HSA-73856,-0.5194362815674642,-2.1041391261980498,0.0,0.00029097599850425954,0.022,33/65,24.82%,RBM8A;CDC40;SRSF1;PABPN1;SRSF3;SNRPF;SRSF5;CPSF6;SNRPG;CPSF2;SNRPE;FYTTD1;SLBP;CHTOP;SRSF2;THOC7;SNRPB;U2AF1L4;PCF11;THOC2;MAGOHB;CSTF2T;ALYREF;U2AF2;FIP1L1;SARNP;SRSF7;SRSF11;NCBP2;THOC1;DDX39B;SRSF6;CPSF1
gsea,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.554884166777978,-2.102997388582262,0.0,0.0002961664149830589,0.023,23/50,24.12%,UBB;RPS27A;JUN;MAPK1;H2AZ1;CDKN1B;H2AJ;UBA52;MAPK3;CEBPB;UBC;STAT3;H2BC4;H2AX;CDK4;CDKN2D;UBE2S;UBE2D1;ANAPC16;ANAPC11;UBE2E1;IGFBP7;FZR1
gsea,Amino Acids Regulate mTORC1 R-HSA-9639288,-0.5514229869363694,-2.0992606143732484,0.0,0.00030132199645193346,0.023,28/49,29.23%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;FNIP2;ATP6V1E1;RRAGA;ATP6V1F;ATP6V0E2;LAMTOR3;ATP6V1G1;LAMTOR2;SEC13;ATP6V1B2;RRAGD;SESN1;RHEB;ATP6V1H;SEH1L;FLCN;ATP6V0B;RRAGC;ATP6V0D1;WDR59;ITFG2;ATP6V1C1;FNIP1;MIOS
gsea,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.6594271359464641,-2.097758735768529,0.0,0.00030644309242603297,0.024,9/25,8.05%,ATP6V0C;ATP6V1D;ATP6V1A;ATP6V1G2;ATP6V1E1;ATP6V1F;ATP6V0E2;ATP6V1G1;ATP6V1B2
gsea,Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.713488670557094,-2.0977204348208884,0.0,0.0003054216154512795,0.024,10/16,19.50%,GNB2;GNG2;GNG10;GNG3;GNB1;GNG13;GRIK3;GNG11;GNG7;PLCB1
gsea,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.7088922368292913,-2.0909234583302942,0.0,0.0003287594797548657,0.026,10/17,15.43%,GNB2;GNG2;GNAI2;GNG10;P2RY12;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,MHC Class II Antigen Presentation R-HSA-2132295,-0.5011580034140632,-2.0888740390332243,0.0,0.000364078746895565,0.029,36/78,24.88%,CAPZA2;DYNLL1;DYNLL2;AP2M1;CTSB;CANX;CLTA;ACTR1B;DCTN1;AP2S1;KIF5B;SEC13;KIFAP3;ACTR10;DCTN3;DCTN6;CTSL;CAPZB;CTSO;SEC24A;CLTC;DYNC1H1;SAR1B;AP1S2;AP2B1;ACTR1A;DCTN5;AP1S1;DCTN4;KIF15;AP2A2;DCTN2;CTSD;KIF5C;CTSS;SPTBN2
gsea,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.7262335915834854,-2.0871276460869947,0.0,0.00036892511965402083,0.03,9/16,15.43%,GNB2;GNG2;CDC42;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.6376050114998758,-2.0863494441138895,0.0,0.0003677115501814747,0.03,7/27,6.01%,CALM1;HSP90AA1;HSP90AB1;VAMP2;SNAP25;EEF2;STX1B
gsea,Cyclin D Associated Events In G1 R-HSA-69231,-0.5811264661084224,-2.086301816798326,0.0,0.0003665059385415355,0.03,18/38,27.14%,UBB;RPS27A;CDKN1B;SKP1;UBA52;PPP2R1A;CCNH;PPP2CA;UBC;CDK4;TFDP2;CDKN2D;CCND3;E2F4;RB1;PPP2R2A;CCNE1;CDK7
gsea,Late Endosomal Microautophagy R-HSA-9615710,-0.6333927408360254,-2.086027369352232,0.0,0.0003772855249692277,0.03,13/26,21.10%,UBB;RPS27A;HSPA8;UBA52;CHMP2A;CHMP4B;UBC;PARK7;VPS28;CHMP7;VPS37D;CHMP6;TSG101
gsea,Post-translational Protein Phosphorylation R-HSA-8957275,-0.5082410795438546,-2.0838758148354217,0.0,0.0003820257339846624,0.031,21/76,17.50%,PPP3CA;SPARCL1;SCG2;CST3;APOE;CHGB;APLP2;HSP90B1;GOLM1;KTN1;FAM20A;CALU;IGFBP5;P4HB;MIA3;PRSS23;SCG3;EVA1A;VGF;TMEM132A;ADAM10
gsea,Signaling By VEGF R-HSA-194138,-0.48829775153206323,-2.083554914451664,0.0,0.0003867351624220747,0.031,24/86,13.02%,CALM1;HSP90AA1;WASF1;ABI1;AKT3;BRK1;NCKAP1;PTK2B;AAMP;CYFIP2;AHCYL1;CDC42;AXL;ROCK2;ELMO2;ITPR1;PRKACB;PKN2;VEGFB;PIK3R1;PRKCB;NCK1;BAIAP2;RICTOR
gsea,COPI-mediated Anterograde Transport R-HSA-6807878,-0.5043355115946666,-2.0825521689592237,0.0,0.0003854835923171489,0.031,30/71,18.68%,CAPZA2;DYNLL1;DYNLL2;ARF5;ARF3;BET1L;NAPG;GOLGB1;TMED7;NSF;TMED2;TMED9;DCTN1;ARF4;RAB1A;RAB1B;ACTR10;DCTN3;DCTN6;CAPZB;COPZ1;COPG1;COPG2;DYNC1H1;COPB2;ACTR1A;DCTN5;DCTN4;COPE;KDELR1
gsea,Interleukin-12 Family Signaling R-HSA-447115,-0.5834187175891055,-2.079232677306216,0.0,0.00040197425517458723,0.032,20/40,19.95%,PPIA;HNRNPA2B1;AURKAIP1;HSPA9;CANX;SOD1;PDCD4;CDC42;HNRNPF;RPLP0;STAT3;P4HB;TCP1;PKN2;PSME2;HNRNPDL;GSTO1;RALA;TALDO1;TYK2
gsea,Asparagine N-linked Glycosylation R-HSA-446203,-0.415342248145967,-2.0790168061279855,0.0,0.00040068173345376865,0.032,119/255,32.25%,UBB;RPS27A;CNIH2;CAPZA2;DYNLL1;DYNLL2;ARF5;ARF3;B4GALT6;BET1L;CANX;CNIH1;NAPG;GOLGB1;TMED7;NSF;SLC35A1;UBA52;TMED2;TMED9;DCTN1;DDOST;ARF4;VCP;CHGA;DPM3;UBC;TRAPPC6B;SEC13;PDIA3;PSMC1;RAB1A;NANP;RAB1B;ACTR10;DCTN3;TRAPPC6A;DCTN6;RNF5;TRAPPC2;MIA3;MCFD2;CAPZB;DAD1;SEC24A;FPGT;COPZ1;COPG1;COPG2;ST6GALNAC6;STT3A;ST8SIA3;DYNC1H1;DERL1;TRAPPC2L;SAR1B;RPN2;CTSZ;B4GALT2;UAP1;CMAS;DPM1;RNF139;FUOM;MANEA;FUT8;ALG13;COPB2;UBXN1;ACTR1A;ALG2;DCTN5;LMAN2;DCTN4;COPE;KDELR1;TBC1D20;SEC23IP;RAD23B;ARFGAP2;TUSC3;RNF185;RNF103;SEC22B;AMFR;LMAN1;ARCN1;B4GALT4;PMM1;DCTN2;GMPPB;FUCA1;SPTBN2;YKT6;TRAPPC4;CALR;PPP6C;ANK1;SEC24C;GNPNAT1;SEL1L;COPA;ST6GALNAC4;SRD5A3;MAN2A2;SEC23A;AMDHD2;SEC22C;COPB1;ANKRD28;USO1;TRAPPC1;MLEC;ST6GALNAC5;TRAPPC5;ST8SIA1;GNE;ST6GAL1;NAGK
gsea,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.5163501879949726,-2.0789245012747353,0.0,0.0003993974971285963,0.032,19/62,13.89%,TUBA4A;RAN;TUBA1A;TUBB2A;BANF1;TUBB4A;PPP2R1A;CHMP2A;CHMP4B;SUMO1;TUBB2B;PPP2CA;SEC13;EMD;TUBB4B;TUBA1B;UBE2I;CHMP7;TUBB3
gsea,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.47463191231941204,-2.0783101982518293,0.0,0.00040397619423907264,0.033,40/109,22.63%,UBB;RPS27A;HMGB1;JUN;MAPK1;NDUFA2;DUSP3;MEF2A;UBE2N;SKP1;USP14;UBE2V1;UBA52;PPP2R1A;MAPK3;PELI2;PPP2CA;TBK1;UBC;DUSP7;PPP2R5D;IRAK1;MEF2C;NKIRAS1;NFKB2;NFKBIA;MAPK9;IRF3;UBE2D1;BIRC2;FBXW11;DUSP6;TANK;S100A1;PTPN11;VRK3;TAB2;MAP2K1;S100B;CREB1
gsea,Toll-like Receptor Cascades R-HSA-168898,-0.46536765447617,-2.0782470555424553,0.0,0.000408525727673686,0.034,44/123,22.63%,UBB;RPS27A;HMGB1;JUN;MAPK1;NDUFA2;DUSP3;MEF2A;UBE2N;CTSB;SKP1;USP14;UBE2V1;HSP90B1;UBA52;PPP2R1A;MAPK3;PELI2;PPP2CA;TBK1;UBC;DUSP7;PPP2R5D;IRAK1;GSDME;MEF2C;NKIRAS1;NFKB2;CTSL;NFKBIA;MAPK9;IRF3;UBE2D1;BIRC2;FBXW11;DUSP6;TANK;S100A1;PTPN11;VRK3;TAB2;MAP2K1;S100B;CREB1
gsea,Death Receptor Signaling R-HSA-73887,-0.47119603536776217,-2.0769677526328345,0.0,0.00040722882060170604,0.034,41/119,23.64%,UBB;RPS27A;RACK1;BEX3;SQSTM1;YWHAE;BAG4;MAGED1;RTN4;ARHGDIA;APH1A;USP2;UBA52;PSENEN;HDAC2;UBC;CLIP3;OTUD7B;IRAK1;ARHGEF4;NSMAF;CYLD;PRDM4;ARHGEF12;ARHGEF9;MAG;OTULIN;NFKBIA;ARHGEF2;SOS2;BIRC2;BAD;TIAM1;TANK;TAB2;TAX1BP1;ARHGEF1;VAV2;PRPF38B;XIAP;FASN
gsea,Estrogen-dependent Gene Expression R-HSA-9018519,-0.4780271551390781,-2.076926121958775,0.0,0.00040594012180233355,0.034,40/89,26.80%,HSP90AA1;DDX5;HSP90AB1;JUN;H2AZ1;SMC1A;RAD21;SMC3;H2AJ;POLR2G;PTGES3;JUND;TNRC6A;STAG2;PRMT1;H2BC4;YY1;POLR2C;POLR2L;H2AX;GTF2A1;CDK9;CBFB;POLR2I;POLR2F;POLR2E;FOSB;NCOA1;GTF2F1;CXXC5;TBP;KDM1A;CCNT1;CTSD;CREBBP;GTF2F2;GTF2A2;CXCL12;TNRC6B;EBAG9
gsea,DNA Double Strand Break Response R-HSA-5693606,-0.5595586051195746,-2.076384106266458,0.0,0.0004046595535947552,0.034,14/42,15.21%,UBB;RPS27A;UBE2N;UBA52;SUMO1;UBE2V2;RNF168;UBC;UIMC1;EYA1;H2BC4;H2AX;UBE2I;BAZ1B
gsea,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.6233010495805036,-2.075117992365426,0.0,0.0004149123832545684,0.034,11/29,17.50%,UBB;RPS27A;MIB1;APH1A;UBA52;PSENEN;UBC;MIB2;NEURL1B;NUMB;ADAM10
gsea,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.5612575642450397,-2.069338433473154,0.0,0.0004538239677865408,0.037,14/41,15.21%,UBB;RPS27A;UBE2N;UBA52;SUMO1;UBE2V2;RNF168;UBC;UIMC1;EYA1;H2BC4;H2AX;UBE2I;BAZ1B
gsea,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.6515315337621698,-2.0679073354898163,0.0,0.00045813242317691927,0.037,6/23,9.21%,CALM1;PPP3CA;PPP3R1;PPP3CB;AHCYL1;ITPR1
gsea,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.5355209489037227,-2.0674002974249257,0.0,0.00046241403460847935,0.037,25/52,23.15%,CDK5R1;MAPK1;DUSP3;MEF2A;EGR3;CDK5R2;PPP2R1A;MAPK3;JUND;TCF12;PPP2CA;DUSP7;PPP2R5D;MEF2C;EGR4;VGF;EGR1;RNASEH2A;DUSP6;FOSB;VRK3;ASCL1;ID4;CREB1;ID2
gsea,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.47097974618901417,-2.0668045461979263,0.0,0.0004723601381824137,0.038,24/93,18.24%,HSP90AA1;TUBA4A;DYNLL1;TUBA1A;YWHAG;CETN2;YWHAE;PAFAH1B1;TUBB4A;AHI1;AKAP9;CSNK1E;PPP2R1A;DCTN1;DCTN3;TUBB4B;TTBK2;RAB11A;DYNC1H1;CEP290;B9D2;TCTN1;ACTR1A;SEPTIN2
gsea,Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.5727309146097219,-2.066556162687209,0.0,0.0004765711894348139,0.038,18/42,16.20%,UBB;RPS27A;CETN2;UBE2N;SUMO2;UBA52;CCNH;SUMO1;UBE2V2;GTF2H1;UBC;RBX1;GTF2H5;UBE2I;PARP2;XPA;PARP1;DDB2
gsea,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.6481171436852751,-2.066463866873996,0.0,0.00047510029070199037,0.038,9/24,13.10%,UBB;RPS27A;MIB1;APH1A;UBA52;PSENEN;UBC;MIB2;NEURL1B
gsea,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.6276606517974691,-2.0663828169742837,0.001949317738791423,0.00047363844365367653,0.038,14/27,19.60%,UBB;RPS27A;MAPK1;UBA52;PPP2R1A;MAPK3;PPP2CA;UBC;BRAF;SPRY2;FGFR2;FGF13;FGF9;PTPN11
gsea,RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.48938658284073966,-2.0616262660542244,0.0,0.0005171556188009395,0.043,34/74,24.78%,ELOB;TCEA1;RTF1;POLR2G;CCNH;GTF2H1;TAF11;ELOC;TAF3;CDC73;GTF2H5;IWS1;POLR2C;POLR2L;AFF4;TAF10;GTF2A1;GTF2B;CDK9;EAF1;POLR2I;TAF7;PAF1;POLR2F;SSRP1;POLR2E;GTF2F1;TBP;CTR9;NCBP2;CCNT1;GTF2H4;GTF2F2;GTF2A2
gsea,Amyloid Fiber Formation R-HSA-977225,-0.5868732930889089,-2.059700512231437,0.0018867924528301887,0.0005323863021627808,0.045,14/42,11.10%,UBB;ITM2B;RPS27A;CST3;APOE;H2AZ1;APH1A;UBA52;PSENEN;UBC;SNCA;SORL1;H2BC4;H2AX
gsea,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.5220764785836965,-2.059051123803577,0.0,0.0005363501539632226,0.045,19/54,14.66%,UBB;RPS27A;SKP1;MAMLD1;MIB1;APH1A;UBA52;NCOR1;SNW1;PSENEN;HDAC2;UBC;FBXW7;HDAC8;MIB2;RBX1;HEY1;NEURL1B;HDAC5
gsea,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.6133532762088134,-2.0554057438414395,0.0,0.0005681399047300396,0.05,15/32,25.37%,UBB;RPS27A;RACK1;USP2;UBA52;UBC;CLIP3;OTUD7B;CYLD;OTULIN;BIRC2;TANK;TAX1BP1;XIAP;IKBKG
gsea,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.7390247935628115,-2.0526178066682776,0.0,0.000577524509216965,0.051,10/16,14.22%,TUBA4A;TUBA1A;TUBB2A;TUBB4A;TUBB2B;TUBB4B;TUBA1B;ARL2;TUBB3;TBCC
gsea,EGFR Downregulation R-HSA-182971,-0.6195641390228983,-2.049899705846148,0.0,0.0005979250961100578,0.053,11/27,17.58%,UBB;RPS27A;UBA52;SH3KBP1;CDC42;UBC;STAM;EPN1;SPRY2;SH3GL1;STAM2
gsea,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.537420009804272,-2.0492050540552103,0.0,0.0006016437846540266,0.053,25/52,25.60%,H2AZ1;DEK;CHD3;CBX3;RBBP7;H2AJ;GSK3B;HDAC2;POLR1F;TAF1D;H2BC4;SF3B1;POLR2L;H2AX;BAZ1B;GATAD2B;POLR2F;POLR2E;ERCC6;POLR1D;TBP;MYBBP1A;POLR1H;SMARCA5;POLR1G
gsea,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.6156743583890854,-2.0462375143576725,0.0,0.0006163463230728524,0.054,12/27,23.05%,GNB2;MAPK1;GNG2;MAPK3;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7;GNA11;GNA15
gsea,MAP2K And MAPK Activation R-HSA-5674135,-0.5758464886850341,-2.0455373575089077,0.0,0.0006199875906466093,0.054,13/31,14.67%,YWHAB;PEBP1;MAPK1;LAMTOR3;VCL;MAPK3;KSR1;LAMTOR2;CNKSR2;BRAF;RAP1A;ARAF;HRAS
gsea,Glucose Metabolism R-HSA-70326,-0.492508787761624,-2.0406448449342793,0.0,0.0006509583087528764,0.054,29/74,25.33%,MDH2;ENO2;MDH1;ALDOC;TPI1;PKM;TPR;PPP2R1A;PPP2CA;PGK1;SEC13;PPP2R5D;GOT2;PRKACB;SLC25A11;PGAM2;NUP88;PGP;G6PC3;PFKL;NUP50;PCK2;SEH1L;NUP205;NUP62;PFKM;PCNX4;MAP4K5;NUP107
gsea,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.6797724085370864,-2.035069623044138,0.0,0.0006926525921841518,0.057,11/20,19.95%,UBB;RPS27A;ELOB;UBA52;RNF7;UBC;STAT3;ELOC;UBE2D1;HCK;TYK2
gsea,Transport Of Small Molecules R-HSA-382551,-0.3813395473820675,-2.031933576721162,0.0,0.0007177861110902476,0.061,125/496,15.88%,CALM1;ATP1B1;FTH1;SLC25A4;UBB;GNAS;RPS27A;ATP6V0C;ATP6V1D;ATP2B1;CAMK2B;ATP6V1A;GNB2;APOE;PRKAR1A;SLC15A2;PSMA7;ATP6V1G2;AP2M1;BSG;ADD2;SEM1;GNG2;SLC25A5;ATP1A2;SLC38A2;SLC4A4;VDAC1;ATP6V1E1;PSMC2;PSMB5;SLC1A3;ATP6AP1;NCEH1;ATP6V1F;ABCB10;ATP1B2;SKP1;ATP6V0E2;PSMA4;SLC4A10;PSMC6;LCAT;ATP1A3;CLTA;PSMC5;SLC8A2;SLC35A1;UBA52;ADCY1;NEDD8;ARL2BP;EIF2S2;ATP6V1G1;TRPC4;PSMC3;VDAC2;PSMA1;CAMK2A;ATP13A4;AP2S1;VCP;PRKAR1B;UBC;PSMC1;CLCN4;PSMD2;ATP6V1B2;CLCN3;SMDT1;PHB2;PSME3;SLCO1C1;ZDHHC8;P4HB;SLC17A7;PSMB3;PRKACB;PSMB1;RNF5;GNG10;IREB2;SLC22A17;ABCC4;TFRC;PDZD11;TPCN1;PSMA3;PSME2;PSMD6;SLC39A3;GNG3;RAB11A;GNB1;SLC12A6;ARL2;ERLEC1;NIPA1;PSMA5;GNG13;PSMB4;PSMD12;SLC16A10;APOD;CLTC;ATP11C;MICU3;SLC24A4;AKAP1;ADD3;SLC38A1;GNG11;DERL1;SLC39A6;CUTC;PSMA2;PSMD14;PSME4;PSMC4;SAR1B;ATP13A5;GNG7;PMPCA;PSME1;PSMD4
gsea,Signaling By Insulin Receptor R-HSA-74752,-0.5122514044366745,-2.0316607072780646,0.0,0.0007210841690240267,0.062,22/59,19.60%,ATP6V0C;ATP6V1D;ATP6V1A;MAPK1;ATP6V1G2;ATP6V1E1;ATP6AP1;ATP6V1F;ATP6V0E2;MAPK3;ATP6V1G1;ATP6V1B2;PIK3R1;FGFR1;INSR;HRAS;FGFR3;FGFR2;ATP6V1H;FGF13;FGF9;PTPN11
gsea,Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.5188726526460417,-2.0300154712716916,0.0,0.0007243627693888752,0.062,26/53,24.28%,ELOB;TCEA1;RTF1;POLR2G;CCNH;GTF2H1;ELOC;CDC73;GTF2H5;IWS1;POLR2C;POLR2L;AFF4;CDK9;EAF1;POLR2I;PAF1;POLR2F;SSRP1;POLR2E;GTF2F1;CTR9;NCBP2;CCNT1;GTF2H4;GTF2F2
gsea,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.5134928082472844,-2.0280834786036626,0.0,0.0007437914635107631,0.063,15/58,14.49%,UBB;RPS27A;UBE2N;SUMO2;PPP4C;UBA52;UBE2V2;RNF168;UBC;UIMC1;H2BC4;H2AX;UBE2I;ATRIP;RFC3
gsea,ERK/MAPK Targets R-HSA-198753,-0.6369152713347893,-2.027837425924149,0.0,0.0007416102568729016,0.063,9/21,9.47%,MAPK1;DUSP3;MEF2A;PPP2R1A;MAPK3;PPP2CA;DUSP7;PPP2R5D;MEF2C
gsea,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.6999185361005215,-2.0264204150393854,0.0,0.0007501583537399848,0.064,12/16,26.57%,YWHAB;XRN1;DCP2;EXOSC4;EXOSC3;AKT1;EXOSC9;EXOSC5;EXOSC2;EXOSC1;EXOSC7;DIS3
gsea,Mitotic Prophase R-HSA-68875,-0.47231166259475155,-2.024427974724867,0.0,0.0007586566074766477,0.066,22/84,11.10%,SET;MAPK1;H2AZ1;ENSA;BANF1;RAB2A;TPR;H2AJ;PPP2R1A;MAPK3;PPP2CA;NEK9;SEC13;RAB1A;NCAPH2;RAB1B;EMD;SMC4;H2BC4;NUP88;H2AX;PRKCB
gsea,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.5898985531224585,-2.0234001231539156,0.0,0.0007617783315616215,0.067,15/32,25.03%,UBB;RPS27A;MAPK1;UBA52;MAPK3;UBC;CDK9;TFDP2;SMAD2;RNASEH2A;E2F4;CCNT1;SMAD3;SMAD7;SMAD4
gsea,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.7245597757222637,-2.0232385934764814,0.0,0.0007595702784266604,0.067,5/15,7.28%,UBB;RPS27A;USP14;UBA52;UBC
gsea,G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,-0.7064331549176147,-2.022210969594095,0.0,0.0007838566315628216,0.072,9/15,19.50%,GNB2;GNG2;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7;PLCB1
gsea,SARS-CoV-1 Infection R-HSA-9678108,-0.5513322925407877,-2.0220367530286674,0.0,0.0007815976787341102,0.072,18/45,14.43%,DDX5;UBB;RPS27A;CANX;UBA52;CHMP2A;GSK3B;MAP1LC3B;CHMP4B;SUMO1;VCP;UBC;PARP4;CTSL;PARP8;UBE2I;CHMP7;GALNT1
gsea,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.4834307188145229,-2.0218099934143594,0.0,0.0007793517083929202,0.072,27/81,16.20%,UBB;RPS27A;CETN2;UBE2N;SUMO2;UBA52;COPS6;CCNH;PCNA;SUMO1;UBE2V2;GTF2H1;POLD4;COPS8;UBC;RBX1;YY1;GTF2H5;COPS7A;GPS1;UBE2I;RFC3;PARP2;XPA;COPS3;PARP1;DDB2
gsea,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.627200921576495,-2.021303390377781,0.00199203187250996,0.0007823694103537075,0.073,10/22,15.43%,GNB2;GNG2;KCNJ3;KCNJ4;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.6274504081195683,-2.0190186212174566,0.0,0.0007906056674253121,0.073,12/25,19.95%,UBB;RPS27A;ELOB;UBA52;RNF7;UBC;STAT3;ELOC;UBE2D1;HCK;PTPN11;TYK2
gsea,Ion Homeostasis R-HSA-5578775,-0.5415010595550127,-2.0185823724156378,0.0,0.0007883532296263796,0.073,11/42,6.66%,CALM1;ATP1B1;ATP2B1;CAMK2B;ORAI2;ATP1A2;ATP1B2;ATP1A3;SLC8A2;CAMK2A;AHCYL1
gsea,G Alpha (I) Signaling Events R-HSA-418594,-0.43115338158718153,-2.0172672967487686,0.0,0.0008069377908229829,0.075,43/164,15.43%,CALM1;PPP3CA;PPP3R1;GNAS;CAMK2B;GNB2;PRKAR1A;MAPK1;PPP3CB;GNG2;GNAL;PPP2R1A;ADCY1;P2RY14;CX3CL1;CAMK2A;GRM2;AHCYL1;PPP2CA;PPP1CA;PRKAR1B;NPY1R;PPP2R5D;ITPR1;CNOT6;GNAI2;PRKACB;GNG10;P2RY12;CXCR6;CAMKK1;GNG3;GNB1;NPY5R;NPY;ADORA1;GNG13;RGS4;PPP1R1B;GNG11;ADRA2C;SSTR2;GNG7
gsea,Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.5189376960682011,-2.0148520130110565,0.0,0.0008098431503184069,0.075,18/53,16.27%,CBX6;JUN;MAPK1;CHD3;RRAGA;LAMTOR3;RBBP7;MAPK3;LAMTOR2;HDAC2;RING1;RRAGD;PTEN;CBX8;HDAC5;RHEB;GATAD2B;EGR1
gsea,Neurotransmitter Release Cycle R-HSA-112310,-0.5371005237492323,-2.0130036656050594,0.0,0.0008179087329034265,0.077,14/43,12.22%,HSPA8;VAMP2;LIN7C;RAB3A;SNAP25;SLC38A2;SLC1A3;ARL6IP5;GAD1;DNAJC5;LIN7B;SLC17A7;SYN3;PPFIA3
gsea,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.48180026449745755,-2.0124490235525103,0.0,0.0008259288755865586,0.079,22/69,16.09%,CETN2;SMC1A;NSMCE3;SUMO2;TPR;RAD21;SMC3;SUMO1;RNF168;RING1;SEC13;TDG;SMC5;SMC6;STAG2;NUP88;XRCC4;UBE2I;NUP50;CBX8;NSMCE4A;PARP1
gsea,COPII-mediated Vesicle Transport R-HSA-204005,-0.5054130492790656,-2.0110585055991264,0.0,0.0008287564059717305,0.079,31/58,31.17%,CNIH2;CNIH1;NAPG;NSF;TMED2;TRAPPC6B;SEC13;RAB1A;RAB1B;TRAPPC6A;TRAPPC2;MCFD2;SEC24A;TRAPPC2L;SAR1B;CTSZ;LMAN2;TBC1D20;SEC23IP;SEC22B;LMAN1;YKT6;TRAPPC4;PPP6C;SEC24C;SEC23A;SEC22C;ANKRD28;USO1;TRAPPC1;TRAPPC5
gsea,Metalloprotease DUBs R-HSA-5689901,-0.630263436134098,-2.0083353571023315,0.0019120458891013384,0.0008675000506095166,0.085,8/23,14.73%,UBB;RPS27A;UBA52;UBC;H2AC25;UIMC1;STAM;PSMD14
gsea,Diseases Of Programmed Cell Death R-HSA-9645723,-0.538600471289421,-2.0060659590499603,0.0,0.0008804332601835767,0.087,12/46,12.49%,CDK5R1;JUN;H2AZ1;YWHAE;FOXO3;RBBP7;H2AJ;PRDX1;GSDME;H2BC4;H2AX;PRDX2
gsea,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.691085878124623,-2.005868393836032,0.0,0.0008830853393828081,0.088,9/15,22.31%,AP2M1;CLTA;AP2S1;PRKCB;CLTC;AP2B1;CLTB;AP2A2;FZD4
gsea,DNA Damage Recognition In GG-NER R-HSA-5696394,-0.5649051871664694,-2.005149317598041,0.0,0.000890813045066232,0.089,19/36,23.77%,UBB;RPS27A;CETN2;UBA52;COPS6;COPS8;UBC;RBX1;YY1;COPS7A;GPS1;PARP2;COPS3;PARP1;DDB2;RAD23B;ACTR8;INO80E;DDB1
gsea,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.6695765056209385,-2.0030366172797756,0.0,0.0009391080142684773,0.094,7/19,7.28%,UBB;RPS27A;NDUFA2;UBE2N;UBE2V1;UBA52;UBC
gsea,mRNA 3-End Processing R-HSA-72187,-0.5053569927574956,-2.001983173994219,0.0,0.0009567627401153343,0.096,32/57,30.40%,RBM8A;CDC40;SRSF1;PABPN1;SRSF3;SRSF5;CPSF6;CPSF2;FYTTD1;CHTOP;SRSF2;THOC7;U2AF1L4;PCF11;THOC2;MAGOHB;CSTF2T;ALYREF;U2AF2;FIP1L1;SARNP;SRSF7;SRSF11;NCBP2;THOC1;DDX39B;SRSF6;CPSF1;U2AF1;SLU7;SRRM1;MAGOH
gsea,O-linked Glycosylation R-HSA-5173105,0.4771814785096527,1.9999066851999658,0.0,0.004886716429509445,0.11,23/73,12.57%,ST6GALNAC3;GALNTL6;ADAMTS18;GALNT14;GALNT10;THSD7B;ADAMTS3;GALNT9;THSD7A;ADAMTS17;ADAMTS9;ADAMTSL1;SEMA5B;SBSPON;GALNT18;ADAMTS1;THSD4;MUC15;ADAMTS16;DAG1;ADAMTS20;ADAMTS10;B3GLCT
gsea,Signaling By NOTCH3 R-HSA-9012852,-0.5287987067263034,-1.9998368649938605,0.0,0.0009692719035809202,0.098,13/44,13.10%,UBB;RPS27A;MAMLD1;MIB1;APH1A;UBA52;SNW1;PSENEN;UBC;WWC1;MIB2;HEY1;NEURL1B
gsea,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.664232043433794,-1.9958479444586767,0.0,0.0010068844465426798,0.1,11/19,23.05%,GNB2;GNG2;AAMP;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7;GNA11;GNA15
gsea,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.5448002609014371,-1.9944619209582517,0.0,0.0010141671176080844,0.1,14/37,19.72%,NPM1;PLK2;CDKN1B;BTG2;PCNA;BAX;CNOT6;PRMT1;CNOT6L;TFDP2;CNOT10;CNOT7;CNOT11;CNOT8
gsea,G-protein Beta:Gamma Signaling R-HSA-397795,-0.6141749537378712,-1.994461150236139,0.0,0.0010113961691993192,0.1,12/25,19.50%,GNB2;GNG2;AKT3;CDC42;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7;AKT1;PLCB1
gsea,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.49178928039805303,-1.9936456431470386,0.0,0.001013633590244301,0.101,28/75,19.46%,UBB;RPS27A;HMGN1;TCEA1;UBA52;POLR2G;COPS6;CCNH;PCNA;GTF2H1;POLD4;COPS8;UBC;RBX1;GTF2H5;POLR2C;POLR2L;COPS7A;GPS1;PRPF19;RFC3;XPA;POLR2I;COPS3;POLR2F;POLR2E;ERCC6;POLE3
gsea,Regulation Of Complement Cascade R-HSA-977606,-0.6419277429313415,-1.9934028194590998,0.0018796992481203006,0.0010108791511403762,0.101,5/21,5.69%,PSMA7;CD81;CLU;VTN;HNRNPC
gsea,Oncogene Induced Senescence R-HSA-2559585,-0.6117033212275869,-1.9846111939703848,0.0,0.0011471933848657815,0.114,11/27,13.14%,UBB;RPS27A;MAPK1;ETS2;UBA52;MAPK3;UBC;TNRC6A;CDK4;TFDP2;CDKN2D
gsea,Ca2+ Pathway R-HSA-4086398,-0.5157007793393867,-1.9827991589654184,0.0019723865877712033,0.00117876234287683,0.116,15/49,15.43%,CALM1;PPP3CA;PPP3R1;GNB2;PPP3CB;GNG2;CAMK2A;TNRC6A;ITPR1;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.552337297995919,-1.9825322179264486,0.0,0.001175585085887944,0.116,20/38,25.60%,H2AZ1;DEK;H2AJ;GSK3B;POLR1F;TAF1D;H2BC4;SF3B1;POLR2L;H2AX;BAZ1B;POLR2F;POLR2E;ERCC6;POLR1D;TBP;MYBBP1A;POLR1H;SMARCA5;POLR1G
gsea,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.5841320657355025,-1.9814924346364962,0.0020161290322580645,0.0012069079965413465,0.119,10/25,15.13%,APOE;DEK;NPM1;SUMO1;CHGA;HSPD1;YY1;KCTD1;UBE2I;CITED2
gsea,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.5633800759993075,-1.9790800080182938,0.0,0.0012282370594555476,0.121,16/35,20.98%,UBB;RPS27A;CANX;UBA52;VCP;UBC;PDIA3;PSMC1;RNF5;DERL1;RNF139;UBXN1;RAD23B;RNF185;RNF103;AMFR
gsea,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.4705467946047425,-1.9770038406515311,0.0,0.0012445522511971925,0.125,21/84,17.50%,PPP3CA;SPARCL1;SCG2;CST3;APOE;CHGB;APLP2;HSP90B1;GOLM1;KTN1;FAM20A;CALU;IGFBP5;P4HB;MIA3;PRSS23;SCG3;EVA1A;VGF;TMEM132A;ADAM10
gsea,Signaling By NOTCH1 R-HSA-1980143,-0.47316104860073194,-1.9715540011032067,0.0,0.0013438551079856297,0.132,21/69,14.66%,UBB;RPS27A;SKP1;MAMLD1;MIB1;APH1A;UBA52;NCOR1;SNW1;PSENEN;HDAC2;UBC;FBXW7;HDAC8;MIB2;RBX1;HEY1;TLE1;NEURL1B;NUMB;HDAC5
gsea,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.528178714506134,-1.9694737170007601,0.0,0.0013695235203480245,0.135,19/43,24.68%,RAB6B;RAB6A;STX16;NAPG;NSF;STX6;SCOC;VAMP4;TMF1;NAA30;M6PR;NAA38;VPS53;ARFRP1;VPS52;VAMP3;RIC1;VPS54;SYS1
gsea,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.6967883950379238,-1.965079359912715,0.0019646365422396855,0.0014922721900829095,0.143,6/15,7.28%,UBB;RPS27A;UBE2N;UBE2V1;UBA52;UBC
gsea,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.6494517294234232,-1.9648537293863906,0.0,0.0015028682665062963,0.145,10/19,17.96%,GNB2;GNG2;AKT3;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7;AKT1
gsea,Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.6205138652893717,-1.964694574151667,0.0,0.0014989029148796305,0.145,11/22,20.80%,VAMP2;RAB3A;SNAP25;SLC38A2;SLC1A3;ARL6IP5;SLC17A7;PPFIA3;GLS2;SLC1A2;STXBP1
gsea,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.6823129198161377,-1.9625405855914704,0.001984126984126984,0.0015383604525624974,0.148,11/15,26.57%,YWHAB;XRN1;DCP2;EXOSC4;EXOSC3;EXOSC9;EXOSC5;EXOSC2;EXOSC1;EXOSC7;DIS3
gsea,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.3892590488738205,-1.959879647748718,0.0,0.001601659810161828,0.153,68/247,24.73%,CALM1;HSP90AA1;TUBA4A;DYNLL1;TUBA1A;DYNLL2;YWHAG;ATP5PB;CETN2;YWHAE;PAFAH1B1;HSPA9;CYCS;TUBB4A;AHI1;AKAP9;CSNK1E;PPP2R1A;NCOR1;CCT2;DCTN1;ARF4;IFT20;DYNLRB1;MTX2;KIFAP3;DCTN3;TUBB4B;TCP1;MEF2C;IDH2;CCT8;MICOS10;TTBK2;RAB11A;CCT5;DYNC1H1;CEP290;TFAM;SIRT3;B9D2;BBIP1;CHD9;NUDT19;TCTN1;BBS5;HSPB11;ACTR1A;MICOS13;SEPTIN2;EXOC8;NCOA1;GLUD1;TFB2M;EXOC3;POLG2;SSNA1;EXOC5;CREB1;DCTN2;CEP83;INPP5E;CREBBP;IFT122;CCT3;IMMT;ESRRA;SAMM50
gsea,Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.597227069377438,-1.9594889689753603,0.0,0.0016022641815821052,0.154,13/26,15.43%,GNAS;GNB2;PRKAR1A;GNG2;ADCY1;PRKAR1B;PRKACB;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,Signaling By EGFR R-HSA-177929,-0.5225846945235267,-1.9570811942991595,0.0,0.0016507121252849833,0.158,17/45,21.00%,UBB;RPS27A;UBA52;AAMP;SH3KBP1;CDC42;UBC;PIK3R1;STAM;EPN1;SPRY2;SH3GL1;HRAS;ADAM10;STAM2;PTPN11;PXDN
gsea,EPHB-mediated Forward Signaling R-HSA-3928662,-0.5601324160838437,-1.9568543479908358,0.0,0.0016511856085334798,0.158,10/31,7.69%,ACTG1;ARPC2;ACTR2;ARPC5;WASL;ARPC1A;ACTR3;ARPC3;CDC42;ROCK2
gsea,Condensation Of Prophase Chromosomes R-HSA-2299718,-0.6338057415788675,-1.956816149625682,0.0,0.0016468968147450812,0.158,7/20,11.10%,SET;H2AZ1;H2AJ;NCAPH2;SMC4;H2BC4;H2AX
gsea,Oxidative Stress Induced Senescence R-HSA-2559580,-0.4854711036129101,-1.9548219690252413,0.0,0.0016568727014377703,0.161,20/65,15.71%,UBB;RPS27A;CBX6;JUN;MAPK1;H2AZ1;RBBP7;H2AJ;UBA52;MAPK3;UBC;TNRC6A;RING1;H2BC4;H2AX;CDK4;TFDP2;CDKN2D;CBX8;MAPK9
gsea,Translesion Synthesis By POLH R-HSA-110320,-0.6459806701932744,-1.9522011301579505,0.0019230769230769232,0.0017188844404467359,0.168,6/19,7.28%,UBB;RPS27A;UBA52;PCNA;VCP;UBC
gsea,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.5281405584776022,1.949061244827707,0.0,0.00849577384645173,0.182,14/40,9.59%,PCDH15;ATP2B4;KCNMA1;CDH23;EPS8;EPB41L3;MSN;ESPN;PLS1;XIRP2;CASK;MYO1E;MYO3B;STRC
gsea,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.47180885289043756,-1.948140791384735,0.0,0.001794745575332261,0.171,24/66,21.67%,ARF5;ARF3;NAPG;TMED7;NSF;TMED2;TMED9;ARF4;KIF5B;RAB1A;KIFAP3;RAB1B;COPZ1;COPG1;COPG2;KIF21A;COPB2;COPE;KDELR1;UBE2Z;ARFGAP2;KIF15;SEC22B;ARCN1
gsea,Budding And Maturation Of HIV Virion R-HSA-162588,-0.5897135551313064,-1.9481328771451039,0.0,0.0017901318334933606,0.171,18/27,28.95%,UBB;PPIA;RPS27A;UBA52;CHMP2A;CHMP4B;UBC;VPS28;CHMP7;CHMP5;VPS37D;VPS4B;CHMP6;TSG101;VTA1;VPS37B;VPS4A;PDCD6IP
gsea,Regulation Of TP53 Activity R-HSA-5633007,-0.4237003802716225,-1.9479735865369239,0.0,0.0017902405459528845,0.171,36/131,19.08%,PDZD2;UBB;RPS27A;CDK5R1;CHD3;AKT3;RBBP7;USP2;UBA52;PPP2R1A;PIP4K2A;PPP2CA;HDAC2;UBC;DYRK2;HIPK2;TAF11;CSNK2B;PPP1R13B;TAF3;BRD7;TAF10;KAT6A;PIP4P1;RICTOR;ATRIP;RFC3;HIPK1;GATAD2B;TAF7;PIP4K2B;KMT5A;AKT1;SSRP1;PHF20;MAPKAPK5
gsea,RNA Polymerase I Promoter Clearance R-HSA-73854,-0.5029000003402035,-1.947854441423663,0.00199203187250996,0.0017904563069057152,0.172,22/56,20.30%,H2AZ1;CHD3;CBX3;RBBP7;H2AJ;MAPK3;CCNH;GTF2H1;HDAC2;POLR1F;TAF1D;H2BC4;GTF2H5;POLR2L;H2AX;GATAD2B;POLR2F;POLR2E;ERCC6;POLR1D;RRN3;TBP
gsea,RNA Polymerase I Transcription R-HSA-73864,-0.5029000003402035,-1.947854441423663,0.00199203187250996,0.0017904563069057152,0.172,22/56,20.30%,H2AZ1;CHD3;CBX3;RBBP7;H2AJ;MAPK3;CCNH;GTF2H1;HDAC2;POLR1F;TAF1D;H2BC4;GTF2H5;POLR2L;H2AX;GATAD2B;POLR2F;POLR2E;ERCC6;POLR1D;RRN3;TBP
gsea,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.5929102795933144,-1.9473569184354698,0.0,0.0018092150655739916,0.172,14/28,20.92%,UBB;RPS27A;UBA52;UBC;UBA1;OTULIN;UBE2S;UBE2G1;CDC34;UBE2D1;USP9X;UBE2E3;UBE2Z;UBE2E1
gsea,VLDLR Internalisation And Degradation R-HSA-8866427,-0.7258602682878729,-1.9473312632891582,0.0,0.0018092742397545342,0.172,9/15,16.57%,UBB;RPS27A;AP2M1;CLTA;UBA52;AP2S1;UBC;CLTC;AP2B1
gsea,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.5696012522426631,-1.9467565934286573,0.0,0.0018186117456744544,0.173,11/27,14.67%,YWHAB;PEBP1;MAPK1;VCL;MAPK3;KSR1;CNKSR2;BRAF;RAP1A;ARAF;HRAS
gsea,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.4943376888364149,-1.9467279505224748,0.0,0.0018140192917712361,0.173,22/62,19.46%,UBB;RPS27A;HMGN1;TCEA1;UBA52;POLR2G;CCNH;PCNA;GTF2H1;POLD4;UBC;RBX1;GTF2H5;POLR2C;POLR2L;PRPF19;RFC3;POLR2I;POLR2F;POLR2E;ERCC6;POLE3
gsea,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.42142900889497314,-1.9455747206568605,0.0,0.0018556094117594113,0.175,40/141,16.09%,DDX5;TOP1;CETN2;HNRNPK;CHD3;SMC1A;NPM1;NSMCE3;SUMO2;TPR;RAD21;CBX5;SMC3;MITF;TOP2B;HNRNPC;THRA;PCNA;SUMO1;RNF168;HDAC2;RING1;SEC13;TDG;SMC5;PARK7;SMC6;HIPK2;STAG2;NFKB2;NUP88;XRCC4;UBE2I;SP3;NUP50;CBX8;NOP58;NFKBIA;NSMCE4A;PARP1
gsea,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.5760132465358888,-1.9446998383814587,0.0,0.0018693644604002937,0.177,12/27,17.96%,PDZD2;CHD3;AKT3;RBBP7;PIP4K2A;HDAC2;BRD7;KAT6A;PIP4P1;GATAD2B;PIP4K2B;AKT1
gsea,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.662951413585869,-1.9368125563960525,0.0,0.002007056330108408,0.19,6/17,7.59%,HSPA8;VAMP2;RAB3A;SNAP25;GAD1;DNAJC5
gsea,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.5033057265978492,1.9355248649130543,0.0,0.008678531772218424,0.203,18/47,12.57%,ADAMTS18;THSD7B;NOTCH2;ADAMTS3;THSD7A;ADAMTS17;ADAMTS9;ADAMTSL1;SEMA5B;SBSPON;ADAMTS1;THSD4;MUC15;ADAMTS16;DAG1;ADAMTS20;ADAMTS10;B3GLCT
gsea,Signal Amplification R-HSA-392518,-0.5855129316912415,-1.9350378026003867,0.0,0.002079921201223213,0.198,11/26,15.43%,GNB2;GNG2;AAMP;GNAI2;GNG10;P2RY12;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,Gene Silencing By RNA R-HSA-211000,-0.46011088263245525,-1.9350264529931598,0.0,0.0020747343653099385,0.198,23/74,20.24%,HSP90AA1;RAN;H2AZ1;TPR;H2AJ;POLR2G;TSN;TNRC6A;SEC13;IPO8;TSNAX;H2BC4;NUP88;POLR2C;POLR2L;H2AX;NUP50;POLR2I;SEH1L;POLR2F;POLR2E;PRKRA;NUP205
gsea,Deadenylation Of mRNA R-HSA-429947,-0.5924135016531997,-1.9346105554226931,0.0,0.0020832489292721603,0.2,12/24,19.72%,EIF4A2;EIF4A1;PABPC1;CNOT6;TUT4;CNOT6L;EIF4B;PAIP1;CNOT10;CNOT7;CNOT11;CNOT8
gsea,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.6456389434535749,-1.9338706112029809,0.0038314176245210726,0.0021053628975773067,0.202,9/20,13.10%,UBB;RPS27A;MIB1;APH1A;UBA52;PSENEN;UBC;MIB2;NEURL1B
gsea,Inwardly Rectifying K+ Channels R-HSA-1296065,-0.5914459235359324,-1.9337955645879235,0.0020325203252032522,0.002113759497034103,0.202,10/24,15.43%,GNB2;GNG2;KCNJ3;KCNJ4;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,trans-Golgi Network Vesicle Budding R-HSA-199992,-0.47183638975534153,-1.9337077818185677,0.0019230769230769232,0.0021085403377821667,0.202,22/65,20.37%,FTH1;HSPA8;VAMP2;NECAP1;GOLGB1;CLTA;CHMP2A;BLOC1S4;TFRC;PUM1;CLTC;PIK3C2A;M6PR;AP1S2;CTSZ;CLTB;SNX5;AP1S1;PICALM;HOMER2;YIPF6;SNAPIN
gsea,PERK Regulates Gene Expression R-HSA-381042,-0.5826426404132605,-1.9319016190810028,0.0,0.002171051187665992,0.205,17/26,29.24%,EIF2S2;DCP2;CEBPB;EXOSC4;EXOSC3;NFYB;ATF6;HSPA5;CEBPG;EXOSC9;ATF4;EXOSC5;EXOSC2;EXOSC1;EXOSC7;DIS3;HERPUD1
gsea,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.604288456479493,-1.9316363085458432,0.0,0.0021702194395211314,0.206,10/24,18.98%,H2AZ1;CHD3;CBX3;RBBP7;H2AJ;HDAC2;H2BC4;H2AX;GATAD2B;ERCC6
gsea,Metabolism Of Cofactors R-HSA-8978934,-0.6221855847133312,-1.9299863762088416,0.0,0.002187357745952546,0.209,2/18,0.06%,CALM1;HSP90AA1
gsea,Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.5860886661934922,-1.927628231316561,0.001841620626151013,0.0022312953226611815,0.211,7/27,7.28%,UBB;RPS27A;LCT;IDS;DCXR;UBA52;UBC
gsea,Complement Cascade R-HSA-166658,-0.581790004568689,-1.9273725444701988,0.0,0.002234792308180094,0.212,5/26,5.69%,PSMA7;CD81;CLU;VTN;HNRNPC
gsea,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.49572318010955296,-1.9252140377519744,0.003795066413662239,0.002251648405881696,0.214,18/51,20.37%,FTH1;HSPA8;VAMP2;NECAP1;GOLGB1;CLTA;BLOC1S4;TFRC;PUM1;CLTC;PIK3C2A;AP1S2;SNX5;AP1S1;PICALM;HOMER2;YIPF6;SNAPIN
gsea,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.6377838251164482,-1.923969130415468,0.0,0.0022862142282809375,0.218,11/19,19.96%,UBB;RPS27A;UBA52;SH3KBP1;UBC;CBLL1;STAM;SH3GL1;STAM2;RNMT;CTNNB1
gsea,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.4501225602121169,-1.921201394855026,0.0,0.002333924015409778,0.221,27/82,25.37%,HSP90AA1;HSP90AB1;CNBP;UBE2N;G3BP2;TPR;UBE2V1;TBK1;SEC13;IRAK1;NUP88;G3BP1;SEC24A;NUP50;SAR1B;IRF3;B2M;SEH1L;PTPN11;TYK2;NUP205;TAB2;LARP1;NUP62;CREBBP;NUP107;IKBKG
gsea,FLT3 Signaling R-HSA-9607240,-0.5516846766009654,-1.9178407976749456,0.003816793893129771,0.00239910892137092,0.226,14/34,19.60%,UBB;RPS27A;CDKN1B;FOXO3;AKT3;UBA52;PTPRJ;UBC;PIK3R1;HRAS;HCK;AKT1;SEPSECS;PTPN11
gsea,ISG15 Antiviral Mechanism R-HSA-1169408,-0.4744450672758892,-1.917830294319069,0.0,0.0023933279360182193,0.226,14/63,10.51%,PDZD2;UBB;RPS27A;EIF4A2;EIF4A1;UBE2N;EIF4G2;TPR;UBA52;MAPK3;UBC;SEC13;NEDD4;NUP88
gsea,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.4553547222244199,-1.9174468159096423,0.0,0.0024096003411324504,0.227,40/77,30.53%,RBM8A;CDC40;SRSF1;TPR;SRSF3;SRSF5;SEC13;CPSF2;NUP88;FYTTD1;SLBP;CHTOP;SRSF2;NUP50;THOC7;U2AF1L4;THOC2;MAGOHB;SEH1L;ALYREF;U2AF2;FIP1L1;SARNP;SRSF7;NUP205;SRSF11;NCBP2;THOC1;DDX39B;NUP62;SRSF6;NXF1;CPSF1;NUP107;GLE1;U2AF1;SLU7;SRRM1;MAGOH;NUP133
gsea,Ion Channel Transport R-HSA-983712,-0.41454893131248416,-1.9169934602376593,0.0,0.002412611034284208,0.228,26/129,8.12%,CALM1;ATP1B1;UBB;RPS27A;ATP6V0C;ATP6V1D;ATP2B1;CAMK2B;ATP6V1A;ATP6V1G2;ATP1A2;ATP6V1E1;ATP6AP1;ATP6V1F;ATP1B2;ATP6V0E2;ATP1A3;UBA52;ATP6V1G1;TRPC4;CAMK2A;ATP13A4;UBC;CLCN4;ATP6V1B2;CLCN3
gsea,G Alpha (Z) Signaling Events R-HSA-418597,-0.5256384124480528,-1.9162433570813493,0.0,0.0024375275338408336,0.232,14/38,15.43%,GNAS;GNB2;GNG2;ADCY1;GNAI2;GNG10;PRKCB;GNG3;GNB1;GNG13;RGS4;GNG11;ADRA2C;GNG7
gsea,Transcription Of HIV Genome R-HSA-167172,-0.4686522474831728,-1.9160724458008906,0.001949317738791423,0.0024360836249121146,0.232,38/64,36.62%,ELOB;TCEA1;POLR2G;CCNH;GTF2H1;TAF11;ELOC;TAF3;GTF2H5;POLR2C;POLR2L;TAF10;GTF2A1;GTF2B;CDK9;POLR2I;TAF7;POLR2F;SSRP1;POLR2E;GTF2F1;RNMT;TBP;NCBP2;CCNT1;GTF2H4;GTF2F2;GTF2A2;CDK7;POLR2J;TAF1;POLR2B;CCNT2;POLR2K;GTF2H3;TAF9;POLR2D;GTF2E1
gsea,GPER1 Signaling R-HSA-9634597,-0.5373815820139954,-1.9159786400736365,0.0,0.002430283425805181,0.232,14/35,15.43%,GNAS;GNB2;PRKAR1A;GNG2;ADCY1;PRKAR1B;GNAI2;PRKACB;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.6025166428325234,-1.9139856292043271,0.0,0.0024723916044132083,0.234,15/22,29.24%,DCP2;CEBPB;EXOSC4;EXOSC3;NFYB;ATF6;CEBPG;EXOSC9;ATF4;EXOSC5;EXOSC2;EXOSC1;EXOSC7;DIS3;HERPUD1
gsea,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.699526092668212,-1.9138872736850452,0.004008016032064128,0.0024708753439589295,0.235,9/15,19.60%,UBB;RPS27A;NDUFA2;UBA52;TBK1;UBC;IRF3;TANK;PTPN11
gsea,Aquaporin-mediated Transport R-HSA-445717,-0.5447849910289317,-1.9133749167069933,0.0,0.0024780306955763387,0.238,14/33,15.43%,GNAS;GNB2;PRKAR1A;GNG2;ADCY1;PRKAR1B;PRKACB;GNG10;GNG3;RAB11A;GNB1;GNG13;GNG11;GNG7
gsea,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.5800364153030567,-1.9124343130977008,0.0,0.0025024403115041158,0.24,12/28,18.49%,H2AZ1;ATRX;H2AJ;POLR2G;TERF1;H2BC4;POLR2C;POLR2L;H2AX;POLR2I;POLR2F;POLR2E
gsea,P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.45354216223437127,-1.9123847281207569,0.0,0.002500864051224595,0.24,24/84,18.45%,UBB;RPS27A;BEX3;SQSTM1;YWHAE;MAGED1;RTN4;ARHGDIA;APH1A;UBA52;PSENEN;HDAC2;UBC;IRAK1;ARHGEF4;PRDM4;ARHGEF12;ARHGEF9;MAG;NFKBIA;ARHGEF2;SOS2;BAD;TIAM1
gsea,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.658680444529646,-1.9114931390414305,0.0019801980198019802,0.002512200329909116,0.241,5/16,7.28%,UBB;RPS27A;SKP1;UBA52;UBC
gsea,Basigin Interactions R-HSA-210991,-0.6219699391254481,-1.9086708268475683,0.0,0.002596441367887927,0.248,4/20,3.82%,ATP1B1;PPIA;BSG;ATP1B2
gsea,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.5060487864218659,-1.9081274491369664,0.0,0.0025989381389569157,0.249,15/48,11.85%,BSG;MDH2;VDAC1;IDH3B;GLO1;LDHB;FAHD1;LDHA;SDHA;IDH3A;SDHD;HAGH;IDH2;DLAT;SUCLG1
gsea,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.6252619456025013,1.907246930794271,0.0019230769230769232,0.010495683400487267,0.262,7/20,6.95%,GRIA4;PTPRD;GRIA3;GRIN2B;LRFN2;PTPRS;PTPRF
gsea,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.44113355747258515,-1.906653951075767,0.0,0.002644139579920867,0.252,25/91,15.43%,CALM1;GNAS;GNB2;PRKAR1A;GNG2;GLP2R;PLK2;ADCY1;AHCYL1;PRKAR1B;CHGA;ITPR1;GNAI2;PRKACB;GNG10;MC4R;GPR27;RAMP2;GNG3;GNB1;ADRB1;GNG13;PTRH2;GNG11;GNG7
gsea,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.46330875342325445,-1.906389878100926,0.0,0.002646513812026668,0.253,36/68,30.53%,RBM8A;CDC40;SRSF1;TPR;SRSF3;SRSF5;SEC13;NUP88;FYTTD1;CHTOP;SRSF2;NUP50;THOC7;U2AF1L4;THOC2;MAGOHB;SEH1L;ALYREF;U2AF2;SARNP;SRSF7;NUP205;SRSF11;NCBP2;THOC1;DDX39B;NUP62;SRSF6;NXF1;NUP107;GLE1;U2AF1;SLU7;SRRM1;MAGOH;NUP133
gsea,HIV Elongation Arrest And Recovery R-HSA-167287,-0.5574809384151207,-1.9057597671772102,0.0,0.002648877026814113,0.254,18/29,33.64%,ELOB;TCEA1;POLR2G;ELOC;POLR2C;POLR2L;CDK9;POLR2I;POLR2F;SSRP1;POLR2E;GTF2F1;CCNT1;GTF2F2;POLR2J;POLR2B;CCNT2;POLR2K
gsea,TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.6868157534099621,-1.9023021066914325,0.0,0.0027530365059427833,0.266,5/15,7.28%,UBB;RPS27A;NDUFA2;UBA52;UBC
gsea,Long-term Potentiation R-HSA-9620244,-0.5927598390047449,-1.9018361159039354,0.0,0.0027593749645390426,0.267,5/22,0.64%,NRGN;CALM1;GRIA2;NEFL;CAMK2B
gsea,Ion Transport By P-type ATPases R-HSA-936837,-0.507410791021931,-1.9012583511688033,0.0,0.0027614617950018914,0.267,13/42,15.20%,CALM1;ATP1B1;ATP2B1;CAMK2B;ATP1A2;ATP1B2;ATP1A3;CAMK2A;ATP13A4;PDZD11;ATP11C;CUTC;ATP13A5
gsea,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.5463263897290872,-1.9007791942156953,0.0,0.0027761771666536994,0.267,14/32,15.43%,GNAS;GNB2;PRKAR1A;GNG2;ADCY1;PRKAR1B;PRKACB;GNG10;GNG3;RAB11A;GNB1;GNG13;GNG11;GNG7
gsea,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.5140699515089291,-1.8989301217301453,0.004158004158004158,0.002853870782909433,0.272,13/36,15.78%,CCT6A;CCT2;FBXW2;STAT3;FBXW7;TCP1;CCT8;AP3M1;FBXO6;DCAF7;CCT5;FBXL3;NOP56
gsea,Chromatin Modifying Enzymes R-HSA-3247509,-0.38635530401868035,-1.8977682347631666,0.0,0.002901854799436413,0.276,82/203,32.59%,RPS2;H2AZ1;MORF4L1;CHD3;MORF4L2;USP22;RBBP7;H2AJ;MBIP;SAP18;CLOCK;NCOR1;ATF7IP;ASH1L;HDAC2;MSL1;H2AC25;MSL2;KDM4C;MRGBP;SMARCE1;HDAC8;PRMT1;PBRM1;NSD1;ENY2;NFKB2;H2BC4;H2AX;TAF10;KAT6A;ACTL6B;KDM7A;CDK4;BRD8;GPS2;SETD3;PHF2;TADA3;SMARCC2;GATAD2B;SETD7;SETD1B;TADA2B;KMT5A;SMARCD2;NCOA1;PHF20;ARID4A;KMT2C;KDM6B;KDM1A;PRMT7;DOT1L;PRMT6;KDM5A;CREBBP;SETD6;NSD2;SUV39H1;SMARCD1;HAT1;JADE1;HCFC1;ING3;HMG20B;ACTL6A;TADA1;JMJD6;MCRS1;MSL3;ARID1B;BRMS1L;SETD2;YEATS4;PADI2;PRDM16;HDAC10;KAT5;JADE3;H2AC21;ARID2
gsea,RMTs Methylate Histone Arginines R-HSA-3214858,-0.5128649149679977,-1.8962445232280027,0.0020325203252032522,0.002932884279881465,0.282,21/39,33.06%,RPS2;H2AZ1;RBBP7;H2AJ;H2AC25;SMARCE1;PRMT1;PBRM1;H2AX;ACTL6B;CDK4;SMARCC2;SMARCD2;PRMT7;PRMT6;SMARCD1;ACTL6A;ARID1B;H2AC21;ARID2;PRMT3
gsea,Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.4504531182980582,-1.8956217143649012,0.0,0.00294707508667795,0.285,36/84,27.09%,UBB;RPS27A;MAPK1;FKBP1A;SKIL;UBA52;MAPK3;NEDD8;NCOR1;SNW1;PPP1CB;PPP1CA;UBC;TGFB2;CDK9;TFDP2;SMAD2;UBE2D1;PARP1;RNASEH2A;PARD3;STUB1;USP9X;PPM1A;UBE2M;E2F4;CCNT1;ZFYVE9;USP15;SMAD3;SMAD7;SMAD4;BAMBI;ITGB1;PPP1CC;XPO1
gsea,Dual Incision In TC-NER R-HSA-6782135,-0.47921507241618755,-1.8945224525781712,0.0,0.0029653662300178777,0.287,23/63,19.46%,UBB;RPS27A;HMGN1;TCEA1;UBA52;POLR2G;CCNH;PCNA;GTF2H1;POLD4;UBC;RBX1;GTF2H5;POLR2C;POLR2L;PRPF19;RFC3;XPA;POLR2I;POLR2F;POLR2E;ERCC6;POLE3
gsea,Assembly Of HIV Virion R-HSA-175474,-0.6483799352480147,-1.8943367864047294,0.002066115702479339,0.0029586420435552523,0.287,6/17,8.18%,UBB;PPIA;RPS27A;UBA52;UBC;VPS28
gsea,Translesion Synthesis By POLI R-HSA-5656121,-0.6451148072832731,-1.8925193515364103,0.0019083969465648854,0.0030099922101940583,0.292,9/17,17.80%,UBB;RPS27A;UBA52;PCNA;UBC;REV1;RFC3;POLI;REV3L
gsea,Ovarian Tumor Domain Proteases R-HSA-5689896,-0.546068271327288,-1.8917360530406557,0.0,0.003011470917135867,0.294,12/32,17.45%,UBB;RPS27A;UBA52;VCPIP1;VCP;OTUB1;UBC;OTUD7B;PTEN;YOD1;UBE2D1;ZRANB1
gsea,DNA Repair R-HSA-73894,-0.37279979936529206,-1.890057526585573,0.0,0.003062470792768235,0.296,130/273,40.84%,UBB;RPS27A;H2AZ1;CETN2;SEM1;UBE2N;SUMO2;HMGN1;TCEA1;H2AJ;PPP4C;UBA52;POLR2G;COPS6;TERF1;CCNH;PCNA;SUMO1;VCP;UBE2V2;GTF2H1;POLD4;RNF168;COPS8;UBC;TDG;UIMC1;RBX1;EYA1;H2BC4;YY1;GTF2H5;POLR2C;POLR2L;XRCC4;H2AX;REV1;COPS7A;GPS1;PRPF19;USP1;UBE2I;ATRIP;CENPX;ALKBH5;RFC3;PARP2;BAZ1B;XPA;POLR2I;COPS3;PARP1;DDB2;POLI;REV3L;UBXN1;POLR2F;POLR2E;ADPRS;ERCC6;POLE3;RAD23B;ACTR8;POLG2;FEN1;RNF4;RCHY1;BRCA2;INO80E;DDB1;MSH2;GTF2H4;NSD2;RAD18;SMARCA5;RAD51D;SIRT6;CDK7;APEX1;MAD2L2;FAAP20;ACTL6A;POLL;MAPK8;MCRS1;TOP3A;POLR2J;LIG4;APBB1;MUS81;POLD2;RPA3;TDP2;POLR2B;KAT5;XRCC2;ERCC1;NFRKB;XRCC6;POLR2K;COPS2;RAD17;GTF2H3;MLH1;LRIF1;POLR2D;NTHL1;PIAS1;RFC2;RAD9A;ASCC3;SPIDR;CUL4B;INO80B;BABAM1;RAD50;XAB2;FANCC;FANCE;RBBP8;OGG1;POLK;MPG;PARG;RAD9B;RAD23A;COPS5;ERCC5;USP32;EP300
gsea,SUMOylation R-HSA-2990846,-0.4046056369128385,-1.8880075758353,0.0,0.003113241455476413,0.299,40/147,16.09%,DDX5;TOP1;CETN2;HNRNPK;CHD3;SMC1A;NPM1;NSMCE3;SUMO2;TPR;RAD21;CBX5;SMC3;MITF;TOP2B;HNRNPC;THRA;PCNA;SUMO1;RNF168;HDAC2;RING1;SEC13;TDG;SMC5;PARK7;SMC6;HIPK2;STAG2;NFKB2;NUP88;XRCC4;UBE2I;SP3;NUP50;CBX8;NOP58;NFKBIA;NSMCE4A;PARP1
gsea,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.5874874067199657,-1.8849167824183224,0.0,0.003196654934812944,0.304,9/24,17.38%,CALM1;ORAI2;SH3KBP1;AHCYL1;ITPR1;PIK3R1;NCK1;CLSTN1;STIM1
gsea,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.6050405829607967,-1.8842269231616091,0.001937984496124031,0.0031977028194899067,0.305,10/20,23.05%,GNB2;GNG2;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7;GNA11;GNA15
gsea,G-protein Activation R-HSA-202040,-0.6115085268414014,-1.883252561538757,0.0,0.0032151078983665943,0.308,10/20,23.05%,GNB2;GNG2;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7;GNA11;GNA15
gsea,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.5613665885658142,-1.8823065764429796,0.0,0.0032242727332718597,0.309,14/27,24.28%,ELOB;TCEA1;POLR2G;ELOC;POLR2C;POLR2L;CDK9;POLR2I;POLR2F;SSRP1;POLR2E;GTF2F1;CCNT1;GTF2F2
gsea,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.6117703183344567,-1.8807320868456496,0.0,0.0032781920058437336,0.315,14/20,31.32%,PRNP;VAMP2;VAPA;SEC61G;EMD;SEC61B;BAG6;SGTA;GET3;SERP1;GET1;UBE2J2;GET4;UBL4A
gsea,Cristae Formation R-HSA-8949613,-0.6562202165574897,-1.8801365751813937,0.0021141649048625794,0.0032953028398801025,0.317,7/15,24.73%,ATP5PB;HSPA9;MTX2;MICOS10;MICOS13;IMMT;SAMM50
gsea,Cargo Concentration In ER R-HSA-5694530,-0.5786234244440173,-1.8782392184858783,0.0,0.003365043462272947,0.323,11/25,21.65%,CNIH2;CNIH1;TMED2;MIA3;MCFD2;SEC24A;SAR1B;CTSZ;LMAN2;SEC22B;LMAN1
gsea,RNA Polymerase I Promoter Escape R-HSA-73772,-0.5232504846405286,-1.8780731285070154,0.003838771593090211,0.00336166042966905,0.323,20/39,27.14%,H2AZ1;CBX3;H2AJ;CCNH;GTF2H1;POLR1F;TAF1D;H2BC4;GTF2H5;POLR2L;H2AX;POLR2F;POLR2E;POLR1D;RRN3;TBP;GTF2H4;POLR1H;POLR1G;CDK7
gsea,Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.43727723237159305,-1.8749333482358062,0.0,0.0035278214789130173,0.335,33/90,25.60%,H2AZ1;DEK;CHD3;CBX3;RBBP7;H2AJ;SAP18;GSK3B;CCNH;GTF2H1;HDAC2;TDG;POLR1F;TAF1D;H2BC4;GTF2H5;SF3B1;POLR2L;H2AX;JARID2;BAZ1B;GATAD2B;POLR2F;POLR2E;ERCC6;POLR1D;TBP;MYBBP1A;GTF2H4;POLR1H;SUV39H1;SMARCA5;POLR1G
gsea,Response Of Mtb To Phagocytosis R-HSA-9637690,-0.6325462990080075,-1.8696548011686964,0.001893939393939394,0.0037617202922834514,0.354,8/20,11.95%,UBB;RPS27A;MAPK1;UBA52;MAPK3;PGK1;UBC;CORO1A
gsea,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.45999901221290684,-1.869386014081017,0.0,0.0037655270220769595,0.354,14/67,10.51%,PDZD2;UBB;RPS27A;EIF4A2;EIF4A1;UBE2N;EIF4G2;TPR;UBA52;MAPK3;UBC;SEC13;NEDD4;NUP88
gsea,Unfolded Protein Response (UPR) R-HSA-381119,-0.4404249610256096,-1.8680283186821915,0.0,0.003789366651222659,0.358,30/78,26.94%,HDGF;HSP90B1;DNAJB11;EIF2S2;DCP2;CEBPB;MYDGF;DCTN1;SSR1;EXOSC4;EXOSC3;DNAJB9;NFYB;ATF6;HSPA5;CEBPG;EXOSC9;CREB3L2;ATF4;EXOSC5;TLN1;EXOSC2;EXOSC1;ATP6V0D1;CALR;SERP1;EXOSC7;TSPYL2;DIS3;PPP2R5B
gsea,Biological Oxidations R-HSA-211859,-0.4248003576157969,-1.864679036254122,0.0,0.003929135716678906,0.373,34/100,28.76%,HSP90AB1;PRNP;CYP7B1;GSTM5;MAT2B;AURKAIP1;SULT4A1;TRMT112;GSTP1;GSTM1;PTGES3;VDAC2;MIA3;GCLM;TPST1;BPNT2;AKR1A1;SLC38A1;GSTO1;CYB5B;COMT;NCOA1;PODXL2;PAOX;CYP26B1;N6AMT1;UGP2;PAPSS2;GGT7;ALDH1A1;GCLC;FDX2;CHAC2;CYB5R3
gsea,Glycogen Metabolism R-HSA-8982491,-0.6084506684054478,-1.8642965376042187,0.0018552875695732839,0.003932552826398828,0.374,5/21,7.28%,CALM1;UBB;RPS27A;UBA52;UBC
gsea,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.5717267895270639,-1.8618930408932015,0.0018315018315018315,0.004007662762747659,0.378,6/25,7.28%,UBB;RPS27A;UBA52;PCNA;POLD4;UBC
gsea,Signaling By NOTCH2 R-HSA-1980145,-0.553654513150102,-1.861475635804376,0.0039447731755424065,0.004014869825671917,0.378,10/28,13.10%,UBB;RPS27A;MAMLD1;MIB1;APH1A;UBA52;PSENEN;UBC;MIB2;NEURL1B
gsea,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.6434311632422158,-1.8575773261741848,0.0,0.004156907181726505,0.394,9/15,25.50%,XRN1;DCP2;LSM2;DDX6;LSM5;LSM4;LSM3;LSM7;LSM6
gsea,Signaling By TGFB Family Members R-HSA-9006936,-0.4250753339425601,-1.8575168266496431,0.0,0.004155844875470974,0.395,43/104,27.09%,UBB;RPS27A;MAPK1;FKBP1A;SKIL;DRAP1;UBA52;BMPR2;ACVR1C;MAPK3;NEDD8;NCOR1;SNW1;PPP1CB;PPP1CA;UBC;TGFB2;SMAD9;CDK9;TFDP2;SMAD5;FST;SMAD2;UBE2D1;PARP1;SMAD1;RNASEH2A;PARD3;STUB1;USP9X;PPM1A;UBE2M;E2F4;CCNT1;ZFYVE9;USP15;SMAD3;SMAD7;SMAD4;BAMBI;ITGB1;PPP1CC;XPO1
gsea,Collagen Formation R-HSA-1474290,0.44661051667050866,1.855850990554888,0.0,0.01612616421738117,0.384,16/61,6.39%,COL19A1;COL23A1;COL25A1;COL5A2;P3H2;COL11A1;ADAMTS3;COL4A4;COL28A1;COL13A1;P4HA1;COL12A1;DST;COL4A1;P3H1;COL15A1
gsea,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.6265750799720573,-1.8552502752394202,0.0019120458891013384,0.0042456237492688636,0.405,10/21,17.37%,UBB;RPS27A;MAPK1;UBA52;MAPK3;PGK1;UBC;CORO1A;ATP6V1H;B2M
gsea,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.6031100550827923,-1.8543919044918848,0.0,0.00428772538852893,0.407,9/19,19.72%,NPM1;PLK2;BTG2;CNOT6;CNOT6L;CNOT10;CNOT7;CNOT11;CNOT8
gsea,Regulation Of MECP2 Expression And Activity R-HSA-9022692,-0.5496694018743649,-1.8530082488666884,0.0,0.0043375112683617335,0.412,7/29,8.40%,CALM1;CAMK2B;NCOR1;CAMK2A;HDAC2;TNRC6A;HIPK2
gsea,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.435386549395873,-1.8524477898964538,0.0,0.004351767514374334,0.414,24/78,17.96%,RAB3A;YWHAE;RAB6B;RAB6A;RAB14;SBF1;AKT3;GDI1;RAB12;TRAPPC6B;RAB18;RAB1A;RAB1B;GDI2;DENND5B;TRAPPC6A;DENND4A;TRAPPC2;RAB39B;SBF2;TRAPPC2L;RAB5B;RAB31;AKT1
gsea,Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.47233724232683705,-1.8503590272962585,0.0,0.004432529085780108,0.421,19/52,20.24%,RAN;H2AZ1;TPR;H2AJ;POLR2G;TNRC6A;SEC13;IPO8;H2BC4;NUP88;POLR2C;POLR2L;H2AX;NUP50;POLR2I;SEH1L;POLR2F;POLR2E;NUP205
gsea,Cleavage Of Damaged Purine R-HSA-110331,-0.6261737740310441,-1.849772352750502,0.007736943907156673,0.004454336566496273,0.422,5/17,11.10%,H2AZ1;H2AJ;TERF1;H2BC4;H2AX
gsea,Signaling By NTRKs R-HSA-166520,-0.40777694027680655,-1.8490467124466645,0.0,0.0044799502487683435,0.426,44/117,23.15%,YWHAB;CDK5R1;MAPK1;AP2M1;BCL11B;DUSP3;MEF2A;EGR3;CDK5R2;CLTA;PPP2R1A;MAPK3;JUND;AP2S1;TCF12;PPP2CA;BAX;DUSP7;PPP2R5D;STAT3;MEF2C;BRAF;RAP1A;PIK3R1;CLTC;DNAL4;HRAS;EGR4;VGF;EGR1;AP2B1;RALA;RNASEH2A;TIAM1;DUSP6;FOSB;PTPN11;VRK3;ASCL1;AP2A2;MAP2K1;ID4;CREB1;ID2
gsea,Negative Regulation Of MET Activity R-HSA-6807004,-0.5978736841189788,-1.84839603069445,0.006072874493927126,0.004521018052922125,0.43,10/21,19.55%,UBB;RPS27A;UBA52;SH3KBP1;PTPRJ;UBC;STAM;SH3GL1;STAM2;RNMT
gsea,RAB Geranylgeranylation R-HSA-8873719,-0.47856706613119654,-1.8479547671399965,0.0019646365422396855,0.004530852015656482,0.43,23/49,25.73%,RAB3A;RAB6B;RAB6A;RAB14;RAB2A;RAB40B;RAB12;RAB24;RAB18;RAB1A;RAB1B;RAB39B;RAB11A;RAB22A;RAB3D;RAB5B;RAB31;RAB35;RABGGTB;RAB3C;RAB32;RAB34;RAB15
gsea,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.6613894987426757,-1.847137542525785,0.007874015748031496,0.004560015746970267,0.432,9/15,19.55%,UBB;RPS27A;UBA52;SH3KBP1;UBC;STAM;SH3GL1;STAM2;RNMT
gsea,Calnexin/calreticulin Cycle R-HSA-901042,-0.5574146458163067,-1.8469469877377866,0.0020920502092050207,0.00455426155698237,0.432,11/26,20.98%,UBB;RPS27A;CANX;UBA52;UBC;PDIA3;RNF5;RNF139;RNF185;RNF103;AMFR
gsea,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.5468463511219063,-1.8463027522243354,0.002008032128514056,0.004571679338649679,0.432,10/28,9.47%,JUN;MAPK1;DUSP3;MEF2A;PPP2R1A;MAPK3;PPP2CA;DUSP7;PPP2R5D;MEF2C
gsea,MTOR Signaling R-HSA-165159,-0.4953280549630902,-1.843165448947552,0.0,0.004708369357524137,0.446,15/39,22.81%,YWHAB;RPS6;FKBP1A;RRAGA;LAMTOR3;RPS6KB1;LAMTOR2;RRAGD;AKT1S1;EIF4B;RHEB;AKT1;PPM1A;CAB39;RRAGC
gsea,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.49413667729812527,-1.8422705850695136,0.0018975332068311196,0.004767650626101106,0.452,13/47,9.50%,UBB;RPS27A;APOE;AP2M1;NCEH1;LCAT;CLTA;UBA52;AP2S1;UBC;ZDHHC8;P4HB;PRKACB
gsea,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.6269110929661283,-1.841430303533784,0.0,0.004773011438119368,0.452,11/16,26.57%,YWHAZ;DCP2;EXOSC4;EXOSC3;AKT1;EXOSC9;EXOSC5;EXOSC2;EXOSC1;EXOSC7;DIS3
gsea,HIV Transcription Initiation R-HSA-167161,-0.48386657741850897,-1.8413109055923773,0.0,0.004782175607274732,0.453,29/45,36.62%,POLR2G;CCNH;GTF2H1;TAF11;TAF3;GTF2H5;POLR2C;POLR2L;TAF10;GTF2A1;GTF2B;POLR2I;TAF7;POLR2F;POLR2E;GTF2F1;TBP;GTF2H4;GTF2F2;GTF2A2;CDK7;POLR2J;TAF1;POLR2B;POLR2K;GTF2H3;TAF9;POLR2D;GTF2E1
gsea,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.6147129429649105,-1.8412356446001181,0.006036217303822937,0.004783666052005665,0.453,6/18,12.49%,CDK5R1;JUN;YWHAE;FOXO3;PRDX1;PRDX2
gsea,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.5807782749497213,-1.8407721673756443,0.0,0.004811819130748017,0.456,13/23,26.79%,PRDX5;CYCS;SOD1;GSTP1;PRDX1;P4HB;PRDX2;NCF2;TXNRD1;ATP7A;PRDX3;TXN2;GSR
gsea,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.4742895046916462,-1.8399308068311362,0.0,0.004847459249382341,0.458,20/53,15.16%,UBB;RPS27A;CANX;UBA52;GSK3B;DDOST;SUMO1;UBC;PARP4;CSNK1A1;ZDHHC8;PRMT1;DAD1;PARP8;UBE2I;STT3A;GOLGA7;GALNT1;ZDHHC3;RPN2
gsea,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.5410658072676097,-1.8398082830411011,0.00211864406779661,0.0048488052738724875,0.46,8/31,7.28%,UBB;RPS27A;AKT3;USP2;UBA52;PPP2R1A;PPP2CA;UBC
gsea,PRC2 Methylates Histones And DNA R-HSA-212300,-0.5730268111637654,-1.8373789409646588,0.001937984496124031,0.004944801195612038,0.467,6/21,12.29%,H2AZ1;RBBP7;H2AJ;H2BC4;H2AX;JARID2
gsea,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.5009318871615791,-1.8372725517455797,0.0,0.004942162552704415,0.467,26/41,36.34%,ELOB;TCEA1;POLR2G;CCNH;GTF2H1;ELOC;GTF2H5;POLR2C;POLR2L;CDK9;POLR2I;POLR2F;SSRP1;POLR2E;GTF2F1;NCBP2;CCNT1;GTF2H4;GTF2F2;CDK7;POLR2J;POLR2B;CCNT2;POLR2K;GTF2H3;POLR2D
gsea,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.46371906396112594,-1.8356760555895146,0.0019120458891013384,0.005033800699104422,0.471,31/55,36.34%,JUN;ELOB;TCEA1;POLR2G;CCNH;GTF2H1;ELOC;GTF2H5;POLR2C;POLR2L;CDK9;POLR2I;DDB2;POLR2F;SSRP1;POLR2E;GTF2F1;CDK13;CCNT1;MSH2;GTF2H4;GTF2F2;RAD51D;CDK7;POLR2J;POLR2B;CCNT2;POLR2K;GTF2H3;MLH1;POLR2D
gsea,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.5016015778241867,-1.8354719281029375,0.0,0.005038515931284558,0.471,19/39,24.28%,ELOB;TCEA1;POLR2G;CCNH;GTF2H1;ELOC;GTF2H5;POLR2C;POLR2L;CDK9;POLR2I;POLR2F;SSRP1;POLR2E;GTF2F1;NCBP2;CCNT1;GTF2H4;GTF2F2
gsea,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.4762337474900752,-1.834858493957037,0.0,0.005065742941521837,0.473,15/45,14.66%,UBB;RPS27A;SKP1;MAMLD1;UBA52;NCOR1;SNW1;HDAC2;UBC;FBXW7;HDAC8;RBX1;HEY1;TLE1;HDAC5
gsea,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.5478537103034707,-1.8343500918249505,0.0,0.005092858593844035,0.473,11/31,14.25%,H2AZ1;DEK;H2AJ;CEBPB;STAT3;H2BC4;CEBPA;H2AX;CDK4;TFDP2;CBFB
gsea,Cilium Assembly R-HSA-5617833,-0.3801512291503813,-1.834318676660873,0.0,0.005082465004877007,0.473,46/176,23.95%,HSP90AA1;TUBA4A;DYNLL1;TUBA1A;DYNLL2;YWHAG;CETN2;YWHAE;PAFAH1B1;TUBB4A;AHI1;AKAP9;CSNK1E;PPP2R1A;CCT2;DCTN1;ARF4;IFT20;DYNLRB1;KIFAP3;DCTN3;TUBB4B;TCP1;CCT8;TTBK2;RAB11A;CCT5;DYNC1H1;CEP290;B9D2;BBIP1;NUDT19;TCTN1;BBS5;HSPB11;ACTR1A;SEPTIN2;EXOC8;EXOC3;SSNA1;EXOC5;DCTN2;CEP83;INPP5E;IFT122;CCT3
gsea,Glycolysis R-HSA-70171,-0.456754632298857,-1.8334084572106817,0.001893939393939394,0.0051131683890214205,0.474,22/60,25.33%,ENO2;ALDOC;TPI1;PKM;TPR;PPP2R1A;PPP2CA;PGK1;SEC13;PPP2R5D;PRKACB;PGAM2;NUP88;PGP;PFKL;NUP50;SEH1L;NUP205;NUP62;PFKM;MAP4K5;NUP107
gsea,HCMV Infection R-HSA-9609646,-0.41794225269079494,-1.8284753403880845,0.0,0.005322530347315591,0.485,39/94,28.29%,DYNLL1;DYNLL2;HNRNPK;CEBPD;TPR;RBBP7;CHMP2A;NCOR1;CHMP4B;SEC13;H2AC25;VPS28;H2BC4;NUP88;CHMP7;GPS2;NUP50;CBX1;DYNC1H1;VPS37D;SEH1L;VPS36;NUP205;CHMP6;TSG101;SNF8;CREB1;PML;NUP62;TXN2;VPS25;NUP107;TRMU;VPS37B;ITGB1;IRS1;VPS4A;DAXX;DUT
gsea,Signaling By ERBB2 R-HSA-1227986,-0.4764964044849346,-1.8279190590353402,0.00392156862745098,0.0053377538310917325,0.487,13/44,17.96%,HSP90AA1;UBB;RPS27A;AKT3;UBA52;ERBIN;UBC;PIK3R1;CDC37;ERBB3;HRAS;STUB1;AKT1
gsea,Translesion Synthesis By REV1 R-HSA-110312,-0.6360033458083948,-1.827902463437509,0.0018832391713747645,0.005330658235669903,0.487,8/16,17.80%,UBB;RPS27A;UBA52;PCNA;UBC;REV1;RFC3;REV3L
gsea,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.5109475591601355,-1.8278614947429113,0.005639097744360902,0.005323591309320485,0.487,15/35,27.24%,UBB;RPS27A;YWHAZ;SOX4;UBA52;UBC;TLE1;CTNNBIP1;AKT1;CTNNB1;XIAP;CTBP1;CBY1;XPO1;PYGO1
gsea,Phase II - Conjugation Of Compounds R-HSA-156580,-0.4726266395484815,-1.8276934351370657,0.0,0.005320247494957772,0.487,21/53,27.96%,PRNP;GSTM5;MAT2B;SULT4A1;TRMT112;GSTP1;GSTM1;GCLM;TPST1;BPNT2;AKR1A1;SLC38A1;GSTO1;COMT;PODXL2;N6AMT1;UGP2;PAPSS2;GGT7;GCLC;CHAC2
gsea,Meiosis R-HSA-1500620,-0.4621437756883027,-1.8265806797489086,0.0,0.005361163326352037,0.49,14/56,14.54%,H2AZ1;SMC1A;RAD21;SMC3;H2AJ;TERF1;HSPA2;STAG2;H2BC4;H2AX;CDK4;SUN1;UBE2I;MLH3
gsea,FGFR2 Alternative Splicing R-HSA-6803529,-0.5655739614200234,-1.826453417353578,0.001996007984031936,0.0053540777166459245,0.49,15/24,24.28%,HNRNPH1;HNRNPA1;POLR2G;HNRNPF;POLR2C;POLR2L;HNRNPM;TIA1;POLR2I;TIAL1;POLR2F;POLR2E;GTF2F1;NCBP2;GTF2F2
gsea,Transmission Across Chemical Synapses R-HSA-112315,-0.37416720783684193,-1.8199283842689524,0.0,0.005648157650068953,0.511,50/198,13.15%,NRGN;CALM1;GRIA2;NEFL;CAMK2B;HSPA8;VAMP2;GNB2;LIN7C;RAB3A;SNAP25;PRKAR1A;MAPK1;NCALD;AP2M1;GNG2;SLC38A2;GNAL;GABRG2;GLUL;SLC1A3;GLRB;ARL6IP5;NSF;KCNJ3;ADCY1;MAPK3;TSPAN7;CAMK2A;AP2S1;PRKAR1B;GAD1;DNAJC5;LIN7B;KCNJ4;GNAI2;SLC17A7;RASGRF1;PRKACB;GNG10;SYN3;GABRA1;PRKCB;CAMKK1;GNG3;GNB1;PPFIA3;GNG13;GRIK3;ARHGEF9
gsea,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.5698779523465275,-1.8174822751604476,0.0037593984962406013,0.00579079382895626,0.519,8/21,11.85%,MDH2;IDH3B;FAHD1;SDHA;IDH3A;SDHD;IDH2;SUCLG1
gsea,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.500190509778277,-1.8163173605150669,0.0018248175182481751,0.0058487324922945625,0.523,12/37,19.46%,UBB;RPS27A;UBA52;PCNA;VCP;POLD4;UBC;REV1;RFC3;POLI;REV3L;POLE3
gsea,Regulation Of TP53 Degradation R-HSA-6804757,-0.5416920198175584,-1.8159053225312267,0.0021231422505307855,0.005858984376087294,0.523,8/30,7.28%,UBB;RPS27A;AKT3;USP2;UBA52;PPP2R1A;PPP2CA;UBC
gsea,Peroxisomal Protein Import R-HSA-9033241,-0.46837809841167566,-1.8154551624882531,0.0019723865877712033,0.0058801250974755285,0.524,16/51,24.66%,UBB;RPS27A;UBA52;UBC;ACOX1;ZFAND6;PEX12;UBE2D1;NUDT19;PEX5;USP9X;MPV17;ACOT8;PAOX;PEX13;ECH1
gsea,FLT3 Signaling In Disease R-HSA-9682385,-0.5634190865782536,-1.8145716477857807,0.004201680672268907,0.0059229977567873135,0.526,7/24,14.67%,UBB;RPS27A;GOLGB1;UBA52;UBC;PIK3R1;HRAS
gsea,RND3 GTPase Cycle R-HSA-9696264,-0.5074426227135028,-1.8132219476118239,0.002070393374741201,0.005980215710063866,0.529,10/35,11.22%,CKB;RASAL2;CCDC88A;ARHGAP5;KTN1;KCTD13;ARHGAP21;NISCH;PIK3R1;TXNL1
gsea,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.5304719170160975,-1.8111518020028705,0.0,0.006066180306888062,0.535,10/30,19.46%,UBB;RPS27A;UBA52;PCNA;POLD4;UBC;REV1;RFC3;POLI;POLE3
gsea,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.5314487316745697,-1.8106357507388682,0.0,0.006068673282162111,0.536,11/26,17.96%,HSP90AA1;UBB;RPS27A;AKT3;UBA52;ERBIN;UBC;CDC37;ERBB3;STUB1;AKT1
gsea,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.4297220931320544,-1.8073906209799335,0.0,0.006226272144908368,0.543,19/75,20.30%,PDZD2;UBB;RPS27A;CDK5R1;UBA52;UBC;DYRK2;HIPK2;TAF11;CSNK2B;TAF3;TAF10;ATRIP;RFC3;HIPK1;TAF7;SSRP1;MAPKAPK5;TBP
gsea,Cellular Senescence R-HSA-2559583,-0.40395988622077267,-1.8066470914562842,0.0,0.006271643859915076,0.546,38/118,24.12%,UBB;RPS27A;CBX6;JUN;MAPK1;H2AZ1;ETS2;CDKN1B;RBBP7;H2AJ;UBA52;MAPK3;CEBPB;TERF1;UBC;TNRC6A;RING1;STAT3;H2BC4;H2AX;CDK4;TFDP2;CDKN2D;UBE2S;CBX8;MAPK9;UBE2D1;ETF1;ANAPC16;MAPKAPK5;ANAPC11;KDM6B;UBE2E1;HMGA1;IGFBP7;RB1;TXN2;FZR1
gsea,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.4357326814864456,-1.8063626324820004,0.0,0.006273719300916871,0.546,21/70,15.43%,GNAS;GNB2;PRKAR1A;GNG2;GLP2R;ADCY1;PRKAR1B;CHGA;GNAI2;PRKACB;GNG10;MC4R;GPR27;RAMP2;GNG3;GNB1;ADRB1;GNG13;PTRH2;GNG11;GNG7
gsea,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.5921905924731095,-1.8047957396509404,0.008213552361396304,0.006369026877199284,0.551,9/20,20.92%,UBB;RPS27A;UBA52;UBC;UBE2S;UBE2D1;ANAPC16;ANAPC11;UBE2E1
gsea,Mitochondrial Biogenesis R-HSA-1592230,-0.4312718408735944,-1.8043301238297638,0.0,0.006378062328916173,0.552,22/71,24.73%,CALM1;ATP5PB;HSPA9;CYCS;NCOR1;MTX2;MEF2C;IDH2;MICOS10;TFAM;SIRT3;CHD9;MICOS13;NCOA1;GLUD1;TFB2M;POLG2;CREB1;CREBBP;IMMT;ESRRA;SAMM50
gsea,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.5005019941593613,-1.8036376383870802,0.0040650406504065045,0.006390634737337299,0.555,15/35,15.43%,GNAS;GNB2;PRKAR1A;GNG2;PRKAR1B;ITPR1;PRKACB;GNG10;RAP1A;GNG3;GNB1;KCNB1;GNG13;GNG11;GNG7
gsea,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.5763943356215473,-1.7994857084809088,0.0019011406844106464,0.006609941732062322,0.575,6/22,11.10%,H2AZ1;H2AJ;TERF1;TDG;H2BC4;H2AX
gsea,Chromosome Maintenance R-HSA-73886,-0.42082269207997003,-1.7982135859910882,0.0,0.006661156475240333,0.581,39/89,33.64%,H2AZ1;NPM1;ATRX;RBBP7;NOP10;H2AJ;POLR2G;HJURP;TERF1;PCNA;POLD4;H2BC4;POLR2C;POLR2L;H2AX;CENPX;RSF1;GAR1;RFC3;POLR2I;POLR2F;POLR2E;CENPW;FEN1;DKC1;NHP2;CENPP;SMARCA5;PPP6C;CHTF18;DAXX;ANKRD28;POLR2J;POLD2;KNL1;RPA3;POLR2B;MIS18A;POLR2K
gsea,Interferon Signaling R-HSA-913531,-0.40433763586442684,-1.7982025820775154,0.0,0.006648247257265062,0.581,20/117,8.59%,PDZD2;UBB;RPS27A;CAMK2B;EIF4A2;EIF4A1;BCL11B;UBE2N;EIF4G2;TRIM35;TPR;TRIM2;UBA52;MAPK3;CAMK2A;SUMO1;UBC;IFNGR2;SEC13;NEDD4
gsea,Pyroptosis R-HSA-5620971,-0.6399561354938408,-1.7970078434261958,0.005714285714285714,0.006706278875440861,0.584,9/15,20.81%,HMGB1;CYCS;CHMP2A;CHMP4B;BAX;GSDME;CHMP7;IL18;CHMP6
gsea,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.566339542084829,-1.7966863425936646,0.0019880715705765406,0.006718096305891658,0.584,9/21,20.98%,UBB;RPS27A;UBA52;UBC;RNF5;RNF139;RNF185;RNF103;AMFR
gsea,Defective Pyroptosis R-HSA-9710421,-0.5659828811359979,-1.785403233478932,0.001996007984031936,0.007450168885574563,0.607,6/22,11.10%,H2AZ1;RBBP7;H2AJ;GSDME;H2BC4;H2AX
gsea,Signaling By ERBB4 R-HSA-1236394,-0.4431823592275748,-1.784812308109905,0.0,0.007474606688909585,0.609,15/53,14.67%,UBB;RPS27A;APOE;GABRG2;STMN1;APH1A;UBA52;NCOR1;PSENEN;UBC;NEDD4;PIK3R1;GABRA1;ERBB3;HRAS
gsea,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.41140089697010906,-1.7824683514977315,0.0,0.0076290919452647816,0.621,18/90,14.49%,UBB;RPS27A;SEM1;UBE2N;SUMO2;PPP4C;UBA52;PCNA;UBE2V2;POLD4;RNF168;UBC;UIMC1;H2BC4;H2AX;UBE2I;ATRIP;RFC3
gsea,Translesion Synthesis By POLK R-HSA-5655862,-0.6167443121098579,-1.7823016286013236,0.003875968992248062,0.00763202979300094,0.621,8/17,17.80%,UBB;RPS27A;UBA52;PCNA;UBC;REV1;RFC3;REV3L
gsea,Triglyceride Metabolism R-HSA-8979227,-0.5663147443718852,-1.7810099325768094,0.012244897959183673,0.007701530142584081,0.623,7/20,15.59%,GPD2;PPP1CB;PPP1CA;DGAT2;PRKACB;FABP3;MGLL
gsea,FOXO-mediated Transcription R-HSA-9614085,-0.4502415349527216,-1.7793956411549325,0.003913894324853229,0.007812731552497999,0.63,22/53,25.03%,YWHAB;YWHAZ;YWHAG;PINK1;YWHAQ;CDKN1B;FOXO3;AKT3;HDAC2;NPY;NFYB;CITED2;CCNG2;SMAD2;SIRT3;FBXO32;AKT1;CREBBP;BTG1;TXN2;SMAD3;SMAD4
gsea,DNA Damage Bypass R-HSA-73893,-0.4721560716008638,-1.7791301062033147,0.001893939393939394,0.0078118122900567265,0.632,17/46,24.81%,UBB;RPS27A;UBA52;PCNA;VCP;POLD4;UBC;RBX1;REV1;USP1;RFC3;POLI;REV3L;POLE3;RCHY1;DDB1;RAD18
gsea,Rab Regulation Of Trafficking R-HSA-9007101,-0.39804196837535966,-1.776072492540464,0.0,0.008019930328161734,0.644,31/108,19.58%,RAB3A;GABARAPL2;YWHAE;RAB6B;RAB6A;RAB14;SBF1;AKT3;GABARAP;GDI1;MAP1LC3B;RAB12;TRAPPC6B;RAB18;RAB1A;RAB1B;GDI2;DENND5B;TRAPPC6A;DENND4A;TRAPPC2;RAB39B;RAB11A;RABGAP1;SBF2;TRAPPC2L;RAB5B;RAB31;AKT1;TBC1D20;RAB35
gsea,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.5509068817394609,-1.7752361559268515,0.007476635514018692,0.008046439675380579,0.648,6/24,11.10%,H2AZ1;H2AJ;TERF1;TDG;H2BC4;H2AX
gsea,Activation Of GABAB Receptors R-HSA-991365,-0.49990878163526226,-1.7737323972386636,0.006012024048096192,0.008156145412619395,0.652,13/33,15.43%,GNB2;GNG2;GNAL;KCNJ3;ADCY1;KCNJ4;GNAI2;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7
gsea,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.5941911914244421,-1.773452325691074,0.003937007874015748,0.00816151220419525,0.652,5/17,14.67%,CALM1;AHCYL1;ITPR1;PRKCB;HRAS
gsea,Drug ADME R-HSA-9748784,-0.5237229854740088,-1.772452007878843,0.001949317738791423,0.008232553204409394,0.654,13/28,27.99%,BSG;GMPS;NME2;GSTP1;GUK1;GSTM1;ABCC4;SLC38A1;VAV2;SLC16A1;GGT7;IMPDH2;NUDT15
gsea,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.4718617366049768,-1.767681064326173,0.001890359168241966,0.008575962874535928,0.667,20/50,25.37%,UBB;RPS27A;UBA52;TBK1;TRIM32;UBC;NKIRAS1;NFKB2;POLR2L;POLR3D;NFKBIA;IRF3;POLR2F;POLR2E;POLR1D;DDX41;CTNNB1;CREBBP;POLR3H;IKBKG
gsea,Telomere Maintenance R-HSA-157579,-0.4361625805985241,-1.767524540975537,0.0019569471624266144,0.008563287248254297,0.667,28/68,31.84%,H2AZ1;ATRX;NOP10;H2AJ;POLR2G;TERF1;PCNA;POLD4;H2BC4;POLR2C;POLR2L;H2AX;GAR1;RFC3;POLR2I;POLR2F;POLR2E;FEN1;DKC1;NHP2;PPP6C;CHTF18;DAXX;ANKRD28;POLR2J;POLD2;RPA3;POLR2B
gsea,Hemostasis R-HSA-109582,-0.3369114849087002,-1.7671514065250995,0.0,0.008581602463411562,0.667,93/400,17.96%,CALM1;ATP1B1;TMSB4X;PPIA;GNAS;TUBA4A;CAPZA2;ATP2B1;GNB2;YWHAZ;ORAI2;PRKAR1A;MAPK1;RASGRP1;BSG;GNG2;DGKH;APLP2;RHOB;PFN1;CLU;CD47;ATP1B2;SOD1;VCL;CBX5;SLC8A2;PPP2R1A;ITGA2;MAPK3;SIRPA;TMX3;OLA1;AAMP;TSPAN7;CAP1;PPP2CA;CDC42;PRKAR1B;HDAC2;KIF5B;FAM3C;DAGLA;NHLRC2;PPP2R5D;KIFAP3;CALU;VTI1B;JMJD1C;TGFB2;ITPR1;GNAI2;PRKACB;GNG10;ABHD12;MANF;P2RY12;HABP4;EHD3;RAP1A;ABCC4;VEGFB;PIK3R1;CAPZB;PRKCB;GNG3;GNB1;SCCPDH;MERTK;TIMP3;GNG13;PDGFA;MAG;SCG3;AKAP1;HSPA5;GNG11;HRAS;LAMP2;ADRA2C;JAM2;GNG7;MGLL;CD63;GPC1;MAGED2;PPP2R5E;STIM1;KIF21A;ITPK1;C1QBP;ENDOD1;AKT1
gsea,Cardiac Conduction R-HSA-5576891,-0.40372189113991575,-1.7664168186337506,0.0,0.008610144192890565,0.668,21/97,9.57%,CALM1;ATP1B1;KCND2;ATP2B1;CAMK2B;ORAI2;ATP1A2;KCNK1;ATP1B2;AKAP9;ATP1A3;SLC8A2;CAMK2A;SCN3B;SCN1B;AHCYL1;SCN2B;HIPK2;KCNJ4;ITPR1;SCN3A
gsea,HATs Acetylate Histones R-HSA-3214847,-0.40813501985979195,-1.7628388401980462,0.0,0.008892050621063794,0.676,32/81,32.41%,MORF4L1;MORF4L2;USP22;RBBP7;MBIP;CLOCK;MSL1;H2AC25;MSL2;MRGBP;ENY2;H2BC4;TAF10;KAT6A;BRD8;TADA3;TADA2B;NCOA1;PHF20;CREBBP;HAT1;JADE1;HCFC1;ING3;ACTL6A;TADA1;MCRS1;MSL3;YEATS4;KAT5;JADE3;H2AC21
gsea,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.5512968165619239,-1.7611268632352326,0.005893909626719057,0.009039568111043093,0.682,9/23,20.92%,UBB;RPS27A;UBA52;UBC;UBE2S;UBE2D1;ANAPC16;ANAPC11;UBE2E1
gsea,Translation Of Structural Proteins R-HSA-9683701,-0.5343689576797352,-1.7597183698664722,0.006036217303822937,0.009111460483295156,0.683,11/27,14.43%,UBB;RPS27A;CANX;UBA52;GSK3B;SUMO1;UBC;PARP4;PARP8;UBE2I;GALNT1
gsea,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.47149275870630936,-1.7583615991878696,0.0017921146953405018,0.009210335109817024,0.686,12/47,15.43%,GNAS;GNB2;GNG2;GLP2R;GNG10;RAMP2;GNG3;GNB1;GNG13;PTRH2;GNG11;GNG7
gsea,O-linked Glycosylation Of Mucins R-HSA-913709,0.5020659096291558,1.7561641020534358,0.004081632653061225,0.03538049751107953,0.681,6/31,5.10%,ST6GALNAC3;GALNTL6;GALNT14;GALNT10;GALNT9;GALNT18
gsea,Dual Incision In GG-NER R-HSA-5696400,-0.4823830406792696,-1.7540183831279856,0.009433962264150943,0.009557033332469909,0.7,14/41,16.20%,UBB;RPS27A;UBA52;PCNA;GTF2H1;POLD4;UBC;RBX1;GTF2H5;RFC3;PARP2;XPA;PARP1;DDB2
gsea,Signaling By MET R-HSA-6806834,-0.4367852583331434,-1.7525524827922159,0.0,0.009651323048260434,0.702,16/57,19.60%,UBB;RPS27A;UBA52;ITGA2;SH3KBP1;PTPRJ;UBC;STAT3;RAP1A;PIK3R1;STAM;SH3GL1;HRAS;STAM2;RNMT;PTPN11
gsea,DNA Double-Strand Break Repair R-HSA-5693532,-0.38281689035028943,-1.751775961749578,0.0,0.009704616579681137,0.704,46/124,33.20%,UBB;RPS27A;SEM1;UBE2N;SUMO2;PPP4C;UBA52;PCNA;SUMO1;UBE2V2;POLD4;RNF168;UBC;UIMC1;EYA1;H2BC4;XRCC4;H2AX;UBE2I;ATRIP;RFC3;PARP2;BAZ1B;PARP1;UBXN1;POLE3;FEN1;RNF4;BRCA2;NSD2;SMARCA5;RAD51D;SIRT6;POLL;MAPK8;TOP3A;LIG4;APBB1;MUS81;POLD2;RPA3;TDP2;KAT5;XRCC2;ERCC1;XRCC6
gsea,Homology Directed Repair R-HSA-5693538,-0.4006140449979922,-1.7512712381340663,0.0,0.009720521893975225,0.705,20/95,16.09%,UBB;RPS27A;SEM1;UBE2N;SUMO2;PPP4C;UBA52;PCNA;UBE2V2;POLD4;RNF168;UBC;UIMC1;H2BC4;H2AX;UBE2I;ATRIP;RFC3;PARP2;PARP1
gsea,Integration Of Energy Metabolism R-HSA-163685,-0.4054751022813517,-1.7483583404786023,0.0,0.009955732216367674,0.715,33/90,20.80%,GNAS;VAMP2;GNB2;MARCKS;SNAP25;PRKAR1A;ACSL3;GNG2;PPP2R1A;ADCY1;AHCYL1;PPP2CA;PRKAR1B;PPP2R5D;SYT5;ITPR1;GNAI2;PRKACB;GNG10;RAP1A;GNG3;GNB1;KCNB1;GNG13;GNG11;ADRA2C;GNG7;ACLY;TALDO1;PLCB1;GNA11;AKAP5;STXBP1
gsea,RHO GTPases Activate Formins R-HSA-5663220,-0.3949822601012462,-1.7474215532264339,0.0019801980198019802,0.010041858481547032,0.717,15/98,8.09%,RPS27;ACTG1;DYNLL1;DYNLL2;PFN2;RHOB;PAFAH1B1;DIAPH2;PFN1;ZWINT;PPP2R1A;PPP2CA;CDC42;SEC13;PPP2R5D
gsea,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.5419223978165453,-1.7451854192686842,0.004106776180698152,0.010184830163690924,0.723,15/23,34.46%,RBM15;HNRNPC;CCT2;ROCK2;TXNL1;GPS1;TRA2B;CCT7;DBN1;VIM;SRRM1;CUL3;RNF20;STK38;COPS2
gsea,Regulation Of Insulin Secretion R-HSA-422356,-0.4254090708556016,-1.7439923187771436,0.00199203187250996,0.010246727384316005,0.724,23/67,15.43%,GNAS;VAMP2;GNB2;MARCKS;SNAP25;PRKAR1A;ACSL3;GNG2;AHCYL1;PRKAR1B;SYT5;ITPR1;GNAI2;PRKACB;GNG10;RAP1A;GNG3;GNB1;KCNB1;GNG13;GNG11;ADRA2C;GNG7
gsea,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.5159946649449153,-1.7431614896868177,0.009487666034155597,0.010291647561239459,0.725,9/30,14.49%,UBB;RPS27A;UBA52;PCNA;POLD4;UBC;RBX1;USP1;RFC3
gsea,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.5766110001442046,-1.7426464646734658,0.0137524557956778,0.010326371699053481,0.726,7/19,17.67%,CDK5R1;JUN;YWHAE;FOXO3;PRDX1;PRDX2;C1QBP
gsea,FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.5375826392180266,-1.7408157611362052,0.009633911368015413,0.010471121395307802,0.728,9/23,18.66%,BAG4;CPSF6;STAT3;PIK3R1;FGFR1;TRIM24;CUX1;FGF13;FGF9
gsea,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.6251054644271846,-1.7382380649042914,0.019569471624266144,0.010635335962041647,0.732,5/15,7.28%,UBB;RPS27A;FKBP1A;UBA52;UBC
gsea,RNA Polymerase I Transcription Initiation R-HSA-73762,-0.4623121045141838,-1.7377680577250871,0.006060606060606061,0.010665921460097134,0.732,20/45,27.14%,CHD3;RBBP7;CCNH;GTF2H1;HDAC2;POLR1F;TAF1D;GTF2H5;POLR2L;GATAD2B;POLR2F;POLR2E;ERCC6;POLR1D;RRN3;TBP;GTF2H4;POLR1H;POLR1G;CDK7
gsea,Apoptotic Factor-Mediated Response R-HSA-111471,-0.5884550452399081,-1.7366141681109593,0.01125703564727955,0.01072627434264222,0.732,8/17,17.67%,MAPK1;CYCS;MAPK3;BAX;GSDME;DIABLO;SEPTIN4;C1QBP
gsea,Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.44221829186752293,-1.7337549354213146,0.001941747572815534,0.01095872639020667,0.742,17/54,19.20%,JUN;H2AZ1;RBBP7;H2AJ;POLR2G;NCOR1;CNOT6;H2BC4;YY1;CTCF;POLR2C;POLR2L;H2AX;POLR2I;POLR2F;POLR2E;KMT2C
gsea,Post NMDA Receptor Activation Events R-HSA-438064,-0.4474731946900774,-1.7301672670154815,0.002136752136752137,0.011286265905268222,0.753,13/56,9.50%,NRGN;CALM1;GRIA2;NEFL;CAMK2B;PRKAR1A;MAPK1;ADCY1;MAPK3;CAMK2A;PRKAR1B;RASGRF1;PRKACB
gsea,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.3998235443126637,-1.7293598486540762,0.00398406374501992,0.011338571107672366,0.753,16/85,10.00%,RPS27;DYNLL1;DYNLL2;PAFAH1B1;SMC1A;RAD21;ZWINT;SMC3;PPP2R1A;PPP2CA;PDS5B;SEC13;PPP2R5D;STAG2;HDAC8;NUDC
gsea,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.6061327968805671,-1.7254901741644761,0.014583333333333334,0.011713687999789718,0.761,5/15,8.18%,UBB;RPS27A;UBA52;UBC;VPS28
gsea,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.3714574338088422,-1.722161236651075,0.0,0.012008497986324994,0.778,37/144,13.15%,NRGN;CALM1;GRIA2;NEFL;CAMK2B;GNB2;LIN7C;PRKAR1A;MAPK1;NCALD;AP2M1;GNG2;GNAL;GABRG2;GLRB;NSF;KCNJ3;ADCY1;MAPK3;TSPAN7;CAMK2A;AP2S1;PRKAR1B;LIN7B;KCNJ4;GNAI2;RASGRF1;PRKACB;GNG10;GABRA1;PRKCB;CAMKK1;GNG3;GNB1;GNG13;GRIK3;ARHGEF9
gsea,Pyruvate Metabolism R-HSA-70268,-0.5361751627623427,-1.7209978284782999,0.01782178217821782,0.012105205102724906,0.78,15/25,31.82%,BSG;VDAC1;GLO1;LDHB;LDHA;HAGH;DLAT;MPC2;SLC16A1;LDHD;PLPP6;PDHA1;MPC1;PDPK1;PCDHB16
gsea,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.45967938585971135,-1.7198520645536037,0.005474452554744526,0.012172062162832927,0.781,17/41,22.03%,EPHA7;AP2M1;EPHA5;APH1A;CLTA;AP2S1;EFNB3;PSENEN;EFNA3;CLTC;AP2B1;CLTB;ADAM10;TIAM1;EPHA4;AP2A2;VAV2
gsea,RHO GTPases Activate PAKs R-HSA-5627123,-0.568576776227076,-1.7181428638927723,0.011538461538461539,0.012363030676874292,0.785,7/20,11.89%,CALM1;MYL6;MYL12B;PPP1CB;CDC42;PKN2;MYH10
gsea,Signaling By FGFR1 In Disease R-HSA-5655302,-0.4969023592257171,-1.7127792821808487,0.005825242718446602,0.012899571758471689,0.798,10/29,18.66%,BAG4;CPSF6;STAT3;PIK3R1;FGFR1;TRIM24;CUX1;HRAS;FGF13;FGF9
gsea,NGF-stimulated Transcription R-HSA-9031628,-0.5018477782968946,-1.7110831618923499,0.005780346820809248,0.013091826897190966,0.805,14/31,23.15%,CDK5R1;EGR3;CDK5R2;JUND;TCF12;EGR4;VGF;EGR1;RNASEH2A;FOSB;ASCL1;ID4;CREB1;ID2
gsea,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.4385292257959011,-1.710194366764028,0.001968503937007874,0.013172731201399591,0.807,27/53,39.62%,RAN;HMGCS1;FDPS;INSIG1;HMGCR;NFYB;SEC24A;SAR1B;CHD9;NCOA1;CREBBP;SQLE;FASN;PMVK;SEC24C;SEC23A;GGPS1;SC5D;KPNB1;INSIG2;MBTPS2;TM7SF2;TBL1X;SREBF2;NCOA6;IDI1;TBL1XR1
gsea,Signaling By NODAL R-HSA-1181150,-0.5910245167710391,-1.7097162094467462,0.005747126436781609,0.013207860285206928,0.807,5/15,5.08%,MAPK1;FOXO3;DRAP1;ACVR1C;MAPK3
gsea,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.4231751885719886,-1.7088527864228595,0.0,0.013285029418284331,0.812,17/64,18.45%,UBB;RPS27A;BEX3;SQSTM1;YWHAE;MAGED1;APH1A;UBA52;PSENEN;UBC;ARHGEF4;ARHGEF12;ARHGEF9;ARHGEF2;SOS2;BAD;TIAM1
gsea,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.5114666608596969,-1.7066937454421867,0.004081632653061225,0.013517334747446206,0.819,19/26,36.34%,POLR2G;CCNH;GTF2H1;GTF2H5;POLR2C;POLR2L;POLR2I;POLR2F;POLR2E;GTF2F1;RNMT;GTF2H4;GTF2F2;CDK7;POLR2J;POLR2B;POLR2K;GTF2H3;POLR2D
gsea,Phospholipid Metabolism R-HSA-1483257,-0.3523096166544841,-1.7040562846549956,0.0,0.01375851658175764,0.824,45/174,20.20%,PLEKHA2;ARF3;RAB14;SBF1;CDS2;INPP4B;GPD2;GDE1;CDIPT;PIP4K2A;DGAT2;LPGAT1;DDHD2;CSNK2B;GPD1;CRLS1;OSBPL5;PIK3R1;PTPMT1;PNPLA8;PITPNM3;RUFY1;PIP4P1;MTMR9;CEPT1;PTEN;PIK3C2A;CLSTN1;SBF2;MIGA1;MGLL;INPP5F;PLEKHA5;PIP4K2B;CPNE3;GPD1L;AGPAT3;LPCAT3;PLA2G6;PIP5K1C;SELENOI;CHPT1;PLEKHA3;GPCPD1;PLD3
gsea,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.5569413484984245,-1.7036197527753487,0.004073319755600814,0.013789140680691219,0.824,8/20,22.03%,CALM1;HSP90AA1;AKT3;PKN2;RICTOR;AKT1;CTNNB1;VAV2
gsea,MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.5207976246863154,-1.7007511371990287,0.006097560975609756,0.01408374753288343,0.827,14/24,36.34%,RAN;POLR2G;POLR2C;POLR2L;POLR2I;POLR2F;POLR2E;PRKRA;POLR2J;AGO4;POLR2B;AGO3;POLR2K;POLR2D
gsea,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.5306712192643067,-1.6996912564427322,0.007936507936507936,0.014200497636297911,0.829,16/25,28.79%,UBB;RPS27A;UBA52;PPP1CB;PPP1CA;UBC;SMAD2;STUB1;ZFYVE9;USP15;SMAD3;SMAD7;BAMBI;PPP1CC;XPO1;SRFBP1
gsea,Metabolism Of Carbohydrates R-HSA-71387,-0.3461268655721305,-1.69757896873504,0.0,0.014425956162383553,0.833,66/228,25.67%,CALM1;UBB;RPS27A;MDH2;CHST1;ENO2;MDH1;B4GALT6;B4GAT1;ALDOC;TPI1;PKM;IDS;B3GALT2;TPR;DCXR;UBA52;PPP2R1A;PPP2CA;PGK1;UBC;SEC13;CHORDC1;PPP2R5D;GOT2;PHGDH;PRKACB;CHST15;SLC25A11;PGAM2;NUP88;B3GALT6;PGP;G6PC3;CHST2;NDST4;DSEL;PFKL;ST6GALNAC6;NDST1;NUP50;AKR1A1;PCK2;BCAN;B4GALT2;CSGALNACT1;GPC1;SEH1L;TALDO1;GAA;NUP205;HYAL2;SDC2;RPE;B4GALT4;UGP2;NUP62;PFKM;MAN2B2;PAPSS2;PCNX4;MAP4K5;OGN;B3GALT4;NUP107;ALDH1A1
gsea,Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.583985456368885,-1.6958569398165892,0.014583333333333334,0.014564125844491432,0.837,10/16,26.97%,PPP2R1A;GSK3B;PPP2CA;PPP2R5D;CSNK1A1;PPP2R5E;CTNNB1;PPP2R5A;PPP2R5B;FRAT1
gsea,Signaling By FGFR In Disease R-HSA-1226099,-0.4256908540705818,-1.6928450804565092,0.0039447731755424065,0.014912889977479754,0.845,26/52,31.84%,BAG4;POLR2G;CPSF6;STAT3;PIK3R1;POLR2C;POLR2L;FGFR1;TRIM24;CUX1;HRAS;FGFR3;POLR2I;FGFR2;POLR2F;FGF13;POLR2E;FGF9;GTF2F1;NCBP2;GTF2F2;NRAS;FGF16;POLR2J;CEP43;POLR2B
gsea,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.538192900014153,-1.6907840570772088,0.011881188118811881,0.015151891849461039,0.851,10/20,27.09%,MAPK1;CDKN1B;FOXO3;AKT3;MAPK3;UHMK1;AKT1;CREB1;PTK2;XPO1
gsea,Signaling By GPCR R-HSA-372790,-0.3268349517857892,-1.6879113140679358,0.0,0.015396436426905719,0.851,75/382,15.59%,CALM1;PPP3CA;PLPPR4;PPP3R1;GNAS;CAMK2B;GNB2;PRKAR1A;MAPK1;PPP3CB;RASGRP1;GNG2;GRM1;DGKH;GNAL;RHOB;GLP2R;AKT3;ARHGEF25;PPP2R1A;ADCY1;MAPK3;P2RY14;CX3CL1;CAMK2A;CHRM1;GRM2;AHCYL1;PPP2CA;PPP1CA;CDC42;PRKAR1B;NPY1R;S1PR1;CHGA;DAGLA;ROCK2;PPP2R5D;ARHGEF4;ITPR1;CNOT6;GNAI2;PRKACB;GNG10;ABHD12;MC4R;P2RY12;GPR27;PIK3R1;CXCR6;ARHGEF12;PRKCB;RAMP2;CAMKK1;GNG3;GNB1;NPY5R;NPY;ADORA1;ADRB1;GNG13;RGS4;PLPPR5;PPP1R1B;PTRH2;ARHGEF9;TAC1;GNG11;HRAS;ADRA2C;ECE1;ARHGEF2;SSTR2;GNG7;MGLL
gsea,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.4959009163190123,-1.684532055449071,0.0019880715705765406,0.01586283515250083,0.859,13/28,24.82%,PABPN1;SNRPF;CPSF6;SNRPG;CPSF2;SNRPE;SLBP;SNRPB;PCF11;CSTF2T;FIP1L1;NCBP2;CPSF1
gsea,Glutathione Conjugation R-HSA-156590,-0.5286259315751226,-1.6845012729316098,0.014084507042253521,0.01583851919849772,0.859,7/24,16.42%,PRNP;GSTM5;GSTP1;GSTM1;GCLM;AKR1A1;GSTO1
gsea,G-protein Mediated Events R-HSA-112040,-0.4392479854803544,-1.6819216628733882,0.007984031936127744,0.016147186375363668,0.867,13/48,11.37%,CALM1;CAMK2B;PRKAR1A;MAPK1;GNAL;ADCY1;CAMK2A;AHCYL1;PRKAR1B;ITPR1;GNAI2;PRKACB;CAMKK1
gsea,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.5463234005575238,-1.679745548233583,0.017208413001912046,0.016372497582688796,0.869,7/20,18.49%,HSP90AA1;POLR2G;POLR2C;POLR2L;POLR2I;POLR2F;POLR2E
gsea,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.5440312509041785,-1.6785338524586355,0.014,0.016505405370180873,0.871,15/19,36.34%,POLR2G;POLR2C;POLR2L;POLR2I;FGFR2;POLR2F;FGF13;POLR2E;GTF2F1;NCBP2;GTF2F2;POLR2J;POLR2B;POLR2K;POLR2D
gsea,HCMV Late Events R-HSA-9610379,-0.4093215792192755,-1.676163839337967,0.0020242914979757085,0.01679871453246315,0.879,27/65,27.46%,HNRNPK;CEBPD;TPR;CHMP2A;CHMP4B;SEC13;H2AC25;VPS28;H2BC4;NUP88;CHMP7;NUP50;VPS37D;SEH1L;VPS36;NUP205;CHMP6;TSG101;SNF8;NUP62;TXN2;VPS25;NUP107;TRMU;VPS37B;IRS1;VPS4A
gsea,RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.571011610329527,-1.6752186867230094,0.014141414141414142,0.01688005443746711,0.88,4/16,11.10%,PDZD2;MAPK1;MAPK3;PRKCB
gsea,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.5041535493557396,-1.6735115257970379,0.00796812749003984,0.017089989604205217,0.882,16/25,36.27%,CDKN1B;FOXO3;AKT3;GSK3B;AKT1S1;RICTOR;AKT1;BAD;CREB1;MDM2;CASP9;PDPK1;MLST8;GSK3A;TSC2;RPS6KB2
gsea,RHO GTPase Cycle R-HSA-9012999,-0.32188378847190124,-1.6699708247338008,0.0,0.017525134133171878,0.885,104/382,23.23%,HSP90AA1;HSP90AB1;CKB;ACTG1;RASAL2;CCT6A;WIPF3;WASF1;TMEM59;RHOB;DIAPH2;HSPE1;ABI1;CCDC88A;ARHGDIA;BASP1;ATP6AP1;RBM15;WASL;ARHGAP5;ARHGEF25;KTN1;BRK1;NCKAP1;NDUFA5;EFHD2;HNRNPC;PHIP;PTK2B;ERBIN;CYFIP2;KCTD13;CCT2;VCP;CDC42;EMC3;GJA1;TWF1;GARRE1;ROCK2;RALGAPA1;ARHGAP21;IQGAP2;ARMCX3;ELMO2;ARHGEF4;EMD;TUBA1B;PKN2;NUDC;NISCH;PIK3R1;TFRC;CDC37;ARHGEF12;CAPZB;ARHGAP20;TXNL1;MACO1;NCK1;GPS1;BAIAP2;STAM;ARHGEF9;CLTC;PGRMC2;SPATA13;ADD3;SLITRK5;KCTD3;SOWAHC;GOLGA3;SLK;SLITRK3;ARHGEF2;MYO9A;TRA2B;OPHN1;ARHGAP26;STAM2;C1QBP;SOS2;NCF2;VAMP3;PICALM;TRIP10;USP9X;TIAM1;HOMER2;GFOD1;CCT7;ARFGAP2;NIPSNAP2;DBN1;ARHGEF1;LMAN1;VAV2;HMOX2;CDC42SE2;CCDC115;WHAMM;DDX39B;PRPF38B;FILIP1
gsea,Viral Messenger RNA Synthesis R-HSA-168325,-0.4437329181465739,-1.66773742050857,0.002036659877800407,0.017773971754569847,0.887,26/43,36.60%,TPR;POLR2G;SEC13;PBRM1;NUP88;POLR2C;POLR2L;NUP50;POLR2I;SEH1L;GNL3;POLR2F;POLR2E;GTF2F1;NUP205;NUP62;GTF2F2;NUP107;POLR2J;NUP133;POLR2B;POLR2K;NUP85;NUP54;POLR2D;POM121
gsea,SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.436899122056447,-1.6671006184569463,0.015968063872255488,0.01783745625802831,0.887,18/40,31.31%,DDX5;NPM1;SUMO2;SUMO1;RING1;PARK7;HIPK2;UBE2I;CBX8;NCOA1;DDX17;CREBBP;CTBP1;PIAS2;ING3;DAXX;PHC3;UHRF2
gsea,Semaphorin Interactions R-HSA-373755,-0.42152223112678944,-1.6646634480290492,0.0,0.018134863688141222,0.889,13/60,11.89%,HSP90AA1;HSP90AB1;MYL6;CDK5R1;RHOB;SEMA5A;DPYSL2;MYL12B;GSK3B;ROCK2;PKN2;ARHGEF12;MYH10
gsea,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.5784787689024833,-1.6641162129751472,0.01606425702811245,0.01817258611935113,0.889,3/15,1.06%,VAMP2;RAB3A;SNAP25
gsea,GPCR Downstream Signaling R-HSA-388396,-0.32697222139006465,-1.6631746806970287,0.0,0.01826307181017668,0.889,71/351,15.59%,CALM1;PPP3CA;PPP3R1;GNAS;CAMK2B;GNB2;PRKAR1A;MAPK1;PPP3CB;RASGRP1;GNG2;GRM1;DGKH;GNAL;RHOB;GLP2R;AKT3;ARHGEF25;PPP2R1A;ADCY1;MAPK3;P2RY14;CX3CL1;CAMK2A;CHRM1;GRM2;AHCYL1;PPP2CA;PPP1CA;CDC42;PRKAR1B;NPY1R;CHGA;DAGLA;ROCK2;PPP2R5D;ARHGEF4;ITPR1;CNOT6;GNAI2;PRKACB;GNG10;ABHD12;MC4R;P2RY12;GPR27;PIK3R1;CXCR6;ARHGEF12;PRKCB;RAMP2;CAMKK1;GNG3;GNB1;NPY5R;NPY;ADORA1;ADRB1;GNG13;RGS4;PPP1R1B;PTRH2;ARHGEF9;TAC1;GNG11;HRAS;ADRA2C;ARHGEF2;SSTR2;GNG7;MGLL
gsea,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.5161061748121437,-1.6629890037863948,0.015810276679841896,0.01827560120659656,0.89,14/22,35.50%,CSNK1G2;PPP2R1A;GSK3B;PPP2CA;PPP2R5D;CSNK1A1;PPP2R5E;CTNNB1;PPP2R5A;PPP2R5B;FRAT1;DVL2;LRP6;AMER1
gsea,NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.4322353637403878,-1.6587823375388102,0.007889546351084813,0.018858621981468853,0.895,21/53,27.14%,H2AZ1;H2AJ;SAP18;CCNH;GTF2H1;HDAC2;POLR1F;TAF1D;H2BC4;GTF2H5;POLR2L;H2AX;POLR2F;POLR2E;POLR1D;TBP;GTF2H4;POLR1H;SMARCA5;POLR1G;CDK7
gsea,RAS Processing R-HSA-9648002,-0.5492373754460937,-1.6564863079466732,0.01859504132231405,0.01914869709305691,0.899,8/17,26.98%,CALM1;ARL2;ABHD17A;GOLGA7;HRAS;LYPLA1;BCL2L1;NRAS
gsea,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.45998347888397595,-1.6563730531536216,0.006072874493927126,0.019134947482708158,0.899,13/33,25.33%,SLC25A4;PSIP1;SLC25A5;BANF1;TPR;SEC13;NUP88;NUP50;SEH1L;NUP205;HMGA1;NUP62;NUP107
gsea,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.4263364593297409,-1.655774778113511,0.004,0.019176775370153065,0.899,22/56,27.14%,H2AZ1;H2AJ;SAP18;CCNH;GTF2H1;HDAC2;POLR1F;TAF1D;H2BC4;GTF2H5;POLR2L;H2AX;POLR2F;POLR2E;POLR1D;TBP;GTF2H4;POLR1H;SUV39H1;SMARCA5;POLR1G;CDK7
gsea,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.4574753602131156,-1.6543548364333904,0.006,0.01940633545168248,0.899,21/42,27.09%,UBB;RPS27A;FKBP1A;UBA52;NEDD8;PPP1CB;PPP1CA;UBC;TGFB2;SMAD2;STUB1;UBE2M;ZFYVE9;USP15;SMAD3;SMAD7;SMAD4;BAMBI;ITGB1;PPP1CC;XPO1
gsea,tRNA Processing In Nucleus R-HSA-6784531,-0.41987062472037673,-1.654078436207109,0.0058823529411764705,0.019413745771403146,0.899,22/51,30.53%,RAN;TPR;TSEN34;SEC13;FAM98B;DDX1;NUP88;ZBTB8OS;TRNT1;RPP21;NUP50;POP5;RPP38;SEH1L;RTRAF;NUP205;NUP62;CPSF1;NUP107;POP7;XPOT;NUP133
gsea,RNA Polymerase I Transcription Termination R-HSA-73863,-0.4777747645234933,-1.6516159855646533,0.019230769230769232,0.019712739843498663,0.903,17/29,35.13%,CCNH;GTF2H1;POLR1F;TAF1D;GTF2H5;POLR2L;POLR2F;POLR2E;POLR1D;TBP;GTF2H4;POLR1H;POLR1G;CDK7;UBTF;POLR2K;GTF2H3
gsea,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.5203543557489964,-1.650236832669679,0.00980392156862745,0.01987283454382824,0.903,9/23,25.37%,RACK1;USP2;OTUD7B;CYLD;BIRC2;TANK;TAB2;XIAP;IKBKG
gsea,Circadian Clock R-HSA-400253,-0.4075570606707412,-1.6457615445352942,0.001949317738791423,0.020619783186727456,0.909,11/59,9.47%,UBB;RPS27A;SKP1;CSNK1E;UBA52;CLOCK;NCOR1;PPP1CB;PPP1CA;UBC;MEF2C
gsea,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.45201782597383056,-1.6447231405484755,0.013916500994035786,0.02073812768914188,0.911,11/34,17.68%,CBX6;RING1;HIPK2;SMARCE1;CSNK2B;PBRM1;ACTL6B;CBFB;CBX8;SMARCC2;SMARCD2
gsea,Neuronal System R-HSA-112316,-0.32319033498643673,-1.6419337492556687,0.0,0.021179286598248793,0.918,69/316,12.35%,NRGN;CALM1;GRIA2;NEFL;KCNA1;KCND2;CAMK2B;HSPA8;VAMP2;GNB2;LIN7C;RAB3A;SNAP25;PRKAR1A;MAPK1;NCALD;AP2M1;IL1RAPL1;LRRTM4;KCNA2;GNG2;GRM1;SLC38A2;GNAL;GABRG2;KCNK1;GLUL;LRRTM1;SLC1A3;SYT7;GLRB;RTN3;ARL6IP5;NSF;KCNJ3;ADCY1;MAPK3;TSPAN7;CAMK2A;AP2S1;KCNC3;PRKAR1B;GAD1;DNAJC5;LIN7B;KCNJ4;SLITRK2;IL1RAP;EPB41;GNAI2;SLC17A7;RASGRF1;PRKACB;GNG10;NLGN3;LRRTM2;KCNQ3;SYN3;GABRA1;PRKCB;HOMER3;CAMKK1;GNG3;GNB1;KCNB1;KCNAB2;PPFIA3;KCNF1;GNG13
gsea,Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.4537203235947713,-1.6418874676043698,0.013618677042801557,0.021147149128306036,0.918,17/34,33.24%,ATRX;CDKN1B;CDK4;TFDP2;UBE2S;UBE2D1;ANAPC16;ANAPC11;UBE2E1;CCND3;RB1;FZR1;CCNE1;ANAPC1;DAXX;E2F2;ANAPC4
gsea,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.4006965655452188,-1.639822429635291,0.0125,0.021431176439427095,0.922,15/68,9.50%,NRGN;CALM1;GRIA2;NEFL;CAMK2B;LIN7C;PRKAR1A;MAPK1;ADCY1;MAPK3;CAMK2A;PRKAR1B;LIN7B;RASGRF1;PRKACB
gsea,Lysosome Vesicle Biogenesis R-HSA-432720,-0.4719094462190119,-1.6386493023164943,0.019646365422396856,0.02158380171179208,0.922,10/31,18.13%,HSPA8;VAMP2;CLTA;CHMP2A;CLTC;M6PR;AP1S2;CTSZ;CLTB;AP1S1
gsea,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.5001675346984845,-1.6381008070390135,0.026748971193415638,0.021611734475155825,0.922,11/24,15.43%,CALM1;GNB2;NCALD;GNG2;GNG10;GNG3;GNB1;GNG13;GRIK3;GNG11;GNG7
gsea,mRNA Capping R-HSA-72086,-0.48719198564450084,-1.634932323804423,0.008350730688935281,0.022132483202850644,0.925,20/28,36.34%,POLR2G;CCNH;GTF2H1;GTF2H5;POLR2C;POLR2L;POLR2I;POLR2F;POLR2E;GTF2F1;RNMT;NCBP2;GTF2H4;GTF2F2;CDK7;POLR2J;POLR2B;POLR2K;GTF2H3;POLR2D
gsea,Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.5131381650585284,-1.6313814694914521,0.01417004048582996,0.022690763048419937,0.93,7/23,12.22%,VAMP2;LIN7C;RAB3A;SNAP25;LIN7B;SYN3;PPFIA3
gsea,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.42517125298327985,-1.6301258438198807,0.005597014925373134,0.022894565042446573,0.931,16/48,26.71%,CALM1;CYCS;NCOR1;MEF2C;IDH2;TFAM;SIRT3;CHD9;NCOA1;GLUD1;TFB2M;POLG2;CREB1;CREBBP;ESRRA;HCFC1
gsea,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.5559285565910542,-1.6301192101576476,0.035269709543568464,0.022859980419540595,0.931,5/17,11.10%,H2AZ1;H2AJ;TAF1D;H2BC4;H2AX
gsea,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.51660060952018,-1.6269374011705808,0.02321083172147002,0.0233902888318393,0.932,10/21,21.14%,AP2M1;AP2S1;PKN2;AP1S2;AP2B1;HCK;ATP6V1H;B2M;AP1S1;AP2A2
gsea,GABA Receptor Activation R-HSA-977443,-0.4301512867370613,-1.626685479510471,0.01859504132231405,0.023417989919249663,0.933,16/45,15.43%,GNB2;GNG2;GNAL;GABRG2;KCNJ3;ADCY1;KCNJ4;GNAI2;GNG10;GABRA1;GNG3;GNB1;GNG13;ARHGEF9;GNG11;GNG7
gsea,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.42480992824956343,-1.6250453494282293,0.010141987829614604,0.02366418653834767,0.936,15/47,19.04%,PLEKHA2;RAB14;INPP4B;PIP4K2A;PIK3R1;RUFY1;MTMR9;PTEN;PIK3C2A;CLSTN1;SBF2;PLEKHA5;PIP4K2B;PIP5K1C;PLEKHA3
gsea,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.5353309124935367,-1.624272475113404,0.015748031496062992,0.023742170994264882,0.936,6/19,11.89%,MYL6;RHOB;MYL12B;ROCK2;ARHGEF12;MYH10
gsea,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.4948861548198901,-1.6242544822069833,0.017130620985010708,0.02370648753937635,0.936,7/26,9.48%,CALM1;NEFL;CAMK2B;MAPK1;MAPK3;CAMK2A;RASGRF1
gsea,Intra-Golgi Traffic R-HSA-6811438,-0.4437190725135358,-1.623968820228265,0.008264462809917356,0.023721575420562305,0.936,8/35,12.66%,BET1L;STX16;NAPG;NSF;STX6;CYTH2;CUX1;CYTH4
gsea,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.47119952265670806,-1.623701209568599,0.013944223107569721,0.023718764999932317,0.936,8/28,13.09%,SLC25A4;SLC25A5;SLC35A1;ARL2BP;SLCO1C1;PDZD11;ARL2;APOD
gsea,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,-0.5216696383389858,-1.621186734078854,0.024793388429752067,0.024096131923723476,0.937,4/20,6.36%,CALM1;NEFL;CAMK2B;CAMK2A
gsea,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.5319924488736952,-1.6203668441715855,0.02095238095238095,0.024235056923138907,0.938,9/18,22.11%,MAPK1;MAPK3;DUSP7;DUSP8;DUSP6;PTPN11;TYK2;MAP2K1;DUSP2
gsea,Phototransduction Cascade R-HSA-2514856,-0.507103161699406,-1.6200420142151644,0.01937984496124031,0.024210081795110618,0.938,4/21,11.63%,CALM1;NMT1;RNF7;GNB1
gsea,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.507103161699406,-1.6200420142151644,0.01937984496124031,0.024210081795110618,0.938,4/21,11.63%,CALM1;NMT1;RNF7;GNB1
gsea,Fanconi Anemia Pathway R-HSA-6783310,-0.4530882859625478,-1.613009760937314,0.011009174311926606,0.02546950688850235,0.947,7/34,13.29%,UBB;RPS27A;UBA52;UBC;USP1;ATRIP;CENPX
gsea,Signaling To ERKs R-HSA-187687,-0.4593597592287761,-1.610490596287631,0.009881422924901186,0.025944142241131517,0.948,8/30,16.80%,YWHAB;MAPK1;BCL11B;MAPK3;BRAF;RAP1A;HRAS;RALA
gsea,Peptide Hormone Metabolism R-HSA-2980736,-0.4118641577292347,-1.6098374782328628,0.013435700575815739,0.026017215300159557,0.949,21/52,23.49%,VAMP2;ATP6AP2;CPE;CHGA;KIF5B;SPCS2;PLA2G7;SPCS3;SPCS1;GNB1;GNG13;CTSZ;SLC30A6;EXOC8;SEC11C;EXOC3;CTNNB1;SEC11A;EXOC5;CTSD;KIF5C
gsea,RHOD GTPase Cycle R-HSA-9013405,-0.42854933749775953,-1.6085272124000383,0.013916500994035786,0.026207524002761714,0.951,23/44,32.95%,DIAPH2;ARHGAP5;EFHD2;ARHGAP21;EMD;PIK3R1;CAPZB;PGRMC2;ADD3;ARHGAP26;VAMP3;DBN1;LMAN1;WHAMM;FILIP1;PLXNA1;ARHGAP39;SLC4A7;ARHGAP17;ARHGAP35;RACGAP1;VAPB;TMPO
gsea,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.4675977769312609,-1.6085217476162115,0.015779092702169626,0.02616852401186563,0.951,9/31,14.13%,H2AZ1;NPM1;RBBP7;H2AJ;HJURP;H2BC4;H2AX;CENPX;RSF1
gsea,Other Interleukin Signaling R-HSA-449836,-0.5422780715906654,-1.6076441360253564,0.025096525096525095,0.02633163671869897,0.951,2/17,1.06%,VAMP2;SNAP25
gsea,SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.4295155838697073,-1.6061961001497114,0.006072874493927126,0.02655268302751076,0.953,14/42,20.24%,HNRNPK;SUMO2;TPR;HNRNPC;SUMO1;RING1;SEC13;NUP88;UBE2I;NUP50;CBX8;NOP58;SEH1L;NUP205
gsea,Formation Of Early Elongation Complex R-HSA-113418,-0.4623421808099416,-1.605782780446134,0.01764705882352941,0.02658335270790914,0.954,19/31,36.34%,POLR2G;CCNH;GTF2H1;GTF2H5;POLR2C;POLR2L;POLR2I;POLR2F;POLR2E;GTF2F1;NCBP2;GTF2H4;GTF2F2;CDK7;POLR2J;POLR2B;POLR2K;GTF2H3;POLR2D
gsea,Netrin-1 Signaling R-HSA-373752,0.43589523403801406,1.6025798560312776,0.010438413361169102,0.10755386254759938,0.95,10/45,5.55%,DCC;SLIT3;SLIT2;TRPC6;TRIO;UNC5C;ROBO1;MYO10;DSCAML1;DSCAM
gsea,Reproduction R-HSA-1474165,-0.3868097845118943,-1.6023370965895543,0.012658227848101266,0.027176211404733246,0.956,14/69,14.54%,H2AZ1;SMC1A;RAD21;SMC3;H2AJ;TERF1;HSPA2;STAG2;H2BC4;H2AX;CDK4;SUN1;UBE2I;MLH3
gsea,RHO GTPases Activate ROCKs R-HSA-5627117,-0.5267458231428069,-1.60004685727926,0.015238095238095238,0.027601387704925633,0.957,6/19,11.89%,MYL6;RHOB;MYL12B;PPP1CB;ROCK2;MYH10
gsea,SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.43646324927507213,-1.5990805269702777,0.014799154334038054,0.027758032968145763,0.957,20/38,36.60%,TOP1;SUMO2;TPR;TOP2B;PCNA;SUMO1;SEC13;NUP88;UBE2I;NUP50;SEH1L;NUP205;NUP62;NUP107;NUP133;INCENP;NUP85;RANGAP1;NUP54;POM121
gsea,RHOH GTPase Cycle R-HSA-9013407,-0.46254453494324477,-1.5989883781485617,0.021739130434782608,0.0277460073251895,0.957,11/31,21.36%,TMEM59;ARHGDIA;VCP;ROCK2;RALGAPA1;TUBA1B;PKN2;TFRC;VAMP3;NIPSNAP2;DBN1
gsea,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.5344653475154981,-1.5961291392409143,0.03125,0.028313018001075958,0.96,4/17,7.28%,UBB;RPS27A;UBA52;UBC
gsea,Base Excision Repair R-HSA-73884,-0.41071412692700465,-1.595374610706569,0.0071174377224199285,0.028407100662351817,0.961,15/52,21.67%,H2AZ1;H2AJ;TERF1;PCNA;POLD4;TDG;H2BC4;H2AX;RFC3;PARP2;PARP1;ADPRS;POLE3;POLG2;FEN1
gsea,Pre-NOTCH Expression And Processing R-HSA-1912422,-0.4006375252441773,-1.595201534525187,0.008438818565400843,0.028394109679607614,0.961,11/51,12.96%,JUN;H2AZ1;RAB6A;MAMLD1;H2AJ;TMED2;SNW1;TNRC6A;H2BC4;H2AX;TFDP2
gsea,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.4984951587730755,-1.594172591286273,0.022641509433962263,0.028565565052679105,0.963,8/19,28.33%,PIK3R1;HRAS;FGFR3;FGF13;FGF9;PTPN11;NRAS;FGF16
gsea,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.4884429346848776,-1.591884588899471,0.030737704918032786,0.02900402568583799,0.967,10/23,15.43%,GNB2;GNG2;GNAI2;GNG10;GNG3;GNB1;GNG13;GNG11;ADRA2C;GNG7
gsea,Signaling By WNT In Cancer R-HSA-4791275,-0.4723863341362232,-1.5915775594592052,0.01768172888015717,0.029047606241932197,0.967,18/28,36.09%,PPP2R1A;GSK3B;PPP2CA;PPP2R5D;CSNK1A1;PPP2R5E;CTNNB1;FZD8;FZD4;CTBP2;CTBP1;PPP2R5A;PPP2R5B;TNKS2;LRP6;PORCN;AMER1;TNKS
gsea,Transcriptional Regulation By MECP2 R-HSA-8986944,-0.40728045781160727,-1.589221425187139,0.014553014553014554,0.029567106622560485,0.968,13/56,13.22%,CALM1;GRIA2;CAMK2B;NCOR1;CAMK2A;HDAC2;GAD1;TNRC6A;HIPK2;IRAK1;MEF2C;PTEN;GPS2
gsea,Smooth Muscle Contraction R-HSA-445355,-0.47362031321946285,-1.588608155804529,0.02185792349726776,0.029644031107191535,0.968,14/32,24.79%,CALM1;MYL6;VCL;MYL12B;TPM1;PKN2;CACNA1H;PXDN;TLN1;CALD1;MYL12A;GUCY1B1;CACNA1G;MYL9
gsea,PI Metabolism R-HSA-1483255,-0.3758366708496727,-1.5874700450986095,0.005836575875486381,0.02981505798010665,0.97,20/75,19.04%,PLEKHA2;ARF3;RAB14;SBF1;INPP4B;GDE1;PIP4K2A;PIK3R1;RUFY1;PIP4P1;MTMR9;PTEN;PIK3C2A;CLSTN1;SBF2;INPP5F;PLEKHA5;PIP4K2B;PIP5K1C;PLEKHA3
gsea,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.546126958053952,-1.5873873034639785,0.016260162601626018,0.029800015563657554,0.97,3/16,1.06%,VAMP2;RAB3A;SNAP25
gsea,Cell-cell Junction Organization R-HSA-421270,0.41943637204288164,1.5852826860972955,0.014344262295081968,0.1122278046768399,0.964,9/43,4.45%,CDH10;CADM1;CDH13;SDK2;NECTIN1;CDH2;PATJ;NECTIN3;CDH12
gsea,Sensory Perception Of Taste R-HSA-9717189,-0.5413954567170056,-1.5852809381023185,0.021484375,0.03018686548236348,0.974,7/16,14.38%,GRM1;SCN1B;SCN2B;SCN3A;GNB1;GNG13;SCN2A
gsea,HDACs Deacetylate Histones R-HSA-3214815,-0.4427798834488066,-1.5848391204549566,0.020366598778004074,0.03024812210168107,0.974,25/39,43.05%,CHD3;RBBP7;SAP18;NCOR1;HDAC2;H2AC25;HDAC8;H2BC4;GPS2;GATAD2B;ARID4A;KDM1A;HMG20B;BRMS1L;HDAC10;H2AC21;MTA1;TBL1X;HDAC1;RBBP4;TBL1XR1;REST;H2BC21;SUDS3;SAP30
gsea,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.45439149238496923,-1.583364425798178,0.020161290322580645,0.03050522683814315,0.974,19/31,40.84%,APOE;NCOR1;TNRC6A;RXRB;APOD;GPS2;ARL4C;ABCA1;NCOA1;KDM1A;PLTP;TNRC6B;ABCG1;AGO4;AGO3;TBL1X;KDM1B;TBL1XR1;EP300
gsea,Muscle Contraction R-HSA-397014,-0.3439553036707411,-1.58056184420525,0.005434782608695652,0.03109059664408071,0.976,26/139,9.88%,CALM1;ATP1B1;KCND2;ATP2B1;CAMK2B;MYL6;ORAI2;ATP1A2;KCNK1;ATP1B2;AKAP9;VCL;ATP1A3;MYL12B;TPM1;SLC8A2;CAMK2A;SCN3B;SCN1B;AHCYL1;SCN2B;HIPK2;KCNJ4;ITPR1;SCN3A;PKN2
gsea,Adherens Junctions Interactions R-HSA-418990,0.4777563513062266,1.5784647913127845,0.013806706114398421,0.10936827006286873,0.972,7/26,4.45%,CDH10;CADM1;CDH13;NECTIN1;CDH2;NECTIN3;CDH12
gsea,EPHA-mediated Growth Cone Collapse R-HSA-3928663,-0.5479020130188248,-1.577232939718598,0.025193798449612403,0.031761959774380046,0.98,4/15,11.89%,MYL6;MYL12B;ROCK2;MYH10
gsea,RHO GTPases Activate CIT R-HSA-5625900,-0.5452943825167605,-1.5763325418603555,0.029354207436399216,0.03186848319000434,0.98,6/17,11.89%,MYL6;RHOB;CDKN1B;MYL12B;PPP1CB;MYH10
gsea,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.4608925791136327,-1.5747313157303664,0.033663366336633666,0.03216103728804383,0.981,7/29,9.50%,CALM1;PRKAR1A;ADCY1;AHCYL1;PRKAR1B;ITPR1;PRKACB
gsea,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.49163067446061115,-1.5742860046309655,0.026119402985074626,0.03221587199780097,0.981,4/26,5.23%,PIANP;ICAM5;CD81;NPDC1
gsea,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.4632659725666378,-1.573311506139796,0.014553014553014554,0.03238595102089374,0.981,11/29,20.44%,TUBA1A;TUBB2A;TUBB4A;TUBB2B;TUBB4B;TPGS1;TUBA1B;TUBB3;TTLL3;NICN1;AGTPBP1
gsea,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.4401740440356803,-1.5673609927089636,0.014056224899598393,0.0337612678969396,0.982,22/36,42.05%,APOE;NCOR1;TNRC6A;RXRB;APOD;GPS2;ARL4C;ABCA1;NCOA1;KDM1A;FASN;PLTP;TNRC6B;ABCG1;AGO4;ANGPTL3;AGO3;TBL1X;KDM1B;TBL1XR1;EP300;NRIP1
gsea,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.529117816509636,-1.5641922833093849,0.032504780114722756,0.034641265737800256,0.982,5/17,11.10%,H2AZ1;H2AJ;ORC4;H2BC4;H2AX
gsea,Protein-protein Interactions At Synapses R-HSA-6794362,0.37395168808451257,1.559379135381267,0.02268041237113402,0.11668188002913589,0.982,22/84,6.95%,NLGN1;GRIA4;PTPRD;IL1RAPL2;DLGAP2;NRXN1;GRIA3;GRM5;GRIN2B;NRXN3;LRFN2;PTPRS;LRRTM3;EPB41L3;NTRK3;LIN7A;APBA1;SHANK1;DLGAP3;SHANK3;HOMER1;PTPRF
gsea,PLC Beta Mediated Events R-HSA-112043,-0.4182173449228474,-1.5592662121992946,0.023762376237623763,0.035779161538508145,0.982,11/44,11.37%,CALM1;CAMK2B;PRKAR1A;MAPK1;ADCY1;CAMK2A;AHCYL1;PRKAR1B;ITPR1;PRKACB;CAMKK1
gsea,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.49135922722644576,-1.5524518604711095,0.03636363636363636,0.037582246354415615,0.985,10/21,29.00%,CANX;SEC13;PDIA3;SEC24A;HSPA5;SAR1B;B2M;CALR;SEC24C;SEC23A
gsea,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",-0.5082816803539425,-1.5497535282689272,0.03632478632478633,0.03840490581607492,0.986,4/20,0.64%,CALM1;GRIA2;NEFL;CAMK2B
gsea,Degradation Of Extracellular Matrix R-HSA-1474228,0.36770816114661975,1.5462867288715254,0.011086474501108648,0.11911371296929273,0.986,18/72,9.09%,COL19A1;ADAMTS18;COL23A1;COL25A1;ERC2;CTSK;SPOCK3;COL13A1;ADAMTS9;KLKB1;COL12A1;LAMB1;ADAMTS1;TIMP2;COL15A1;CD44;LAMB3;ADAMTS16
gsea,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.41499537835550043,-1.5414779555722948,0.02448210922787194,0.04067546500571698,0.99,16/43,31.46%,HSP90AB1;UBE2N;UBE2V1;AAMP;IRAK1;CYLD;NFKB2;SUGT1;BIRC2;TAB2;BCL2L1;TXN2;IKBKG;IRAK2;NLRC4;CASP9
gsea,DAG And IP3 Signaling R-HSA-1489509,-0.43015999943921407,-1.5295131623818958,0.0326530612244898,0.04404476761424303,0.993,10/37,11.37%,CALM1;CAMK2B;PRKAR1A;ADCY1;CAMK2A;AHCYL1;PRKAR1B;ITPR1;PRKACB;CAMKK1
gsea,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.3777142024846506,-1.5289881043540048,0.015358361774744027,0.044091943562326145,0.993,26/60,39.68%,UBB;RPS27A;SEM1;UBA52;PCNA;POLD4;UBC;ATRIP;RFC3;POLE3;BRCA2;RAD51D;TOP3A;MUS81;POLD2;RPA3;KAT5;XRCC2;RAD17;RFC2;RAD9A;SPIDR;RAD50;RBBP8;POLK;RAD9B
gsea,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.5077802545005891,-1.5262648589090253,0.040169133192389,0.04493029619302368,0.994,5/19,9.48%,CALM1;NEFL;CAMK2B;CAMK2A;RASGRF1
gsea,Mitotic Spindle Checkpoint R-HSA-69618,-0.34719658641843976,-1.525584631796442,0.009861932938856016,0.04507302230566023,0.994,35/91,34.41%,RPS27;DYNLL1;DYNLL2;PAFAH1B1;ZWINT;PPP2R1A;PPP2CA;SEC13;PPP2R5D;NUDC;UBE2S;DYNC1H1;UBE2D1;B9D2;PPP2R5E;SEH1L;ANAPC16;ANAPC11;UBE2E1;RCC2;CENPP;NUP107;PPP2R5A;PPP2R5B;PPP1CC;XPO1;ANAPC1;BUB3;NUP133;KNL1;INCENP;ANAPC4;DYNC1LI2;NUP85;RANGAP1
gsea,Stimuli-sensing Channels R-HSA-2672351,0.36061139500660894,1.5238720866999833,0.017204301075268817,0.13022475563899724,0.989,17/70,6.93%,ANO3;TRPM3;RYR2;ANO4;ANO2;UNC79;TRPC6;ASIC2;CLCN5;ANO6;RYR3;UNC80;TRDN;SCNN1A;BEST3;TPCN2;ASIC4
gsea,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.4440722148615039,-1.5225583636610176,0.03347280334728033,0.04596825993520195,0.994,7/30,6.50%,GRIA2;CAMK2B;AP2M1;NSF;TSPAN7;CAMK2A;AP2S1
gsea,Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.5242249622252647,-1.5197589319473148,0.04911591355599214,0.046725361169265886,0.995,4/16,7.28%,UBB;RPS27A;UBA52;UBC
gsea,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.5023865535823725,-1.5171565649070557,0.03612167300380228,0.04737530829069275,0.996,7/18,27.14%,PPP2R1A;CCNH;PPP2CA;PPP2R2A;LCMT1;XPO1;CDK7
gsea,Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.5086908882554932,-1.5169601083715571,0.047520661157024795,0.047353669533065745,0.996,5/18,12.22%,VAMP2;RAB3A;SNAP25;SYN3;PPFIA3
gsea,Ca-dependent Events R-HSA-111996,-0.434135199761301,-1.513326462747692,0.032454361054766734,0.048515260573305956,0.997,9/33,11.37%,CALM1;CAMK2B;PRKAR1A;MAPK1;ADCY1;CAMK2A;PRKAR1B;PRKACB;CAMKK1
gsea,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.3577045208855199,-1.513039032037419,0.00922509225092251,0.04854143120053858,0.997,18/76,22.49%,ATP1B1;PPIA;BSG;CD47;ATP1B2;SIRPA;TSPAN7;PIK3R1;MERTK;MAG;HRAS;JAM2;GPC1;SELENOP;PTPN11;SELPLG;SDC2;SLC16A1
gsea,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.4850569447419157,-1.5113821441479918,0.048828125,0.04904760235916252,0.997,13/21,36.34%,POLR2G;POLR2C;POLR2L;POLR2I;POLR2F;POLR2E;GTF2F1;NCBP2;GTF2F2;POLR2J;POLR2B;POLR2K;POLR2D
gsea,tRNA Processing R-HSA-72306,-0.34055031061088764,-1.5100093423123122,0.011741682974559686,0.04945090962997264,0.997,28/96,25.66%,RAN;TPR;TRMT112;TSEN34;SEC13;FAM98B;DDX1;QTRT2;NUP88;ZBTB8OS;TRNT1;RPP21;NUP50;LAGE3;POP5;RPP38;SEH1L;OSGEP;CTU1;RTRAF;NUP205;TRMT6;HSD17B10;NUP62;TRIT1;CPSF1;NUP107;TRMU
gsea,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.5224269701820208,-1.509730976225432,0.04921259842519685,0.04946736122732993,0.997,8/15,21.14%,AP2M1;AP2S1;AP1S2;AP2B1;ATP6V1H;B2M;AP1S1;AP2A2
gsea,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.4224690674583166,-1.50861466661222,0.038834951456310676,0.049841530390335474,0.997,15/32,33.24%,CDKN1B;CDK4;TFDP2;UBE2S;UBE2D1;ANAPC16;ANAPC11;UBE2E1;CCND3;RB1;FZR1;CCNE1;ANAPC1;E2F2;ANAPC4
gsea,RAC3 GTPase Cycle R-HSA-9013423,-0.3589263227128485,-1.5058914793869231,0.01026694045174538,0.0507599816965189,0.998,34/79,30.72%,WASF1;ABI1;ARHGAP5;BRK1;NCKAP1;ERBIN;CDC42;GARRE1;ARHGAP21;EMD;PKN2;PIK3R1;TFRC;BAIAP2;PGRMC2;SLITRK5;SLITRK3;OPHN1;ARHGAP26;NCF2;VAMP3;TIAM1;LMAN1;VAV2;GIT1;YKT6;ITGB1;ARHGAP39;FERMT2;JAG1;ARHGAP17;ARHGAP35;NOX1;RACGAP1
gsea,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.4222119607504412,-1.504276749223424,0.02240325865580448,0.05125909578784847,0.998,18/33,36.60%,RAN;NPM1;TPR;SEC13;NUP88;NUP50;RANBP1;SEH1L;NUP205;NUP62;NUP107;XPO1;NUP133;KPNB1;NUP85;RANGAP1;NUP54;POM121
gsea,HCMV Early Events R-HSA-9609690,-0.3652131321037492,-1.5029364482946754,0.012448132780082987,0.05165069224386906,0.998,38/70,41.61%,DYNLL1;DYNLL2;TPR;RBBP7;NCOR1;SEC13;H2AC25;H2BC4;NUP88;GPS2;NUP50;CBX1;DYNC1H1;SEH1L;NUP205;CREB1;PML;NUP62;TXN2;NUP107;ITGB1;IRS1;DAXX;DUT;NUP133;H2AC21;DYNC1LI2;NUP85;NUP54;TBL1X;POM121;RBBP4;PCSK2;TBL1XR1;DYNC1I2;H2BC21;EGFR;NFKB1
gsea,Keratan Sulfate Biosynthesis R-HSA-2022854,-0.4724674644965925,-1.5002761953782229,0.051923076923076926,0.05246736124632381,0.998,7/20,24.67%,CHST1;B4GALT6;B4GAT1;CHST2;B4GALT2;B4GALT4;OGN
gsea,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.34609032320296296,-1.49919123596749,0.019011406844106463,0.0527584214193444,0.998,26/83,19.60%,MAPK1;AKT3;PPP2R1A;MAPK3;PIP4K2A;PPP2CA;PPP2R5D;IRAK1;IL1RAP;PIK3R1;FGFR1;PDGFA;PTEN;INSR;CLSTN1;ERBB3;FGFR3;FGFR2;PIP4K2B;PPP2R5E;AKT1;FGF13;FGF9;PIP5K1C;RNMT;PTPN11
gsea,Collagen Degradation R-HSA-1442490,0.456298072733733,1.4986411636968449,0.05215419501133787,0.1453337126795144,0.995,7/23,6.39%,COL19A1;COL23A1;COL25A1;CTSK;COL13A1;COL12A1;COL15A1
gsea,Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.4061776920210882,-1.4938076404213458,0.026584867075664622,0.0547241547968554,0.999,9/38,12.96%,JUN;H2AZ1;MAMLD1;H2AJ;SNW1;TNRC6A;H2BC4;H2AX;TFDP2
gsea,Signaling By FGFR2 In Disease R-HSA-5655253,-0.41237938007444225,-1.4935710106771865,0.028056112224448898,0.05471371470425001,0.999,19/35,33.64%,POLR2G;PIK3R1;POLR2C;POLR2L;HRAS;POLR2I;FGFR2;POLR2F;FGF13;POLR2E;FGF9;GTF2F1;NCBP2;GTF2F2;NRAS;FGF16;POLR2J;POLR2B;POLR2K
gsea,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.3733875649254787,-1.492372353026722,0.02857142857142857,0.055097339729937016,0.999,18/59,26.09%,HSP90AA1;HSPA8;CEBPD;FOXO3;HSP90B1;S1PR1;NDN;STAT3;PIK3R1;IL18;RNASEH2A;AKT1;FGF13;TYK2;BCL2L1;FN1;VIM;ITGB1
gsea,RHOG GTPase Cycle R-HSA-9013408,-0.3655502474408527,-1.4922846108228895,0.022556390977443608,0.05504865298961723,0.999,15/63,10.63%,HSPE1;ARHGDIA;ARHGAP5;KTN1;NDUFA5;ERBIN;CDC42;GARRE1;ARHGAP21;IQGAP2;ELMO2;EMD;PKN2;PIK3R1;TFRC
gsea,Signaling By FGFR3 In Disease R-HSA-5655332,-0.48892793158887493,-1.4920425953867789,0.05113636363636364,0.05507545553692809,0.999,7/16,28.33%,PIK3R1;HRAS;FGFR3;FGF13;FGF9;NRAS;FGF16
gsea,Glycerophospholipid Biosynthesis R-HSA-1483206,-0.3401125210547421,-1.4902525118880405,0.008733624454148471,0.055620769265467614,0.999,28/100,23.78%,CDS2;GPD2;CDIPT;DGAT2;LPGAT1;DDHD2;CSNK2B;GPD1;CRLS1;OSBPL5;PTPMT1;PNPLA8;PITPNM3;CEPT1;MIGA1;MGLL;CPNE3;GPD1L;AGPAT3;LPCAT3;PLA2G6;SELENOI;CHPT1;GPCPD1;PLD3;PITPNB;PITPNM1;HADHB
gsea,PKA Activation R-HSA-163615,-0.5247613711508938,-1.4872523190463014,0.04526748971193416,0.056719879507818885,0.999,5/15,9.50%,CALM1;PRKAR1A;ADCY1;PRKAR1B;PRKACB
gsea,Sema4D In Semaphorin Signaling R-HSA-400685,-0.4806423387051711,-1.4854377370135372,0.06639839034205232,0.05730941908875719,0.999,6/21,11.89%,MYL6;RHOB;MYL12B;ROCK2;ARHGEF12;MYH10
gsea,Platelet Calcium Homeostasis R-HSA-418360,-0.45405484336212654,-1.48459762134849,0.05204460966542751,0.057509329641075815,0.999,5/23,9.21%,CALM1;ATP2B1;ORAI2;SLC8A2;ITPR1
gsea,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.41415477160610176,-1.4839246328644133,0.042643923240938165,0.05765790216822522,0.999,7/33,11.10%,UBE2N;UBE2V2;RNF168;UIMC1;H2BC4;XRCC4;H2AX
gsea,Phase I - Functionalization Of Compounds R-HSA-211945,-0.38758447598513684,-1.4836060233321424,0.03429602888086643,0.05772868647682613,0.999,10/46,20.63%,HSP90AB1;CYP7B1;AURKAIP1;PTGES3;VDAC2;MIA3;CYB5B;NCOA1;PAOX;CYP26B1
gsea,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.49071854283413197,-1.4828558695932719,0.04878048780487805,0.05795907865308002,0.999,4/17,8.97%,BANF1;PPP2R1A;PPP2CA;EMD
gsea,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.4325365401116873,-1.4799910270179861,0.037109375,0.05889096147450419,0.999,6/31,11.10%,H2AZ1;CDKN1B;H2AJ;TERF1;H2BC4;H2AX
gsea,Cell Junction Organization R-HSA-446728,0.35568361879319377,1.4795345437044503,0.025157232704402517,0.15528548399810077,0.998,15/65,9.23%,CDH10;CADM1;CDH13;SDK2;NECTIN1;CDH2;PATJ;NECTIN3;CDH12;DST;FLNA;CDH9;LAMB3;RSU1;CDH4
gsea,GPCR Ligand Binding R-HSA-500792,-0.3102482413772095,-1.4738678435835542,0.0033112582781456954,0.06113478405280873,0.999,34/184,15.43%,PLPPR4;GNAS;GNB2;GNG2;GRM1;GLP2R;P2RY14;CX3CL1;CHRM1;GRM2;NPY1R;S1PR1;CHGA;CNOT6;GNG10;MC4R;P2RY12;CXCR6;RAMP2;GNG3;GNB1;NPY5R;NPY;ADORA1;ADRB1;GNG13;PLPPR5;PTRH2;TAC1;GNG11;ADRA2C;ECE1;SSTR2;GNG7
gsea,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,-0.5129624779913872,-1.4711056307776242,0.06653225806451613,0.06208058983588134,1.0,9/15,26.57%,EXOSC4;EXOSC3;EXOSC9;EXOSC5;EXOSC2;HBS1L;EXOSC1;EXOSC7;DIS3
gsea,Downstream Signal Transduction R-HSA-186763,-0.43802646975793924,-1.4692192196580287,0.0392156862745098,0.06281710526115435,1.0,8/25,26.98%,STAT3;PIK3R1;NCK1;PDGFA;HRAS;PTPN11;BCAR1;NRAS
gsea,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.3461792091935593,-1.4692002208653754,0.023575638506876228,0.06273968180257193,1.0,28/75,34.41%,RPS27;DYNLL1;DYNLL2;PAFAH1B1;ZWINT;PPP2R1A;PPP2CA;SEC13;PPP2R5D;NUDC;DYNC1H1;B9D2;PPP2R5E;SEH1L;RCC2;CENPP;NUP107;PPP2R5A;PPP2R5B;PPP1CC;XPO1;BUB3;NUP133;KNL1;INCENP;DYNC1LI2;NUP85;RANGAP1
gsea,Metabolism Of Non-Coding RNA R-HSA-194441,-0.377503445508,-1.4675841825322005,0.043121149897330596,0.06331469304285978,1.0,17/47,25.33%,SNRPD2;TPR;SNRPF;SNRPG;SEC13;NUP88;DDX20;SNRPE;NUP50;SNRPB;SEH1L;GEMIN6;NUP205;PHAX;NCBP2;NUP62;NUP107
gsea,PPARA Activates Gene Expression R-HSA-1989781,-0.33309163927571306,-1.46301809573083,0.011472275334608031,0.06511149385859479,1.0,23/98,18.97%,HMGCS1;CLOCK;NCOR1;MED25;ACOX1;MED19;MED28;MIA3;HMGCR;NFYB;RXRB;GPS2;THRAP3;MED22;MED10;MED31;MED21;MED4;CDK19;CHD9;ABCA1;TXNRD1;NCOA1
gsea,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.4448981054823879,-1.460407138370297,0.06130268199233716,0.06609481735063337,1.0,14/26,34.79%,POLR2L;BDP1;SNAPC5;POLR3D;SNAPC2;POLR2F;POLR2E;POLR1D;TBP;SNAPC3;POLR3H;POLR3A;POLR2K;BRF2
gsea,Metabolism Of Steroids R-HSA-8957322,-0.32779073400932085,-1.4599731803789167,0.009652509652509652,0.06619980650313717,1.0,43/107,39.62%,RAN;CYP7B1;SUMO2;HMGCS1;CHGA;FDPS;INSIG1;HMGCR;NFYB;SEC24A;UBE2I;SAR1B;STARD5;CHD9;OSBPL3;NCOA1;ACOT8;STARD4;HSD17B11;CREBBP;SQLE;FASN;PLPP6;PMVK;SEC24C;FDX2;SRD5A3;SEC23A;GGPS1;SC5D;CYP46A1;KPNB1;INSIG2;HSD3B2;MBTPS2;TM7SF2;TBL1X;MSMO1;SREBF2;SLC10A1;NCOA6;IDI1;TBL1XR1
gsea,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.4987093369623799,-1.4574004299074332,0.0658682634730539,0.06717350246077168,1.0,5/16,11.81%,CPSF6;STAT3;PIK3R1;TRIM24;CUX1
gsea,Sensory Perception R-HSA-9709957,-0.3142973514622149,-1.4573697476689529,0.005309734513274336,0.06708526796380078,1.0,27/145,13.48%,CALM1;CAPZA2;ATP2B1;VAMP2;APOE;RAB3A;SNAP25;SYP;NMT1;GRM1;GNAL;RIMBP2;RNF7;SCN1B;SCN2B;TWF1;DNAJC5;RDX;C1D;SCN3A;CAPZB;GNB1;OR10H1;GNG13;NAPEPLD;REEP1;STRA6
gsea,Extracellular Matrix Organization R-HSA-1474244,0.29821054449632206,1.4560750988490005,0.0022675736961451248,0.17072850272852647,1.0,40/197,9.09%,DMD;COL19A1;ADAMTS18;COL23A1;NRXN1;ADAM12;COL25A1;COL5A2;ITGA8;P3H2;COL11A1;LTBP4;ADAMTS3;ERC2;PTPRS;CTSK;SPOCK3;COL4A4;COL28A1;COL13A1;ADAMTS9;KLKB1;P4HA1;COL12A1;DST;COL4A1;LAMB1;ADAMTS1;FBN2;ADAM19;P3H1;TIMP2;COL15A1;ITGA3;CD44;CASK;ITGAM;MUSK;LAMB3;ADAMTS16
gsea,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.4972385234777331,-1.4553001968920927,0.06439393939393939,0.06789784301438045,1.0,4/16,17.20%,HSP90AB1;NFKB2;SUGT1;IL18
gsea,Growth Hormone Receptor Signaling R-HSA-982772,-0.4952335608161246,-1.4537103535132319,0.07034220532319392,0.06855124983148847,1.0,3/16,8.44%,MAPK1;MAPK3;STAT3
gsea,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.3287418044874687,-1.4499623170163631,0.017110266159695818,0.070012031849601,1.0,23/100,18.97%,HMGCS1;CLOCK;NCOR1;MED25;ACOX1;MED19;MED28;MIA3;HMGCR;NFYB;RXRB;GPS2;THRAP3;MED22;MED10;MED31;MED21;MED4;CDK19;CHD9;ABCA1;TXNRD1;NCOA1
gsea,Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.4445554161225107,-1.4478309355098207,0.053604436229205174,0.07083000968741536,1.0,8/21,19.53%,VDAC1;VDAC2;SMDT1;PHB2;MICU3;AKAP1;PMPCA;PMPCB
gsea,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.40426451339794234,-1.4441098731521664,0.050880626223091974,0.07248123479182568,1.0,17/32,36.60%,RAN;TPR;SEC13;PBRM1;NUP88;NUP50;SEH1L;GNL3;NUP205;NUP62;NUP107;XPO1;HSPA1A;NUP133;NUP85;NUP54;POM121
gsea,PKA-mediated Phosphorylation Of CREB R-HSA-111931,-0.48803120951983475,-1.4415738824114335,0.07024793388429752,0.07355592233225794,1.0,5/17,9.50%,CALM1;PRKAR1A;ADCY1;PRKAR1B;PRKACB
gsea,CTLA4 Inhibitory Signaling R-HSA-389513,-0.4591467583939676,-1.4383128918886974,0.0625,0.07494942617129487,1.0,9/19,26.94%,AKT3;PPP2R1A;PPP2CA;PPP2R5D;PPP2R5E;AKT1;PTPN11;PPP2R5A;PPP2R5B
gsea,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.3357506387936412,-1.4381658417456553,0.028680688336520075,0.07492895099970796,1.0,24/77,19.60%,MAPK1;PPP2R1A;MAPK3;PIP4K2A;PPP2CA;PPP2R5D;IRAK1;IL1RAP;PIK3R1;FGFR1;PDGFA;INSR;CLSTN1;ERBB3;FGFR3;FGFR2;PIP4K2B;PPP2R5E;AKT1;FGF13;FGF9;PIP5K1C;RNMT;PTPN11
gsea,Signaling By Hippo R-HSA-2028269,-0.4593891476332127,-1.4375953475085976,0.07909604519774012,0.0751181874883647,1.0,3/20,9.67%,YWHAB;YWHAE;WWC1
gsea,RAC2 GTPase Cycle R-HSA-9013404,-0.3474880286516296,-1.436573433850313,0.03131115459882583,0.07550590960940673,1.0,37/74,36.84%,ABI1;ARHGDIA;BRK1;NCKAP1;ERBIN;CDC42;GARRE1;ARHGAP21;ARMCX3;EMD;PKN2;PIK3R1;TFRC;PGRMC2;SLITRK5;OPHN1;ARHGAP26;NCF2;VAMP3;TIAM1;LMAN1;VAV2;GIT1;SAMM50;ITGB1;ARHGAP39;ARHGAP17;ARHGAP35;RACGAP1;VAPB;CDC42EP4;TMPO;PLD2;DSG2;MPP7;ABR;ABI2
gsea,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.46271373899703305,-1.434945237492726,0.0841300191204589,0.076179033634179,1.0,7/18,28.33%,PIK3R1;HRAS;FGF13;FGF9;PTPN11;NRAS;FGF16
gsea,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.3678278036815072,-1.4337384671776456,0.046468401486988845,0.07664922718907681,1.0,9/55,8.05%,CAPZA2;ATP2B1;VAMP2;RAB3A;SNAP25;SYP;TWF1;DNAJC5;RDX
gsea,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.3333241987920037,-1.4325893560634289,0.03125,0.07705890308942114,1.0,29/79,34.41%,RPS27;DYNLL1;DYNLL2;PAFAH1B1;ZWINT;PPP2R1A;PPP2CA;NEK9;SEC13;PPP2R5D;NUDC;DYNC1H1;B9D2;PPP2R5E;SEH1L;RCC2;CENPP;NUP107;PPP2R5A;PPP2R5B;PPP1CC;XPO1;BUB3;NUP133;KNL1;INCENP;DYNC1LI2;NUP85;RANGAP1
gsea,Insulin Receptor Signaling Cascade R-HSA-74751,-0.38465515814705714,-1.4308566967431313,0.040697674418604654,0.07774243779105444,1.0,19/40,34.59%,MAPK1;MAPK3;PIK3R1;FGFR1;INSR;HRAS;FGFR3;FGFR2;FGF13;FGF9;PTPN11;NRAS;IRS1;FGF16;IRS2;PDPK1;PIK3CB;PIK3C3;THEM4
gsea,Recycling Pathway Of L1 R-HSA-437239,-0.43658337931066593,-1.429320459671753,0.05761316872427984,0.0782854631470162,1.0,9/25,16.57%,MAPK1;AP2M1;CLTA;DPYSL2;AP2S1;RDX;CLTC;NUMB;AP2B1
gsea,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.34656793915264117,-1.426918655738116,0.03155818540433925,0.07939082484099722,1.0,18/69,18.97%,CEBPD;CEBPB;NCOR1;MED25;MED19;MED28;NR2F2;CEBPA;CDK4;THRAP3;MED22;MED10;MED31;MED21;MED4;CDK19;CHD9;NCOA1
gsea,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.4475631497518098,-1.4255581180405048,0.08253358925143954,0.08000681312017037,1.0,14/24,35.70%,BNIP3L;PRELID3A;BAX;TRIAP1;PPP1R13B;PRELID1;RABGGTB;CREBBP;FASN;NDRG1;BBC3;NLRC4;TMEM219;IGFBP3
gsea,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.36348447221644264,-1.4219196532177307,0.04462474645030426,0.08167408488168275,1.0,19/47,32.92%,CCT2;ARF4;TCP1;CCT8;RAB11A;CCT5;BBIP1;NUDT19;BBS5;EXOC8;EXOC3;EXOC5;INPP5E;CCT3;BBS2;EXOC1;EXOC2;UNC119B;SMOX
gsea,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.3932055194851378,-1.4188471781371452,0.053169734151329244,0.08311721723219807,1.0,19/35,37.13%,TPR;SUMO1;SEC13;NUP88;UBE2I;NUP50;SEH1L;NUP205;PML;NUP62;NUP107;PIAS2;MDM2;NUP133;NUP85;NUP54;POM121;PIAS1;VHL
gsea,G Alpha (S) Signaling Events R-HSA-418555,-0.3287333235057758,-1.4184857282695746,0.017341040462427744,0.08317747777679423,1.0,21/91,15.43%,GNAS;GNB2;PRKAR1A;GNG2;GLP2R;ADCY1;PRKAR1B;CHGA;GNAI2;PRKACB;GNG10;MC4R;GPR27;RAMP2;GNG3;GNB1;ADRB1;GNG13;PTRH2;GNG11;GNG7
gsea,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.30495427794517727,-1.4160963899228827,0.023032629558541268,0.08420728456004652,1.0,54/139,35.09%,CALM1;HSP90AA1;APOE;MOCS2;PANK3;RIMBP2;PDXK;PARP4;C1D;GPHN;SLC25A16;PDZD11;VKORC1;PARP8;NAXD;GSTO1;GPC1;TTPA;MMACHC;AKT1;MMADHC;DHFR;PARP16;SDC2;NAXE;COQ3;ALDH1L1;RETSAT;VKORC1L1;FASN;MMUT;LPL;NMNAT3;LMBRD1;TCN2;NADK2;PANK4;PTGS2;CYB5R3;PNPO;ENPP1;SDC3;THTPA;TTR;RFK;MTHFD1L;COQ7;PARP6;FLAD1;LRP12;AGRN;RDH11;SLC52A2;PANK2
gsea,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.41361595221052916,-1.414347424660423,0.07115384615384615,0.08486569547782154,1.0,13/29,23.12%,DDX5;CHMP2A;MAP1LC3B;CHMP4B;VCP;CTSL;ISCU;CHMP7;GPC1;CHMP6;SDC2;ZCRB1;RB1
gsea,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,-0.4841981319351059,-1.414051688719384,0.08151093439363817,0.08490044074940693,1.0,6/16,11.10%,GRIA2;AP2M1;NSF;TSPAN7;AP2S1;PRKCB
gsea,Intraflagellar Transport R-HSA-5620924,-0.38293111087725534,-1.4127918865968105,0.06358381502890173,0.08546989456126636,1.0,5/38,8.14%,DYNLL1;DYNLL2;IFT20;DYNLRB1;KIFAP3
gsea,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.42129766504508187,-1.4124009985113901,0.0821917808219178,0.08558217399148063,1.0,16/26,33.64%,POLR2G;POLR2C;POLR2L;POLR2I;FGFR2;POLR2F;FGF13;POLR2E;FGF9;GTF2F1;NCBP2;GTF2F2;FGF16;POLR2J;POLR2B;POLR2K
gsea,L1CAM Interactions R-HSA-373760,-0.32626038728531265,-1.4123120327864789,0.02040816326530612,0.08551973741113315,1.0,21/88,14.38%,HSPA8;MAPK1;AP2M1;SDCBP;CLTA;DPYSL2;ITGA2;MAPK3;SCN3B;SCN1B;AP2S1;SCN2B;RDX;CSNK2B;SCN3A;KCNQ3;FGFR1;CHL1;CLTC;NUMB;SCN2A
gsea,Nuclear Import Of Rev Protein R-HSA-180746,-0.40026086125923893,-1.4092368455874873,0.06930693069306931,0.08698962920080534,1.0,15/30,36.60%,RAN;NPM1;TPR;SEC13;NUP88;NUP50;SEH1L;NUP205;NUP62;NUP107;NUP133;KPNB1;NUP85;NUP54;POM121
gsea,Telomere Extension By Telomerase R-HSA-171319,-0.45375853741062844,-1.4087186198964534,0.07916666666666666,0.08714976835718738,1.0,7/19,29.90%,NOP10;TERF1;GAR1;DKC1;NHP2;PPP6C;ANKRD28
gsea,PKMTs Methylate Histone Lysines R-HSA-3214841,-0.36858820137609477,-1.4083025263846363,0.057971014492753624,0.08725912334850498,1.0,14/44,25.00%,RBBP7;ATF7IP;ASH1L;NSD1;NFKB2;SETD3;SETD7;SETD1B;KMT5A;KMT2C;DOT1L;SETD6;NSD2;SUV39H1
gsea,G Alpha (12/13) Signaling Events R-HSA-416482,-0.35025721164450574,-1.4080576062747057,0.046875,0.08723243538592841,1.0,19/65,23.18%,GNB2;GNG2;RHOB;ROCK2;ARHGEF4;GNG10;ARHGEF12;GNG3;GNB1;GNG13;ARHGEF9;GNG11;ARHGEF2;GNG7;SOS2;TIAM1;ARHGEF1;VAV2;PRPF38B
gsea,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.3976527452399829,-1.4077275257075959,0.064453125,0.08729619186836915,1.0,16/31,36.60%,RAN;TPR;SEC13;PBRM1;NUP88;NUP50;SEH1L;GNL3;NUP205;NUP62;NUP107;XPO1;NUP133;NUP85;NUP54;POM121
gsea,Sensory Processing Of Sound R-HSA-9659379,-0.354595167570383,-1.4076731103977724,0.04512635379061372,0.08720434731946547,1.0,9/60,8.05%,CAPZA2;ATP2B1;VAMP2;RAB3A;SNAP25;SYP;TWF1;DNAJC5;RDX
gsea,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.3959906465994707,-1.401480599228724,0.05179282868525897,0.09022705280720955,1.0,16/31,36.60%,RAN;TPR;SEC13;NUP88;NUP50;RANBP1;SEH1L;NUP205;NUP62;NUP107;XPO1;NUP133;NUP85;RANGAP1;NUP54;POM121
gsea,CaM Pathway R-HSA-111997,-0.41040850688896013,-1.3986911415451513,0.07628865979381444,0.09160898435182459,1.0,8/31,11.37%,CALM1;CAMK2B;PRKAR1A;ADCY1;CAMK2A;PRKAR1B;PRKACB;CAMKK1
gsea,SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.46521482940069814,1.3979047416922585,0.08982035928143713,0.23032108756442626,1.0,2/18,0.54%,ERBB4;NRG1
gsea,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.42069101511234314,-1.3972568834584047,0.09349593495934959,0.09222068363656155,1.0,11/23,38.61%,CCT2;TCP1;CCT8;CCT5;BBIP1;BBS5;CCT3;BBS2;SMOX;BBS7;TTC8
gsea,Diseases Of Glycosylation R-HSA-3781865,0.3065328910113595,1.3942970432204493,0.0205761316872428,0.2246234109041192,1.0,27/110,12.57%,ADAMTS18;GPC6;EXT1;THSD7B;NOTCH2;GPC3;ADAMTS3;GPC5;THSD7A;ADAMTS17;HEXB;ADAMTS9;ADAMTSL1;SEMA5B;SBSPON;ADAMTS1;THSD4;DHDDS;MUC15;ADAMTS16;ALG12;DAG1;ADAMTS20;ALG8;ALG9;ADAMTS10;B3GLCT
gsea,RND1 GTPase Cycle R-HSA-9696273,-0.3870736771350376,-1.3916943287421595,0.07042253521126761,0.09510205795733556,1.0,7/34,11.22%,RASAL2;TMEM59;CCDC88A;ARHGAP5;PIK3R1;TFRC;TXNL1
gsea,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.3597544259227421,-1.3916053554033858,0.06313645621181263,0.09503757930795113,1.0,27/50,38.66%,CHD3;SUMO2;TPR;CBX5;SUMO1;HDAC2;RING1;SEC13;NUP88;UBE2I;NUP50;CBX8;SEH1L;NUP205;NUP62;NUP107;PIAS2;L3MBTL2;PHC3;NUP133;NUP85;NUP54;PCGF2;POM121;PIAS1;HDAC1;CBX4
gsea,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.377514414874012,-1.3896061169288352,0.05859375,0.09607478262758742,1.0,18/40,39.62%,HMGCS1;FDPS;HMGCR;NFYB;CHD9;NCOA1;CREBBP;SQLE;FASN;PMVK;GGPS1;SC5D;TM7SF2;TBL1X;SREBF2;NCOA6;IDI1;TBL1XR1
gsea,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.4358013982721305,-1.389237747660424,0.0855397148676171,0.09613579889277835,1.0,9/21,25.62%,IVD;ALDH6A1;ACAD8;HIBADH;PPM1K;SLC25A44;HSD17B10;LDHD;SOAT1
gsea,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.4149800871289403,-1.3875614946044994,0.08703703703703704,0.09699760684702774,1.0,12/25,31.41%,PCNA;POLD4;RFC3;PARP2;PARP1;ADPRS;POLE3;POLG2;FEN1;APEX1;POLD2;RPA3
gsea,G Alpha (Q) Signaling Events R-HSA-416476,-0.3043074006615367,-1.3873393604104223,0.025594149908592323,0.09698291939933885,1.0,32/124,24.43%,GNB2;MAPK1;RASGRP1;GNG2;GRM1;DGKH;ARHGEF25;MAPK3;CHRM1;DAGLA;ITPR1;GNG10;ABHD12;PIK3R1;GNG3;GNB1;GNG13;RGS4;TAC1;GNG11;HRAS;GNG7;MGLL;PLCB1;GNA11;PROKR2;CREB1;DGKI;GNA15;DGKD;DGKE;LPAR4
gsea,RND2 GTPase Cycle R-HSA-9696270,-0.390294456631085,-1.387119377529982,0.07984031936127745,0.09694848719774138,1.0,9/35,14.46%,ARHGAP5;KTN1;KCTD13;NUDC;NISCH;PIK3R1;TFRC;TXNL1;GOLGA3
gsea,HS-GAG Biosynthesis R-HSA-2022928,0.43833311403638014,1.3835842949362938,0.08565737051792828,0.22889796670103346,1.0,9/23,13.03%,GPC6;EXT1;GPC3;GPC5;HS3ST4;HS6ST3;HS3ST2;NDST3;HS6ST2
gsea,Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.40671186438939255,-1.3824117698873875,0.08686868686868687,0.09954192623259155,1.0,7/29,9.57%,CALM1;CAMK2B;CAMK2A;SCN3B;SCN1B;SCN2B;SCN3A
gsea,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.4434131178394182,-1.3784378902264451,0.08082706766917293,0.10168690000086787,1.0,7/20,25.37%,HMGB1;NKIRAS1;NFKB2;NFKBIA;TANK;S100B;IKBKG
gsea,RHOF GTPase Cycle R-HSA-9035034,-0.3925382276636025,-1.3784106393431717,0.07421875,0.10156746560281421,1.0,9/34,18.00%,DIAPH2;BASP1;ARHGAP5;ARHGAP21;PIK3R1;CAPZB;ADD3;SOWAHC;VAMP3
gsea,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.4633700900142008,-1.3761959045460892,0.12453531598513011,0.10269545593361815,1.0,5/18,19.45%,HMGB1;NDUFA2;NFKB2;NFKBIA;S100A1
gsea,Costimulation By CD28 Family R-HSA-388841,-0.36294619263869876,-1.3761005843733631,0.0735009671179884,0.10261183689515427,1.0,11/41,19.60%,AKT3;PPP2R1A;PPP2CA;CDC42;PPP2R5D;PKN2;PIK3R1;RICTOR;PPP2R5E;AKT1;PTPN11
gsea,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.4622615238068145,-1.3759694044804327,0.12403100775193798,0.10254070766464285,1.0,6/17,26.72%,MAPK1;MAPK3;HEY1;CBFB;RB1;GLI3
gsea,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.38318572766115966,-1.375176285752388,0.08055009823182711,0.1028960522643348,1.0,14/38,24.98%,SSB;NFIX;POLR2L;BDP1;SNAPC5;POLR3D;SNAPC2;POLR2F;POLR2E;POLR1D;GTF3C6;TBP;SNAPC3;POLR3H
gsea,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.46288771865119366,-1.3738891378686364,0.10176125244618395,0.10349266488856441,1.0,9/17,33.04%,UBE2N;UBE2V1;IRAK1;MAPK9;TAB2;IKBKG;MAPK8;IRAK2;MAP2K7
gsea,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.42528164394453416,-1.3735093238771274,0.07739307535641547,0.10360634207984484,1.0,6/21,14.67%,HSP90AA1;ERBIN;PIK3R1;CDC37;ERBB3;HRAS
gsea,Interferon Gamma Signaling R-HSA-877300,-0.37534617030079676,-1.3723611588362699,0.08151093439363817,0.10411989612228573,1.0,7/42,7.46%,CAMK2B;BCL11B;TRIM35;TRIM2;CAMK2A;SUMO1;IFNGR2
gsea,Potassium Channels R-HSA-1296071,-0.3223963428568315,-1.3697105871058077,0.05148514851485148,0.10564338728492449,1.0,17/78,12.35%,KCNA1;KCND2;GNB2;KCNA2;GNG2;KCNK1;KCNJ3;KCNC3;KCNJ4;GNG10;KCNQ3;GNG3;GNB1;KCNB1;KCNAB2;KCNF1;GNG13
gsea,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,-0.44919262648358604,-1.3674269324874873,0.10377358490566038,0.10688539721609717,1.0,2/19,1.05%,PRNP;CYP7B1
gsea,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.382970491030457,-1.3674236592048978,0.07459677419354839,0.10674363939485568,1.0,16/31,36.60%,PSIP1;BANF1;TPR;SEC13;NUP88;NUP50;SEH1L;NUP205;HMGA1;NUP62;NUP107;NUP133;KPNA1;NUP85;NUP54;POM121
gsea,SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.38886971517978874,-1.3671013835540868,0.07966457023060797,0.10677216050623935,1.0,11/31,25.33%,SUMO2;TPR;SUMO1;SEC13;NUP88;UBE2I;NUP50;SEH1L;NUP205;NUP62;NUP107
gsea,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.361767004204826,-1.361633096308396,0.0688976377952756,0.11007298061621115,1.0,15/39,25.33%,TPR;SEC13;CPSF2;NUP88;SLBP;NUP50;SEH1L;ALYREF;FIP1L1;NUP205;NCBP2;NUP62;NXF1;CPSF1;NUP107
gsea,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.3813255273774705,-1.3601241520950387,0.09038461538461538,0.11078452953378352,1.0,12/32,35.57%,EEF2;ARSA;ARSJ;DOHH;TPST1;DPH3;DPH7;DNAJC24;DHPS;PROS1;EIF5A2;ARSB
gsea,Platelet Sensitization By LDL R-HSA-432142,-0.46406791173810136,-1.3586910892561883,0.11377245508982035,0.11148936584288553,1.0,7/15,26.94%,PPP2R1A;PPP2CA;PPP2R5D;PPP2R5E;PTPN11;PPP2R5A;PPP2R5B
gsea,SLC Transporter Disorders R-HSA-5619102,-0.3272352372716049,-1.3522455941450309,0.06274509803921569,0.11535762343594218,1.0,28/63,36.60%,BSG;SLC4A4;SLC1A3;TPR;SLC35A1;SEC13;NUP88;SLC12A6;SLC24A4;NUP50;SLC2A9;SEH1L;NUP205;SLC16A1;NUP62;SLC9A9;MAP4K5;NUP107;SLC22A5;SLC3A1;NUP133;SLC33A1;NUP85;NUP54;SLC26A2;SLC24A5;SLC11A2;POM121
gsea,IRE1alpha Activates Chaperones R-HSA-381070,-0.36093643857991925,-1.350897531722544,0.09195402298850575,0.11601118566479536,1.0,23/45,45.35%,HDGF;DNAJB11;MYDGF;DCTN1;SSR1;DNAJB9;HSPA5;TLN1;ATP6V0D1;SERP1;TSPYL2;PPP2R5B;PDIA6;SRPRB;GSK3A;DNAJC3;LMNA;FKBP14;CUL7;CXXC1;TATDN2;KLHDC3;SEC31A
gsea,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.46184914471000227,-1.350538051131258,0.10176125244618395,0.11606342461120188,1.0,3/16,6.98%,TERF1;PCNA;POLD4
gsea,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.35869000104011467,-1.3503737096269472,0.07874015748031496,0.11600009150623992,1.0,21/42,33.07%,UBB;RPS27A;CDKN1B;UBA52;UBC;ELMO2;STAT3;CDK4;ERBB3;HRAS;KHDRBS1;AKT1;PXDN;BCAR1;CCNE1;PTPN1;NRAS;ARHGAP35;HIF1A;GPNMB;NRG2
gsea,TRP Channels R-HSA-3295583,0.4515802455590918,1.349562601691453,0.11182795698924732,0.26578435750216345,1.0,2/16,1.16%,TRPM3;TRPC6
gsea,RHOB GTPase Cycle R-HSA-9013026,-0.33777115275376135,-1.3493006353936239,0.08536585365853659,0.11651094092128718,1.0,20/61,23.18%,RHOB;ARHGAP5;ARHGEF25;ERBIN;ROCK2;ARHGAP21;PKN2;PIK3R1;TFRC;ARHGEF12;SOWAHC;SLK;ARHGEF2;MYO9A;OPHN1;ARHGAP26;VAMP3;ARHGEF1;VAV2;PRPF38B
gsea,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.40206660091612434,-1.3490871284747192,0.11134903640256959,0.11652394302583634,1.0,14/26,36.60%,RAN;SUMO1;SEC13;UBE2I;SEH1L;NUP205;NUP62;NUP107;NUP133;KPNB1;NUP85;RANGAP1;NUP54;POM121
gsea,WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.4658149565316266,-1.3488328059513786,0.11214953271028037,0.11652014289240109,1.0,9/16,38.40%,VPS29;VPS35;SNX3;VPS26A;WNT5B;PORCN;WNT9A;TMED5;WNT16
gsea,TBC/RABGAPs R-HSA-8854214,-0.3589636377666495,-1.347058434229881,0.09784735812133072,0.11747567958278131,1.0,18/40,35.98%,GABARAPL2;RAB6B;RAB6A;GABARAP;MAP1LC3B;RAB11A;RABGAP1;RAB5B;TBC1D20;RAB35;TBC1D15;GGA2;TBC1D10B;RAB5A;RAB33A;TBC1D14;RAB33B;TSC2
gsea,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.42371715514484654,-1.3464596080971836,0.14122137404580154,0.11773824084347016,1.0,8/20,23.75%,ATAD1;PEX12;GDAP1;ABCD2;FIS1;SLC25A17;PXMP4;PEX13
gsea,Integrin Cell Surface Interactions R-HSA-216083,-0.3502016624259204,-1.3453471491371458,0.08224299065420561,0.118257817838913,1.0,7/46,7.02%,ICAM5;BSG;CD47;ITGA2;VTN;ITGA7;ITGA11
gsea,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.41349428983920056,-1.3452865566604315,0.0865979381443299,0.11814931360786297,1.0,6/22,14.67%,HSP90AA1;ERBIN;PIK3R1;CDC37;ERBB3;HRAS
gsea,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.44352606340706235,-1.3450336900759914,0.10416666666666667,0.11817198618403506,1.0,3/18,6.98%,TERF1;PCNA;POLD4
gsea,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.3619741225032465,-1.3434906067985055,0.09523809523809523,0.1190146035057737,1.0,22/43,45.35%,HDGF;DNAJB11;MYDGF;DCTN1;SSR1;DNAJB9;TLN1;ATP6V0D1;SERP1;TSPYL2;PPP2R5B;PDIA6;SRPRB;GSK3A;DNAJC3;LMNA;FKBP14;CUL7;CXXC1;TATDN2;KLHDC3;SEC31A
gsea,NOD1/2 Signaling Pathway R-HSA-168638,-0.40291800950838713,-1.339626200675185,0.09922178988326848,0.12143357705938683,1.0,10/27,31.46%,UBE2N;UBE2V1;AAMP;IRAK1;CYLD;BIRC2;TAB2;IKBKG;IRAK2;CASP9
gsea,Syndecan Interactions R-HSA-3000170,-0.4656184662933236,-1.3393568051537634,0.1324376199616123,0.12145902493685011,1.0,7/16,30.48%,ITGA2;VTN;FGF13;SDC2;TRAPPC4;ITGB1;SDC3
gsea,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.44343751555566724,-1.3343296989216589,0.11787819253438114,0.12463569519834308,1.0,9/17,35.73%,PPP2R1A;PPP2CA;ORC4;TFDP2;RB1;ORC6;MCM8;ORC5;PRIM1
gsea,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,-0.44550838695270867,-1.3286238553463787,0.12603305785123967,0.12844496185493387,1.0,10/17,34.07%,GRIA2;HDAC2;GPRIN1;RNMT;CREB1;FKBP5;PTPN1;MECP2;NOTCH1;PTPN4
gsea,Nuclear Envelope Breakdown R-HSA-2980766,-0.34251709910081274,-1.3246828669241146,0.08349146110056926,0.13103295755060682,1.0,20/46,36.60%,BANF1;TPR;NEK9;SEC13;EMD;NUP88;PRKCB;NUP50;CTDNEP1;SEH1L;NUP205;NUP62;NUP107;VRK1;CNEP1R1;NUP133;TMPO;NUP85;NUP54;POM121
gsea,RHOU GTPase Cycle R-HSA-9013420,-0.3567339092579724,-1.3226210941676597,0.10272536687631027,0.13228175727746228,1.0,10/36,18.32%,PTK2B;CDC42;PKN2;PIK3R1;TXNL1;NCK1;STAM;CLTC;STAM2;USP9X
gsea,Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.42832578208994915,-1.322378140417687,0.12127236580516898,0.132245989199322,1.0,8/20,24.82%,PABPN1;CPSF6;CPSF2;PCF11;CSTF2T;FIP1L1;NCBP2;CPSF1
gsea,Meiotic Recombination R-HSA-912446,-0.38072508924793064,-1.3199329282190186,0.09981515711645102,0.1337229144826289,1.0,14/31,41.34%,H2AZ1;H2AJ;H2BC4;H2AX;CDK4;MLH3;BRCA2;MSH4;TOP3A;RPA3;MLH1;RAD50;RBBP8;H2BC21
gsea,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.3497405597038791,1.318968620416588,0.1134453781512605,0.301102869990951,1.0,15/44,13.03%,GPC6;EXT1;GPC3;GPC5;NAGLU;B3GAT2;HPSE2;XYLT2;HS3ST4;SGSH;HS6ST3;HS3ST2;NDST3;B3GAT1;HS6ST2
gsea,RUNX2 Regulates Bone Development R-HSA-8941326,-0.41781907506158755,-1.3185634615478632,0.13619402985074627,0.13455466738558217,1.0,8/21,26.72%,MAPK1;MAPK3;HEY1;CBFB;SMAD1;RB1;SMAD4;GLI3
gsea,Platelet Homeostasis R-HSA-418346,-0.3210948447935302,-1.3181521771547022,0.09504950495049505,0.1347085303303975,1.0,19/70,17.38%,CALM1;GNAS;ATP2B1;GNB2;ORAI2;GNG2;SLC8A2;PPP2R1A;PPP2CA;PPP2R5D;ITPR1;GNG10;GNG3;GNB1;GNG13;GNG11;GNG7;PPP2R5E;STIM1
gsea,Cholesterol Biosynthesis R-HSA-191273,-0.4026486395162016,-1.3075975156682045,0.13307240704500978,0.14220852225315267,1.0,12/23,39.45%,HMGCS1;FDPS;HMGCR;SQLE;PLPP6;PMVK;GGPS1;SC5D;TM7SF2;MSMO1;SREBF2;IDI1
gsea,Inflammasomes R-HSA-622312,-0.4546184393140511,-1.3057714652185852,0.15922330097087378,0.143426458695025,1.0,5/16,24.06%,HSP90AB1;NFKB2;SUGT1;BCL2L1;TXN2
gsea,Visual Phototransduction R-HSA-2187338,-0.32552564232671105,-1.3026690071996894,0.09057301293900184,0.14555054077156512,1.0,9/57,13.48%,CALM1;APOE;NMT1;RIMBP2;RNF7;C1D;GNB1;NAPEPLD;STRA6
gsea,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.3652316374209444,-1.301427117339282,0.12450592885375494,0.1463292467872552,1.0,16/31,36.60%,TPR;SEC13;PBRM1;NUP88;NUP50;SEH1L;GNL3;NUP205;NUP62;NUP107;NUP133;KPNB1;KPNA1;NUP85;NUP54;POM121
gsea,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.44617731266306243,-1.2986906029144094,0.1596958174904943,0.14820409030069837,1.0,5/16,15.86%,TBK1;NKIRAS1;NFKB2;NFKBIA;IRF3
gsea,SLC-mediated Transmembrane Transport R-HSA-425407,-0.27001253730590635,-1.2920129738406751,0.048598130841121495,0.15325955761667928,1.0,51/155,32.86%,CALM1;SLC25A4;SLC15A2;BSG;SLC25A5;SLC38A2;SLC4A4;SLC1A3;SLC4A10;SLC8A2;SLC35A1;ARL2BP;SLCO1C1;SLC17A7;PDZD11;SLC39A3;SLC12A6;ARL2;SLC16A10;APOD;SLC24A4;SLC38A1;SLC39A6;SLC2A9;SLC30A6;SLC41A1;SLC1A2;SLC43A2;SLC30A1;SRI;SLC16A1;SLC9A5;SLC9A9;SLC39A7;SLC38A5;SLC4A8;SLC18A2;SLC22A5;SLC6A15;SLC4A7;SLC50A1;SLC3A1;SLC32A1;SLC25A18;AHCYL2;SLC36A4;SLC33A1;SLC22A15;SLC25A22;SLC27A1;SLC26A7
gsea,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.37193561684910403,-1.2887731895664984,0.13696060037523453,0.15552316716943987,1.0,16/29,45.72%,ACSL3;TECR;HSD17B8;HACD4;ACLY;FASN;PPT1;ACSL6;ELOVL4;ELOVL7;ELOVL5;HACD2;HSD17B12;HACD3;ELOVL2;ACSL5
gsea,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.36701124612434477,-1.286606837239221,0.12773722627737227,0.15706567866838614,1.0,13/30,34.79%,ACOT13;NDUFAB1;DBI;MCEE;ACOT11;ACOT12;ACBD6;HADHB;MMUT;ECI1;ACOT1;THEM4;ACOT9
gsea,Neurexins And Neuroligins R-HSA-6794361,0.3328527797078632,1.2851336890093872,0.1392931392931393,0.345758237936989,1.0,14/54,6.74%,NLGN1;DLGAP2;NRXN1;GRM5;GRIN2B;NRXN3;LRRTM3;EPB41L3;LIN7A;APBA1;SHANK1;DLGAP3;SHANK3;HOMER1
gsea,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,-0.380233129301035,-1.2835149940730441,0.15087040618955513,0.15939760805582373,1.0,7/25,24.67%,CHST1;B4GALT6;B4GAT1;CHST2;B4GALT2;B4GALT4;OGN
gsea,Extension Of Telomeres R-HSA-180786,-0.33939640561280643,-1.2794444322221428,0.11764705882352941,0.16262253069483615,1.0,14/45,31.41%,NOP10;TERF1;PCNA;POLD4;GAR1;RFC3;FEN1;DKC1;NHP2;PPP6C;CHTF18;ANKRD28;POLD2;RPA3
gsea,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.34369796481791637,-1.2787897172713671,0.1282051282051282,0.16298870784559874,1.0,14/38,25.33%,TPR;SEC13;CPSF2;NUP88;NUP50;SEH1L;ALYREF;FIP1L1;NUP205;NCBP2;NUP62;NXF1;CPSF1;NUP107
gsea,Signaling By PDGFR In Disease R-HSA-9671555,-0.41853372287143914,-1.2783907828617442,0.1550695825049702,0.16305816853360205,1.0,7/18,33.25%,STAT3;PIK3R1;HRAS;FIP1L1;STRN;NRAS;PIK3CB
gsea,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.4130395390305788,-1.2778703445204609,0.1524390243902439,0.1632590086562506,1.0,10/19,37.88%,UBE2S;UBE2D1;ANAPC16;ANAPC11;UBE2E1;RB1;FZR1;ANAPC1;ANAPC4;CDC26
gsea,RNA Polymerase III Transcription Initiation R-HSA-76046,-0.36269305071942937,-1.27637062949819,0.14772727272727273,0.16438367610786828,1.0,12/34,24.98%,POLR2L;BDP1;SNAPC5;POLR3D;SNAPC2;POLR2F;POLR2E;POLR1D;GTF3C6;TBP;SNAPC3;POLR3H
gsea,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.3059886715175799,-1.2738788436775554,0.10337972166998012,0.1663389043809143,1.0,33/70,37.44%,POLR2G;TAF11;POLR2C;POLR2L;GTF2A1;GTF2B;SNAPC5;CDK9;PCF11;POLR2I;SNAPC2;SSU72;POLR2F;POLR2E;GTF2F1;TBP;PHAX;NCBP2;CCNT1;SNAPC3;GTF2F2;GTF2A2;INTS13;CDK7;POLR2J;POLR2B;CCNT2;POLR2K;TAF9;POLR2D;GTF2E1;INTS6;ICE1
gsea,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.3557080718308789,-1.2705945352707304,0.12955465587044535,0.1688732444298721,1.0,12/32,25.33%,TPR;SEC13;NUP88;SLBP;NUP50;SEH1L;ALYREF;NUP205;NCBP2;NUP62;NXF1;NUP107
gsea,NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.3452035513229035,-1.2690248315728936,0.1342685370741483,0.1700693189376414,1.0,21/37,43.11%,PABPN1;TPR;SEC13;NUP88;NUP50;SEH1L;GNL3;NUP205;NUP62;NUP107;NUP133;KPNA3;KPNB1;KPNA1;NUP85;NUP54;POM121;CPSF4;EIF2AK2;KPNA4;ISG15
gsea,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.38178613748486273,-1.2628246738824622,0.14531548757170173,0.17545955763644897,1.0,7/23,19.60%,PIK3R1;FGFR1;FLRT3;HRAS;FGF13;FGF9;PTPN11
gsea,RNA Polymerase III Transcription Termination R-HSA-73980,-0.413315319399327,-1.2626596739836418,0.17063492063492064,0.1754028701996312,1.0,7/21,18.99%,SSB;NFIX;POLR2L;POLR3D;POLR2F;POLR2E;POLR1D
gsea,Olfactory Signaling Pathway R-HSA-381753,0.4125190956093379,1.262439532861615,0.16056910569105692,0.37398235484117875,1.0,8/17,12.99%,ADCY8;ANO2;OR4K5;LDB2;RTP2;OR52B2;OR10H5;EBF1
gsea,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.29915846258737566,-1.26205336202942,0.1124031007751938,0.17569864586836975,1.0,32/78,36.50%,CALM1;SLC15A2;SLC38A2;SLC4A4;SLC1A3;SLC4A10;SLC8A2;SLC17A7;SLC12A6;SLC16A10;SLC24A4;SLC38A1;SLC1A2;SLC43A2;SRI;SLC9A5;SLC9A9;SLC38A5;SLC4A8;SLC6A15;SLC4A7;SLC3A1;SLC32A1;SLC25A18;AHCYL2;SLC36A4;SLC25A22;SLC26A7;SLC25A26;SLC26A2;SLC24A5;SLC36A1
gsea,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,-0.3921768649747175,-1.2610909657167813,0.16194331983805668,0.17635013610160327,1.0,5/23,8.34%,NEFL;CAMK2B;LIN7C;CAMK2A;LIN7B
gsea,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.3486123043723117,-1.2610736116169399,0.13114754098360656,0.17613965040131588,1.0,18/38,39.63%,PCNA;POLD4;TDG;RFC3;PARP2;PARP1;ADPRS;POLE3;POLG2;FEN1;APEX1;POLD2;RPA3;NTHL1;RFC2;OGG1;MPG;PARG
gsea,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.34249390556402654,-1.2593377824230412,0.14979757085020243,0.1774271659193239,1.0,12/41,26.79%,H2AZ1;H2AJ;TNRC6A;PRMT1;H2BC4;H2AX;CBFB;SETD1B;KMT2C;PRMT6;MYL9;TNRC6B
gsea,Voltage Gated Potassium Channels R-HSA-1296072,-0.34858705185110533,-1.2549468499216183,0.1527777777777778,0.1812292190883862,1.0,8/37,12.32%,KCNA1;KCND2;KCNA2;KCNC3;KCNQ3;KCNB1;KCNAB2;KCNF1
gsea,HS-GAG Degradation R-HSA-2024096,0.42366484105386937,1.2528302662524173,0.16913319238900634,0.3789905440061327,1.0,6/17,8.14%,GPC6;GPC3;GPC5;NAGLU;HPSE2;SGSH
gsea,Miscellaneous Transport And Binding Events R-HSA-5223345,-0.40386850331205876,-1.2521817960339652,0.16795366795366795,0.18347805666478514,1.0,11/19,42.28%,ADD2;NIPA1;ADD3;NIPAL3;TUSC3;LRRC8B;NIPA2;MMGT1;LRRC8A;SLC66A1;MRS2
gsea,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.3987300765780572,-1.2520900447816794,0.18052738336713997,0.18332109305116578,1.0,7/21,23.18%,MAMLD1;SNW1;WWC1;HEY1;MAML2;FABP7;CREBBP
gsea,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.4007973289514949,-1.2500295073842118,0.192,0.18500385160092903,1.0,5/18,14.67%,HSP90AA1;ERBIN;CDC37;ERBB3;HRAS
gsea,Synthesis Of PA R-HSA-1483166,-0.37370228229990554,-1.249152422874474,0.17165668662674652,0.18558157313245313,1.0,6/25,17.82%,GPD2;DDHD2;GPD1;MIGA1;GPD1L;AGPAT3
gsea,G1/S-Specific Transcription R-HSA-69205,-0.3865618466514085,-1.2474508932382173,0.189453125,0.1869429148618865,1.0,13/23,46.18%,PCNA;TFDP2;DHFR;E2F4;TYMS;CCNE1;E2F6;HDAC1;RBBP4;LIN54;SLC25A15;CDC45;RBL2
gsea,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.40207428657243927,-1.246831478046222,0.16865079365079366,0.18729086145432952,1.0,12/19,39.94%,GOT2;ADO;TXN2;MRI1;CDO1;ENOPH1;ETHE1;MPST;MTRR;APIP;VSIG2;AHCY
gsea,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,-0.4309803110394751,-1.2443498311368,0.20233463035019456,0.1893260448903199,1.0,4/15,14.49%,SUMO1;RING1;UBE2I;CBX8
gsea,DNA Strand Elongation R-HSA-69190,-0.360430573754968,-1.243524699425609,0.170873786407767,0.18980770032414276,1.0,7/31,14.49%,GINS2;PCNA;POLD4;GINS4;MCM6;MCM3;RFC3
gsea,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.33856839850290277,-1.2435085602931255,0.16477272727272727,0.1895880289209881,1.0,6/36,12.63%,H2AZ1;H2AJ;CDC73;H2BC4;H2AX;TLE1
gsea,Fatty Acid Metabolism R-HSA-8978868,-0.2734306907112332,-1.2427250608260005,0.09854014598540146,0.19010190846584452,1.0,61/123,46.41%,PTGDS;ACSL3;GPX4;TECR;PTGES3;ACOT13;HSD17B8;NDUFAB1;ACOX1;CBR1;DBI;HACD4;MCEE;PON2;ACLY;ACOT11;NUDT19;ACOT12;THRSP;ACOT8;SLC25A17;ALOX5AP;ACBD6;FASN;HADHB;MMUT;PPT1;MID1IP1;SLC22A5;ECI1;PTGS2;ACOT1;ACSL6;ABCD1;CROT;PRXL2B;PTGR1;FA2H;THEM4;ACOT9;EHHADH;ELOVL4;ELOVL7;PHYH;PRKAB2;DECR1;ELOVL5;HACD2;HSD17B12;TBXAS1;GPX1;ECHS1;HACD3;ELOVL2;ACADS;ACOT4;PCCA;PTGES2;ACSL5;PTGR2;HSD17B4
gsea,Inositol Phosphate Metabolism R-HSA-1483249,-0.3261233155383215,-1.2403218887106127,0.1702127659574468,0.1920630354282337,1.0,20/44,35.46%,CALM1;NUDT3;INPP4B;MTMR9;PTEN;NUDT11;ITPK1;IMPA1;PLCB1;MINPP1;IP6K2;IMPA2;NUDT10;SYNJ1;ISYNA1;ITPKB;INPP1;ITPKA;INPP5A;NUDT4
gsea,RHOC GTPase Cycle R-HSA-9013106,-0.30591003754599433,-1.2391709521512368,0.15841584158415842,0.19292477837108044,1.0,19/65,22.03%,ARHGDIA;ARHGAP5;ARHGEF25;ERBIN;ROCK2;ARHGAP21;PKN2;PIK3R1;TFRC;ARHGEF12;MACO1;SLK;OPHN1;ARHGAP26;C1QBP;VAMP3;ARHGEF1;LMAN1;VAV2
gsea,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.3625657349637262,-1.2373709704500597,0.14575645756457564,0.19433551742458785,1.0,13/30,39.68%,SEM1;ATRIP;RFC3;BRCA2;TOP3A;RPA3;KAT5;RAD17;RFC2;RAD9A;RAD50;RBBP8;RAD9B
gsea,Insulin Processing R-HSA-264876,-0.37573727676414115,-1.2345265529563396,0.18163672654690619,0.19682800913115536,1.0,8/24,23.49%,VAMP2;CPE;KIF5B;SLC30A6;EXOC8;EXOC3;EXOC5;KIF5C
gsea,Myogenesis R-HSA-525793,-0.37121522804163515,-1.234464932724552,0.16666666666666666,0.19663043602753374,1.0,8/25,19.96%,MEF2A;TCF12;CDC42;MEF2C;BNIP2;SPAG9;CDH15;CTNNB1
gsea,RNA Polymerase III Chain Elongation R-HSA-73780,-0.4187971083829778,-1.227243217080525,0.22030651340996169,0.203544720106828,1.0,8/17,33.64%,POLR2L;POLR3D;POLR2F;POLR2E;POLR1D;POLR3H;POLR3A;POLR2K
gsea,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.3555258549902513,-1.2232785539793516,0.18979591836734694,0.20712267172797102,1.0,18/28,45.88%,RRAGA;LAMTOR3;LAMTOR2;RRAGD;RHEB;PPM1A;CAB39;RRAGC;MLST8;TSC2;STRADA;LAMTOR4;PRKAB2;STK11;LAMTOR1;RRAGB;SLC38A9;LAMTOR5
gsea,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.40278866944102687,-1.220150700984209,0.20795660036166366,0.20988365593514657,1.0,8/17,36.25%,PIGP;PIGN;PIGM;PIGH;PIGB;PIGC;DPM2;PIGG
gsea,Transcriptional Regulation By E2F6 R-HSA-8953750,-0.3444895670558944,-1.2128646206166107,0.18304431599229287,0.21710806576602135,1.0,22/31,53.89%,CBX3;RBBP7;CBX5;RING1;TFDP2;MAX;L3MBTL2;PHC3;E2F6;PCGF2;RBBP4;CDC7;RBBP8;RYBP;YAF2;UXT;TFDP1;PCGF6;CHEK1;BRCA1;EHMT2;SUZ12
gsea,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.34047002358506845,-1.2101683883369037,0.17153284671532848,0.2196947658023582,1.0,15/35,39.68%,SEM1;ATRIP;RFC3;BRCA2;RAD51D;TOP3A;RPA3;KAT5;XRCC2;RAD17;RFC2;RAD9A;RAD50;RBBP8;RAD9B
gsea,Processing Of SMDT1 R-HSA-8949664,-0.4040629783365125,-1.2065158011838881,0.2309197651663405,0.22327577272893537,1.0,6/15,24.72%,SMDT1;PHB2;MICU3;PMPCA;PMPCB;STOML2
gsea,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.36894392067192566,-1.2044727018630237,0.20758483033932135,0.22515962168731862,1.0,10/26,28.80%,POLR2L;BDP1;POLR3D;POLR2F;POLR2E;POLR1D;GTF3C6;TBP;POLR3H;POLR3A
gsea,RAC1 GTPase Cycle R-HSA-9013149,-0.25519341298227244,-1.201452669493811,0.12571428571428572,0.22789764192934167,1.0,31/150,18.45%,WIPF3;WASF1;ABI1;ARHGDIA;WASL;ARHGAP5;ARHGEF25;KTN1;BRK1;NCKAP1;ERBIN;CYFIP2;CDC42;GARRE1;ARHGAP21;IQGAP2;ARHGEF4;EMD;PKN2;NISCH;PIK3R1;TFRC;ARHGAP20;BAIAP2;SPATA13;OPHN1;ARHGAP26;SOS2;NCF2;VAMP3;TIAM1
gsea,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.34141649736092783,-1.2005498217647574,0.21442885771543085,0.2285865264939873,1.0,5/29,6.62%,APOE;STMN1;APH1A;NCOR1;PSENEN
gsea,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.37751976356374617,-1.1948440209812177,0.21455223880597016,0.23438717129861084,1.0,9/21,31.41%,PCNA;POLD4;RFC3;POLE3;POLG2;FEN1;APEX1;POLD2;RPA3
gsea,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.40596326991599974,-1.1941505194293949,0.23658051689860835,0.23488796656890282,1.0,12/15,56.10%,PCNA;TFDP2;MAX;E2F4;HDAC1;RBBP4;LIN54;RBL2;TFDP1;LIN37;E2F5;LIN9
gsea,Cell-Cell Communication R-HSA-1500931,0.2698923915566205,1.1932760827919253,0.15257731958762888,0.4876860332611931,1.0,19/94,9.23%,CDH10;CADM1;CDH13;KIRREL3;SDK2;ACTN2;NECTIN1;CDH2;PATJ;NECTIN3;CDH12;DST;FLNA;SKAP2;CASK;CDH9;LAMB3;RSU1;CDH4
gsea,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.38102803690460263,1.1896441946180525,0.2248995983935743,0.4798986039270233,1.0,5/19,6.95%,PTPRD;IL1RAPL2;PTPRS;NTRK3;PTPRF
gsea,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.3582564895036262,-1.1863191461675544,0.23333333333333334,0.24312515032470136,1.0,10/27,28.80%,POLR2L;BDP1;POLR3D;POLR2F;POLR2E;POLR1D;GTF3C6;TBP;POLR3H;POLR3A
gsea,Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.3928366498511904,-1.1853814483754241,0.2359081419624217,0.2438870429687377,1.0,3/16,14.67%,GOLGB1;PIK3R1;HRAS
gsea,FCERI Mediated MAPK Activation R-HSA-2871796,-0.3570888527065861,-1.184621358736902,0.22988505747126436,0.24440321069529367,1.0,6/24,15.71%,JUN;MAPK1;MAPK3;PKN2;HRAS;MAPK9
gsea,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.2989027712020697,1.1841608658018272,0.21108742004264391,0.47617378389020276,1.0,13/52,10.57%,NEGR1;NTM;CNTN5;CNTN4;LSAMP;ALPL;OTOA;RTN4RL1;MELTF;PIGO;NTNG2;GPLD1;LYPD6B
gsea,RHOV GTPase Cycle R-HSA-9013424,-0.3331831961043841,-1.1816989177576676,0.2165991902834008,0.24732786377171784,1.0,9/33,18.32%,WASL;CDC42;PKN2;PIK3R1;TXNL1;NCK1;CLTC;MYO9A;USP9X
gsea,Effects Of PIP2 Hydrolysis R-HSA-114508,-0.35630849082408583,-1.1812889286858348,0.24524714828897337,0.24751426170069388,1.0,9/26,24.37%,RASGRP1;DGKH;DAGLA;ITPR1;ABHD12;MGLL;DGKI;DGKD;DGKE
gsea,Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.3351401815411687,-1.1804673258031486,0.21560574948665298,0.24816217811151384,1.0,15/31,36.60%,TPR;SEC13;NUP88;NUP50;SEH1L;ALYREF;NUP205;NCBP2;NUP62;NXF1;NUP107;NUP133;NUP85;NUP54;POM121
gsea,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.3739031945304644,-1.1803034864430852,0.2471264367816092,0.2480278642918824,1.0,15/20,51.81%,ACSL3;TECR;HACD4;ACSL6;ELOVL4;ELOVL7;ELOVL5;HACD2;HSD17B12;HACD3;ELOVL2;ACSL5;ACSBG1;ACSL4;ACSL1
gsea,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,-0.40838550302055193,-1.179209143771881,0.2391304347826087,0.24894664694367452,1.0,12/16,50.34%,INPP4B;PIK3C2A;INPP5F;PI4K2B;PIK3C3;MTMR4;FIG4;MTMR2;PIKFYVE;MTM1;PI4K2A;INPP4A
gsea,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.3392461330190132,1.1773899517195954,0.23404255319148937,0.4753311376038757,1.0,5/30,3.99%,GPC6;EXT1;GPC3;GPC5;HEXB
gsea,Signaling By ALK R-HSA-201556,-0.362819794098742,-1.1719052494566926,0.2254335260115607,0.2570384683978618,1.0,10/23,40.84%,HDAC2;STAT3;PIK3R1;PTN;IRS1;HIF1A;PIK3CB;MYCN;HDAC1;EP300
gsea,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.328748461298063,-1.170096716388756,0.2058287795992714,0.2589292549161157,1.0,15/36,39.68%,SEM1;ATRIP;RFC3;BRCA2;RAD51D;TOP3A;RPA3;KAT5;XRCC2;RAD17;RFC2;RAD9A;RAD50;RBBP8;RAD9B
gsea,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.4037788742698839,-1.1695598565326366,0.252465483234714,0.2593377739350999,1.0,11/15,47.27%,ARF3;PIK3C2A;INPP5E;SACM1L;PI4K2B;PIK3C3;FIG4;PI4KB;OCRL;PIKFYVE;PI4K2A
gsea,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.33558254942114596,-1.1649470380423885,0.2404040404040404,0.26453424772869505,1.0,13/28,36.60%,TPR;SEC13;NUP88;NUP50;SEH1L;NUP205;NUP62;MAP4K5;NUP107;NUP133;NUP85;NUP54;POM121
gsea,IRS-mediated Signaling R-HSA-112399,-0.3229998805894719,-1.1594586065482944,0.2529182879377432,0.27059776130660235,1.0,16/35,34.59%,PIK3R1;FGFR1;HRAS;FGFR3;FGFR2;FGF13;FGF9;PTPN11;NRAS;IRS1;FGF16;IRS2;PDPK1;PIK3CB;PIK3C3;THEM4
gsea,Diseases Of DNA Repair R-HSA-9675135,-0.3073318066558918,-1.1558135088626822,0.24319419237749546,0.2748013816352196,1.0,19/45,39.68%,SEM1;ATRIP;RFC3;BRCA2;MSH2;RAD51D;TOP3A;RPA3;KAT5;XRCC2;RAD17;MLH1;NTHL1;RFC2;RAD9A;RAD50;RBBP8;OGG1;RAD9B
gsea,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.2532731798861919,-1.154047700013385,0.18196994991652754,0.2766340036119355,1.0,20/127,15.38%,PLPPR4;P2RY14;CX3CL1;CHRM1;NPY1R;S1PR1;CHGA;CNOT6;MC4R;P2RY12;CXCR6;NPY5R;NPY;ADORA1;ADRB1;PLPPR5;TAC1;ADRA2C;ECE1;SSTR2
gsea,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.359032682957228,1.1520717756410341,0.24950884086444008,0.5162484818070098,1.0,5/22,5.43%,GPC6;GPC3;GPC5;B3GAT2;XYLT2
gsea,Nuclear Receptor Transcription Pathway R-HSA-383280,0.30307856427406177,1.1513419415223984,0.23695652173913043,0.5028301038157995,1.0,7/40,6.09%,THRB;NR2F1;NR3C2;RARB;PPARG;RORA;ESR1
gsea,Sphingolipid Metabolism R-HSA-428157,-0.26810339046166165,-1.147648221298639,0.2043222003929273,0.28415244359085656,1.0,26/74,35.57%,PRKD1;CSNK1G2;VAPA;CERS4;ARSA;ARSJ;PLPP3;ORMDL2;GBA2;SAMD8;KDSR;ORMDL3;UGCG;ASAH2;GLB1L;SMPD1;B3GALNT1;VAPB;DEGS1;GLTP;ACER3;FA2H;ALDH3B2;DEGS2;SPTLC2;ARSB
gsea,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.3939292197315041,1.1464553988711894,0.2874251497005988,0.4987532945820672,1.0,3/16,2.52%,GPC6;GPC3;GPC5
gsea,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.3593119629741337,-1.1450411035335524,0.2804642166344294,0.28715394524409926,1.0,4/23,14.49%,TERF1;PCNA;POLD4;RFC3
gsea,Arachidonic Acid Metabolism R-HSA-2142753,-0.3492175256798838,-1.1437000430183741,0.28875968992248063,0.2885878120667952,1.0,4/27,8.77%,PTGDS;GPX4;PTGES3;CBR1
gsea,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,-0.3864250995331116,-1.1321901295466705,0.3080082135523614,0.30237386704862335,1.0,3/17,8.50%,UBE2N;UBE2V1;IRAK1
gsea,SUMOylation Of Intracellular Receptors R-HSA-4090294,0.33572850804863935,1.1281843103827764,0.3,0.5245152469504124,1.0,6/23,6.09%,THRB;NR3C2;HDAC4;PPARG;RORA;ESR1
gsea,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.3637550387278502,-1.1258406027144687,0.30417495029821073,0.31046196934951426,1.0,9/19,37.88%,UBE2S;UBE2D1;ANAPC16;ANAPC11;UBE2E1;ANAPC1;BUB3;ANAPC4;CDC26
gsea,Interleukin-2 Family Signaling R-HSA-451927,-0.341720854697865,-1.124789768227554,0.2899628252788104,0.31141820322506947,1.0,6/26,17.73%,PTK2B;STAT3;PIK3R1;CLSTN1;HAVCR2;SOS2
gsea,Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.30008999081167376,-1.1208190714637594,0.26452905811623245,0.31630794463789236,1.0,16/40,34.83%,PRKD1;CSNK1G2;VAPA;CERS4;PLPP3;ORMDL2;SAMD8;KDSR;ORMDL3;VAPB;DEGS1;ACER3;FA2H;ALDH3B2;DEGS2;SPTLC2
gsea,CD28 Co-Stimulation R-HSA-389356,-0.33846746899856006,-1.1200177561444535,0.3008130081300813,0.31703407429636504,1.0,6/25,17.96%,AKT3;CDC42;PKN2;PIK3R1;RICTOR;AKT1
gsea,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.3086403291525934,-1.1187654472443438,0.27041742286751363,0.3183371989931,1.0,15/38,39.68%,SEM1;ATRIP;RFC3;BRCA2;RAD51D;TOP3A;RPA3;KAT5;XRCC2;RAD17;RFC2;RAD9A;RAD50;RBBP8;RAD9B
gsea,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,-0.3654978857421273,-1.117061685761182,0.32150313152400833,0.32032447764072935,1.0,8/17,33.44%,TNRC6A;CBFB;PTPN11;CCND3;PML;TNRC6B;AGO4;AGO3
gsea,Phosphorylation Of APC/C R-HSA-176412,-0.3735457477472636,-1.1148662816100834,0.32181425485961124,0.3228737700704734,1.0,8/17,37.88%,UBE2S;UBE2D1;ANAPC16;ANAPC11;UBE2E1;ANAPC1;ANAPC4;CDC26
gsea,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.2569150612692447,-1.113588760449775,0.2316831683168317,0.3242253350487135,1.0,34/93,35.09%,MOCS2;PANK3;PDXK;PARP4;GPHN;SLC25A16;PDZD11;PARP8;NAXD;GSTO1;MMACHC;MMADHC;DHFR;PARP16;NAXE;ALDH1L1;FASN;MMUT;NMNAT3;LMBRD1;TCN2;NADK2;PANK4;PTGS2;CYB5R3;PNPO;ENPP1;THTPA;RFK;MTHFD1L;PARP6;FLAD1;SLC52A2;PANK2
gsea,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.3801542125032741,1.1132787213495716,0.3223938223938224,0.5439244323610913,1.0,3/16,2.52%,GPC6;GPC3;GPC5
gsea,G0 And Early G1 R-HSA-1538133,-0.3495012160494242,-1.1131130259239563,0.29922779922779924,0.3245070886459172,1.0,12/20,51.49%,PCNA;TFDP2;MAX;E2F4;CCNE1;HDAC1;RBBP4;LIN54;RBL2;CCNE2;TFDP1;LIN37
gsea,Signal Transduction By L1 R-HSA-445144,-0.36543286943834985,-1.1104362224549875,0.3157894736842105,0.3277351504498887,1.0,7/19,26.09%,MAPK1;MAPK3;CSNK2B;FGFR1;MAP2K1;VAV2;ITGB1
gsea,Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.3394250400168139,-1.1097057020039447,0.30988593155893535,0.3284825436980713,1.0,5/23,20.40%,CYP7B1;STARD5;OSBPL3;NCOA1;ACOT8
gsea,RHOA GTPase Cycle R-HSA-8980692,-0.2434721726377805,-1.1097037459976873,0.26129666011787817,0.32810997707982614,1.0,46/125,32.95%,ARHGDIA;ATP6AP1;ARHGAP5;ARHGEF25;KTN1;ERBIN;EMC3;ROCK2;ARHGAP21;ARHGEF4;PKN2;PIK3R1;TFRC;ARHGEF12;ARHGAP20;MACO1;PGRMC2;SOWAHC;SLK;ARHGEF2;MYO9A;OPHN1;ARHGAP26;C1QBP;VAMP3;TIAM1;ARHGEF1;LMAN1;VAV2;HMOX2;CCDC115;PRPF38B;YKT6;ARHGAP39;ARHGAP24;TEX2;FAF2;ARHGAP10;ARHGAP35;MCF2L;RACGAP1;VAPB;ARHGAP23;FAM13A;RHPN1;TMPO
gsea,Laminin Interactions R-HSA-3000157,-0.3723788910205377,-1.10892399343805,0.32233009708737864,0.32876177250691324,1.0,2/17,6.38%,ITGA2;ITGA7
gsea,PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.26105147214822655,-1.1078690723516842,0.2799227799227799,0.3298807964886695,1.0,20/79,19.60%,CDKN1B;FOXO3;AKT3;GSK3B;PIK3R1;FGFR1;AKT1S1;PDGFA;RICTOR;PTEN;CLSTN1;ERBB3;FGFR3;FGFR2;AKT1;BAD;FGF13;FGF9;RNMT;PTPN11
gsea,RHOJ GTPase Cycle R-HSA-9013409,-0.30338947858405174,-1.1074929011111967,0.2874251497005988,0.3299951677622012,1.0,11/46,18.00%,WASL;ARHGAP5;CDC42;GJA1;ARHGAP21;PKN2;PIK3R1;TFRC;OPHN1;ARHGAP26;VAMP3
gsea,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.33841915216253304,-1.1007453967420708,0.3314176245210728,0.3388169650668472,1.0,8/22,28.33%,PIK3R1;HRAS;FGFR2;FGF13;FGF9;PTPN11;NRAS;FGF16
gsea,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.29819685590671324,-1.0950090781538715,0.3026315789473684,0.34588153466128047,1.0,16/38,34.59%,PIK3R1;FGFR1;HRAS;FGFR3;FGFR2;FGF13;FGF9;PTPN11;NRAS;IRS1;FGF16;IRS2;PDPK1;PIK3CB;PIK3C3;THEM4
gsea,IGF1R Signaling Cascade R-HSA-2428924,-0.29819685590671324,-1.0950090781538715,0.3026315789473684,0.34588153466128047,1.0,16/38,34.59%,PIK3R1;FGFR1;HRAS;FGFR3;FGFR2;FGF13;FGF9;PTPN11;NRAS;IRS1;FGF16;IRS2;PDPK1;PIK3CB;PIK3C3;THEM4
gsea,Signaling By Retinoic Acid R-HSA-5362517,-0.3370233765771368,-1.0949960986234724,0.3224043715846995,0.34550249120049004,1.0,14/25,41.26%,DLAT;RDH14;RXRB;CYP26B1;LDHD;ALDH1A1;RARA;PDHA1;PDPK1;RDH11;DHRS3;PDHB;PDHX;DHRS4
gsea,Metabolism Of Nucleotides R-HSA-15869,-0.2558810823323546,-1.094372417860831,0.2981132075471698,0.3459773932712722,1.0,39/78,41.05%,GMPS;NME2;GUK1;ADK;APRT;PAICS;DTYMK;ITPA;NUDT5;NME4;NT5C;ADA;TXNRD1;SCO2;DPYD;ATIC;DCTPP1;TK2;TXN2;TYMS;IMPDH2;AMPD2;GSR;NUDT15;DUT;UCKL1;AK1;NUDT18;RRM2B;NT5C1A;ENTPD5;AMPD3;NUDT16;UCK1;DHODH;GMPR;CTPS2;ENTPD1;AK2
gsea,IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.3003748955871043,-1.0933690295915617,0.3173996175908222,0.34702978772018644,1.0,16/37,34.59%,PIK3R1;FGFR1;HRAS;FGFR3;FGFR2;FGF13;FGF9;PTPN11;NRAS;IRS1;FGF16;IRS2;PDPK1;PIK3CB;PIK3C3;THEM4
gsea,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.3248036366543636,-1.092473649768077,0.32558139534883723,0.3478927327063154,1.0,5/30,19.60%,YWHAZ;PIK3R1;CLSTN1;HCK;PTPN11
gsea,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.30687386221292423,1.091558463960719,0.3200883002207506,0.58060815182499,1.0,9/32,13.32%,COL5A2;COL11A1;COL4A4;DST;COL4A1;COL15A1;LAMB3;TLL1;COL5A1
gsea,RET Signaling R-HSA-8853659,0.31282680241351596,1.091176607572939,0.32669322709163345,0.5665293056576788,1.0,12/31,17.94%,SHC3;DOK5;SHANK3;GFRA1;GAB2;DOK2;PIK3R3;GFRA2;FRS2;RAP1GAP;PLCG1;GRB10
gsea,NCAM1 Interactions R-HSA-419037,0.32523122895831647,1.0899251195572297,0.32595573440643866,0.5553534241920124,1.0,5/25,5.50%,CACNA1C;CACNB2;COL4A4;CACNB4;COL4A1
gsea,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.3122316584353928,-1.0850435910771357,0.30925925925925923,0.35808008036681765,1.0,19/30,40.20%,APOE;RIMBP2;C1D;VKORC1;GPC1;TTPA;SDC2;RETSAT;VKORC1L1;LPL;SDC3;TTR;LRP12;AGRN;RDH11;LRP10;RBP1;UBIAD1;RBP4
gsea,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.3191238162928599,-1.0849673625021912,0.3169811320754717,0.35775424639352416,1.0,17/29,45.90%,ORC4;MCM6;ATRIP;MCM3;RFC3;ORC6;RPA3;MCM8;RAD17;ORC5;RFC2;RAD9A;CDC7;RAD9B;RFC4;SLC25A15;CDC45
gsea,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.319406803343504,-1.084440928509673,0.32899628252788105,0.3580930565122706,1.0,9/27,26.33%,RASGRP1;RAP1A;ADRA2C;AKT1;TLN1;BCAR1;FN1;PTK2;PTPN1
gsea,RHOQ GTPase Cycle R-HSA-9013406,-0.28133102800745674,-1.074878231145546,0.3531746031746032,0.3716437158535104,1.0,13/51,19.34%,WASL;ARHGAP5;CDC42;GJA1;ARHGAP21;PKN2;TFRC;ARHGEF9;OPHN1;ARHGAP26;VAMP3;TRIP10;GFOD1
gsea,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.3370372924162466,-1.0741410578493593,0.34579439252336447,0.37228561599880955,1.0,8/22,39.16%,SEM1;BRCA2;RAD51D;TOP3A;KAT5;XRCC2;RAD50;RBBP8
gsea,Sialic Acid Metabolism R-HSA-4085001,0.30235378751729325,1.0734763999560453,0.33820459290187893,0.579693201848503,1.0,3/31,3.28%,ST6GALNAC3;ST3GAL6;NPL
gsea,Transcriptional Regulation By VENTX R-HSA-8853884,-0.29188669519008226,-1.0681673251856951,0.3625,0.38085310153432883,1.0,14/34,33.44%,CEBPB;TNRC6A;UBE2S;UBE2D1;ANAPC16;CTNNB1;ANAPC11;UBE2E1;FZR1;TNRC6B;ANAPC1;AGO4;ANAPC4;AGO3
gsea,Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.3660934528935523,-1.0673174939365055,0.3481781376518219,0.381737408319604,1.0,9/15,42.07%,DPM3;DPM1;SRD5A3;GALT;GNE;DPM2;PMM2;DOLK;NUS1
gsea,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.24429234295512642,-1.0657487233346867,0.3262135922330097,0.3836275966477201,1.0,12/93,10.93%,CAPZA2;PRKAR1A;CBX5;CDC42;PRKAR1B;HDAC2;KIF5B;KIFAP3;JMJD1C;PRKACB;EHD3;CAPZB
gsea,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.34363095705516244,-1.0574994525946955,0.3856589147286822,0.3955040048821004,1.0,3/21,4.21%,NDUFA2;MAGED1;APPL1
gsea,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.32896733134202444,-1.0518196843187546,0.37474541751527496,0.4039315137736708,1.0,8/22,25.03%,FOXO3;HDAC2;NPY;SMAD2;SIRT3;FBXO32;SMAD3;SMAD4
gsea,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.3605151697727085,1.0481995136284141,0.39960629921259844,0.6256116627875885,1.0,3/16,2.52%,GPC6;GPC3;GPC5
gsea,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.30010608752005496,-1.0466391277652816,0.37218045112781956,0.41141225506566764,1.0,10/31,37.08%,TERF1;PCNA;POLD4;RFC3;FEN1;CHTF18;POLD2;RPA3;PRIM1;RFC2
gsea,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.36377252827214823,-1.043264846757921,0.42411642411642414,0.41619983197319654,1.0,4/15,15.13%,PINK1;FOXO3;NFYB;CITED2
gsea,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.3230043326980858,-1.0414342780584187,0.375,0.4185477111594134,1.0,5/23,20.63%,CYP7B1;VDAC2;MIA3;NCOA1;CYP26B1
gsea,CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.35860743723485605,-1.03966843390156,0.4007936507936508,0.42080548935717266,1.0,9/15,41.61%,PRKACB;PKN2;HRAS;CREBBP;NRAS;RPS6KA5;RELB;EP300;NFKB1
gsea,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.32397380147022736,-1.0384073782734606,0.392578125,0.42231028975881507,1.0,10/22,39.62%,CLOCK;CHD9;NCOA1;CREBBP;BHLHE41;NOCT;TBL1X;BHLHE40;NCOA6;TBL1XR1
gsea,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.3118673485872004,-1.034812776089852,0.39473684210526316,0.4275242245257478,1.0,1/24,0.02%,CALM1
gsea,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.33815982839272,-1.0344527381720245,0.37916666666666665,0.4276452306514451,1.0,9/18,37.88%,UBE2S;UBE2D1;ANAPC16;ANAPC11;UBE2E1;FZR1;ANAPC1;ANAPC4;CDC26
gsea,FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.3518946741466674,-1.0327852238602364,0.41776937618147447,0.4298270460020289,1.0,6/15,26.98%,FGFR1;HRAS;FGF13;FGF9;PTPN11;NRAS
gsea,Integrin Signaling R-HSA-354192,-0.31432270036554416,-1.0279498215518776,0.4191033138401559,0.4371128345579827,1.0,8/23,26.33%,RASGRP1;RAP1A;AKT1;TLN1;BCAR1;FN1;PTK2;PTPN1
gsea,PI3K Cascade R-HSA-109704,-0.2942635981817083,-1.0271135932394275,0.41420118343195267,0.4380013038284411,1.0,14/32,34.59%,PIK3R1;FGFR1;FGFR3;FGFR2;FGF13;FGF9;PTPN11;IRS1;FGF16;IRS2;PDPK1;PIK3CB;PIK3C3;THEM4
gsea,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,0.3425516365152395,1.0269171490025517,0.4407894736842105,0.6627879867460413,1.0,5/16,15.39%,KLKB1;F2R;SERPINE2;F8;PRTN3
gsea,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.2921124751481765,-1.0244894364658523,0.4149797570850202,0.4416191348933598,1.0,13/30,36.60%,TPR;NEK9;SEC13;NUP88;NUP50;SEH1L;NUP205;NUP62;NUP107;NUP133;NUP85;NUP54;POM121
gsea,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.32233899589915505,-1.0217730895271824,0.4329501915708812,0.44567163122840703,1.0,4/21,20.40%,CYP7B1;OSBPL3;NCOA1;ACOT8
gsea,Nicotinate Metabolism R-HSA-196807,-0.31837494612873746,-1.0183726958941084,0.4324853228962818,0.450761354021894,1.0,9/22,32.77%,PARP4;PARP8;NAXD;PARP16;NAXE;NMNAT3;NADK2;PTGS2;PARP6
gsea,Signaling By Erythropoietin R-HSA-9006335,-0.3200875265872786,-1.0171670411617777,0.4163424124513619,0.45219306354787564,1.0,4/20,14.67%,EPOR;PIK3R1;CLSTN1;HRAS
gsea,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.30088363677410324,-1.0165645814479727,0.42585551330798477,0.45268795090148345,1.0,11/26,29.59%,NME2;GUK1;DTYMK;NME4;TXNRD1;DCTPP1;TXN2;TYMS;GSR;DUT;AK1
gsea,Metal Ion SLC Transporters R-HSA-425410,-0.3195270869408815,-1.0117631253269406,0.41767068273092367,0.4602526886008873,1.0,6/20,24.28%,SLC39A3;SLC39A6;SLC30A6;SLC41A1;SLC30A1;SLC39A7
gsea,CRMPs In Sema3A Signaling R-HSA-399956,-0.35023751866573516,-0.9997000634890013,0.47334754797441364,0.4801390867614267,1.0,3/15,5.36%,CDK5R1;DPYSL2;GSK3B
gsea,tRNA Aminoacylation R-HSA-379724,-0.3015651884990518,-0.9991791769220426,0.4635108481262327,0.48049539386026197,1.0,14/26,44.21%,AIMP1;EEF1E1;LARS2;YARS2;MARS1;WARS2;WARS1;FARSB;AIMP2;PARS2;FARS2;EARS2;MARS2;PPA2
gsea,Processive Synthesis On Lagging Strand R-HSA-69183,-0.3429725047505002,-0.998546788354797,0.4330097087378641,0.4810990439205986,1.0,6/15,35.73%,PCNA;POLD4;FEN1;POLD2;RPA3;PRIM1
gsea,Regulation Of Beta-Cell Development R-HSA-186712,0.2973049724952932,0.9926535180271698,0.4731404958677686,0.73348838270282,1.0,11/24,14.50%,FGF10;PAX6;MAML3;RFX6;ONECUT1;AKT2;FOXO1;SLC2A2;KAT2A;RBPJ;HNF4G
gsea,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.24238246758811835,-0.9915660749059945,0.4662698412698413,0.49280421002364794,1.0,21/60,32.25%,SLC35A1;DPM3;NANP;FPGT;ST6GALNAC6;ST8SIA3;UAP1;CMAS;DPM1;FUOM;PMM1;GMPPB;GNPNAT1;ST6GALNAC4;SRD5A3;AMDHD2;ST6GALNAC5;ST8SIA1;GNE;ST6GAL1;NAGK
gsea,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,0.3291663226691873,0.9869743026589353,0.49075975359342916,0.7316428719140253,1.0,6/18,8.95%,HLCS;MCCC1;CUBN;AMN;MCCC2;CD320
gsea,VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.31934771691717423,-0.9823155859278673,0.45746691871455575,0.5080206595399678,1.0,7/18,32.45%,ARF4;RAB11A;EXOC8;EXOC3;EXOC5;EXOC1;EXOC2
gsea,Endogenous Sterols R-HSA-211976,-0.32829257612235674,-0.977196830055063,0.484629294755877,0.5162503726126816,1.0,5/17,31.03%,CYP7B1;MIA3;NCOA1;FDX2;CYP46A1
gsea,FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.3237921512678109,-0.9755952723320965,0.5066666666666667,0.5184702350921716,1.0,7/17,28.33%,HRAS;FGFR2;FGF13;FGF9;PTPN11;NRAS;FGF16
gsea,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.2592523587459889,0.9744208107788827,0.48717948717948717,0.7474571521788095,1.0,7/42,5.43%,GPC6;GPC3;GPC5;CHST9;HEXB;B3GAT2;XYLT2
gsea,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,-0.30116629924867705,-0.9735598802282948,0.4780952380952381,0.5214881931158626,1.0,8/24,39.16%,SEM1;BRCA2;RAD51D;TOP3A;KAT5;XRCC2;RAD50;RBBP8
gsea,Ephrin Signaling R-HSA-3928664,-0.3301949663453707,-0.9723300115378785,0.47195357833655704,0.5230649912742064,1.0,3/16,9.88%,SDCBP;EFNB3;PKN2
gsea,Lagging Strand Synthesis R-HSA-69186,-0.3098195668252884,-0.9721739938820766,0.4875239923224568,0.5227634043214905,1.0,8/20,37.08%,PCNA;POLD4;RFC3;FEN1;POLD2;RPA3;PRIM1;RFC2
gsea,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.24422274197575192,0.9685215626281827,0.5042553191489362,0.7462610397767845,1.0,10/53,11.57%,ERBB4;NRG1;FGF10;LCK;FLT3;ESR1;TRAT1;FGF7;GAB2;PIK3R3
gsea,Tie2 Signaling R-HSA-210993,-0.3183110073553556,-0.9592284618276768,0.4980392156862745,0.5452350391319555,1.0,6/15,33.25%,PIK3R1;HRAS;PTPN11;NRAS;ANGPT2;PIK3CB
gsea,Mismatch Repair R-HSA-5358508,-0.3296470523205487,-0.9567690372742691,0.5115830115830116,0.549023882166327,1.0,6/15,35.36%,PCNA;POLD4;MSH2;POLD2;RPA3;MLH1
gsea,DAP12 Interactions R-HSA-2172127,0.29981805160168595,0.9542430887160538,0.5171026156941649,0.7508288318903691,1.0,3/21,2.81%,PLCG2;VAV3;LCK
gsea,DAP12 Signaling R-HSA-2424491,0.29981805160168595,0.9542430887160538,0.5171026156941649,0.7508288318903691,1.0,3/21,2.81%,PLCG2;VAV3;LCK
gsea,HDMs Demethylate Histones R-HSA-3214842,-0.30309448753645063,-0.9514590599835551,0.5099601593625498,0.5578856037053207,1.0,11/19,39.78%,KDM4C;KDM7A;PHF2;KDM6B;KDM1A;KDM5A;JMJD6;KDM3B;KDM1B;KDM2A;KDM4D
gsea,Diseases Of Metabolism R-HSA-5668914,-0.1973366988820029,-0.9467798161371463,0.5882352941176471,0.5657513462160976,1.0,13/179,7.28%,UBB;PRNP;RPS27A;CYP7B1;LCT;B4GAT1;IDS;SEMA5A;DCXR;UBA52;APRT;DPM3;UBC
gsea,PI-3K cascade:FGFR2 R-HSA-5654695,-0.3212788173651238,-0.9428259618666105,0.546875,0.57208445849356,1.0,5/16,19.60%,PIK3R1;FGFR2;FGF13;FGF9;PTPN11
gsea,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.28327590633459154,-0.9427280694172112,0.5423076923076923,0.5716510212856895,1.0,9/25,38.91%,NDUFAB1;GOT2;DLAT;LDHD;PDHA1;LIPT1;PDHB;AMT;PDHX
gsea,Peptide Ligand-Binding Receptors R-HSA-375276,-0.2271758176113547,-0.9398837606056152,0.5798165137614679,0.5761333160344533,1.0,25/69,39.37%,CX3CL1;NPY1R;CNOT6;MC4R;CXCR6;NPY5R;NPY;TAC1;ECE1;SSTR2;HEBP1;PROKR2;SST;GPR37L1;CXCL12;CCL28;GPNMB;INSL5;PENK;NMUR1;PDYN;CCR5;KISS1R;XK;OPRL1
gsea,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.30615952220529064,-0.9371866214106174,0.5551102204408818,0.5803717564562036,1.0,6/17,24.47%,MAMLD1;SNW1;HEY1;MAML2;CREBBP;SMAD3
gsea,Notch-HLH Transcription Pathway R-HSA-350054,-0.27078778081672183,-0.9313492777842156,0.5535714285714286,0.5905381890657305,1.0,5/27,9.22%,MAMLD1;NCOR1;SNW1;HDAC2;HDAC8
gsea,Apoptotic Execution Phase R-HSA-75153,-0.2487401779234888,-0.9306929512238767,0.5700575815738963,0.5911265688384264,1.0,17/40,41.75%,HMGB1;DNM1L;PKN2;BIRC2;CTNNB1;FZR1;PTK2;VIM;GSN;DFFB;KPNB1;KPNA1;DSG2;DBNL;LMNA;ACIN1;FNTA
gsea,Signaling By NTRK2 (TRKB) R-HSA-9006115,-0.2923609875966757,-0.9303276619128499,0.548728813559322,0.5911553348205855,1.0,5/21,19.60%,CDK5R1;PIK3R1;HRAS;TIAM1;PTPN11
gsea,Nephrin Family Interactions R-HSA-373753,-0.299874007435898,-0.9298982307972664,0.5576131687242798,0.5913095267143489,1.0,4/20,11.44%,WASL;MAGI2;PIK3R1;NCK1
gsea,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.25386897584890933,-0.9273278342158985,0.5767716535433071,0.5953652195240867,1.0,19/39,46.89%,TRMT112;QTRT2;LAGE3;OSGEP;CTU1;TRMT6;TRIT1;TRMU;LCMT2;THG1L;METTL1;CDKAL1;URM1;WDR4;TRMT44;ADAT2;TYW5;PUS3;NSUN6
gsea,Regulation Of Signaling By CBL R-HSA-912631,-0.31587118521478175,-0.9266337222172758,0.5515873015873016,0.595963699315964,1.0,3/17,17.29%,PIK3R1;CLSTN1;HCK
gsea,Amine Ligand-Binding Receptors R-HSA-375280,0.28934986413424324,0.9226749272701869,0.5807770961145194,0.8129495351033521,1.0,4/22,6.68%,CHRM3;HRH2;HTR2C;HTR7
gsea,CDC42 GTPase Cycle R-HSA-9013148,-0.20115240714095817,-0.9172414331804877,0.6276803118908382,0.6122614725535062,1.0,23/127,18.45%,WIPF3;ARHGDIA;WASL;ARHGAP5;ARHGEF25;KTN1;CDC42;ARHGAP21;IQGAP2;ARHGEF4;PKN2;PIK3R1;TFRC;ARHGEF12;ARHGAP20;BAIAP2;ARHGEF9;SPATA13;KCTD3;OPHN1;ARHGAP26;VAMP3;TIAM1
gsea,Interaction Between L1 And Ankyrins R-HSA-445095,-0.28333942942435336,-0.9166605685729939,0.5793991416309013,0.6126380787076461,1.0,6/24,14.38%,SCN3B;SCN1B;SCN2B;SCN3A;KCNQ3;SCN2A
gsea,Plasma Lipoprotein Remodeling R-HSA-8963899,-0.30746393521143445,-0.9100445149462453,0.583793738489871,0.6241160288462462,1.0,9/17,34.55%,APOE;LCAT;P4HB;PLTP;LPL;ABCG1;TRNP1;ANGPTL3;MBTPS2
gsea,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.21205286339172869,-0.9053985916427056,0.6454720616570327,0.6319120451053634,1.0,26/74,35.97%,SLC35A1;DPM3;NANP;FPGT;ST6GALNAC6;ST8SIA3;UAP1;CMAS;DPM1;FUOM;ALG13;ALG2;PMM1;GMPPB;GNPNAT1;ST6GALNAC4;SRD5A3;AMDHD2;ST6GALNAC5;ST8SIA1;GNE;ST6GAL1;NAGK;DPM2;ALG11;ST6GAL2
gsea,Signaling By KIT In Disease R-HSA-9669938,-0.2967734889576169,-0.9047632652975678,0.5889328063241107,0.6324619414952788,1.0,3/18,14.67%,STAT3;PIK3R1;HRAS
gsea,NRAGE Signals Death Thru JNK R-HSA-193648,0.23508704097721864,0.9019447828720742,0.6352459016393442,0.8475253046604646,1.0,7/47,4.98%,TRIO;VAV3;PLEKHG5;KALRN;ITSN1;AKAP13;ARHGEF18
gsea,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.2642308869217108,-0.8989482504054054,0.6082089552238806,0.642272036663232,1.0,10/28,39.16%,SEM1;BRCA2;RAD51D;TOP3A;MUS81;KAT5;XRCC2;SPIDR;RAD50;RBBP8
gsea,NCAM Signaling For Neurite Out-Growth R-HSA-375165,-0.24238138049397492,-0.8984480398503395,0.5903361344537815,0.6425097648102741,1.0,17/43,33.52%,PRNP;MAPK1;MAPK3;FGFR1;CACNA1H;HRAS;CREB1;COL4A5;CACNA1G;CACNB3;SPTBN2;PTK2;NRAS;NCAM1;CNTN2;COL6A1;AGRN
gsea,Retinoid Metabolism And Transport R-HSA-975634,-0.2647283137639722,-0.8908477865546734,0.6186131386861314,0.6558505542478666,1.0,15/26,40.20%,APOE;RIMBP2;C1D;GPC1;SDC2;RETSAT;LPL;SDC3;TTR;LRP12;AGRN;RDH11;LRP10;RBP1;RBP4
gsea,Heme Signaling R-HSA-9707616,-0.24316473127206245,-0.889294486186765,0.6759776536312849,0.6580356273248237,1.0,18/39,42.96%,CLOCK;NCOR1;MEF2C;CHD9;NCOA1;CREB1;CREBBP;XPO1;NFE2L2;MAFK;TBL1X;CRTC2;LY96;NCOA6;TBL1XR1;EP300;NRIP1;MEF2D
gsea,Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.27994635378390126,-0.8824828624000864,0.6235059760956175,0.6696165741299797,1.0,13/21,46.21%,SLC38A2;SLC16A10;SLC38A1;SLC43A2;SLC38A5;SLC6A15;SLC3A1;SLC36A4;SLC36A1;SLC3A2;SLC7A3;SLC25A29;SLC7A2
gsea,Non-integrin membrane-ECM Interactions R-HSA-3000171,0.24808350391244552,0.8814593707074395,0.6708595387840671,0.8807127239943451,1.0,6/34,10.03%,DMD;NRXN1;LAMB1;CASK;LAMB3;DAG1
gsea,SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.3058526114622316,-0.8807667856941758,0.6325757575757576,0.6720277244261783,1.0,6/15,28.33%,HRAS;FGFR2;FGF13;FGF9;NRAS;FGF16
gsea,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.2948196439954212,-0.8680803384038092,0.6337448559670782,0.6944228042820274,1.0,4/17,17.96%,AKT3;PIK3R1;RICTOR;AKT1
gsea,Glycosaminoglycan Metabolism R-HSA-1630316,-0.20004397040621852,-0.8680423874965351,0.7244701348747592,0.6937251843661453,1.0,15/96,16.64%,CHST1;B4GALT6;B4GAT1;IDS;CHORDC1;CHST15;B3GALT6;CHST2;NDST4;DSEL;NDST1;BCAN;B4GALT2;CSGALNACT1;GPC1
gsea,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.272550938760548,-0.86702640488425,0.672,0.6948126390121099,1.0,9/22,31.97%,B4GALT6;CHGA;ST8SIA3;B4GALT2;FUT8;B4GALT4;FUCA1;MAN2A2;ST6GAL1
gsea,Signaling To RAS R-HSA-167044,0.29341030149855685,0.863378535503602,0.6421471172962226,0.9063406357224663,1.0,6/16,18.69%,SHC3;MAPK14;MAPKAPK2;SHC2;MAPK12;RALB
gsea,Keratinization R-HSA-6805567,-0.2703625306739427,-0.8587344751974055,0.6721915285451197,0.7092906896307214,1.0,13/24,44.32%,KRT10;KAZN;RCAN1;PPL;PKP2;CAPNS1;TCHH;EVPL;DSG2;KRT77;KRT1;FURIN;KLK8
gsea,Signaling By NTRK3 (TRKC) R-HSA-9034015,0.2872025579974324,0.852985043020997,0.6428571428571429,0.9134778975967278,1.0,3/16,3.49%,NTF3;PTPRS;NTRK3
gsea,Signaling By PDGF R-HSA-186797,-0.23405953531592574,-0.8520588194648444,0.6944971537001897,0.7203814885293874,1.0,11/39,33.25%,STAT3;PIK3R1;NCK1;PDGFA;HRAS;PTPN11;COL4A5;BCAR1;NRAS;COL6A1;PIK3CB
gsea,Resolution Of D-Loop Structures R-HSA-5693537,-0.2483449235346172,-0.8499601250506387,0.707089552238806,0.7233066905422452,1.0,10/29,39.16%,SEM1;BRCA2;RAD51D;TOP3A;MUS81;KAT5;XRCC2;SPIDR;RAD50;RBBP8
gsea,MET Activates PTK2 Signaling R-HSA-8874081,-0.2952018460742384,-0.8429180104582211,0.6900584795321637,0.735000366749626,1.0,4/15,26.09%,ITGA2;RNMT;PTK2;ITGB1
gsea,Metabolism Of Steroid Hormones R-HSA-196071,-0.2716322285538576,-0.8425475069181487,0.6779359430604982,0.7348385644919548,1.0,6/20,34.32%,CHGA;STARD4;HSD17B11;FDX2;SRD5A3;HSD3B2
gsea,Nucleotide Catabolism R-HSA-8956319,-0.24972350369589913,-0.8318090023713817,0.7378640776699029,0.7527592326145737,1.0,16/25,47.42%,ITPA;NUDT5;NT5C;SCO2;DPYD;NUDT15;NUDT18;NT5C1A;ENTPD5;NUDT16;ENTPD1;GDA;ENTPD3;NUDT1;ADPRM;SAMHD1
gsea,Glycosphingolipid Metabolism R-HSA-1660662,-0.2296923011905944,-0.8266593072983525,0.7403100775193798,0.7605697811894204,1.0,9/34,31.55%,ARSA;ARSJ;GBA2;UGCG;ASAH2;GLB1L;SMPD1;B3GALNT1;GLTP
gsea,RORA Activates Gene Expression R-HSA-1368082,-0.2829481575595737,-0.8254140113181708,0.748,0.7620081652398236,1.0,7/17,40.84%,CHD9;NCOA1;CREBBP;TBL1X;NCOA6;TBL1XR1;EP300
gsea,ECM Proteoglycans R-HSA-3000178,-0.22037796549167513,-0.8205263767072221,0.785140562248996,0.7693269919564429,1.0,4/40,9.06%,ITGA2;VTN;ITGA7;TGFB2
gsea,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.21289762229146766,-0.8135676889604693,0.7721774193548387,0.7796910187375918,1.0,11/43,26.06%,BSG;SLC39A3;SLC39A6;SLC30A6;SLC41A1;SLC30A1;SLC16A1;SLC39A7;SLC18A2;SLC22A5;SLC6A15
gsea,N-Glycan Antennae Elongation R-HSA-975577,0.2784509451422584,0.8098528403932836,0.7357723577235772,0.9879834194106699,1.0,1/15,0.31%,MGAT4C
gsea,Signaling By BMP R-HSA-201451,-0.2526542934620108,-0.808250931618893,0.7665995975855131,0.7872969409368497,1.0,7/20,25.03%,BMPR2;SMAD9;SMAD5;UBE2D1;SMAD1;SMAD7;SMAD4
gsea,Role Of Phospholipids In Phagocytosis R-HSA-2029485,-0.2558624901788191,-0.802963697788025,0.7408163265306122,0.7946683824402481,1.0,5/21,20.20%,AHCYL1;ITPR1;PIK3R1;PLA2G6;PLD3
gsea,Chondroitin Sulfate Biosynthesis R-HSA-2022870,-0.26826817790162916,-0.8022952990499448,0.7274509803921568,0.794833202807029,1.0,6/17,35.66%,CHST15;BCAN;CSGALNACT1;CHPF;CSPG5;CSGALNACT2
gsea,Activation Of SMO R-HSA-5635838,0.2795079004021828,0.7976415599626916,0.7372881355932204,0.9934869026779469,1.0,5/15,15.37%,BOC;CDON;EVC;EVC2;IQCE
gsea,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.23139596899706477,-0.7964353080454322,0.781431334622824,0.8030550198956061,1.0,12/32,39.68%,ATRIP;RFC3;TOP3A;RPA3;KAT5;ERCC1;RAD17;RFC2;RAD9A;RAD50;RBBP8;RAD9B
gsea,Activation Of Pre-Replicative Complex R-HSA-68962,-0.23431748400573113,-0.7767224727991386,0.8007518796992481,0.8308778266448349,1.0,10/26,38.94%,ORC4;MCM6;MCM3;POLE3;ORC6;RPA3;MCM8;ORC5;PRIM1;CDC7
gsea,Molecules Associated With Elastic Fibres R-HSA-2129379,0.24639495250220975,0.7756384544617375,0.8075313807531381,1.0,1.0,2/21,1.84%,ITGA8;LTBP4
gsea,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.21302036758006776,0.7719418137399422,0.8386454183266933,1.0,1.0,7/32,13.22%,TJP2;SATB1;TJP1;PRKCD;STK26;SPTAN1;CLSPN
gsea,Formation Of Cornified Envelope R-HSA-6809371,-0.2657688309118808,-0.7718561108626173,0.779783393501805,0.8367827207849386,1.0,8/17,35.84%,KAZN;RCAN1;PPL;PKP2;CAPNS1;TCHH;EVPL;DSG2
gsea,Nucleotide Salvage R-HSA-8956321,0.24248239853076192,0.7685635473800037,0.80625,0.9918385651605761,1.0,5/20,8.26%,UPP2;UPP1;DGUOK;UCK2;DCK
gsea,Acyl Chain Remodelling Of PE R-HSA-1482839,0.2619747064155281,0.7673280527189634,0.8046709129511678,0.9772418634854275,1.0,4/15,11.70%,PLA2G4E;PLA2G4A;PLA2G3;MBOAT1
gsea,GPVI-mediated Activation Cascade R-HSA-114604,0.22593409314661586,0.758426374641714,0.8245243128964059,0.9747298826520832,1.0,3/24,2.81%,PLCG2;VAV3;LCK
gsea,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,-0.24005425309841494,-0.7522095420603823,0.8235294117647058,0.8619312062728857,1.0,7/21,39.16%,BRCA2;RAD51D;TOP3A;KAT5;XRCC2;RAD50;RBBP8
gsea,Acyl Chain Remodelling Of PC R-HSA-1482788,0.2508388580976148,0.7451772216578224,0.8181818181818182,0.977474153536033,1.0,3/16,9.61%,PLA2G4E;PLA2G4A;PLA2G3
gsea,MET Promotes Cell Motility R-HSA-8875878,0.23094195033864745,0.7441393618041143,0.84,0.9633966059932306,1.0,4/24,9.07%,TNS3;LAMB1;ITGA3;LAMB3
gsea,Metabolism Of Porphyrins R-HSA-189445,-0.23833381060115777,-0.7402063465594153,0.8510204081632653,0.8754785749017818,1.0,7/20,34.53%,CPOX;COX15;HMOX2;HMBS;UROD;BLVRA;FECH
gsea,Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.2420901962026853,-0.7367067525898612,0.834307992202729,0.8786874338174047,1.0,8/18,44.21%,LARS2;YARS2;WARS2;PARS2;FARS2;EARS2;MARS2;PPA2
gsea,Other Semaphorin Interactions R-HSA-416700,0.23917259177283617,0.7297182120607143,0.8864541832669323,0.9662602937166838,1.0,4/19,11.19%,PLXNA4;SEMA3E;PLXNA2;SEMA6A
gsea,Elastic Fibre Formation R-HSA-1566948,0.21033230335444547,0.71059543462978,0.9156378600823045,0.9721913108447109,1.0,3/26,5.62%,ITGA8;LTBP4;FBN2
gsea,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.21294490530779442,0.7005454974908606,0.8891213389121339,0.9673980216761378,1.0,7/24,14.30%,PRX;LAMB1;SMARCA4;ADGRV1;DAG1;UTRN;DRP2
gsea,Interleukin-37 Signaling R-HSA-9008059,-0.23986938024544324,-0.6963714754692534,0.8786127167630058,0.9186034302713108,1.0,7/15,37.56%,TBK1;STAT3;PTPN11;SMAD3;PTPN4;PTPN18;PTPN13
gsea,Interferon Alpha/Beta Signaling R-HSA-909733,-0.21214898716491198,-0.6936058609625373,0.905123339658444,0.9201175629073682,1.0,9/26,32.90%,IRF3;EGR1;PTPN11;TYK2;IP6K2;PTPN1;IFITM3;KPNB1;KPNA1
gsea,Tight Junction Interactions R-HSA-420029,0.20947482397827677,0.615553144782879,0.9417879417879418,1.0,1.0,6/15,20.87%,PATJ;CLDN14;F11R;PARD6B;PARD6G;CLDN16
gsea,Synthesis Of PC R-HSA-1483191,0.19361979996257553,0.6143627548173644,0.950199203187251,0.99623931258381,1.0,1/22,0.74%,SLC44A5
gsea,Signaling By SCF-KIT R-HSA-1433557,-0.1748254655809901,-0.6020068988871471,0.9685658153241651,0.9742783750808097,1.0,4/30,19.60%,STAT3;PIK3R1;HRAS;PTPN11
gsea,Interleukin Receptor SHC Signaling R-HSA-912526,0.20365106577861442,0.5995364634771071,0.9384920634920635,0.9875877517227349,1.0,4/16,11.57%,IL5;INPP5D;GAB2;PIK3R3
gsea,Peroxisomal Lipid Metabolism R-HSA-390918,-0.16721886518497225,-0.5658013159702656,0.9865125240847784,0.9845155898725457,1.0,8/26,37.54%,ACOX1;NUDT19;ACOT8;SLC25A17;ABCD1;CROT;EHHADH;PHYH
gsea,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,0.17572038741502743,0.554904021800568,0.99,0.9865312348113345,1.0,19/19,82.45%,ALG12;ALG8;ALG9;RFT1;GLB1;DPAGT1;MAN1B1;ALG6;MPDU1;ALG14;B4GALT1;EGFL7;ALG1;ALG3;CTSA;ALG11;MOGS;ALG2;ALG13
gsea,Kinesins R-HSA-983189,-0.15073302316310302,-0.5239484744936528,0.991701244813278,0.9918738761438994,1.0,5/32,23.49%,KIF5B;KIFAP3;KIF21A;KIF15;KIF5C
